Atorvastatin Hemicalcium
| Title | Journal |
|---|---|
| The enhancement of cardiotoxicity that results from inhibiton of CYP 3A4 activity and hERG channel by berberine in combination with statins. | Chemico-biological interactions 20180925 |
| Establishment of a drug-induced rhabdomyolysis mouse model by co-administration of ciprofloxacin and atorvastatin. | Toxicology letters 20180701 |
| Atorvastatin induces MicroRNA-145 expression in HEPG2 cells via regulation of the PI3K/AKT signalling pathway. | Chemico-biological interactions 20180501 |
| Rosuvastatin safety: An experimental study of myotoxic effects and mitochondrial alterations in rats. | Toxicology letters 20170104 |
| Atorvastatin protected from paraquat-induced cytotoxicity in alveolar macrophages via down-regulation of TLR-4. | Environmental toxicology and pharmacology 20170101 |
| Statin-induced myotoxicity is exacerbated by aging: A biophysical and molecular biology study in rats treated with atorvastatin. | Toxicology and applied pharmacology 20160901 |
| Elucidation of the mechanism of atorvastatin-induced myopathy in a rat model. | Toxicology 20160601 |
| Involvement of pregnane X receptor in the impaired glucose utilization induced by atorvastatin in hepatocytes. | Biochemical pharmacology 20160115 |
| Anacetrapib lowers LDL by increasing ApoB clearance in mildly hypercholesterolemic subjects. | The Journal of clinical investigation 20150601 |
| Atorvastatin induces bile acid-synthetic enzyme Cyp7a1 by suppressing FXR signaling in both liver and intestine in mice. | Journal of lipid research 20141201 |
| Atorvastatin ameliorates arsenic-induced hypertension and enhancement of vascular redox signaling in rats. | Toxicology and applied pharmacology 20141101 |
| Atorvastatin restores arsenic-induced vascular dysfunction in rats: modulation of nitric oxide signaling and inflammatory mediators. | Toxicology and applied pharmacology 20141001 |
| Statins alter the hepatobiliary transport of unconjugated and conjugated bilirubin in sandwich-cultured rat hepatocytes. | Toxicology in vitro : an international journal published in association with BIBRA 20140901 |
| [Atorvastatin inhibits cardiomyocyte apoptosis via down-cegulation the expression mitofusin 2 after myocardial ischemia/reperfusion injury in rats]. | Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology 20140401 |
| Effects of serum lipoproteins on cyclosporine A cellular uptake and renal toxicity in vitro. | Canadian journal of physiology and pharmacology 20140201 |
| Chemically induced mouse liver tumors are resistant to treatment with atorvastatin. | BMC cancer 20140101 |
| Antifibrotic effect of atorvastatin on paraquat-induced pulmonary fibrosis: role of PPARγ receptors. | European journal of pharmacology 20131115 |
| Elucidation of the biochemical basis for a clinical drug-drug interaction between atorvastatin and 5-(N-(4-((4-ethylbenzyl)thio)phenyl)sulfamoyl)-2-methyl benzoic acid (CP-778875), a subtype selective agonist of the peroxisome proliferator-activated receptor alpha. | Xenobiotica; the fate of foreign compounds in biological systems 20131101 |
| Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice. | The Journal of nutritional biochemistry 20130801 |
| Genetic variation in the ABCC2 gene is associated with dose decreases or switches to other cholesterol-lowering drugs during simvastatin and atorvastatin therapy. | The pharmacogenomics journal 20130601 |
| The influence of oral antidiabetic drugs on cellular drug uptake mediated by hepatic OATP family members. | Basic & clinical pharmacology & toxicology 20130401 |
| Treatment with low-dose atorvastatin, losartan, and their combination increases expression of vasoactive-related genes in rat aortas. | Journal of cardiovascular pharmacology and therapeutics 20130301 |
| Effects of simvastatin, atorvastatin, ezetimibe, and ezetimibe + simvastatin combination on the inflammatory process and on the liver metabolic changes of arthritic rats. | Fundamental & clinical pharmacology 20121201 |
| Atorvastatin suppresses oxidized LDL-induced dendritic cell-like differentiation of RAW264.7 cells regulated by the p38 MAPK pathway. | Molecular and cellular biochemistry 20121201 |
| Statins have therapeutic potential for the treatment of Alzheimer's disease, likely via protection of the neurovascular unit in the AD brain. | Journal of the neurological sciences 20121115 |
| Disposition of atorvastatin, rosuvastatin, and simvastatin in oatp1b2-/- mice and intraindividual variability in human subjects. | Journal of clinical pharmacology 20121101 |
| Simultaneous determination of atorvastatin and niacin in human plasma by LC-MS/MS and its application to a human pharmacokinetic study. | Biomedical chromatography : BMC 20121101 |
| Early statin treatment prior to primary PCI for acute myocardial infarction: REPERATOR, a randomized placebo-controlled pilot trial. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20121101 |
| Statin use and the risk of Clostridium difficile in academic medical centres. | Gut 20121101 |
| Atorvastatin added to interferon β for relapsing multiple sclerosis: a randomized controlled trial. | Journal of neurology 20121101 |
| Anticancer effect of atorvastatin nanostructured polymeric micelles based on stearyl-grafted chitosan. | International journal of biological macromolecules 20121101 |
| The effects of atorvastatin therapy on rheological characteristics of erythrocyte membrane, serum lipid profile and oxidative status in patients with dyslipidemia. | The Journal of membrane biology 20121101 |
| Atorvastatin reduces serum cholesterol and triglycerides with limited improvement in vascular function in adults with sickle cell anemia. | Haematologica 20121101 |
| Genetic variation in MDR1, LPL and eNOS genes and the response to atorvastatin treatment in ischemic stroke. | Human genetics 20121101 |
| Spectroscopic characterization and quantitative determination of atorvastatin calcium impurities by novel HPLC method. | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20121101 |
| Interaction between SNPs in the RXRA and near ANGPTL3 gene region inhibits apoB reduction after statin-fenofibric acid therapy in individuals with mixed dyslipidemia. | Journal of lipid research 20121101 |
| The involvement of nitric oxide in the anti-seizure effect of acute atorvastatin treatment in mice. | Neurological research 20121101 |
| Effect of fenofibrate and atorvastatin on VLDL apoE metabolism in men with the metabolic syndrome. | Journal of lipid research 20121101 |
| Drug-drug interaction study to assess the effects of atorvastatin co-administration on pharmacokinetics and anti-thrombotic properties of cilostazol in male Wistar rats. | Biopharmaceutics & drug disposition 20121101 |
| Relationship between atorvastatin dose and the harm caused by torcetrapib. | Journal of lipid research 20121101 |
| Effects of 90-day hypolipidemic treatment on insulin resistance, adipokines and proinflammatory cytokines in patients with mixed hyperlipidemia and impaired fasting glucose. | International journal of clinical pharmacology and therapeutics 20121101 |
| Atorvastatin delays murine platelet activation in vivo even in the absence of endothelial NO synthase. | Arteriosclerosis, thrombosis, and vascular biology 20121101 |
| Effect of multidose cilostazol on pharmacokinetic and lipid profile of atorvastatin in male Wistar rats. | The Journal of pharmacy and pharmacology 20121101 |
| Comparison of cardioprotective efficacy resulting from a combination of atorvastatin and ischaemic post-conditioning in diabetic and non-diabetic rats. | Clinical and experimental pharmacology & physiology 20121101 |
| Atorvastatin delays progression of pancreatic lesions to carcinoma by regulating PI3/AKT signaling in p48Cre/+ LSL-KrasG12D/+ mice. | International journal of cancer 20121015 |
| Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: a possible compensatory mechanism. | Nutrition, metabolism, and cardiovascular diseases : NMCD 20121001 |
| The effects of triple vs. dual and monotherapy with rosiglitazone, glimepiride, and atorvastatin on lipid profile and glycemic control in type 2 diabetes mellitus rats. | Fundamental & clinical pharmacology 20121001 |
| Low-dose atorvastatin reduces ambulatory blood pressure in patients with mild hypertension and hypercholesterolaemia: a double-blind, randomized, placebo-controlled study. | Journal of human hypertension 20121001 |
| Effects of atorvastatin on cerebral blood flow in middle-aged adults at risk for Alzheimer's disease: a pilot study. | Current Alzheimer research 20121001 |
| Atorvastatin inhibits the inflammatory response caused by anti-M(3) peptide IgG in patients with primary Sjögren's syndrome. | Inflammopharmacology 20121001 |
| Atorvastatin and pitavastatin enhance lipoprotein lipase production in L6 skeletal muscle cells through activation of adenosine monophosphate-activated protein kinase. | Metabolism: clinical and experimental 20121001 |
| Atorvastatin up-regulate toxicologically relevant genes in rainbow trout gills. | Ecotoxicology (London, England) 20121001 |
| Genetic predisposition to atorvastatin-induced myopathy: a case report. | Journal of clinical pharmacy and therapeutics 20121001 |
| Disproportionation of the calcium salt of atorvastatin in the presence of acidic excipients. | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20121001 |
| Atorvastatin inhibits proliferation and apoptosis, but induces senescence in hepatic myofibroblasts and thereby attenuates hepatic fibrosis in rats. | Laboratory investigation; a journal of technical methods and pathology 20121001 |
| Long-term effects of ezetimibe-plus-statin therapy on low-density lipoprotein cholesterol levels as compared with double-dose statin therapy in patients with coronary artery disease. | Atherosclerosis 20121001 |
| Association of cholesteryl ester transfer protein mass with peripheral leukocyte count following statin therapy: a pilot study. | American journal of cardiovascular drugs : drugs, devices, and other interventions 20121001 |
| Effect of intensive atorvastatin therapy on coronary atherosclerosis progression, composition, arterial remodeling, and microvascular function. | The Journal of invasive cardiology 20121001 |
| Chemoprevention of mouse lung and colon tumors by suberoylanilide hydroxamic acid and atorvastatin. | International journal of cancer 20120915 |
| Immunomodulatory synergy by combining atorvastatin and rapamycin in the treatment of experimental autoimmune encephalomyelitis (EAE). | Journal of neuroimmunology 20120915 |
| Atorvastatin and whisker stimulation synergistically enhance angiogenesis in the barrel cortex of rats following focal ischemia. | Neuroscience letters 20120913 |
| Effects of preoperative short term use of atorvastatin on endothelial progenitor cells after coronary surgery: a randomized, controlled trial. | Stem cell reviews 20120901 |
| Statin-dependent activation of protein kinase Cδ in acute promyelocytic leukemia cells and induction of leukemic cell differentiation. | Leukemia & lymphoma 20120901 |
| Accelerated platelet inhibition by switching from atorvastatin to a non-CYP3A4-metabolized statin in patients with high platelet reactivity (ACCEL-STATIN) study. | European heart journal 20120901 |
| Effect of intensive lipid-lowering therapy on cardiovascular outcome in patients with and those without inflammatory joint disease. | Arthritis and rheumatism 20120901 |
| Atorvastatin improves sodium handling and decreases blood pressure in salt-loaded rats with chronic renal insufficiency. | Nutrition (Burbank, Los Angeles County, Calif.) 20120901 |
| Comparison of the effects of different statins and doses on lipid levels in patients with diabetes: results from VOYAGER. | Nutrition, metabolism, and cardiovascular diseases : NMCD 20120901 |
| Selective induction of apoptosis by HMG-CoA reductase inhibitors in hepatoma cells and dependence on p53 expression. | Oncology reports 20120901 |
| Diabetes mellitus reduces the clearance of atorvastatin lactone: results of a population pharmacokinetic analysis in renal transplant recipients and in vitro studies using human liver microsomes. | Clinical pharmacokinetics 20120901 |
| Relation of improvement in glomerular filtration rate with atorvastatin to reductions in heart failure morbidity. | The American journal of cardiology 20120901 |
| Atorvastatin prevents dehydromonocrotaline-induced pulmonary hypertension in beagles. | Experimental lung research 20120901 |
| Mitochondria of trained skeletal muscle are protected from deleterious effects of statins. | Muscle & nerve 20120901 |
| Efficacy of atorvastatin and antihistamines in comparison with antihistamines plus placebo in the treatment of chronic idiopathic urticaria: a controlled clinical trial. | Iranian journal of allergy, asthma, and immunology 20120901 |
| Vitamin D levels do not predict cardiovascular events in statin-treated patients with stable coronary disease. | American heart journal 20120901 |
| Modeling of the LDL cholesterol-lowering effect of atorvastatin in Korean dyslipidemic patients and non-patient volunteers. | International journal of clinical pharmacology and therapeutics 20120901 |
| Neuroprotective potential of atorvastatin and simvastatin (HMG-CoA reductase inhibitors) against 6-hydroxydopamine (6-OHDA) induced Parkinson-like symptoms. | Brain research 20120830 |
| Effects of atorvastatin in the regulation of circulating EPCs and angiogenesis in traumatic brain injury in rats. | Journal of the neurological sciences 20120815 |
| Atorvastatin preserves the integrity of endothelial adherens junctions by inhibiting vascular endothelial cadherin tyrosine phosphorylation. | Experimental cell research 20120815 |
| Effects of atorvastatin on carotid intima media thickness: a meta-analysis of randomized controlled trials. | International journal of cardiology 20120809 |
| High-dose atorvastatin enhances impaired cerebral vasomotor reactivity. | Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 20120801 |
| Effects of atorvastatin on apelin, visfatin (nampt), ghrelin and early carotid atherosclerosis in patients with type 2 diabetes. | Acta diabetologica 20120801 |
| Atorvastatin treatment in a dog preclinical model of Alzheimer's disease leads to up-regulation of haem oxygenase-1 and is associated with reduced oxidative stress in brain. | The international journal of neuropsychopharmacology 20120801 |
| Drug interaction profile for GSK2248761, a next generation non-nucleoside reverse transcriptase inhibitor. | British journal of clinical pharmacology 20120801 |
| MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression. | Clinical science (London, England : 1979) 20120801 |
| Effects of Ginkgo biloba extracts on pharmacokinetics and efficacy of atorvastatin based on plasma indices. | Xenobiotica; the fate of foreign compounds in biological systems 20120801 |
| Pravastatin and simvastatin improves acetylsalicylic acid-mediated in vitro blood platelet inhibition. | European journal of clinical investigation 20120801 |
| Atorvastatin protects obese mice against hepatic ischemia-reperfusion injury by Toll-like receptor-4 suppression and endothelial nitric oxide synthase activation. | Journal of gastroenterology and hepatology 20120801 |
| Elevated concentration of placental growth factor (PlGF) and long term risk in patients with acute coronary syndrome in the PROVE IT-TIMI 22 trial. | Journal of thrombosis and thrombolysis 20120801 |
| Atorvastatin prevents the downregulation of aquaporin-2 receptor after bilateral ureteral obstruction and protects renal function in a rat model. | Urology 20120801 |
| Fate and transport of atorvastatin and simvastatin drugs during conventional wastewater treatment. | Chemosphere 20120801 |
| The UGT1A3*2 polymorphism affects atorvastatin lactonization and lipid-lowering effect in healthy volunteers. | Pharmacogenetics and genomics 20120801 |
| Protective effects of atorvastatin against oxidized LDL-induced downregulation of KLF expression in EA.hy926 cells. | International journal of molecular medicine 20120801 |
| Plasma pentraxin-3 levels are associated with coronary plaque vulnerability and are decreased by statin. | Coronary artery disease 20120801 |
| Study design, rationale, and baseline characteristics: evaluation of fenofibric acid on carotid intima-media thickness in patients with type IIb dyslipidemia with residual risk in addition to atorvastatin therapy (FIRST) trial. | Cardiovascular drugs and therapy 20120801 |
| Polymer-directed crystallization of atorvastatin. | Journal of pharmaceutical sciences 20120801 |
| Coenzyme Q10 reverses mitochondrial dysfunction in atorvastatin-treated mice and increases exercise endurance. | Journal of applied physiology (Bethesda, Md. : 1985) 20120801 |
| Deleterious effects of high concentrations of (-)-epigallocatechin-3-gallate and atorvastatin in mice with colon inflammation. | Nutrition and cancer 20120801 |
| Highly upregulated expression of CD36 and MSR1 in circulating monocytes of patients with acute coronary syndromes. | The protein journal 20120801 |
| Regression of inflammation in atherosclerosis by the LXR agonist R211945: a noninvasive assessment and comparison with atorvastatin. | JACC. Cardiovascular imaging 20120801 |
| Statin-induced rhabdomyolysis and dermatomyositis: a rare combination. | JAAPA : official journal of the American Academy of Physician Assistants 20120801 |
| Atorvastatin does not impair endothelial cell wound healing in an in vitro model of vascular injury. | Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20120801 |
| Synergistic inhibition of interleukin-6 production in adipose stem cells by tart cherry anthocyanins and atorvastatin. | Phytomedicine : international journal of phytotherapy and phytopharmacology 20120715 |
| Low-density lipoprotein-independent improvement of flow-mediated dilatation with atorvastatin: a meta-analysis and meta-regression of randomized controlled trials. | International journal of cardiology 20120712 |
| [Effects of atorvastatin and CoQ(10) on myocardial energy metabolism in rabbits with hypercholesterolemia]. | Zhonghua yi xue za zhi 20120710 |
| Immediate antioxidant and antiplatelet effect of atorvastatin via inhibition of Nox2. | Circulation 20120703 |
| Prospective, randomized, single-blind comparison of effects of 6 months' treatment with atorvastatin versus pravastatin on leptin and angiogenic factors in patients with coronary artery disease. | Heart and vessels 20120701 |
| Long-term impact of multifactorial treatment on new-onset diabetes and related cardiovascular events in metabolic syndrome: a post hoc ATTEMPT analysis. | Angiology 20120701 |
| Self-microemulsifying smaller molecular volume oil (Capmul MCM) using non-ionic surfactants: a delivery system for poorly water-soluble drug. | Drug development and industrial pharmacy 20120701 |
| Lipoprotein-associated phospholipase A2 and outcome in patients with type 2 diabetes on haemodialysis. | European journal of clinical investigation 20120701 |
| Atorvastatin in pulmonary arterial hypertension (APATH) study. | The European respiratory journal 20120701 |
| The effect of a high dose of atorvastatin on the occurrence of atrial fibrillation after coronary artery bypass grafting. | The Annals of thoracic surgery 20120701 |
| Statin therapy prevents expansive remodeling in venous bypass grafts. | Atherosclerosis 20120701 |
| Atorvastatin inhibits myocardin expression in vascular smooth muscle cells. | Hypertension (Dallas, Tex. : 1979) 20120701 |
| Atorvastatin enhances neurite outgrowth in cortical neurons in vitro via up-regulating the Akt/mTOR and Akt/GSK-3β signaling pathways. | Acta pharmacologica Sinica 20120701 |
| Non-every day statin administration--a literature review. | European journal of internal medicine 20120701 |
| Effect of phosphatidylinositol 3-kinase-γ inhibitor CAY10505 in hypertension, and its associated vascular endothelium dysfunction in rats. | Canadian journal of physiology and pharmacology 20120701 |
| Atorvastatin and pitavastatin reduce senile plaques and inflammatory responses in a mouse model of Alzheimer's disease. | Neurological research 20120701 |
| Invited commentary. | The Annals of thoracic surgery 20120701 |
| Cholesterol level goal attainment with statins: clinical management guideline recommendations versus management in actual clinical practice. | Pharmacotherapy 20120701 |
| What price atorvastatin? | Drug and therapeutics bulletin 20120701 |
| Combined effect of atorvastatin and probucol on plasma cystatin C levels and severity of coronary lesion in patients with borderline coronary lesion. | Chinese medical journal 20120701 |
| [Roles of periostin in proliferation and migration of vascular smooth muscle cells and the effect of atorvastatin on them]. | Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20120701 |
| [Atorvastatin inhibits the H₂O₂-induced apoptosis of human vascular endothelial cells through a down-regulation of cleaved caspase-9/caspase-3]. | Zhonghua yi xue za zhi 20120626 |
| Safety and efficacy of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease, SAR236553/REGN727, in patients with primary hypercholesterolemia receiving ongoing stable atorvastatin therapy. | Journal of the American College of Cardiology 20120619 |
| PCSK9 inhibition: the next statin? | Journal of the American College of Cardiology 20120619 |
| Lipitor goes generic: business as usual or more big business? | Annals of internal medicine 20120619 |
| Comparison of effects of atorvastatin (20 mg) versus rosuvastatin (10 mg) therapy on mild coronary atherosclerotic plaques (from the ARTMAP trial). | The American journal of cardiology 20120615 |
| Relation of improvement in estimated glomerular filtration rate with atorvastatin to reductions in hospitalizations for heart failure (from the Treating to New Targets [TNT] study). | The American journal of cardiology 20120615 |
| Cytotoxic effects of combination of oxidosqualene cyclase inhibitors with atorvastatin in human cancer cells. | Journal of medicinal chemistry 20120614 |
| Cholesterol metabolism differs after statin therapy according to the type of hyperlipemia. | Life sciences 20120606 |
| Differential effect of the rs4149056 variant in SLCO1B1 on myopathy associated with simvastatin and atorvastatin. | The pharmacogenomics journal 20120601 |
| Prescribing high-dose lipid-lowering therapy early to avoid subsequent cardiovascular events: is this a cost-effective strategy? | European journal of preventive cardiology 20120601 |
| Low-density lipoprotein cholesterol and high-sensitivity C-reactive protein lowering with atorvastatin in patients of South Asian compared with European origin: insights from the Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAST) study. | Journal of clinical pharmacology 20120601 |
| Opposite effects of statins on mitochondria of cardiac and skeletal muscles: a 'mitohormesis' mechanism involving reactive oxygen species and PGC-1. | European heart journal 20120601 |
| Effect of atorvastatin on the cortical bones of corticosteroid treated rabbits. | Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20120601 |
| Myocardial infarction in an young patient associated with oral contraceptive, smoking and elevated cholesterol level. | Archives of gynecology and obstetrics 20120601 |
| Effect of atorvastatin on erectile functions in comparison with regular tadalafil use. A prospective single-blind study. | International urology and nephrology 20120601 |
| Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20120601 |
| Atorvastatin attenuates TNF-α-induced increase of glucose oxidation through PGC-1α upregulation in cardiomyocytes. | Journal of cardiovascular pharmacology 20120601 |
| Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis. | Cardiovascular research 20120601 |
| Effects of atorvastatin on plasma fibrin clot properties in apparently healthy individuals and patients with previous venous thromboembolism. | Thrombosis and haemostasis 20120601 |
| Anti-inflammatory effects of perioperative statin therapy. | Canadian journal of anaesthesia = Journal canadien d'anesthesie 20120601 |
| Perioperative statin therapy: understanding the evidence in a Bayesian context. | Canadian journal of anaesthesia = Journal canadien d'anesthesie 20120601 |
| If steatosis is the atherosclerosis of the liver, are statins the 'aspirin' for steatosis? | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20120601 |
| Nitric oxide-donating statins: a new concept to boost the lipid-independent effects. | Cardiovascular research 20120601 |
| Statins synergize dexamethasone-induced adipocyte fatty acid binding protein expression in macrophages. | Atherosclerosis 20120601 |
| PPARA: a novel genetic determinant of CYP3A4 in vitro and in vivo. | Clinical pharmacology and therapeutics 20120601 |
| STAR VaS--Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo-controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery. | Canadian journal of anaesthesia = Journal canadien d'anesthesie 20120601 |
| Pharmacokinetic evaluation of atorvastatin and sitagliptin in combination for the treatment of type 2 diabetes. | Expert opinion on drug metabolism & toxicology 20120601 |
| A review of time courses and predictors of lipid changes with fenofibric acid-statin combination. | Cardiovascular drugs and therapy 20120601 |
| Atorvastatin treatment improves diabetic polyneuropathy electrophysiological changes in non-insulin dependent diabetic patients: a double blind, randomized clinical trial. | Minerva endocrinologica 20120601 |
| Polymorphisms in the mitochondrial ribosome recycling factor EF-G2mt/MEF2 compromise cell respiratory function and increase atorvastatin toxicity. | PLoS genetics 20120601 |
| The evaluation of analgesic effects of simvastatin, pravastatin and atorvastatin in hot plate test. | European review for medical and pharmacological sciences 20120601 |
| Single high dose atorvastatin does not ameliorate endothelial function and large arterial stiffness in dyslipidemic patients without atherosclerosis. | European review for medical and pharmacological sciences 20120601 |
| Atorvastatin therapy reduces serum uric acid levels: a meta-analysis of randomized controlled trials. | International journal of cardiology 20120531 |
| Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. | Journal of medicinal chemistry 20120524 |
| Autophagy activation: a novel mechanism of atorvastatin to protect mesenchymal stem cells from hypoxia and serum deprivation via AMP-activated protein kinase/mammalian target of rapamycin pathway. | Stem cells and development 20120520 |
| Atorvastatin reduces coronary plaque volume in dependence on reductions in low-density lipoprotein: a meta-analysis and meta-regression of randomized controlled trials. | International journal of cardiology 20120517 |
| Plasma PCSK9 levels and clinical outcomes in the TNT (Treating to New Targets) trial: a nested case-control study. | Journal of the American College of Cardiology 20120515 |
| Pfizer Australia faces scrutiny over atorvastatin advertising campaign. | BMJ (Clinical research ed.) 20120515 |
| Inhibition of hepatic uptake transporters by flavonoids. | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20120512 |
| Atorvastatin synergizes with IFN-γ in treating human non-small cell lung carcinomas via potent inhibition of RhoA activity. | European journal of pharmacology 20120505 |
| Systemic exposure to atorvastatin between Asian and Caucasian subjects: a combined analysis of 22 studies. | American journal of therapeutics 20120501 |
| Estimation of financial burden due to oversupply of medications for chronic diseases. | Asia-Pacific journal of public health 20120501 |
| Expression of let-7i is associated with Toll-like receptor 4 signal in coronary artery disease: effect of statins on let-7i and Toll-like receptor 4 signal. | Immunobiology 20120501 |
| Small unruptured partially thrombosed aneurysms and stroke: report of three cases and review of the literature. | Journal of neurointerventional surgery 20120501 |
| Rhabdomyolysis precipitated by a sitagliptin-atorvastatin drug interaction. | Diabetic medicine : a journal of the British Diabetic Association 20120501 |
| Use of atorvastatin to inhibit hypoxia-induced myocardin expression. | European journal of clinical investigation 20120501 |
| Effects of rosuvastatin and atorvastatin on glycaemic control in Type 2 diabetes---the CORALL study. | Diabetic medicine : a journal of the British Diabetic Association 20120501 |
| Influence of atorvastatin on the pharmacodynamic and pharmacokinetic activity of repaglinide in rats and rabbits. | Molecular and cellular biochemistry 20120501 |
| Co-administration of statins with cytochrome P450 3A4 inhibitors in a UK primary care population. | Pharmacoepidemiology and drug safety 20120501 |
| Atorvastatin sensitizes human non-small cell lung carcinomas to carboplatin via suppression of AKT activation and upregulation of TIMP-1. | The international journal of biochemistry & cell biology 20120501 |
| Comparison of lipid-modifying efficacy of rosuvastatin versus atorvastatin in patients with acute coronary syndrome (from the LUNAR study). | The American journal of cardiology 20120501 |
| Genome-wide association study of genetic determinants of LDL-c response to atorvastatin therapy: importance of Lp(a). | Journal of lipid research 20120501 |
| Immediate administration of atorvastatin decreased the serum MMP-2 level and improved the prognosis for acute heart failure. | Journal of cardiology 20120501 |
| Statins and glycaemic control--a cause for concern? | Diabetic medicine : a journal of the British Diabetic Association 20120501 |
| Intensive statin therapy for Chinese patients with coronary artery disease undergoing percutaneous coronary intervention (ISCAP study): rationale and design. | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 20120501 |
| Lysophosphatidic acid pretreatment prevents micromolar atorvastatin-induced endothelial cell death and ensures the beneficial effects of high-concentration statin therapy on endothelial gene expression. | Annals of vascular surgery 20120501 |
| Comparison of alternate-day atorvastatin treatment to daily treatment in maintaining LDL-cholesterol targets in patients with variable coronary risk profile. | Journal of cardiovascular pharmacology 20120501 |
| Determinants of residual risk in secondary prevention patients treated with high- versus low-dose statin therapy: the Treating to New Targets (TNT) study. | Circulation 20120424 |
| Reducing residual risk in secondary prevention of cardiovascular disease. | Circulation 20120424 |
| [In addition to atorvastatin. Innovative antibody lowers LDL around 72%]. | MMW Fortschritte der Medizin 20120419 |
| Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study. | Neurology 20120410 |
| Proteomic analysis of endothelial lipid rafts reveals a novel role of statins in antioxidation. | Journal of proteome research 20120406 |
| Meta-analysis of the comparative efficacy and safety of pitavastatin and atorvastatin in patients with dyslipidaemia. | Journal of clinical pharmacy and therapeutics 20120401 |
| Statins lower calcium-induced oxidative stress in isolated mitochondria. | Human & experimental toxicology 20120401 |
| Proinflammatory cytokine levels in hyperlipidemic patients with periodontitis after periodontal treatment. | Oral diseases 20120401 |
| Chronic administration of atorvastatin induced anti-convulsant effects in mice: the role of nitric oxide. | Epilepsy & behavior : E&B 20120401 |
| Targeting HDL-cholesterol to reduce residual cardiovascular risk. | Current opinion in lipidology 20120401 |
| Effective prevention of cardiovascular disease and diabetes-related events with atorvastatin in Japanese elderly patients with type 2 diabetes mellitus: adjusting for treatment changes using a marginal structural proportional hazards model and a rank-preserving structural failure time model. | Geriatrics & gerontology international 20120401 |
| Improvement of arterial stiffness by reducing oxidative stress damage in elderly hypertensive patients after 6 months of atorvastatin therapy. | Journal of clinical hypertension (Greenwich, Conn.) 20120401 |
| Reversible dysphasia and statins. | Journal of Korean medical science 20120401 |
| The effect of herb-partition moxibustion on Toll-like receptor 4 in rabbit aorta during atherosclerosis. | Journal of acupuncture and meridian studies 20120401 |
| Long-term outcome after statin treatment in routine clinical practice: results from a prospective PCI cohort study. | EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 20120401 |
| Ambivalent effects of atorvastatin on angiogenesis, epidermal cell proliferation and tumorgenesis in animal models. | Iranian biomedical journal 20120401 |
| Solid-state NMR studies of form I of atorvastatin calcium. | The journal of physical chemistry. B 20120322 |
| Effect of a monoclonal antibody to PCSK9 on LDL cholesterol. | The New England journal of medicine 20120322 |
| Protective effect of atorvastatin on bone tissue in orchidectomised male albino Wistar rats. | European journal of pharmacology 20120315 |
| Atorvastatin, not rosuvastatin, improves cardiac function in heart failure: a meta-analysis of randomized trials. | International journal of cardiology 20120308 |
| Effect of atorvastatin monotherapy and low-dose atorvastatin/ezetimibe combination on fasting and postprandial triglycerides in combined hyperlipedemia. | Journal of cardiovascular pharmacology and therapeutics 20120301 |
| Effect of HMGCR variant alleles on low-density lipoprotein cholesterol-lowering response to atorvastatin in healthy Korean subjects. | Journal of clinical pharmacology 20120301 |
| Effects of atorvastatin metabolites on induction of drug-metabolizing enzymes and membrane transporters through human pregnane X receptor. | British journal of pharmacology 20120301 |
| SLCO1B1 haplotypes are not associated with atorvastatin-induced myalgia in Brazilian patients with familial hypercholesterolemia. | European journal of clinical pharmacology 20120301 |
| Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr(-/-) mice. | Annals of the rheumatic diseases 20120301 |
| Statins exhibit anticancer effects through modifications of the pAkt signaling pathway. | International journal of oncology 20120301 |
| Rationale and design of a trial on the effect of high dose statins on cardiovascular risk in adults after successful coarctation repair. | Contemporary clinical trials 20120301 |
| The effects of 3-month atorvastatin therapy on arterial inflammation, calcification, abdominal adipose tissue and circulating biomarkers. | European journal of nuclear medicine and molecular imaging 20120301 |
| Pilot double-blind, randomized controlled trial of short-term atorvastatin for prevention of acute kidney injury after cardiac surgery. | Nephrology (Carlton, Vic.) 20120301 |
| Atorvastatin inhibits collar-induced intimal thickening of rat carotid artery: effect on C-type natriuretic peptide expression. | Molecular medicine reports 20120301 |
| Monitoring anti-inflammatory therapies in patients with atherosclerosis: FDG PET emerges as the method of choice. | European journal of nuclear medicine and molecular imaging 20120301 |
| Statin use in COPD patients is associated with a reduction in mortality: a national cohort study. | Primary care respiratory journal : journal of the General Practice Airways Group 20120301 |
| Postoperative adhesion prevention using a statin-containing cellulose film in an experimental model. | The British journal of surgery 20120301 |
| Functionality of postprandial larger HDL2 particles is enhanced following CETP inhibition therapy. | Atherosclerosis 20120301 |
| Alternate-day versus daily atorvastatin in coronary artery disease: a randomized study. | Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 20120301 |
| Development and characterization of self-nanoemulsifying drug delivery systems (SNEDDS) of atorvastatin calcium. | Current drug delivery 20120301 |
| Postoperative adhesion prevention using a statin-containing cellulose film in an experimental model (Br J Surg 2012; 99: 423-429). | The British journal of surgery 20120301 |
| Statins for COPD: a challenge to conventional beliefs? | Primary care respiratory journal : journal of the General Practice Airways Group 20120301 |
| Asymptomatic individuals with a positive family history for premature coronary artery disease and elevated coronary calcium scores benefit from statin treatment: a post hoc analysis from the St. Francis Heart Study. | JACC. Cardiovascular imaging 20120301 |
| Statin therapy for subclinical atherosclerosis in primary prevention: time to prove it? | JACC. Cardiovascular imaging 20120301 |
| [Protective effect of atrovastatin against myocardial ischemia-reperfusion injury and on liver and kidney functions in aged rats]. | Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20120301 |
| Tendinous xanthoma. | The Journal of the Association of Physicians of India 20120301 |
| [Pharmacokinetics and bioequivalence of atorvastatin calcium tablets in healthy male Chinese volunteers]. | Zhonghua xin xue guan bing za zhi 20120301 |
| Identification of pharmacogenetic predictors of lipid-lowering response to atorvastatin in Chilean subjects with hypercholesterolemia. | Clinica chimica acta; international journal of clinical chemistry 20120218 |
| Probucol and atorvastatin in combination protect rat brains in MCAO model: upregulating Peroxiredoxin2, Foxo3a and Nrf2 expression. | Neuroscience letters 20120216 |
| Effect of atorvastatin with or without prednisolone on Freund's adjuvant induced-arthritis in rats. | European journal of pharmacology 20120215 |
| Phospholipase A2 enzymes, high-dose atorvastatin, and prediction of ischemic events after acute coronary syndromes. | Circulation 20120214 |
| Impact of out-of-pocket expenses on discontinuation of statin therapy: a cohort study in Finland. | Journal of clinical pharmacy and therapeutics 20120201 |
| Atorvastatin activates heme oxygenase-1 at the stress response elements. | Journal of cellular and molecular medicine 20120201 |
| Evaluation of C-reactive protein prior to and on-treatment as a predictor of benefit from atorvastatin: observations from the Anglo-Scandinavian Cardiac Outcomes Trial. | European heart journal 20120201 |
| In vitro and in silico strategies to identify OATP1B1 inhibitors and predict clinical drug-drug interactions. | Pharmaceutical research 20120201 |
| Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing. | Journal of hepatology 20120201 |
| Creating controversy where none exists: the important role of C-reactive protein in the CARE, AFCAPS/TexCAPS, PROVE IT, REVERSAL, A to Z, JUPITER, HEART PROTECTION, and ASCOT trials. | European heart journal 20120201 |
| Atorvastatin for prevention of atrial fibrillation recurrence following pulmonary vein isolation: a double-blind, placebo-controlled, randomized trial. | Heart rhythm 20120201 |
| Atorvastatin decreases computed tomography and S100-assessed brain ischemia after subarachnoid aneurysmal hemorrhage: a comparative study. | Critical care medicine 20120201 |
| Differentially expressed genes in human peripheral blood as potential markers for statin response. | Journal of molecular medicine (Berlin, Germany) 20120201 |
| Atorvastatin suppresses inflammatory response induced by oxLDL through inhibition of ERK phosphorylation, IκBα degradation, and COX-2 expression in murine macrophages. | Journal of cellular biochemistry 20120201 |
| Early onset of coronary heart disease in a young woman with familial hypercholesterolemia: coronary findings and effect of short term treatment with high dose atorvastatin. | Journal of thrombosis and thrombolysis 20120201 |
| Trastuzumab-related palmar plantar erythrodysaesthesia. | Clinical oncology (Royal College of Radiologists (Great Britain)) 20120201 |
| Differential modulation of cytochrome P450 activity and the effect of 1-aminobenzotriazole on hepatic transport in sandwich-cultured human hepatocytes. | Drug metabolism and disposition: the biological fate of chemicals 20120201 |
| A randomized placebo controlled trial of early treatment of acute ischemic stroke with atorvastatin and irbesartan. | International journal of stroke : official journal of the International Stroke Society 20120201 |
| The effect of bexarotene on atorvastatin pharmacokinetics: results from a phase I trial of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancer. | Cancer chemotherapy and pharmacology 20120201 |
| Effects of atorvastatin on endothelial function and the expression of proinflammatory cytokines and adhesion molecules in young subjects with successfully repaired coarctation of aorta. | Heart (British Cardiac Society) 20120201 |
| Atorvastatin and hormone therapy effects on APOE mRNA expression in hypercholesterolemic postmenopausal women. | The Journal of steroid biochemistry and molecular biology 20120201 |
| Inhibition of secretory phospholipase A(2) in patients with acute coronary syndromes: rationale and design of the vascular inflammation suppression to treat acute coronary syndrome for 16 weeks (VISTA-16) trial. | Cardiovascular drugs and therapy 20120201 |
| The 719Arg variant of KIF6 and cardiovascular outcomes in statin-treated, stable coronary patients of the treating to new targets and incremental decrease in end points through aggressive lipid-lowering prospective studies. | Circulation. Cardiovascular genetics 20120201 |
| Atorvastatin reduces vascular endothelial growth factor (VEGF) expression in human non-small cell lung carcinomas (NSCLCs) via inhibition of reactive oxygen species (ROS) production. | Molecular oncology 20120201 |
| Altered metabolism of low-density lipoprotein and very-low-density lipoprotein remnant in autosomal recessive hypercholesterolemia: results from stable isotope kinetic study in vivo. | Circulation. Cardiovascular genetics 20120201 |
| Effects of the PPAR-δ agonist MBX-8025 on atherogenic dyslipidemia. | Atherosclerosis 20120201 |
| Statins as neuroprotectants after subarachnoid hemorrhage. | Critical care medicine 20120201 |
| [HDL level or HDL function as the primary target in preventive cardiology]. | Herz 20120201 |
| Effect of 40 mg versus 10 mg of atorvastatin on oxidized low-density lipoprotein, high-sensitivity C-reactive protein, circulating endothelial-derived microparticles, and endothelial progenitor cells in patients with ischemic cardiomyopathy. | Clinical cardiology 20120201 |
| Multiple initiatives continue to enhance the prescribing efficiency for the proton pump inhibitors and statins in Scotland. | Expert review of pharmacoeconomics & outcomes research 20120201 |
| Acquired cerebellar ataxia due to statin use. | Arquivos de neuro-psiquiatria 20120201 |
| Influence of atorvastatin and carboxymethylated glucan on the serum lipoprotein profile and MMP activity of mice with lipemia induced by poloxamer 407. | Canadian journal of physiology and pharmacology 20120201 |
| [Effect of atorvastatin on cardiac function and TGF-β1 signaling pathway after acute myocardial infarction in rats]. | Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20120201 |
| Irreversible atorvastatin-associated hearing loss. | Pharmacotherapy 20120201 |
| Acute rhabdomyolysis caused by combination therapy with atorvastatin and warfarin. | British journal of hospital medicine (London, England : 2005) 20120201 |
| Atorvastatin decreases lipoprotein(a): a meta-analysis of randomized trials. | International journal of cardiology 20120126 |
| [Subclinical carotid atherosclerosis in patients with familial combined hyperlipidemia. Two years follow-up after treatment with high doses of atorvastatin]. | Medicina clinica 20120121 |
| Generic atorvastatin and health care costs. | The New England journal of medicine 20120119 |
| Comparison of topical triamcinolone and oral atorvastatin in treatment of paederus dermatitis Northern Iran. | Pakistan journal of biological sciences : PJBS 20120115 |
| A meta-analysis of randomized head-to-head trials of atorvastatin versus rosuvastatin for reductions in C-reactive protein. | International journal of cardiology 20120112 |
| The interactions of atorvastatin and fluvastatin with carbamazepine, phenytoin and valproate in the mouse maximal electroshock seizure model. | European journal of pharmacology 20120105 |
| Myocardial redox state predicts in-hospital clinical outcome after cardiac surgery effects of short-term pre-operative statin treatment. | Journal of the American College of Cardiology 20120103 |
| Acute effects of statins. | Journal of the American College of Cardiology 20120103 |
| Genotoxic effects in fish induced by pharmacological agents present in the sewage of some Italian water-treatment plants. | Environmental toxicology 20120101 |
| Evaluation of cardiovascular morbidity associated with adherence to atorvastatin therapy. | American journal of therapeutics 20120101 |
| One-year cholesterol lowering treatment reduces medial temporal lobe atrophy and memory decline in stroke-free elderly with atrial fibrillation: evidence from a parallel group randomized trial. | International journal of geriatric psychiatry 20120101 |
| Effects of atorvastatin on NGAL and cystatin C in chronic kidney disease: a post hoc analysis of the LORD trial. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20120101 |
| Mechanism of the inhibitory effect of atorvastatin on leptin expression induced by angiotensin II in cultured human coronary artery smooth muscle cells. | Clinical science (London, England : 1979) 20120101 |
| Short-term statin treatment does not prevent ischemia and reperfusion-induced endothelial dysfunction in humans. | Journal of cardiovascular pharmacology 20120101 |
| Statins amplify TLR-induced responses in microglia via inhibition of cholesterol biosynthesis. | Glia 20120101 |
| Atorvastatin therapy decreases androstenedione and dehydroepiandrosterone sulphate concentrations in patients with polycystic ovary syndrome: randomized controlled study. | Annals of clinical biochemistry 20120101 |
| Biliverdin reductase-A: a novel drug target for atorvastatin in a dog pre-clinical model of Alzheimer disease. | Journal of neurochemistry 20120101 |
| Effects of atorvastatin on pathological changes in brain tissue and plasma MMP-9 in rats with intracerebral hemorrhage. | Cell biochemistry and biophysics 20120101 |
| Antioxidative strategies in cognitive impairment: a novel connection between biliverdin-reductase and statins. | Journal of neurochemistry 20120101 |
| Should children and adolescents with systemic lupus erythematosus be given statin therapy to prevent early atherosclerosis? | Arthritis and rheumatism 20120101 |
| Use of atorvastatin in systemic lupus erythematosus in children and adolescents. | Arthritis and rheumatism 20120101 |
| Release of endothelial microparticles in vivo during atorvastatin treatment; a randomized double-blind placebo-controlled study. | Thrombosis research 20120101 |
| Differential effect of atorvastatin and tacrolimus on proliferation of vascular smooth muscle and endothelial cells. | American journal of physiology. Heart and circulatory physiology 20120101 |
| Virtual histology evaluation of atherosclerosis regression during atorvastatin and ezetimibe administration: HEAVEN study. | Circulation journal : official journal of the Japanese Circulation Society 20120101 |
| Atorvastatin 10 mg plus ezetimibe 10mg compared with atorvastatin 20 mg: impact on the lipid profile in Japanese patients with abnormal glucose tolerance and coronary artery disease. | Journal of cardiology 20120101 |
| Activation of TGF-β receptors and Smad proteins by atorvastatin is related to reduced atherogenesis in ApoE/LDLR double knockout mice. | Journal of atherosclerosis and thrombosis 20120101 |
| Galectin-3 and the development of heart failure after acute coronary syndrome: pilot experience from PROVE IT-TIMI 22. | Clinical chemistry 20120101 |
| Low-density lipoprotein cholesterol lowering therapy and established atherosclerosis. | Circulation journal : official journal of the Japanese Circulation Society 20120101 |
| Aliskiren inhibits atherosclerosis development and improves plaque stability in APOE*3Leiden.CETP transgenic mice with or without treatment with atorvastatin. | Journal of hypertension 20120101 |
| Atorvastatin does not affect ischaemia-induced phosphatidylserine exposition in humans in-vivo. | Journal of atherosclerosis and thrombosis 20120101 |
| Long-term statin therapy in patients with systolic heart failure and normal cholesterol: effects on elevated serum markers of collagen turnover, inflammation, and B-type natriuretic peptide. | Clinical therapeutics 20120101 |
| Does the combination of a renin inhibitor with a statin have potential for improved inhibition of atherosclerosis? | Journal of hypertension 20120101 |
| Effect of low-dose atorvastatin on plasma concentrations of adipokines in patients with metabolic syndrome. | Kidney & blood pressure research 20120101 |
| Atorvastatin treatment is effective when used in combination with mefloquine in an experimental cerebral malaria murine model. | Malaria journal 20120101 |
| [Drug-induced pneumonitis due to sirolimus: an interaction with atorvastatin?]. | Revue des maladies respiratoires 20120101 |
| The differential effect of statins on oxidative stress and endothelial function: atorvastatin versus pravastatin. | Journal of clinical lipidology 20120101 |
| Liver mitochondrial respiratory function and coenzyme Q content in rats on a hypercholesterolemic diet treated with atorvastatin. | Physiological research 20120101 |
| Ezetimibe/simvastatin 10/40 mg versus atorvastatin 40 mg in high cardiovascular risk patients with primary hypercholesterolemia: a randomized, double-blind, active-controlled, multicenter study. | Lipids in health and disease 20120101 |
| Anti-inflammatory effect of atorvastatin on vascular reactivity and insulin resistance in fructose fed rats. | Archives of pharmacal research 20120101 |
| Simvastatin and atorvastatin attenuate VCAM-1 and uPAR expression on human endothelial cells and platelet surface expression of CD40 ligand. | Cardiology journal 20120101 |
| Combination treatment with atorvastatin plus niacin provides effective control of complex dyslipidemias: a literature review. | Postgraduate medicine 20120101 |
| Niacin extended-release/simvastatin combination therapy produces larger favorable changes in high-density lipoprotein particles than atorvastatin monotherapy. | Vascular health and risk management 20120101 |
| Influence of achieved low-density lipoprotein cholesterol level with atorvastatin therapy on stabilization of coronary plaques: sub-analysis of the TWINS study. | Circulation journal : official journal of the Japanese Circulation Society 20120101 |
| Atorvastatin may delay cardiac aging by upregulating peroxisome proliferator-activated receptors in rats. | Pharmacology 20120101 |
| Atorvastatin in clinically-significant macular edema in diabetics with a normal lipid profile. | Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH 20120101 |
| Effects of rosuvastatin and atorvastatin on renal function: meta-analysis. | Circulation journal : official journal of the Japanese Circulation Society 20120101 |
| [Focal myositis as a side effect of antilipidemics - 2 patients with involvement of the forearm]. | Handchirurgie, Mikrochirurgie, plastische Chirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Handchirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Mikrochirurgie der Peripheren Nerven und Gefasse : Organ der V... 20120101 |
| [Dyslipidemia: news in diagnosis and drug therapy]. | Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 20120101 |
| Ask the doctor. After a heart attack six years ago, I went on Lipitor (atorvastatin) because my doctor said it was proven to reduce the risk of a second heart attack in high-risk people like me. Three years ago, I switched to a generic (simvastatin) to save money. Now that Lipitor is going generic, should I switch back? And can I be assured that the generic version will be as effective as brand-name Lipitor at preventing a second heart attack? | Harvard heart letter : from Harvard Medical School 20120101 |
| Preparation, physicochemical characteristics and bioavailability studies of an atorvastatin hydroxypropyl-beta-cyclodextrin complex. | Die Pharmazie 20120101 |
| [Statin-ezetimibe combination in hyperlipidemia treatment]. | Casopis lekaru ceskych 20120101 |
| Daming capsule restores endothelial dysfunction induced by high-fat diet. | BMC complementary and alternative medicine 20120101 |
| Improved preservation of residual beta cell function by atorvastatin in patients with recent onset type 1 diabetes and high CRP levels (DIATOR trial). | PloS one 20120101 |
| Qualitative plaque stabilization but not quantitative plaque regression. | Circulation journal : official journal of the Japanese Circulation Society 20120101 |
| Reverse vessel remodeling but not coronary plaque regression could predict future cardiovascular events in ACS patients with intensive statin therapy--the extended JAPAN-ACS study. | Circulation journal : official journal of the Japanese Circulation Society 20120101 |
| Effect of solvent type on the nanoparticle formation of atorvastatin calcium by the supercritical antisolvent process. | Chemical & pharmaceutical bulletin 20120101 |
| Atorvastatin donor pre-treatment in a model of brain death and allogeneic kidney transplantation in rat. | Annals of transplantation 20120101 |
| Statins but not aspirin reduce thrombotic risk assessed by thrombin generation in diabetic patients without cardiovascular events: the RATIONAL trial. | PloS one 20120101 |
| Effects of statins on the recovery of olfactory function in a 3-methylindole-induced anosmia mouse model. | American journal of rhinology & allergy 20120101 |
| Neuroprotective and anti-inflammatory activities of atorvastatin in a rat chronic constriction injury model. | International journal of immunopathology and pharmacology 20120101 |
| Cell killing and radiosensitizing effects of atorvastatin in PC3 prostate cancer cells. | Journal of radiation research 20120101 |
| Antibacterial activity of statins: a comparative study of atorvastatin, simvastatin, and rosuvastatin. | Annals of clinical microbiology and antimicrobials 20120101 |
| Influence of atorvastatin on serum amyloid A-low density lipoprotein complex in hypercholesterolemic patients. | Pharmacological reports : PR 20120101 |
| A fatal case of cutaneous adverse drug-induced toxic epidermal necrolysis associated with severe rhabdomyolysis. | Annals of Saudi medicine 20120101 |
| Simultaneous determination of atorvastatin calcium, ezetimibe, and fenofibrate in a tablet formulation by HPLC. | Journal of AOAC International 20120101 |
| Effectiveness of lipid-lowering therapy with statins for secondary prevention of atherosclerosis--guidelines vs. reality. | Pharmacological reports : PR 20120101 |
| Combination therapy of atorvastatin and amlodipine inhibits sympathetic nervous system activation and improves cognitive function in hypertensive rats. | Circulation journal : official journal of the Japanese Circulation Society 20120101 |
| [The Saturn study]. | Giornale italiano di cardiologia (2006) 20120101 |
| [Painless myocardial ischemia in patient with extensive constrictive atherosclerosis of coronary arteries]. | Kardiologiia 20120101 |
| Atorvastatin and simvastatin, but not pravastatin, up-regulate LPS-induced MMP-9 expression in macrophages by regulating phosphorylation of ERK and CREB. | Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20120101 |
| Statins affect the presentation of endothelial chemokines by targeting to multivesicular bodies. | PloS one 20120101 |
| Combination treatment of rosuvastatin or atorvastatin, with regular exercise improves arterial wall stiffness in patients with coronary artery disease. | PloS one 20120101 |
| Evaluation of short-term safety and efficacy of HMG-CoA reductase inhibitors in hypercholesterolemic patients with elevated serum alanine transaminase concentrations: PITCH study (PITavastatin versus atorvastatin to evaluate the effect on patients with hypercholesterolemia and mild to moderate hepatic damage). | Journal of clinical lipidology 20120101 |
| The high-dose rosuvastatin once weekly study (the HD-ROWS). | Journal of clinical lipidology 20120101 |
| [Atorvastatin or rosuvastatin? Select from the perspective of evidence-based medicine]. | Kardiologiia 20120101 |
| Beneficial effects of high-dose atorvastatin pretreatment on renal function in patients with acute ST-segment elevation myocardial infarction undergoing emergency percutaneous coronary intervention. | Cardiology 20120101 |
| Regulation of PUMA induced by mechanical stress in rat cardiomyocytes. | Journal of biomedical science 20120101 |
| Virtual histology findings and effects of varying doses of atorvastatin on coronary plaque volume and composition in statin-naive patients: the VENUS study. | Circulation journal : official journal of the Japanese Circulation Society 20120101 |
| Atorvastatin accelerates both neointimal coverage and re-endothelialization after sirolimus-eluting stent implantation in a porcine model: new findings from optical coherence tomography and pathology. | Circulation journal : official journal of the Japanese Circulation Society 20120101 |
| Effect of atorvastatin on dynamic parameters of myocardial repolarization in healthy subjects. | Journal of electrocardiology 20120101 |
| A low-dose atorvastatin and losartan combination directly improves aortic ring relaxation and diminishes ischaemic-reperfusion injury in isolated rat hearts. | Medical science monitor : international medical journal of experimental and clinical research 20120101 |
| A survey of the FDA's AERS database regarding muscle and tendon adverse events linked to the statin drug class. | PloS one 20120101 |
| Chemopreventive efficacy of Atorvastatin against nitrosamine-induced rat bladder cancer: antioxidant, anti-proliferative and anti-inflammatory properties. | International journal of molecular sciences 20120101 |
| [Specific features of hypolipidemic therapy in patients with abdominal ischemic disease]. | Terapevticheskii arkhiv 20120101 |
| [Dynamics of microrheologic properties of erythrocytes in patients with arterial hypertension and dyslipidemia treated with atorvastatin]. | Klinicheskaia meditsina 20120101 |
| Experimental evaluation of analgesic and anti-inflammatory activity of simvastatin and atorvastatin. | Indian journal of pharmacology 20120101 |
| Atorvastatin prevents mesenchymal stem cells from hypoxia and serum-free injury through activating AMP-activated protein kinase. | International journal of cardiology 20111215 |
| A meta-analysis of randomized trials for effects of periprocedural atorvastatin on contrast-induced nephropathy. | International journal of cardiology 20111215 |
| Lessons from Lipitor and the broken blockbuster drug model. | Lancet (London, England) 20111210 |
| [Randomized head-to-head comparison of pitavastatin, atorvastatin, and rosuvastatin for safety and efficacy (quantity and quality of LDL): -- the PATROL trial]. | Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20111210 |
| Trifluoromethylation of arenes and heteroarenes by means of photoredox catalysis. | Nature 20111208 |
| [Symptomatic coronary heart disease. Impressive plaque reduction with high dose statins]. | MMW Fortschritte der Medizin 20111208 |
| Statins for multiple sclerosis. | The Cochrane database of systematic reviews 20111207 |
| Silencing p110β prevents rapid depletion of nuclear pAkt. | Biochemical and biophysical research communications 20111202 |
| Severe toxicity of capecitabine following uncomplicated treatment with 5-fluorouracil/leucovorin. | Medical oncology (Northwood, London, England) 20111201 |
| Statin treatment reduces oxidative stress-associated apoptosis of sciatic nerve in diabetes mellitus. | Biotechnic & histochemistry : official publication of the Biological Stain Commission 20111201 |
| Influence of age, gender, and race on the efficacy of adding ezetimibe to atorvastatin vs. atorvastatin up-titration in patients at moderately high or high risk for coronary heart disease. | International journal of cardiology 20111201 |
| Interactions between CYP7A1 A-204C and ABCG8 C1199A polymorphisms on lipid lowering with atorvastatin. | Journal of clinical pharmacy and therapeutics 20111201 |
| The effect of atorvastatin and its role on systemic cytokine network in treatment of acute experimental colitis. | Immunopharmacology and immunotoxicology 20111201 |
| Lack of association between the Trp719Arg polymorphism in kinesin-like protein-6 and cardiovascular risk and efficacy of atorvastatin among subjects with diabetes on dialysis: the 4D study. | Atherosclerosis 20111201 |
| Enhanced bioavailability of atorvastatin calcium from stabilized gastric resident formulation. | AAPS PharmSciTech 20111201 |
| Opposite effects of pravastatin and atorvastatin on insulin sensitivity in the rat: role of vitamin D metabolites. | Atherosclerosis 20111201 |
| Clinically evident polyvascular disease and regression of coronary atherosclerosis after intensive statin therapy in patients with acute coronary syndrome: serial intravascular ultrasound from the Japanese assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS) trial. | Atherosclerosis 20111201 |
| Short-term effect of atorvastatin on carotid artery elasticity: a pilot study. | Stroke 20111201 |
| Three different spectrophotometric methods manipulating ratio spectra for determination of binary mixture of Amlodipine and Atorvastatin. | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20111201 |
| Pharmacokinetics of a fixed-dose combination of atorvastatin and metformin extended release versus concurrent administration of individual formulations: a randomized, open-label, two-treatment, two-period, two-sequence, single-dose, crossover, bioequivalence study. | Clinical drug investigation 20111201 |
| Progressive neurovascular disturbances in the cerebral cortex of Alzheimer's disease-model mice: protection by atorvastatin and pitavastatin. | Neuroscience 20111201 |
| Pilot trial of bone-targeted therapy combining zoledronate with fluvastatin or atorvastatin for patients with metastatic renal cell carcinoma. | Clinical genitourinary cancer 20111201 |
| Pleiotropic role of atorvastatin in regulation of human retinal pigment epithelial cell behaviors in vitro. | Experimental eye research 20111201 |
| Anti-inflammatory effects of varespladib methyl in diabetic patients with acute coronary syndrome. | Cardiovascular drugs and therapy 20111201 |
| Atorvastatin increases exercise leg blood flow in healthy adults. | Atherosclerosis 20111201 |
| Drug utilization patterns and cardiovascular outcomes in elderly patients newly initiated on atorvastatin or simvastatin. | The American journal of geriatric pharmacotherapy 20111201 |
| Effect of ether- and water-soluble fractions of Carica papaya ethanol extract in experimentally induced hyperlipidemia in rats. | Pharmaceutical biology 20111201 |
| Effect of two intensive statin regimens on progression of coronary disease. | The New England journal of medicine 20111201 |
| [Effects of different statins, ezetimibe/simvastatin combination on hsCRP levels in unstable angina pectoris and non-ST elevation myocardial infarction patients: a randomized trial]. | Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 20111201 |
| Effects of atorvastatin pretreatment on infarct size in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. | American heart journal 20111201 |
| Sildenafil improves the beneficial hemodynamic effects exerted by atorvastatin during acute pulmonary thromboembolism. | European journal of pharmacology 20111130 |
| Blockbuster drug bows out. | Nature 20111129 |
| Atorvastatin ameliorates tissue damage of obstructed ureter in rats. | Life sciences 20111121 |
| Effect of counterions on the properties of amorphous atorvastatin salts. | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20111120 |
| Effects of the CETP inhibitor evacetrapib administered as monotherapy or in combination with statins on HDL and LDL cholesterol: a randomized controlled trial. | JAMA 20111116 |
| Cardiovascular and economic outcomes after initiation of atorvastatin versus simvastatin in an employed population stratified by cardiovascular risk. | American journal of therapeutics 20111101 |
| Effects of atorvastatin on fine particle-induced inflammatory response, oxidative stress and endothelial function in human umbilical vein endothelial cells. | Human & experimental toxicology 20111101 |
| Low-dose sirolimus combined with angiotensin-converting enzyme inhibitor and statin stabilizes renal function and reduces glomerular proliferation in poor prognosis IgA nephropathy. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20111101 |
| Protective effect of dietary tocotrienols against infection and inflammation-induced hyperlipidemia: an in vivo and in silico study. | Phytotherapy research : PTR 20111101 |
| Assessing the treatment effect in metabolic syndrome without perceptible diabetes (ATTEMPT): a prospective-randomized study in middle aged men and women. | Current vascular pharmacology 20111101 |
| Plasma proprotein convertase subtilisin kexin type 9 is a heritable trait of familial combined hyperlipidaemia. | Clinical science (London, England : 1979) 20111101 |
| Effect of atorvastatin (Lipitor) on myocardial apoptosis and caspase-8 activation following coronary microembolization. | Cell biochemistry and biophysics 20111101 |
| Final results of the HEALING IIB trial to evaluate a bio-engineered CD34 antibody coated stent (Genous™Stent) designed to promote vascular healing by capture of circulating endothelial progenitor cells in CAD patients. | Atherosclerosis 20111101 |
| Combination of atorvastatin with sulindac or naproxen profoundly inhibits colonic adenocarcinomas by suppressing the p65/β-catenin/cyclin D1 signaling pathway in rats. | Cancer prevention research (Philadelphia, Pa.) 20111101 |
| The effect of the newly developed angiotensin receptor II antagonist fimasartan on the pharmacokinetics of atorvastatin in relation to OATP1B1 in healthy male volunteers. | Journal of cardiovascular pharmacology 20111101 |
| Atorvastatin modulates anti-proliferative and pro-proliferative signals in Her2/neu-positive mammary cancer. | Biochemical pharmacology 20111101 |
| Comparative long-term efficacy and tolerability of pitavastatin 4 mg and atorvastatin 20-40 mg in patients with type 2 diabetes mellitus and combined (mixed) dyslipidaemia. | Diabetes, obesity & metabolism 20111101 |
| Failure to recapture cardioprotection with high-dose atorvastatin in coronary artery bypass surgery: a randomised controlled trial. | Basic research in cardiology 20111101 |
| Atorvastatin reduces functional deficits caused by photodynamic therapy in rats. | International journal of oncology 20111101 |
| Atorvastatin treatment reduces exercise capacities in rats: involvement of mitochondrial impairments and oxidative stress. | Journal of applied physiology (Bethesda, Md. : 1985) 20111101 |
| The human primary hepatocyte transcriptome reveals novel insights into atorvastatin and rosuvastatin action. | Pharmacogenetics and genomics 20111101 |
| Antinociception induced by atorvastatin in different pain models. | Pharmacology, biochemistry, and behavior 20111101 |
| Predictors of progression in atherosclerosis over 2 years in systemic lupus erythematosus. | Rheumatology (Oxford, England) 20111101 |
| Atorvastatin reduces sympathetic activity in patients with chronic kidney disease. | Journal of hypertension 20111101 |
| Differential effects of atorvastatin treatment and withdrawal on pentylenetetrazol-induced seizures. | Epilepsia 20111101 |
| Efficacy of Atorvastatin combined with adipose-derived mesenchymal stem cell transplantation on cardiac function in rats with acute myocardial infarction. | Acta biochimica et biophysica Sinica 20111101 |
| Sympathoinhibitory effects of statins in chronic kidney disease: are they clinically relevant? | Journal of hypertension 20111101 |
| Apolipoprotein B100 is a better treatment target than calculated LDL and non-HDL cholesterol in statin-treated patients. | Annals of clinical biochemistry 20111101 |
| Statin therapy attenuates growth and malignant potential of human esophageal adenocarcinoma cells. | The Journal of thoracic and cardiovascular surgery 20111101 |
| Atorvastatin for the treatment of plaque-type psoriasis. | Pharmacotherapy 20111101 |
| Statins do not significantly affect muscle sympathetic nerve activity in humans with nonischemic heart failure: a double-blind placebo-controlled trial. | Journal of cardiac failure 20111101 |
| The short-term effect of atorvastatin on carotid plaque morphology assessed by computer-assisted gray-scale densitometry: a pilot study. | Neurological research 20111101 |
| Pitavastatin: an overview. | Atherosclerosis. Supplements 20111101 |
| Pitavastatin: novel effects on lipid parameters. | Atherosclerosis. Supplements 20111101 |
| Pitavastatin: clinical effects from the LIVES Study. | Atherosclerosis. Supplements 20111101 |
| Patent cliff. Billions to be saved--starting now. Lipitor led the way, and other blockbusters are following. | Managed care (Langhorne, Pa.) 20111101 |
| [Atorvastatin protects swine bone marrow mesenchymal stem cells from apoptosis through AMPK but not PI3K/Akt pathway]. | Zhonghua xin xue guan bing za zhi 20111101 |
| [Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH study]. | Nihon rinsho. Japanese journal of clinical medicine 20111101 |
| [Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-aCS) study]. | Nihon rinsho. Japanese journal of clinical medicine 20111101 |
| A meta-analysis of randomized trials for effects of atorvastatin on renal function in chronic kidney disease. | International journal of cardiology 20111020 |
| Additional data supporting the use of statins to prevent contrast induced nephropathy. | International journal of cardiology 20111020 |
| Effect of atorvastatin on angiogenesis in degenerated intervertebral disc in rat. | Spine 20111015 |
| Atorvastatin induces autophagy in prostate cancer PC3 cells through activation of LC3 transcription. | Cancer biology & therapy 20111015 |
| Impact of atorvastatin on serum vaspin levels in hypercholesterolemic patients with moderate cardiovascular risk. | Regulatory peptides 20111010 |
| Enhanced bioavailability of nano-sized chitosan-atorvastatin conjugate after oral administration to rats. | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20111009 |
| Clinical implications of switching from intensive to moderate statin therapy after acute coronary syndromes. | International journal of cardiology 20111006 |
| Statins for women with polycystic ovary syndrome not actively trying to conceive. | The Cochrane database of systematic reviews 20111005 |
| Postoperative statin therapy attenuates the intensity of systemic inflammation and increases fibrinolysis after coronary artery bypass grafting. | Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20111001 |
| Why does atorvastatin inhibit renal crystal retention? | Urological research 20111001 |
| Impact of high-dose atorvastatin on endothelial, platelet, and angiogenic indices: effect of ethnicity, cardiovascular disease, and diabetes. | Angiology 20111001 |
| Synergism between melatonin and atorvastatin against endothelial cell damage induced by lipopolysaccharide. | Journal of pineal research 20111001 |
| Hip circumference is associated with high density lipoprotein cholesterol response following statin therapy in hypertensive subjects. | Journal of endocrinological investigation 20111001 |
| Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. | Archives of neurology 20111001 |
| Atorvastatin and clopidogrel interfere with photosensitization in vitro. | Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology 20111001 |
| Acute localized administration of tetrahydrobiopterin and chronic systemic atorvastatin treatment restore cutaneous microvascular function in hypercholesterolaemic humans. | The Journal of physiology 20111001 |
| Identification of the rate-determining process in the hepatic clearance of atorvastatin in a clinical cassette microdosing study. | Clinical pharmacology and therapeutics 20111001 |
| Long-term results from statin trials: answers but more unresolved questions. | European heart journal 20111001 |
| The Anglo-Scandinavian Cardiac Outcomes Trial: 11-year mortality follow-up of the lipid-lowering arm in the U.K. | European heart journal 20111001 |
| Effect of cytochrome P450 3A5 genotype on atorvastatin pharmacokinetics and its interaction with clarithromycin. | Pharmacotherapy 20111001 |
| The value of atorvastatin over the product life cycle in the United States. | Clinical therapeutics 20111001 |
| Species-dependent sensitivity to contaminants: an approach using primary hepatocyte cultures with three marine fish species. | Marine environmental research 20111001 |
| Anti-inflammatory and anti-thrombotic intervention strategies using atorvastatin, clopidogrel and knock-down of CD40L do not modify radiation-induced atherosclerosis in ApoE null mice. | Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 20111001 |
| Inferring statin-induced gene regulatory relationships in primary human hepatocytes. | Bioinformatics (Oxford, England) 20110915 |
| Serum concentrations and clinical effects of atorvastatin in patients taking grapefruit juice daily. | British journal of clinical pharmacology 20110901 |
| Cholesterol-independent neuroprotective and neurotoxic activities of statins: perspectives for statin use in Alzheimer disease and other age-related neurodegenerative disorders. | Pharmacological research 20110901 |
| Impact of HMG-CoA reductase inhibition on oxidant-induced injury in human retinal pigment epithelium cells. | Journal of cellular biochemistry 20110901 |
| Combined atorvastatin and coenzyme Q10 improve the left ventricular function in isoproterenol-induced heart failure in rat. | European journal of pharmacology 20110901 |
| Nitric oxide involvement in consolidation, but not retrieval phase of cognitive performance enhanced by atorvastatin in mice. | European journal of pharmacology 20110901 |
| Atorvastatin exerts its anti-atherosclerotic effects by targeting the receptor for advanced glycation end products. | Biochimica et biophysica acta 20110901 |
| Lipid raft localization of EGFR alters the response of cancer cells to the EGFR tyrosine kinase inhibitor gefitinib. | Journal of cellular physiology 20110901 |
| Recurrent ischemic stroke in a patient with ulcerative colitis and high levels of lipoprotein (a). | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20110901 |
| Statins induce apoptosis and inhibit proliferation in cholangiocarcinoma cells. | International journal of oncology 20110901 |
| Atorvastatin worsens left ventricular diastolic dysfunction and endothelial dysfunction of epicardial coronary arteries in normocholesterolemic porcine with left ventricular hypertrophy. | Journal of cardiovascular pharmacology 20110901 |
| Oral atorvastatin therapy increases nitric oxide-dependent cutaneous vasodilation in humans by decreasing ascorbate-sensitive oxidants. | American journal of physiology. Regulatory, integrative and comparative physiology 20110901 |
| MBX-8025, a novel peroxisome proliferator receptor-delta agonist: lipid and other metabolic effects in dyslipidemic overweight patients treated with and without atorvastatin. | The Journal of clinical endocrinology and metabolism 20110901 |
| Alteration of panel-reactive antibodies following treatment with either atorvastatin or low-dose mycophenolate mofetil in sensitized hemodialysis patients. | Iranian journal of kidney diseases 20110901 |
| Hypernatremia due to rhabdomyolysis in a patient on statin. | Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 20110901 |
| MR imaging of carotid plaque composition during lipid-lowering therapy a prospective assessment of effect and time course. | JACC. Cardiovascular imaging 20110901 |
| MR imaging-verified plaque delipidation with lipid-lowering therapy important questions remain. | JACC. Cardiovascular imaging 20110901 |
| Simultaneous estimation of ramipril, acetylsalicylic acid and atorvastatin calcium by chemometrics assisted UV-spectrophotometric method in capsules. | Acta pharmaceutica (Zagreb, Croatia) 20110901 |
| Neurotoxic effect of statins on mouse neuroblastoma NB2a cell line. | European review for medical and pharmacological sciences 20110901 |
| [Association between high sensitivity C-reactive protein and contrast induced acute kidney injury in patients with acute coronary syndrome undergoing percutaneous coronary intervention: impact of atorvastatin]. | Zhonghua xin xue guan bing za zhi 20110901 |
| Coenzyme Q10 and cognition in atorvastatin treated dogs. | Neuroscience letters 20110826 |
| Efficiency of atorvastatin in the protection of anthracycline-induced cardiomyopathy. | Journal of the American College of Cardiology 20110823 |
| Statins for acute ischemic stroke. | The Cochrane database of systematic reviews 20110810 |
| Effect of torcetrapib on glucose, insulin, and hemoglobin A1c in subjects in the Investigation of Lipid Level Management to Understand its Impact in Atherosclerotic Events (ILLUMINATE) trial. | Circulation 20110802 |
| Neuroprotective potentials of candesartan, atorvastatin and their combination against stroke induced motor dysfunction. | Inflammopharmacology 20110801 |
| Effect of atorvastatin on CYP2C9 metabolic activity as measured by the formation rate of losartan metabolite in hypercholesterolaemic patients. | Basic & clinical pharmacology & toxicology 20110801 |
| Study of Atorvastatin in experimental allergic airway inflammation in mice. | International immunopharmacology 20110801 |
| Statins regulate interleukin-1β-induced RANKL and osteoprotegerin production by human gingival fibroblasts. | Journal of periodontal research 20110801 |
| Combination therapy of candesartan with statin inhibits progression of atherosclerosis more than statin alone in patients with coronary artery disease. | Coronary artery disease 20110801 |
| Amlodipine and atorvastatin exert protective and additive effects via antiapoptotic and antiautophagic mechanisms after transient middle cerebral artery occlusion in Zucker metabolic syndrome rats. | Journal of neuroscience research 20110801 |
| Statins reverse renal inflammation and endothelial dysfunction induced by chronic high salt intake. | American journal of physiology. Renal physiology 20110801 |
| Current management of symptomatic intracranial stenosis. | Current atherosclerosis reports 20110801 |
| Atorvastatin reduces thrombin generation and expression of tissue factor, P-selectin and GPIIIa on platelet-derived microparticles in patients with peripheral arterial occlusive disease. | Thrombosis and haemostasis 20110801 |
| Atorvastatin and its collateral effects on microparticles. | Thrombosis and haemostasis 20110801 |
| Effect of statin therapy on plasma adiponectin concentrations in patients with the sepsis syndrome: a preliminary investigation. | Intensive care medicine 20110801 |
| Atorvastatin protects against ischemia-reperfusion injury in fructose-induced insulin resistant rats. | Cardiovascular drugs and therapy 20110801 |
| pH-sensitive interaction of HMG-CoA reductase inhibitors (statins) with organic anion transporting polypeptide 2B1. | Molecular pharmaceutics 20110801 |
| Association between the changes in renal function and serum uric acid levels during multifactorial intervention and clinical outcome in patients with metabolic syndrome. A post hoc analysis of the ATTEMPT study. | Current medical research and opinion 20110801 |
| Multifactorial treatment for improvement of renal function and cardiovascular risk: an ATTEMPT for patients with metabolic syndrome and chronic kidney disease. | Current medical research and opinion 20110801 |
| Therapy and clinical trials: aggressive statin therapy versus combined and emerging approaches. | Current opinion in lipidology 20110801 |
| Therapeutic equivalence of the generic and the reference atorvastatin in patients with increased coronary risk. | International angiology : a journal of the International Union of Angiology 20110801 |
| Effects of atorvastatin on progression of diabetic nephropathy and local RAGE and soluble RAGE expressions in rats. | Journal of Zhejiang University. Science. B 20110801 |
| Improving adherence with amlodipine/atorvastatin therapy: IMPACT study. | Journal of clinical hypertension (Greenwich, Conn.) 20110801 |
| Atorvastatin metabolite measurements as a diagnostic tool for statin-induced myopathy. | Molecular diagnosis & therapy 20110801 |
| The role of atorvastatin in bone metabolism in male albino Wistar rats. | Die Pharmazie 20110801 |
| Protective effect of lemongrass oil against dexamethasone induced hyperlipidemia in rats: possible role of decreased lecithin cholesterol acetyl transferase activity. | Asian Pacific journal of tropical medicine 20110801 |
| Long-term efficacy and safety of a generic atorvastatin in usual clinical care setting. | The Medical journal of Malaysia 20110801 |
| [The composition of blood lipoproteins of donors 2 hours later after single atorvastatin intake]. | Klinicheskaia laboratornaia diagnostika 20110801 |
| Managing dyslipidaemia: evolving role of combination therapy. | Journal of the Indian Medical Association 20110801 |
| Rapid, direct effects of statin treatment on arterial redox state and nitric oxide bioavailability in human atherosclerosis via tetrahydrobiopterin-mediated endothelial nitric oxide synthase coupling. | Circulation 20110719 |
| Right hemiparesis in right carotid stenosis. | Circulation 20110719 |
| Regulation mechanism of ABCA1 expression by statins in hepatocytes. | European journal of pharmacology 20110715 |
| Marrow-derived MSCs and atorvastatin improve cardiac function in rat model of AMI. | International journal of cardiology 20110701 |
| Up-regulation of hepatic low-density lipoprotein receptor-related protein 1: a possible novel mechanism of antiatherogenic activity of hydroxymethylglutaryl-coenzyme A reductase inhibitor Atorvastatin and hepatic LRP1 expression. | Metabolism: clinical and experimental 20110701 |
| Distinct effects of pitavastatin and atorvastatin on lipoprotein subclasses in patients with Type 2 diabetes mellitus. | Diabetic medicine : a journal of the British Diabetic Association 20110701 |
| CYR61 downregulation reduces osteosarcoma cell invasion, migration, and metastasis. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20110701 |
| Simultaneous intake of oat bran and atorvastatin reduces their efficacy to lower lipid levels and atherosclerosis in LDLr-/- mice. | Pharmacological research 20110701 |
| Atorvastatin prevents vascular hyporeactivity to norepinephrine in sepsis: role of nitric oxide and α₁-adrenoceptor mRNA expression. | Shock (Augusta, Ga.) 20110701 |
| Endoglin as a possible marker of atorvastatin treatment benefit in atherosclerosis. | Pharmacological research 20110701 |
| Effect of statin and fibrate treatment on inflammation in type 2 diabetes. A randomized, cross-over study. | Diabetes research and clinical practice 20110701 |
| Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs. | Drug metabolism and disposition: the biological fate of chemicals 20110701 |
| Prevention of transplant coronary artery disease by prenylation inhibitors. | The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20110701 |
| Rosuvastatin combined with regular exercise preserves coenzyme Q10 levels associated with a significant increase in high-density lipoprotein cholesterol in patients with coronary artery disease. | Atherosclerosis 20110701 |
| Statins exert differential effects on angiotensin II-induced atherosclerosis, but no benefit for abdominal aortic aneurysms. | Atherosclerosis 20110701 |
| Carotid artery atherosclerosis: effect of intensive lipid therapy on the vasa vasorum--evaluation by using dynamic contrast-enhanced MR imaging. | Radiology 20110701 |
| Rheumatoid arthritis: is it a coronary heart disease equivalent? | Current opinion in cardiology 20110701 |
| Short-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty--contrast-induced nephropathy] trial. | The American journal of cardiology 20110701 |
| Contrast-induced nephropathy: do statins offer protection? | Current opinion in cardiology 20110701 |
| Effects of lamotrigine and phenytoin on the pharmacokinetics of atorvastatin in healthy volunteers. | Epilepsia 20110701 |
| Effects of dexamethasone and atorvastatin on atrial sodium current and its early tachycardia-induced electrical remodeling in rabbits. | Pakistan journal of pharmaceutical sciences 20110701 |
| Hypolipidemic potential of flowers of Nerium oleander in high fat diet-fed Sprague Dawley rats. | Natural product research 20110701 |
| Atorvastatin treatment during epileptogenesis in a rat model for temporal lobe epilepsy. | Epilepsia 20110701 |
| Effects of atorvastatin on bone metabolism and bone mineral density in Wistar rats. | Die Pharmazie 20110701 |
| [The effects of atorvastatin on C-reactive protein induced Toll-like receptor 4 expression on CD14+ monocyte]. | Zhonghua xin xue guan bing za zhi 20110701 |
| [Pharmaco-economic optimization of cholesterol-lowering treatment with statins]. | Medicina clinica 20110625 |
| Downregulation of CD38 activation markers by atorvastatin in HIV patients with undetectable viral load. | AIDS (London, England) 20110619 |
| Effect of statins on cholesterol crystallization and atherosclerotic plaque stabilization. | The American journal of cardiology 20110615 |
| Impact of statins on glucose metabolism--a matter of debate. | The American journal of cardiology 20110615 |
| Statins and prostate cancer diagnosis and grade in a veterans population. | Journal of the National Cancer Institute 20110608 |
| Reduction in coronary heart disease with atorvastatin independent of low-density lipoprotein cholesterol. | International journal of cardiology 20110602 |
| High-density lipoprotein (HDL) cholesterol: leveraging practice-based biobank cohorts to characterize clinical and genetic predictors of treatment outcome. | The pharmacogenomics journal 20110601 |
| Simultaneous estimation of atorvastatin and its two metabolites from human plasma by ESI-LC-MS/MS. | Drug testing and analysis 20110601 |
| Prognostic utility of neopterin and risk of heart failure hospitalization after an acute coronary syndrome. | European heart journal 20110601 |
| Model-based development of anacetrapib, a novel cholesteryl ester transfer protein inhibitor. | The AAPS journal 20110601 |
| Comparison of the effects of combination atorvastatin (40 mg) + ezetimibe (10 mg) versus atorvastatin (40 mg) alone on secretory phospholipase A2 activity in patients with stable coronary artery disease or coronary artery disease equivalent. | The American journal of cardiology 20110601 |
| Impact of statins on progression of atherosclerosis: rationale and design of SATURN (Study of Coronary Atheroma by InTravascular Ultrasound: effect of Rosuvastatin versus AtorvastatiN). | Current medical research and opinion 20110601 |
| Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells. | Naunyn-Schmiedeberg's archives of pharmacology 20110601 |
| Atorvastatin and low-density lipoprotein cholesterol in type 2 diabetes mellitus patients on hemodialysis. | Clinical journal of the American Society of Nephrology : CJASN 20110601 |
| Atorvastatin improving renal ischemia reperfusion injury via direct inhibition of active caspase-3 in rats. | Experimental biology and medicine (Maywood, N.J.) 20110601 |
| The cholesterol ester transfer protein inhibitor, anacetrapib. | Current opinion in lipidology 20110601 |
| Comparative effects of rosuvastatin and atorvastatin on glucose metabolism and adipokine levels in non-diabetic patients with dyslipidaemia: a prospective randomised open-label study. | International journal of clinical practice 20110601 |
| The effects of atorvastatin and rosuvastatin on oxidative stress in diabetic patients. | European journal of internal medicine 20110601 |
| Influence of atorvastatin on fractional and subfractional composition of serum lipoproteins and MMP activity in mice with Triton WR 1339-induced lipaemia. | The Journal of pharmacy and pharmacology 20110601 |
| Suppression of inflammatory response and endothelial nitric oxide synthase downregulation in hyperlipidaemic C57BL/6J mice by eugenosedin-A. | The Journal of pharmacy and pharmacology 20110601 |
| Court refuses to hurry generic Lipitor decision. | Nature reviews. Drug discovery 20110601 |
| A case of recurrent ventricular tachycardia. | BMJ (Clinical research ed.) 20110601 |
| Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22). | American heart journal 20110601 |
| Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin. | Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology 20110601 |
| [Atorvastatin induced increase in homologous angiotensin I converting enzyme (ACE2) mRNA is associated to decreased fibrosis and decreased left ventricular hypertrophy in a rat model of diabetic cardiomyopathy]. | Revista peruana de medicina experimental y salud publica 20110601 |
| [Effect of atorvastatin on advanced glycation end products induced monocyte chemoattractant protein-1 expression in cultured human endothelial cells]. | Zhonghua xin xue guan bing za zhi 20110601 |
| The war over Lipitor. | Fortune 20110523 |
| Combined effects of atorvastatin and metformin on glucose-induced variations of inflammatory process in patients with diabetes mellitus. | International journal of cardiology 20110519 |
| New perspectives of 19F MAS NMR in the characterization of amorphous forms of atorvastatin in dosage formulations. | International journal of pharmaceutics 20110516 |
| Microextraction by packed sorbent as sample preparation step for atorvastatin and its metabolites in biological samples--critical evaluation. | Journal of pharmaceutical and biomedical analysis 20110515 |
| Impact of bezafibrate and atorvastatin on lipoprotein subclass in patients with type III hyperlipoproteinemia: result from a crossover study. | Clinica chimica acta; international journal of clinical chemistry 20110512 |
| The effect of a platelet cholesterol modulation on the acetylsalicylic acid-mediated blood platelet inhibition in hypercholesterolemic patients. | European journal of pharmacology 20110511 |
| Atorvastatin and pitavastatin protect cerebellar Purkinje cells in AD model mice and preserve the cytokines MCP-1 and TNF-α. | Brain research 20110504 |
| Effect of atorvastatin on 5-fluorouracil-induced experimental oral mucositis. | Cancer chemotherapy and pharmacology 20110501 |
| Re: Efflux transporter-mediated interactions with atorvastatin--interesting findings with multiple substrates: istradefylline, verapamil, and rifampicin. | Journal of clinical pharmacology 20110501 |
| Short-term high-dose atorvastatin for periprocedural myocardial infarction prevention in patients with renal dysfunction. | Journal of cardiovascular medicine (Hagerstown, Md.) 20110501 |
| Targeting cholesterol at different levels in the mevalonate pathway protects fatty liver against ischemia-reperfusion injury. | Journal of hepatology 20110501 |
| Lupus Atherosclerosis Prevention Study (LAPS). | Annals of the rheumatic diseases 20110501 |
| Effect of oral atorvastatin on CD4+CD25+ regulatory T cells, FoxP3 expression, and prognosis in patients with ST-segment elevated myocardial infarction before primary percutaneous coronary intervention. | Journal of cardiovascular pharmacology 20110501 |
| Atorvastatin suppresses LPS-induced rapid upregulation of Toll-like receptor 4 and its signaling pathway in endothelial cells. | American journal of physiology. Heart and circulatory physiology 20110501 |
| Effect of two-day atorvastatin pretreatment on long-term outcome of patients with stable angina pectoris undergoing elective percutaneous coronary intervention. | The American journal of cardiology 20110501 |
| The role of atorvastatin in regulating the immune response leading to vascular damage in a model of Kawasaki disease. | Clinical and experimental immunology 20110501 |
| Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis. | Journal of lipid research 20110501 |
| Evaluating optimal lipid levels in patients with mixed dyslipidemia following short- and long-term treatment with fenofibric acid and statin combination therapy: a post hoc analysis. | Current medical research and opinion 20110501 |
| Short-term high-dose atorvastatin for periprocedural myocardial infarction prevention in patients with renal dysfunction. | Journal of cardiovascular medicine (Hagerstown, Md.) 20110501 |
| Benefit of intensive statin therapy in women: results from PROVE IT-TIMI 22. | Circulation. Cardiovascular quality and outcomes 20110501 |
| The beneficial effects of statin therapy may not apply to all forms of crescentic glomerulonephritis. | The American journal of pathology 20110501 |
| High-dose atorvastatin and risk of atrial fibrillation in patients with prior stroke or transient ischemic attack: analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. | American heart journal 20110501 |
| Fabry disease and Factor V Leiden: a potent vascular risk combination. | Internal medicine journal 20110501 |
| [Research on the effect of statins on insulin secretion from pancreatic islet in rats and its mechanisms]. | Zhonghua nei ke za zhi 20110501 |
| Bilateral carotid atherosclerosis: an inevitable consequence of homozygous familial hypercholesterolemia. | The Journal of heart valve disease 20110501 |
| The effects of BuYang HuanWu Decoction and its effective components on proliferation-related factors and ERK1/2 signal transduction pathway in cultured vascular smooth muscle cells. | Journal of ethnopharmacology 20110426 |
| Atorvastatin improved scopolamine-induced impairment in memory acquisition in mice: involvement of nitric oxide. | Brain research 20110422 |
| Oral atorvastatin therapy restores cutaneous microvascular function by decreasing arginase activity in hypercholesterolaemic humans. | The Journal of physiology 20110415 |
| [Series: Clinical study from Japan and its reflections: introduction and summary of results: the ESTABLISH study]. | Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 20110410 |
| Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials. | Journal of the American College of Cardiology 20110405 |
| The role of transcranial Doppler embolic monitoring in the management of intracranial arterial stenosis. | Journal of neuroimaging : official journal of the American Society of Neuroimaging 20110401 |
| Statins potently reduce the cytokine-mediated IL-6 release in SMC/MNC cocultures. | Journal of cellular and molecular medicine 20110401 |
| Simultaneous determination of atorvastatin, amlodipine, ramipril and benazepril in human plasma by LC-MS/MS and its application to a human pharmacokinetic study. | Biomedical chromatography : BMC 20110401 |
| Vascular recovery promoted by atorvastatin and simvastatin after experimental intracerebral hemorrhage: magnetic resonance imaging and histological study. | Journal of neurosurgery 20110401 |
| Statin therapy for the prevention of atrial fibrillation trial (SToP AF trial). | Journal of cardiovascular electrophysiology 20110401 |
| Statins, inflammation, oxidative stress, and atrial fibrillation. | Journal of cardiovascular electrophysiology 20110401 |
| Effect of atorvastatin on lipoprotein (a) and interleukin-10: a randomized placebo-controlled trial. | Diabetes & metabolism 20110401 |
| Effects of atorvastatin on vascular function, inflammation, and androgens in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial. | Fertility and sterility 20110401 |
| Xanthine-oxidase inhibitors and statins in chronic heart failure: effects on vascular and functional parameters. | The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20110401 |
| An eight-week trial investigating the efficacy and tolerability of atorvastatin for children and adolescents with heterozygous familial hypercholesterolemia. | Pediatric cardiology 20110401 |
| Combination of amlodipine and atorvastatin synergistically reduces leukocyte recruitment to mechanically injured mouse femoral artery. | Hypertension research : official journal of the Japanese Society of Hypertension 20110401 |
| Synergistic protection against vascular inflammation with a calcium channel blocker and a statin. | Hypertension research : official journal of the Japanese Society of Hypertension 20110401 |
| Treat the graft to improve the regenerative ability of the host. | Medical hypotheses 20110401 |
| Proactive multiple cardiovascular risk factor management compared with usual care in patients with hypertension and additional risk factors: the CRUCIAL trial. | Current medical research and opinion 20110401 |
| Development and validation of a sensitive, simple, and rapid method for simultaneous quantitation of atorvastatin and its acid and lactone metabolites by liquid chromatography-tandem mass spectrometry (LC-MS/MS). | Analytical and bioanalytical chemistry 20110401 |
| Statins utilisation pattern: a retrospective evaluation in a tertiary care hospital in Thailand. | The International journal of pharmacy practice 20110401 |
| Copeptin levels associate with cardiovascular events in patients with ESRD and type 2 diabetes mellitus. | Journal of the American Society of Nephrology : JASN 20110401 |
| LDL cholesterol goals and cardiovascular risk during statin treatment: the IDEAL study. | European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 20110401 |
| Lifestyle changes and 14-year change in high-density lipoprotein cholesterol in a cohort of male physicians. | American heart journal 20110401 |
| Statin therapy is associated with decreased pulmonary vascular pressures in severe COPD. | COPD 20110401 |
| PDGF-induced proliferation of smooth muscular cells is related to the regulation of CREB phosphorylation and Nur77 expression. | Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20110401 |
| Lipitor kicks off onslaught of drug patent conversions. | Managed care (Langhorne, Pa.) 20110401 |
| [A dyslipidemia animal model induced by poloxamer 407 in golden hamsters and pilot study on the mechanism]. | Yao xue xue bao = Acta pharmaceutica Sinica 20110401 |
| [Asymmetric synthesis of atorvastatin intermediate by Pichia pastoris X-33]. | Sheng wu gong cheng xue bao = Chinese journal of biotechnology 20110401 |
| Protection against ischemic stroke damage by synergistic treatment with amlodipine plus atorvastatin in Zucker metabolic rat. | Brain research 20110325 |
| Continuation of statin therapy in patients with presumed infection: a randomized controlled trial. | American journal of respiratory and critical care medicine 20110315 |
| MYC phosphorylation, activation, and tumorigenic potential in hepatocellular carcinoma are regulated by HMG-CoA reductase. | Cancer research 20110315 |
| Simultaneous determination of rosuvastatin and atorvastatin in human serum using RP-HPLC/UV detection: method development, validation and optimization of various experimental parameters. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20110315 |
| High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trial. | The Journal of infectious diseases 20110315 |
| [Rhabdomyolysis associated with atorvastatin combined with amiodarone and fluconazole]. | Praxis 20110302 |
| Effect of gemfibrozil and fenofibrate on the pharmacokinetics of atorvastatin. | Journal of clinical pharmacology 20110301 |
| [Changes in bone mass with atorvastatin. BM AND AT study]. | Atencion primaria 20110301 |
| Effects of immunomodulatory drugs on plasma inflammatory markers in a rabbit model of atherosclerosis. | Journal of physiology and biochemistry 20110301 |
| Effect atorvastatin on serum tumor necrosis factor alpha and interleukin-1β following acute pulmonary embolism. | Experimental lung research 20110301 |
| Effects of high-dose statin on the human hepatic expression of genes involved in carbohydrate and triglyceride metabolism. | Journal of internal medicine 20110301 |
| Atorvastatin increases intestinal expression of NPC1L1 in hyperlipidemic men. | Journal of lipid research 20110301 |
| Differential metabolic effects of distinct statins. | Atherosclerosis 20110301 |
| Effects of loading dose of atorvastatin before percutaneous coronary intervention on periprocedural myocardial injury. | Coronary artery disease 20110301 |
| Atorvastatin and Aβ(1-40): not as simple as cholesterol reduction in brain and relevance to Alzheimer disease. | Experimental neurology 20110301 |
| Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism of action. | Pharmacological research 20110301 |
| Optimal statin type and dosage for vascular patients. | Journal of vascular surgery 20110301 |
| The effect of atorvastatin on mRNA levels of inflammatory genes expression in human peripheral blood lymphocytes by DNA microarray. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20110301 |
| Markers of fibrinolysis as predictors for maintenance of sinus rhythm after electrical cardioversion. | Thrombosis research 20110301 |
| A novel use of oxidative coupling reactions for determination of some statins (cholesterol-lowering drugs) in pharmaceutical formulations. | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20110301 |
| Disappearance of angina pectoris by lipid-lowering in type III hyperlipoproteinemia. | The American journal of cardiology 20110301 |
| Identification of novel functional organic anion-transporting polypeptide 1B3 polymorphisms and assessment of substrate specificity. | Pharmacogenetics and genomics 20110301 |
| Impact of atorvastatin among older and younger patients in the Anglo-Scandinavian Cardiac Outcomes Trial Lipid-Lowering Arm. | Journal of hypertension 20110301 |
| Effect of atorvastatin in a case of feline multicentric lymphoma - Case report. | Acta veterinaria Hungarica 20110301 |
| Effects of carnitine and coenzyme Q10 on lipid profile and serum levels of lipoprotein(a) in maintenance hemodialysis patients on statin therapy. | Iranian journal of kidney diseases 20110301 |
| Not a graves' situation. | The American journal of medicine 20110301 |
| Low-density lipoprotein cholesterol goal attainment among Malaysian dyslipidemic patients. | The Southeast Asian journal of tropical medicine and public health 20110301 |
| [Atorvastatin and oxidized low density lipoprotein antibody. Relationship to age]. | Medicina clinica 20110226 |
| Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatment. | Toxicology and applied pharmacology 20110215 |
| Influence of atorvastatin on the pharmacokinetics and pharmacodynamics of glyburide in normal and diabetic rats. | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20110214 |
| Dysregulation of angiogenesis-related microRNAs in endothelial progenitor cells from patients with coronary artery disease. | Biochemical and biophysical research communications 20110204 |
| Additive beneficial effects of atorvastatin combined with amlodipine in patients with mild-to-moderate hypertension. | International journal of cardiology 20110203 |
| Enhancement of oral bioavailability of atorvastatin calcium by self-emulsifying drug delivery systems (SEDDS). | Pharmaceutical development and technology 20110201 |
| CYP3AP1*3 allele is associated with lipid-lowering efficacy of simvastatin and atorvastatin in Chinese women. | Journal of clinical pharmacology 20110201 |
| Combined atorvastatin and ramipril mitigate radiation-induced impairment of dentate gyrus neurogenesis. | Journal of neuro-oncology 20110201 |
| Enhanced spectrophotometric determination of two antihyperlipidemic mixtures containing ezetimibe in pharmaceutical preparations. | Drug testing and analysis 20110201 |
| Intensive lipid lowering in patients with rheumatoid arthritis and previous myocardial infarction: an explorative analysis from the incremental decrease in endpoints through aggressive lipid lowering (IDEAL) trial. | Rheumatology (Oxford, England) 20110201 |
| Matrix metalloproteinase-9 may be a potential therapeutic target in epilepsy. | Medical hypotheses 20110201 |
| Effect of atorvastatin on inflammation and modification of vascular risk factors in rheumatoid arthritis. | The Journal of rheumatology 20110201 |
| Beneficial effect of insulin in hyperhomocysteinemia and diabetes mellitus-induced vascular endothelium dysfunction: role of phosphoinositide dependent kinase and protein kinase B. | Molecular and cellular biochemistry 20110201 |
| Atorvastatin inhibits plaque development and adventitial neovascularization in ApoE deficient mice independent of plasma cholesterol levels. | Atherosclerosis 20110201 |
| Antithrombotic properties of pravastatin reducing intra-thrombus fibrin deposition under high shear blood flow conditions. | Thrombosis and haemostasis 20110201 |
| Comparative Effectiveness and Toxicity of Statins Among HIV-Infected Patients. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20110201 |
| Randomized phase II trial of sulindac, atorvastatin, and prebiotic dietary fiber for colorectal cancer chemoprevention. | Cancer prevention research (Philadelphia, Pa.) 20110201 |
| Comparison of fibrate, ezetimibe, low- and high-dose statin therapy for the dyslipidemia of the metabolic syndrome in a mouse model. | Angiology 20110201 |
| Statin wars: efficacy vs. cost. | International journal of clinical practice 20110201 |
| Use of high-intensity statin therapy with simvastatin 80 mg and atorvastatin 80 mg in primary care. | International journal of clinical practice 20110201 |
| Effects of maximal atorvastatin and rosuvastatin treatment on markers of glucose homeostasis and inflammation. | The American journal of cardiology 20110201 |
| AMP-activated protein kinase inhibits homocysteine-induced dysfunction and apoptosis in endothelial progenitor cells. | Cardiovascular drugs and therapy 20110201 |
| The effects of statin monotherapy and low-dose statin/ezetimibe on lipoprotein-associated phospholipase A₂. | Clinical cardiology 20110201 |
| Long-term efficacy of adding fenofibric acid to moderate-dose statin therapy in patients with persistent elevated triglycerides. | Cardiovascular drugs and therapy 20110201 |
| Ameliorative role of atorvastatin on methionine-induced hyperhomocysteinemia and hematological changes in albino rats. | Indian journal of experimental biology 20110201 |
| [The effects of atorvastatin on aging kidney]. | Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology 20110201 |
| [Retention behavior of statins in microemulsion liquid chromatography]. | Se pu = Chinese journal of chromatography 20110201 |
| Atorvastatin and pitavastatin improve cognitive function and reduce senile plaque and phosphorylated tau in aged APP mice. | Brain research 20110131 |
| Pivotal role of inflammation in vascular endothelial dysfunction of hyperlipidemic rabbit and effects by atorvastatin. | International journal of cardiology 20110121 |
| Gas chromatography-mass spectrometry-based simultaneous quantitative analytical method for urinary oxysterols and bile acids in rats. | Analytical biochemistry 20110115 |
| Impact of smoking on cardiovascular events in patients with coronary disease receiving contemporary medical therapy (from the Treating to New Targets [TNT] and the Incremental Decrease in End Points Through Aggressive Lipid Lowering [IDEAL] trials). | The American journal of cardiology 20110115 |
| Synergistic benefit of combined amlodipine plus atorvastatin on neuronal damage after stroke in Zucker metabolic rat. | Brain research 20110112 |
| Prediction of cardiovascular events in statin-treated stable coronary patients by lipid and nonlipid biomarkers. | Journal of the American College of Cardiology 20110104 |
| Coadministration of atorvastatin prevents nitroglycerin-induced endothelial dysfunction and nitrate tolerance in healthy humans. | Journal of the American College of Cardiology 20110104 |
| A large observational study of cardiovascular outcomes associated with atorvastatin or simvastatin therapy in hypertensive patients without prior cardiovascular disease. | American journal of therapeutics 20110101 |
| Preoperative high-dose atorvastatin for prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial. | The Journal of thoracic and cardiovascular surgery 20110101 |
| Comparative neuroprotective profile of statins in quinolinic acid induced neurotoxicity in rats. | Behavioural brain research 20110101 |
| Photochemical fate of atorvastatin (lipitor) in simulated natural waters. | Water research 20110101 |
| Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis Heart Study randomized clinical trial. | The American journal of gastroenterology 20110101 |
| A randomized placebo controlled trial of the effect of preoperative statin use on matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in areas of low and peak wall stress in patients undergoing elective open repair of abdominal aortic aneurysm. | Annals of vascular surgery 20110101 |
| Steroids and statins: an old and a new anti-inflammatory strategy compared. | Perfusion 20110101 |
| Differential effect of genetic variants of Na(+)-taurocholate co-transporting polypeptide (NTCP) and organic anion-transporting polypeptide 1B1 (OATP1B1) on the uptake of HMG-CoA reductase inhibitors. | Xenobiotica; the fate of foreign compounds in biological systems 20110101 |
| Atorvastatin acts synergistically with N-acetyl cysteine to provide therapeutic advantage against Fas-activated erythrocyte apoptosis during chronic arsenic exposure in rats. | Toxicology and applied pharmacology 20110101 |
| Does atorvastatin induce aortic smooth muscle cell apoptosis in vivo? | Vascular pharmacology 20110101 |
| Involvement of the p38 pathway in the differential induction of heme oxygenase-1 by statins in Neuro-2A cells exposed to lipopolysaccharide. | Drug and chemical toxicology 20110101 |
| Differential effects of statins on endogenous H2S formation in perivascular adipose tissue. | Pharmacological research 20110101 |
| Higher baseline LDL-C levels amplify the short-term benefit of early intensive statin treatment in acute coronary syndrome. | Journal of atherosclerosis and thrombosis 20110101 |
| Zebrafish Tie-2 shares a redundant role with Tie-1 in heart development and regulates vessel integrity. | Disease models & mechanisms 20110101 |
| Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. | Atherosclerosis 20110101 |
| Pro-inflammatory cytokine levels in association between periodontal disease and hyperlipidaemia. | Journal of clinical periodontology 20110101 |
| Use of ultra high performance liquid chromatography-tandem mass spectrometry to demonstrate decreased serum statin levels after extracorporeal LDL-cholesterol elimination. | Journal of biomedicine & biotechnology 20110101 |
| Statin treatment decreased serum asymmetric dimethylarginine (ADMA) levels in ischemic stroke patients. | Journal of atherosclerosis and thrombosis 20110101 |
| Aleglitazar, a balanced PPARα/γ agonist, has no clinically relevant pharmacokinetic interaction with high-dose atorvastatin or rosuvastatin. | Expert opinion on investigational drugs 20110101 |
| Paradoxical decrease in HDL-cholesterol and apolipoprotein A1 with simvastatin and atorvastatin in a patient with type 2 diabetes. | Annals of clinical biochemistry 20110101 |
| Atorvastatin prevents ischemic limb loss in type 2 diabetes: role of p53. | Journal of atherosclerosis and thrombosis 20110101 |
| Comparison of effects of rosuvastatin and atorvastatin on plaque regression in Korean patients with untreated intermediate coronary stenosis. | Circulation journal : official journal of the Japanese Circulation Society 20110101 |
| Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA): a randomized double-blind placebo-controlled trial of high- vs. low-dose atorvastatin(1). | Diabetic medicine : a journal of the British Diabetic Association 20110101 |
| Functional dilator capacity is independently associated with insulin sensitivity and age in central obesity and is not improved by high dose statin treatment. | Microcirculation (New York, N.Y. : 1994) 20110101 |
| After FRANCIS: next steps in the clinical evaluation of varespladib methyl. | Future cardiology 20110101 |
| Effect of atorvastatin, vitamin E and C on nonalcoholic fatty liver disease: is the combination required? | The American journal of gastroenterology 20110101 |
| Metformin and atorvastatin combination further protect the liver in type 2 diabetes with hyperlipidaemia. | Diabetes/metabolism research and reviews 20110101 |
| Mechanism of attenuation of diabetes mellitus and hypercholesterolemia induced vascular endothelial dysfunction by protein tyrosine phosphatase inhibition. | Vascular pharmacology 20110101 |
| Effects of short-term anti-inflammatory therapy on endothelial function in patients with non-ST-segment elevation acute coronary syndrome. | Cardiovascular revascularization medicine : including molecular interventions 20110101 |
| Generation of a specific polyclonal antibody with high affinity to atorvastatin and its employment in the development of ELISA for determination of atorvastatin in plasma. | Journal of immunoassay & immunochemistry 20110101 |
| The effect of early and intensive statin therapy on ventricular premature beat or nonsustained ventricular tachycardia in patients with acute coronary syndrome. | Clinical cardiology 20110101 |
| In vivo carotid plaque MRI using quantitative T2* measurements with ultrasmall superparamagnetic iron oxide particles: a dose-response study to statin therapy. | NMR in biomedicine 20110101 |
| Comparison of dietary control and atorvastatin on high fat diet induced hepatic steatosis and hyperlipidemia in rats. | Lipids in health and disease 20110101 |
| Paradoxical decrease in serum high-density lipoprotein cholesterol and lipid-lowering drugs. | Annals of clinical biochemistry 20110101 |
| Effect of atorvastatin and etidronate combination therapy on regression of aortic atherosclerotic plaques evaluated by magnetic resonance imaging. | Journal of atherosclerosis and thrombosis 20110101 |
| Pre-procedural atorvastatin mobilizes endothelial progenitor cells: clues to the salutary effects of statins on healing of stented human arteries. | PloS one 20110101 |
| ASCOT analysis with atorvastatin shows limits of CRP as indicator of cardiovascular risk. | Cardiovascular journal of Africa 20110101 |
| Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study design. | BMC nephrology 20110101 |
| [Atorvastatin attenuates hypoxic pulmonary hypertension in rats by inhibiting RhoA/Rho kinase pathway]. | Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20110101 |
| [Effect of atorvastatin on MMP-9 and TIMP-1 levels in bronchoalveolar lavage fluid and serum of rats with bleomycin-induced pulmonary fibrosis]. | Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20110101 |
| Role of preoperative atorvastatin administration in protection against postoperative atrial fibrillation following conventional coronary artery bypass grafting. | International heart journal 20110101 |
| Glucose-lowering effect of colestimide is associated with baseline HbA1c in type 2 diabetic patients with hypercholesterolemia. | Endocrine journal 20110101 |
| Atorvastatin prevents Plasmodium falciparum cytoadherence and endothelial damage. | Malaria journal 20110101 |
| Atorvastatin reduces high glucose toxicity in rat peritoneal mesothelial cells. | Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 20110101 |
| Proteomic approach to the study of statin pleiotropy in kidney transplant patients. | Pharmacology 20110101 |
| [Effects of early statin treatment on inflammatory biomarkers and clinical deterioration in patients with acute ischemic stroke]. | Rinsho shinkeigaku = Clinical neurology 20110101 |
| The C3435T polymorphism in ABCB1 influences atorvastatin efficacy and muscle symptoms in a high-risk vascular cohort. | Journal of clinical lipidology 20110101 |
| Results of a randomized,open-label,clinical trial investigating the effects of supplementation with Heracleumpersicum extract as an adjunctive therapy for dyslipidemia. | TheScientificWorldJournal 20110101 |
| The influence of statins on levels of calcification biomarkers in patients with aortic sclerosis or mild aortic stenosis. | The Journal of heart valve disease 20110101 |
| Residual beta cell function in newly diagnosed type 1 diabetes after treatment with atorvastatin: the Randomized DIATOR Trial. | PloS one 20110101 |
| ABCA1 and ABCG1 expressions are regulated by statins and ezetimibe in Caco-2 cells. | Drug metabolism and drug interactions 20110101 |
| Atorvastatin affects the tissue concentration of hydrogen sulfide in mouse kidneys and other organs. | Pharmacological reports : PR 20110101 |
| Atorvastatin prevents age-related and amyloid-β-induced microglial activation by blocking interferon-γ release from natural killer cells in the brain. | Journal of neuroinflammation 20110101 |
| Statin-associated rhabdomyolysis: is there a dose-response relationship? | The Canadian journal of cardiology 20110101 |
| Effects of short-term treatment with atorvastatin in smokers with asthma--a randomized controlled trial. | BMC pulmonary medicine 20110101 |
| Reduction in arterial wall strain with aggressive lipid-lowering therapy in patients with carotid artery disease. | Circulation journal : official journal of the Japanese Circulation Society 20110101 |
| Hypolipidemic effect of fresh Triticum aestivum (wheat) grass juice in hypercholesterolemic rats. | Acta poloniae pharmaceutica 20110101 |
| Randomized head-to-head comparison of pitavastatin, atorvastatin, and rosuvastatin for safety and efficacy (quantity and quality of LDL): the PATROL trial. | Circulation journal : official journal of the Japanese Circulation Society 20110101 |
| Plaque-stabilizing effect of atorvastatin is stronger for plaques evaluated as more unstable by angioscopy and intravenous ultrasound. | Circulation journal : official journal of the Japanese Circulation Society 20110101 |
| Influence of polymorphisms and cholesterol-lowering treatment on SCARB1 mRNA expression. | Journal of atherosclerosis and thrombosis 20110101 |
| Strong statins as the major players for dyslipidemia in high-risk patients: are they all the same or not? | Circulation journal : official journal of the Japanese Circulation Society 20110101 |
| A systems biology approach to dynamic modeling and inter-subject variability of statin pharmacokinetics in human hepatocytes. | BMC systems biology 20110101 |
| Clinical use and effectiveness of lipid lowering therapies in diabetes mellitus--an observational study from the Swedish National Diabetes Register. | PloS one 20110101 |
| Atorvastatin reduces lipopolysaccharide-induced expression of C-reactive protein in human lung epithelial cells. | Molecular medicine reports 20110101 |
| Problems in dealing with very rare adverse effects of new anticancer drugs: the example of trabectedin. | Tumori 20110101 |
| [Effect of carvedilol and metoprolol R administered with or without atorvastatin on elastic properties of vascular wall and parameters of inflammation in patients with chronic heart failure of ischemic origin]. | Kardiologiia 20110101 |
| [Pleiotropic effects of nicotinic acid therapy in men with coronary heart disease and elevated lipoprotein(a) levels]. | Kardiologiia 20110101 |
| High-dose atorvastatin treatment in patients with peripheral arterial disease: effects on platelet aggregation, blood rheology and plasma homocysteine. | Clinical hemorheology and microcirculation 20110101 |
| Clinical characteristics and evaluation of LDL-cholesterol treatment of the Spanish Familial Hypercholesterolemia Longitudinal Cohort Study (SAFEHEART). | Lipids in health and disease 20110101 |
| Comparison of preventive effect on cardiovascular events with different statins. -The CIRCLE study-. | Circulation journal : official journal of the Japanese Circulation Society 20110101 |
| The atorvastatin during ischemic stroke study: a pilot randomized controlled trial. | Clinical neuropharmacology 20110101 |
| Drug repurposing for vascular protection after acute ischemic stroke. | Acta neurochirurgica. Supplement 20110101 |
| Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotic plaque formation. | Vascular health and risk management 20110101 |
| Effect of atorvastatin vs. rosuvastatin on cardiac sympathetic nerve activity in non-diabetic patients with dilated cardiomyopathy. | Circulation journal : official journal of the Japanese Circulation Society 20110101 |
| Ethnic variations in lipid-lowering in response to a statin (EVIREST): a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). | Ethnicity & disease 20110101 |
| Atorvastatin given prior to electrical cardioversion does not affect the recurrence of atrial fibrillation in patients with persistent atrial fibrillation who are on antiarrhythmic therapy. | Medical principles and practice : international journal of the Kuwait University, Health Science Centre 20110101 |
| Influence of atorvastatin on coronary calcifications and myocardial perfusion defects in systemic lupus erythematosus patients: a prospective, randomized, double-masked, placebo-controlled study. | Arthritis research & therapy 20110101 |
| Antimalarial activity of potential inhibitors of Plasmodium falciparum lactate dehydrogenase enzyme selected by docking studies. | PloS one 20110101 |
| [Pleiotropic effects of statins in systemic sclerosis]. | Terapevticheskii arkhiv 20110101 |
| Persisting thrombin activity in elderly patients with atrial fibrillation on oral anticoagulation is decreased by anti-inflammatory therapy with intensive cholesterol-lowering treatment. | Journal of clinical lipidology 20110101 |
| Concordance between plasma apolipoprotein B levels and cholesterol indices among patients receiving statins and nonstatin treatment: Post-hoc analyses from the U.K. InPractice study. | Journal of clinical lipidology 20110101 |
| Clinical usefulness of additional treatment with ezetimibe in patients with coronary artery disease on statin therapy. - From the viewpoint of cholesterol metabolism.-. | Circulation journal : official journal of the Japanese Circulation Society 20110101 |
| Study on bioavailability difference between clopidogrel bisulfate form I and form II using liquid chromatography/tandem mass spectrometry. | Arzneimittel-Forschung 20110101 |
| Benefit and tolerability of the coadministration of ezetimibe and atorvastatin in acute coronary syndrome patients. | Le Journal medical libanais. The Lebanese medical journal 20110101 |
| [Analysis of cost-effectiveness of simvastatin versus atorvastatin in the secondary prevention of cardiovascular events within the Brazilian public healthcare system]. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20110101 |
| Comparative efficacy of ezetimibe/simvastatin, rosuvastatin, and atorvastatin in uncontrolled hyperlipidemia patients. | The American journal of managed care 20110101 |
| Treatment of an adrenomyeloneuropathy patient with Lorenzo's oil and supplementation with docosahexaenoic acid--a case report. | Lipids in health and disease 20110101 |
| Atorvastatin ameliorates experimental autoimmune neuritis by decreased Th1/Th17 cytokines and up-regulated T regulatory cells. | Cellular immunology 20110101 |
| RLIP76, a glutathione-conjugate transporter, plays a major role in the pathogenesis of metabolic syndrome. | PloS one 20110101 |
| [Association of a polymorphic marker Trp719Arg of KIF6 gene with effects of atorvastatin and simvastatin in patients with early ischemic heart disease]. | Kardiologiia 20110101 |
| [Clinical description of effectiveness of pioglitazone in a complex therapy of patients with ischemic heart disease on background of metabolic syndrome]. | Likars'ka sprava 20110101 |
| Modeling data with structural and temporal correlation using lower level and higher level multilevel models. | Pharmaceutical statistics 20110101 |
| Atorvastatin inhibits myocardial cell apoptosis in a rat model with post-myocardial infarction heart failure by downregulating ER stress response. | International journal of medical sciences 20110101 |
| Atorvastatin therapy during the peri-infarct period attenuates left ventricular dysfunction and remodeling after myocardial infarction. | PloS one 20110101 |
| Beneficial effect of atorvastatin on renal function in patients with type 2 diabetes. | The Journal of international medical research 20110101 |
| Gender specific influence of fish oil or atorvastatin on functional properties of renal Na,K-ATPase in healthy Wistar and hypertriglyceridemic rats. | Physiological research 20110101 |
| Pleiotropic effects of statins in distal human pulmonary artery smooth muscle cells. | Respiratory research 20110101 |
| [Side effects of the HMG-CoA reductase inhibitors (statins). Lupus erythematosus induced by Atorvastatin therapy]. | Przeglad lekarski 20110101 |
| Pharmacogenetics of OATP transporters reveals that SLCO1B1 c.388A>G variant is determinant of increased atorvastatin response. | International journal of molecular sciences 20110101 |
| Modelling approach to simulate reductions in LDL cholesterol levels after combined intake of statins and phytosterols/-stanols in humans. | Lipids in health and disease 20110101 |
| Does bargaining affect Medicare prescription drug plan reimbursements to independent pharmacies? | Journal of the American Pharmacists Association : JAPhA 20110101 |
| Apolipoprotein E mRNA expression in mononuclear cells from normolipidemic and hypercholesterolemic individuals treated with atorvastatin. | Lipids in health and disease 20110101 |
| Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study). | Journal of clinical lipidology 20110101 |
| Effects of prescription omega-3-acid ethyl esters, coadministered with atorvastatin, on circulating levels of lipoprotein particles, apolipoprotein CIII, and lipoprotein-associated phospholipase A2 mass in men and women with mixed dyslipidemia. | Journal of clinical lipidology 20110101 |
| An evaluation of the effect of atorvastatin on memory and psychomotor functions in hypertensive patients. | Journal of postgraduate medicine 20110101 |
| Evaluation of hypolipidemic activity of leaf juice of Catharanthus roseus (Linn.) G. Donn. in guinea pigs. | Acta poloniae pharmaceutica 20110101 |
| Different statins produce highly divergent changes in gene expression profiles of human hepatoma cells: a pilot study. | Acta biochimica Polonica 20110101 |
| Statins promote the regression of atherosclerosis via activation of the CCR7-dependent emigration pathway in macrophages. | PloS one 20110101 |
| Assessment of atorvastatin effectiveness on serum PSA level in hypercholesterolemic males. | Acta medica Iranica 20110101 |
| Atorvastatin inhibits functional expression of proatherogenic TLR2 in arterial endothelial cells. | Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 20110101 |
| Atorvastatin and fenofibric acid differentially affect the release of adipokines in the visceral and subcutaneous cultures of adipocytes that were obtained from patients with and without mixed dyslipidemia. | Pharmacological reports : PR 20110101 |
| Effects of atorvastatin on heart mitochondrial function and coenzyme Q content in the experiment. | Bratislavske lekarske listy 20110101 |
| Long-term efficacy of upstream therapy with lipophilic or hydrophilic statins on antiarrhythmic drugs in patients with paroxysmal atrial fibrillation: comparison between atorvastatin and pravastatin. | International heart journal 20110101 |
| Effects of rosuvastatin versus atorvastatin on rho-associated coiled-coil containing protein kinase activity and endothelial function in patients with atherosclerosis. | The Journal of international medical research 20110101 |
| [Atorvastatin for secondary prevention in patients with coronary artery disease]. | Kardiologiia 20110101 |
| Usefulness of lymphocyte activation test in atorvastatin hypersensitivity. | Journal of investigational allergology & clinical immunology 20110101 |
| [The effectiveness of pioglitazone in the treatment of patients with coronary heart disease on the background of metabolic syndrome]. | Likars'ka sprava 20110101 |
| Buerger's disease (Thromboangiitis obliterans): a diagnostic challenge. | BMJ case reports 20110101 |
| Differential interactions between statins and P-glycoprotein: implications for exploiting statins as anticancer agents. | International journal of cancer 20101215 |
| Statins for multiple sclerosis. | The Cochrane database of systematic reviews 20101208 |
| Effect of combined administration of ginger (Zingiber officinale Roscoe) and atorvastatin on the liver of rats. | Phytomedicine : international journal of phytotherapy and phytopharmacology 20101201 |
| Statins attenuate high mobility group box-1 protein induced vascular endothelial activation : a key role for TLR4/NF-κB signaling pathway. | Molecular and cellular biochemistry 20101201 |
| Antihypercholesterolaemic effect of ginger rhizome (Zingiber officinale) in rats. | Inflammopharmacology 20101201 |
| Atorvastatin prevents hippocampal cell death, neuroinflammation and oxidative stress following amyloid-β(1-40) administration in mice: evidence for dissociation between cognitive deficits and neuronal damage. | Experimental neurology 20101201 |
| J-curve revisited: An analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial. | European heart journal 20101201 |
| CYP3A4*16 and CYP3A4*18 alleles found in East Asians exhibit differential catalytic activities for seven CYP3A4 substrate drugs. | Drug metabolism and disposition: the biological fate of chemicals 20101201 |
| Circulating proprotein convertase subtilisin kexin type 9 has a diurnal rhythm synchronous with cholesterol synthesis and is reduced by fasting in humans. | Arteriosclerosis, thrombosis, and vascular biology 20101201 |
| p120 catenin/αN-catenin are molecular targets in the neuroprotection and neuronal plasticity mediated by atorvastatin after focal cerebral ischemia. | Journal of neuroscience research 20101201 |
| Attainment of Canadian and European guidelines' lipid targets with atorvastatin plus ezetimibe vs. doubling the dose of atorvastatin. | International journal of clinical practice 20101201 |
| Statins alter intracellular calcium homeostasis in malignant hyperthermia susceptible individuals. | Cardiovascular therapeutics 20101201 |
| Prevention of contrast-induced impairment of renal function by short-term or long-term statin therapy in patients undergoing elective coronary angiography. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20101201 |
| Impact of atorvastatin and omega-3 ethyl esters 90 on plasma plant sterol concentrations and cholesterol synthesis in type 2 diabetes: a randomised placebo controlled factorial trial. | Atherosclerosis 20101201 |
| Atorvastatin attenuates inflammatory infiltration and vascular remodeling in lung of hypercholesterolemia rabbits. | Experimental lung research 20101201 |
| Biomarker assessment of the immunomodulator effect of atorvastatin in stable renal transplant recipients and hypercholesterolemic patients. | Molecular diagnosis & therapy 20101201 |
| Atorvastatin exhibits anti-inflammatory and anti-oxidant properties in adjuvant-induced monoarthritis. | Inflammopharmacology 20101201 |
| Atorvastatin-induced acute elevation of hepatic enzymes and the absence of cross-toxicity of pravastatin. | International journal of clinical pharmacology and therapeutics 20101201 |
| Pitavastatin - results from phase III & IV. | Atherosclerosis. Supplements 20101201 |
| Omega-3 fatty acids and atorvastatin suppress ventricular fibrillation inducibility in hypertriglyceridemic rat hearts: implication of intracellular coupling protein, connexin-43. | Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20101201 |
| Comparison of atorvastatin 5 and 20 mg/d for reducing F-18 fluorodeoxyglucose uptake in atherosclerotic plaques on positron emission tomography/computed tomography: a randomized, investigator-blinded, open-label, 6-month study in Japanese adults scheduled for percutaneous coronary intervention. | Clinical therapeutics 20101201 |
| What is the optimal blood pressure in patients after acute coronary syndromes?: Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction (PROVE IT-TIMI) 22 trial. | Circulation 20101123 |
| Levels of DKK1 in patients with acute myocardial infarction and response to atorvastatin. | International journal of cardiology 20101105 |
| Atorvastatin induces apoptosis in vitro and slows growth of tumor xenografts but not polyp formation in MIN mice. | Digestive diseases and sciences 20101101 |
| Potent anti-ischaemic effects of statins in chronic stable angina: incremental benefit beyond lipid lowering? | European heart journal 20101101 |
| Short-term atorvastatin preload reduces levels of adhesion molecules in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Results from the ARMYDA-ACS CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy. | Journal of cardiovascular medicine (Hagerstown, Md.) 20101101 |
| Atorvastatin and cardiac hypertrophy and function in hypertrophic cardiomyopathy: a pilot study. | European journal of clinical investigation 20101101 |
| Induction of endothelial nitric oxide synthase, SIRT1, and catalase by statins inhibits endothelial senescence through the Akt pathway. | Arteriosclerosis, thrombosis, and vascular biology 20101101 |
| Atorvastatin upregulates nitric oxide synthases with Rho-kinase inhibition and Akt activation in the kidney of spontaneously hypertensive rats. | Journal of hypertension 20101101 |
| Atorvastatin attenuates Coxsackie virus B3m-induced viral myocarditis in mice. | Journal of cardiovascular pharmacology 20101101 |
| Effects of atorvastatin and L-arginine treatments on electrical field stimulation-mediated relaxations in pulmonary arterial rings of monocrotaline-induced pulmonary hypertensive rats. | Journal of cardiovascular pharmacology 20101101 |
| Effect of atorvastatin on kidney function in chronic kidney disease: a randomised double-blind placebo-controlled trial. | Atherosclerosis 20101101 |
| Atorvastatin increases 25-hydroxy vitamin D concentrations in patients with polycystic ovary syndrome. | Clinical chemistry 20101101 |
| Effect of atorvastatin on chronic periodontitis: a randomized pilot study. | Journal of clinical periodontology 20101101 |
| Comparison of rosuvastatin and atorvastatin on clopidogrel response and lipidic and inflammatory parameters after coronary stenting for acute coronary syndrome: the prospective, randomized OSCAR study (optimal statin therapy with clopidogrel after coronary revascularisation). | Thrombosis research 20101101 |
| Atorvastatin inhibits oxidative stress via adiponectin-mediated NADPH oxidase down-regulation in hypercholesterolemic patients. | Atherosclerosis 20101101 |
| Statin therapy for hypertrophic cardiomyopathy: too good to be true? | European journal of clinical investigation 20101101 |
| Severe rhabdomyolysis as a consequence of the interaction of fusidic acid and atorvastatin. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20101101 |
| The effects of atorvastatin on memory deficit and seizure susceptibility in pentylentetrazole-kindled rats. | Epilepsy & behavior : E&B 20101101 |
| Comment and reply on: Atorvastatin: safety and tolerability. Statins and polymyositis: a neglected link? | Expert opinion on drug safety 20101101 |
| Effect of preoperative statin therapy on postoperative atrial fibrillation in cardiac surgery. | Circulation journal : official journal of the Japanese Circulation Society 20101101 |
| Sympathoinhibition by atorvastatin in hypertensive patients. | Circulation journal : official journal of the Japanese Circulation Society 20101101 |
| [On the current debate on lowering LDL cholesterol with ezetimibe]. | Deutsche medizinische Wochenschrift (1946) 20101101 |
| Safety and efficacy of ezetimibe/simvastatin combination versus atorvastatin alone in adults ≥65 years of age with hypercholesterolemia and with or at moderately high/high risk for coronary heart disease (the VYTELD study). | The American journal of cardiology 20101101 |
| Microwave induced solubility enhancement of poorly water soluble atorvastatin calcium. | The Journal of pharmacy and pharmacology 20101101 |
| Effect of different loading doses of atorvastatin on percutaneous coronary intervention for acute coronary syndromes. | The Canadian journal of cardiology 20101101 |
| Statins before stents: does an ounce of prevention improve outcomes? | The Canadian journal of cardiology 20101101 |
| Prevalence of dyslipidemia in statin-treated patients in Canada: results of the DYSlipidemia International Study (DYSIS). | The Canadian journal of cardiology 20101101 |
| Sympathoinhibitory effects of atorvastatin in hypertension. | Circulation journal : official journal of the Japanese Circulation Society 20101101 |
| Effects of different doses of statins on liver regeneration through angiogenesis and possible relation between these effects and acute phase responses. | Transplantation proceedings 20101101 |
| [Electrophysiological effect of atorvastatin on isolated rat hearts injured by ischemia/reperfusion]. | Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20101101 |
| TIAs - management in general practice. | Australian family physician 20101101 |
| [Japanese Guidelines for the Management of Stroke 2009 : important revised points necessary for the neurologist]. | Rinsho shinkeigaku = Clinical neurology 20101101 |
| Photophysical characterization of atorvastatin (Lipitor®) ortho-hydroxy metabolite: role of hydroxyl group on the drug photochemistry. | Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology 20101028 |
| More intensive lipid lowering is associated with regression of coronary atherosclerosis in diabetic patients with acute coronary syndrome--sub-analysis of JAPAN-ACS study. | Journal of atherosclerosis and thrombosis 20101027 |
| [Liver damage in a patient treated with a vitamin K antagonist, a statin and an ACE inhibitor]. | Praxis 20101020 |
| Atorvastatin treatment affects atrial ion currents and their tachycardia-induced remodeling in rabbits. | Life sciences 20101009 |
| In vitro effects of atorvastatin on lipopolysaccharide-induced gene expression in endometriotic stromal cells. | Fertility and sterility 20101001 |
| Efficacy of short-term high-dose atorvastatin for prevention of contrast-induced nephropathy in patients undergoing coronary angiography. | Angiology 20101001 |
| Atorvastatin reduces calcification in rat arteries and vascular smooth muscle cells. | Basic & clinical pharmacology & toxicology 20101001 |
| Short-term effects of periodontal therapy as an adjunct to anti-lipemic treatment. | Oral diseases 20101001 |
| Celecoxib combined with atorvastatin prevents progression of atherosclerosis. | The Journal of surgical research 20101001 |
| Common variants of HMGCR, CETP, APOAI, ABCB1, CYP3A4, and CYP7A1 genes as predictors of lipid-lowering response to atorvastatin therapy. | DNA and cell biology 20101001 |
| Pleiotropic effects of atorvastatin and fenofibrate in metabolic syndrome and different types of pre-diabetes. | Diabetes care 20101001 |
| Markers of cholesterol absorption and synthesis predict the low-density lipoprotein cholesterol response to atorvastatin. | Journal of cardiovascular pharmacology 20101001 |
| Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells. | Journal of hepatology 20101001 |
| Diltiazem overdose: a role for high-dose insulin. | Emergency medicine journal : EMJ 20101001 |
| Effect of increasing doses of Rosuvastatin and Atorvastatin on apolipoproteins, enzymes and lipid transfer proteins involved in lipoprotein metabolism and inflammatory parameters. | Current medical research and opinion 20101001 |
| No clinically relevant drug-drug interactions when dalcetrapib is co-administered with atorvastatin. | Expert opinion on investigational drugs 20101001 |
| Cholesteryl ester transfer protein antagonism by drugs--a poor choice. | Clinical chemistry 20101001 |
| Atorvastatin for reduction of myocardial damage during angioplasty trials. | Journal of cardiovascular medicine (Hagerstown, Md.) 20101001 |
| The effects of atorvastatin on pulmonary arterial hypertension and expression of p38, p27, and Jab1 in rats. | International journal of molecular medicine 20101001 |
| Development of a population pharmacokinetic model for atorvastatin acid and its lactone metabolite. | Clinical pharmacokinetics 20101001 |
| Inhibition of autophagy enhances anticancer effects of atorvastatin in digestive malignancies. | Cancer research 20101001 |
| Effects of statin use on total oxidant and antoxidant capacity and ceruloplasmin activity. | Clinical and investigative medicine. Medecine clinique et experimentale 20101001 |
| Efficacy and safety of fenofibric acid in combination with atorvastatin and ezetimibe in patients with mixed dyslipidemia. | American heart journal 20101001 |
| Multiple organ failure after an overdose of less than 0.4 mg/kg of colchicine: role of coingestants and drugs during intensive care management. | Clinical toxicology (Philadelphia, Pa.) 20101001 |
| Low-dose statin therapy improves endothelial function in type 2 diabetic patients with normal serum total cholesterol: a randomized placebo-controlled study. | Journal of clinical hypertension (Greenwich, Conn.) 20101001 |
| Efficacy and tolerability of a generic and a branded formulation of atorvastatin 20 mg/d in hypercholesterolemic Korean adults at high risk for cardiovascular disease: a multicenter, prospective, randomized, double-blind, double-dummy clinical trial. | Clinical therapeutics 20101001 |
| [Indications for statin therapy in patients with acute coronary syndrome of ischemic origin]. | Giornale italiano di cardiologia (2006) 20101001 |
| Effects of varespladib methyl on biomarkers and major cardiovascular events in acute coronary syndrome patients. | Journal of the American College of Cardiology 20100928 |
| Preoperative atorvastatin treatment in CABG patients rapidly improves vein graft redox state by inhibition of Rac1 and NADPH-oxidase activity. | Circulation 20100914 |
| Effect of atorvastatin on cardiac remodelling and mortality in rats following hyperglycemia and myocardial infarction. | International journal of cardiology 20100903 |
| Purinergic receptor-mediated rapid depletion of nuclear phosphorylated Akt depends on pleckstrin homology domain leucine-rich repeat phosphatase, calcineurin, protein phosphatase 2A, and PTEN phosphatases. | The Journal of biological chemistry 20100903 |
| Cyclosporine A, but not tacrolimus, shows relevant inhibition of organic anion-transporting protein 1B1-mediated transport of atorvastatin. | Drug metabolism and disposition: the biological fate of chemicals 20100901 |
| High-dose atorvastatin causes a rapid sustained increase in human serum PCSK9 and disrupts its correlation with LDL cholesterol. | Journal of lipid research 20100901 |
| Effects of atorvastatin and lisinopril on endothelial dysfunction in patients with Behçet's disease. | Echocardiography (Mount Kisco, N.Y.) 20100901 |
| Atorvastatin or transgenic expression of TFPI inhibits coagulation initiated by anti-nonGal IgG binding to porcine aortic endothelial cells. | Journal of thrombosis and haemostasis : JTH 20100901 |
| Cytotoxicity of atorvastatin and simvastatin on primary rainbow trout (Oncorhynchus mykiss) hepatocytes. | Toxicology in vitro : an international journal published in association with BIBRA 20100901 |
| Plasma PCSK9 is increased by fenofibrate and atorvastatin in a non-additive fashion in diabetic patients. | Atherosclerosis 20100901 |
| Aldosterone, hypertension and heart failure: insights from clinical trials. | Hypertension research : official journal of the Japanese Society of Hypertension 20100901 |
| Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia. | Thrombosis research 20100901 |
| Ultrasound protocols to measure carotid intima-media thickness in trials; comparison of reproducibility, rate of progression, and effect of intervention in subjects with familial hypercholesterolemia and subjects with mixed dyslipidemia. | Annals of medicine 20100901 |
| A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial. | Thrombosis and haemostasis 20100901 |
| Correlation between circulating adiponectin levels and coronary plaque regression during aggressive lipid-lowering therapy in patients with acute coronary syndrome: subgroup analysis of JAPAN-ACS study. | Atherosclerosis 20100901 |
| Statin attenuates experimental anti-glomerular basement membrane glomerulonephritis together with the augmentation of alternatively activated macrophages. | The American journal of pathology 20100901 |
| Impact of restricted reimbursement on the use of statins in Finland: a register-based study. | Medical care 20100901 |
| Lack of clopidogrel-statin interaction in patients undergoing coronary stent implantation. | Arquivos brasileiros de cardiologia 20100901 |
| Effects of drug interactions on biotransformation and antiplatelet effect of clopidogrel in vitro. | British journal of pharmacology 20100901 |
| Office-based global cardiometabolic risk assessment: a simple tool incorporating nontraditional markers. | Critical pathways in cardiology 20100901 |
| Disparate effects of atorvastatin compared with simvastatin on C-reactive protein concentrations in patients with type 2 diabetes. | Diabetes care 20100901 |
| A quadruped study on chitosan microspheres containing atorvastatin calcium: preparation, characterization, quantification and in-vivo application. | Chemical & pharmaceutical bulletin 20100901 |
| Clinical Inquiries: Which drugs should post-MI patients routinely receive? | The Journal of family practice 20100901 |
| Effects of lipid-lowering drugs on reverse cholesterol transport gene expressions in peripheral blood mononuclear and HepG2 cells. | Pharmacogenomics 20100901 |
| Statin loading before percutaneous coronary intervention: proposed mechanisms and applications. | Future cardiology 20100901 |
| Quantitative determination of atorvastatin and ortho-hydroxy atorvastatin in human plasma by liquid chromatography tandem mass spectrometry and pharmacokinetic evaluation. | Methods and findings in experimental and clinical pharmacology 20100901 |
| [Statin reduced triglyceride level via activating peroxisome proliferator activated receptor α and upregulating apolipoprotein A5 in hypertriglyceridemic rats]. | Zhonghua xin xue guan bing za zhi 20100901 |
| Impact of 6 weeks of treatment with low-dose metformin and atorvastatin on glucose-induced changes of endothelial function in adults with newly diagnosed type 2 diabetes mellitus: A single-blind study. | Clinical therapeutics 20100901 |
| Statins and altered glucose metabolism: a laboratory curiosity or a new disease? | Journal of the American College of Cardiology 20100817 |
| On-statin cholesteryl ester transfer protein mass and risk of recurrent coronary events (from the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22 [PROVE IT-TIMI 22] study). | The American journal of cardiology 20100815 |
| Statins for the treatment of dementia. | The Cochrane database of systematic reviews 20100804 |
| Influence of atorvastatin on blood pressure control in treated hypertensive, normolipemic patients - An open, pilot study. | Blood pressure 20100801 |
| Regulation of vascular smooth muscle cell proliferation by nuclear orphan receptor Nur77. | Molecular and cellular biochemistry 20100801 |
| Atorvastatin preconditioning attenuates the production of endothelin-1 and prevents experimental vasospasm in rats. | Acta neurochirurgica 20100801 |
| Atorvastatin affects TLR4 clustering via lipid raft modulation. | International immunopharmacology 20100801 |
| Atorvastatin protects against angiotensin II-induced injury and dysfunction in human umbilical vein endothelial cells through bradykinin 2 receptors. | Journal of cardiovascular pharmacology 20100801 |
| Antioxidant, antinociceptive and anti-inflammatory activities of atorvastatin and rosuvastatin in various experimental models. | Inflammopharmacology 20100801 |
| Neuroprotective effect of atorvastatin in an experimental model of nerve crush injury. | Neurosurgery 20100801 |
| Comparison of atorvastatin 80 mg/day versus simvastatin 20 to 40 mg/day on frequency of cardiovascular events late (five years) after acute myocardial infarction (from the Incremental Decrease in End Points through Aggressive Lipid Lowering [IDEAL] trial). | The American journal of cardiology 20100801 |
| A pilot double-blind randomised placebo-controlled trial of the effects of fixed-dose combination therapy ('polypill') on cardiovascular risk factors. | International journal of clinical practice 20100801 |
| Beneficial effects of atorvastatin on lung structural remodeling and function in ischemic heart failure. | Journal of cardiac failure 20100801 |
| Atorvastatin therapy is associated with improvement of oxidized low-density lipoprotein cholesterol levels, which correlates with the degree of stenosis in patients with carotid atheromatosis with and without prior angioplasty. | International angiology : a journal of the International Union of Angiology 20100801 |
| Incomparable effectiveness--apples to apples? | Mayo Clinic proceedings 20100801 |
| Short-term treatment with high-dose atorvastatin reduces LDL cholesterol but shows no anti-inflammatory effects in normolipidemic subjects with normal CRP levels. | Clinical and translational science 20100801 |
| The effect of statin therapy on stimulation of endothelium-derived nitric oxide before and after coronary artery bypass surgery. | The heart surgery forum 20100801 |
| Amlodipine + atorvastatin single pill is the most effective choice for primary prevention. | Cardiovascular journal of Africa 20100801 |
| Switching to aggressive statin improves vascular endothelial function in patients with stable coronary artery disease. | Journal of atherosclerosis and thrombosis 20100730 |
| C-reactive protein (CRP) up-regulates expression of receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in THP-1 cells: inhibitory effects of atorvastatin. | International journal of cardiology 20100723 |
| Effect of atorvastatin on circulating hsCRP concentrations: a sub-study of the achieve cholesterol targets fast with atorvastatin stratified titration (ACTFAST) study. | International journal of cardiology 20100723 |
| Expression of miR-146a/b is associated with the Toll-like receptor 4 signal in coronary artery disease: effect of renin-angiotensin system blockade and statins on miRNA-146a/b and Toll-like receptor 4 levels. | Clinical science (London, England : 1979) 20100723 |
| Effect of ezetimibe/atorvastatin combination on oxidized low density lipoprotein cholesterol in patients with coronary artery disease or coronary artery disease equivalent. | The American journal of cardiology 20100715 |
| [Managing myocardial infarct in general practice]. | Praxis 20100707 |
| Acute effects of atorvastatin on glomerular filtration rate, tubular function, blood pressure, and vasoactive hormones in patients with type 2 diabetes. | Journal of clinical pharmacology 20100701 |
| Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH. | Journal of gastroenterology 20100701 |
| Evaluation of the lipid lowering ability, anti-inflammatory effects and clinical safety of intensive therapy with Zhibitai, a Chinese traditional medicine. | Atherosclerosis 20100701 |
| Clinical usefulness of AGEs as a biomarker for the attenuation of NASH. | Journal of gastroenterology 20100701 |
| Association between percutaneous coronary intervention and long-term C-reactive protein levels in patients with acute coronary syndromes. | Journal of thrombosis and thrombolysis 20100701 |
| Insulin resistance is associated with increased cholesterol synthesis, decreased cholesterol absorption and enhanced lipid response to statin therapy. | Atherosclerosis 20100701 |
| Aggressive statin treatment, very low serum cholesterol levels and haemorrhagic stroke: is there an association? | Current opinion in cardiology 20100701 |
| The AGEs-RAGE axis and nonalcoholic steatohepatitis: the evidence mounts. | Journal of gastroenterology 20100701 |
| Effects of atorvastatin on the regeneration of pancreatic {beta}-cells after streptozotocin treatment in the neonatal rodent. | American journal of physiology. Endocrinology and metabolism 20100701 |
| Intensive statin therapy: a favorable adjunct to the improvement of small-diameter vascular grafts. | Angiology 20100701 |
| Atorvastatin therapy reduces interferon-regulated chemokine CXCL9 plasma levels in patients with systemic lupus erythematosus. | Lupus 20100701 |
| Incremental cholesterol reduction with ezetimibe/simvastatin, atorvastatin and rosuvastatin in UK General Practice (IN-PRACTICE): randomised controlled trial of achievement of Joint British Societies (JBS-2) cholesterol targets. | International journal of clinical practice 20100701 |
| The influence of Sam-Chil-Geun (Panax notoginseng) on the serum lipid levels and inflammations of rats with hyperlipidemia induced by poloxamer-407. | Yonsei medical journal 20100701 |
| Synergy of mefloquine activity with atorvastatin, but not chloroquine and monodesethylamodiaquine, and association with the pfmdr1 gene. | The Journal of antimicrobial chemotherapy 20100701 |
| Statin loading for acute coronary syndromes. | Current opinion in cardiology 20100701 |
| Effects of atorvastatin versus probucol on low-density lipoprotein subtype distribution and renal function in hyperlipidemic patients with nondiabetic nephropathy. | Renal failure 20100701 |
| Lipid-lowering drugs and heart failure: where do we go after the statin trials? | Current opinion in cardiology 20100701 |
| Atorvastatin: safety and tolerability. | Expert opinion on drug safety 20100701 |
| [Cost-effectiveness analysis of using high doses of atorvastatin for the secondary stroke prevention in Spain]. | Revista de neurologia 20100701 |
| Statin prescribing in the elderly in the Netherlands: a pharmacy database time trend study. | Drugs & aging 20100701 |
| Physiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol? | Pharmacogenomics 20100701 |
| State generic substitution laws can lower drug outlays under Medicaid. | Health affairs (Project Hope) 20100701 |
| Preventing intraperitoneal adhesions with atorvastatin and sodium hyaluronate/carboxymethylcellulose: a comparative study in rats. | American journal of surgery 20100701 |
| Pharmacokinetics and bioequivalence evaluation of two different atorvastatin calcium 10-mg tablets: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy fasted Chinese adult males. | Clinical therapeutics 20100701 |
| Inhibition of tau hyperphosphorylation and beta amyloid production in rat brain by oral administration of atorvastatin. | Chinese medical journal 20100701 |
| Atorvastatin downregulates monocyte CD36 expression, nuclear NFkappaB and TNFalpha levels in type 2 diabetes. | Journal of atherosclerosis and thrombosis 20100630 |
| Statin-induced autophagy by inhibition of geranylgeranyl biosynthesis in prostate cancer PC3 cells. | The Prostate 20100615 |
| The influence of atorvastatin on tendon healing: an experimental study on rabbits. | Orthopedics 20100609 |
| Early intensive statin treatment for six months improves long-term clinical outcomes in patients with acute coronary syndrome (Extended-ESTABLISH trial): a follow-up study. | Atherosclerosis 20100601 |
| Cardiovascular outcomes and their relationships to lipoprotein components in patients with and without chronic kidney disease: results from the IDEAL trial. | Journal of internal medicine 20100601 |
| Effects of atorvastatin 20 mg, rosuvastatin 10 mg, and atorvastatin/ezetimibe 5 mg/5 mg on lipoproteins and glucose metabolism. | Journal of cardiovascular pharmacology and therapeutics 20100601 |
| Effects of clopidogrel on vascular proliferation and apoptosis in an atherosclerotic rabbit model. | Journal of cardiovascular pharmacology 20100601 |
| Solid state characterization of commercial crystalline and amorphous atorvastatin calcium samples. | AAPS PharmSciTech 20100601 |
| Full-dose atorvastatin versus conventional medical therapy after non-ST-elevation acute myocardial infarction in patients with advanced non-revascularisable coronary artery disease. | Current medical research and opinion 20100601 |
| Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin-based regimen in patients undergoing carotid endarterectomy. | Stroke 20100601 |
| Significant increase in systemic exposure of atorvastatin after biliopancreatic diversion with duodenal switch. | Clinical pharmacology and therapeutics 20100601 |
| Diabetes mellitus is a major negative determinant of coronary plaque regression during statin therapy in patients with acute coronary syndrome--serial intravascular ultrasound observations from the Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome Trial (the JAPAN-ACS Trial). | Circulation journal : official journal of the Japanese Circulation Society 20100601 |
| The inhibitory effect of statins on urinary 11-dehydrothromboxane levels. | International angiology : a journal of the International Union of Angiology 20100601 |
| Low density lipoprotein-cholesterol variability in patients with type 2 diabetes taking atorvastatin compared to simvastatin: justification for direct measurement? | Diabetes, obesity & metabolism 20100601 |
| High dose atorvastatin after stroke or transient ischaemic attack (SPARCL)--does every stroke patient in Pakistan deserve a statin? | JPMA. The Journal of the Pakistan Medical Association 20100601 |
| Effects of amlodipine plus atorvastatin association in hypertensive hypercholesterolemic patients. | Expert review of cardiovascular therapy 20100601 |
| Effects of three strong statins (atorvastatin, pitavastatin, and rosuvastatin) on serum uric acid levels in dyslipidemic patients. | Nucleosides, nucleotides & nucleic acids 20100601 |
| Predicted coronary heart disease risk reduction and dual blood pressure/cholesterol goal attainment in patients with hypertension treated in real-world clinical practice. | Journal of clinical hypertension (Greenwich, Conn.) 20100601 |
| Atorvastatin restores the balance between pro-inflammatory and anti-inflammatory mediators in rats with acute myocardial infarction. | European review for medical and pharmacological sciences 20100601 |
| Highly stereoselective hydrogenations--as key-steps in the total synthesis of statins. | Chirality 20100515 |
| Atorvastatin attenuates post-implant tissue degeneration of cardiac prosthetic valve bovine pericardial tissue in a subcutaneous animal model. | International journal of cardiology 20100514 |
| Influence of SCARB1 polymorphisms on serum lipids of hypercholesterolemic individuals treated with atorvastatin. | Clinica chimica acta; international journal of clinical chemistry 20100502 |
| Statins inhibit cyclooxygenase-2 and matrix metalloproteinase-9 in human endothelial cells: anti-angiogenic actions possibly contributing to plaque stability. | Cardiovascular research 20100501 |
| Atorvastatin inhibits homocysteine-induced oxidative stress and apoptosis in endothelial progenitor cells involving Nox4 and p38MAPK. | Atherosclerosis 20100501 |
| Inhibition of C-reactive protein induced expression of matrix metalloproteinases by atorvastatin in THP-1 cells. | Molecular and cellular biochemistry 20100501 |
| Relationships between metabolic syndrome and other baseline factors and the efficacy of ezetimibe/simvastatin and atorvastatin in patients with type 2 diabetes and hypercholesterolemia. | Diabetes care 20100501 |
| Lack of effect of 8 weeks atorvastatin on microvascular endothelial function in patients with systemic sclerosis. | Rheumatology (Oxford, England) 20100501 |
| Identification and assessment of plasma lysozyme as a putative biomarker of atherosclerosis. | Arteriosclerosis, thrombosis, and vascular biology 20100501 |
| Antibodies to platelet factor 4-heparin complex and outcome in hemodialysis patients with diabetes. | Clinical journal of the American Society of Nephrology : CJASN 20100501 |
| A pharmacogenetics-based approach to reduce cardiovascular mortality with the prophylactic use of statins. | Basic & clinical pharmacology & toxicology 20100501 |
| Effect of atorvastatin and ezetimibe treatment on serum lipid profile and oxidative state in rats fed with a high-cholesterol diet. | The American journal of the medical sciences 20100501 |
| Different effects of commonly prescribed statins on abdominal aortic aneurysm wall biology. | European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 20100501 |
| Pretreatment with atorvastatin attenuates lung injury caused by high-stretch mechanical ventilation in an isolated rabbit lung model. | Critical care medicine 20100501 |
| Modeling the 4D Study: statins and cardiovascular outcomes in long-term hemodialysis patients with diabetes. | Clinical journal of the American Society of Nephrology : CJASN 20100501 |
| Atorvastatin reduces tissue damage in rat ovaries subjected to torsion and detorsion: biochemical and histopathologic evaluation. | Naunyn-Schmiedeberg's archives of pharmacology 20100501 |
| Design and rationale of a study in Asia of atorvastatin pretreatment in patients undergoing percutaneous coronary intervention for non-ST elevation acute coronary syndromes. | Journal of cardiology 20100501 |
| Charting new territory by simulated modeling of a clinical trial. | Clinical journal of the American Society of Nephrology : CJASN 20100501 |
| Hypouricemic effect of statins: another pleiotropic benefit? | The Journal of thoracic and cardiovascular surgery 20100501 |
| Approach to the patient who is intolerant of statin therapy. | The Journal of clinical endocrinology and metabolism 20100501 |
| Low-dose versus moderate-dose atorvastatin after acute myocardial infarction: 8-month effects on coronary flow reserve and angiogenic cell mobilisation. | Heart (British Cardiac Society) 20100501 |
| The utility of observational studies in clinical decision making: lessons learned from statin trials. | Postgraduate medicine 20100501 |
| Early outcome of acute ischemic stroke in hyperlipidemic patients under atorvastatin versus simvastatin. | Clinical neuropharmacology 20100501 |
| [Case of branch atheromatous disease presenting capsular warning syndrome]. | Rinsho shinkeigaku = Clinical neurology 20100501 |
| Effect of prostaglandin E1 on TNF-induced vascular inflammation in human umbilical vein endothelial cells. | Canadian journal of physiology and pharmacology 20100501 |
| [A comparative study of the efficacy and safety Zhibitai and atorvastatin]. | Zhonghua nei ke za zhi 20100501 |
| [Effects of atorvastatin calcium on osteopontin in renovascular hypertensive rats]. | Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences 20100418 |
| Statin therapy shortens QTc, QTcd, and improves cardiac function in patients with chronic heart failure. | International journal of cardiology 20100415 |
| Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: down-regulated 12/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability. | Brain research 20100414 |
| Modulation of human T cells signaling transduction by lovastatin. | International journal of cardiology 20100401 |
| Atorvastatin pretreatment augments the effect of metformin in patients with polycystic ovary syndrome (PCOS). | Clinical endocrinology 20100401 |
| Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study. | Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20100401 |
| Effects of atorvastatin on circulating CD34+/CD133+/ CD45- progenitor cells and indices of angiogenesis (vascular endothelial growth factor and the angiopoietins 1 and 2) in atherosclerotic vascular disease and diabetes mellitus. | Journal of internal medicine 20100401 |
| Immunomodulation by atorvastatin upregulates expression of gap junction proteins in coxsackievirus B3 (CVB3)-induced myocarditis. | Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20100401 |
| Atorvastatin increases expression of low-density lipoprotein receptor mRNA in human circulating mononuclear cells. | Clinical and experimental pharmacology & physiology 20100401 |
| Atorvastatin ameliorates inflammatory hyperalgesia in rat model of monoarticular arthritis. | Pharmacological research 20100401 |
| Effect of atorvastatin and diet on non-alcoholic fatty liver disease activity score in hyperlipidemic chickens. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20100401 |
| Von Willebrand disease, angiodysplasia and atorvastatin. | British journal of haematology 20100401 |
| Genetic association of the CCR5 region with lipid levels in at-risk cardiovascular patients. | Circulation. Cardiovascular genetics 20100401 |
| Atorvastatin combined to interferon to verify the efficacy (ACTIVE) in relapsing-remitting active multiple sclerosis patients: a longitudinal controlled trial of combination therapy. | Multiple sclerosis (Houndmills, Basingstoke, England) 20100401 |
| New evidence on pitavastatin: efficacy and safety in clinical studies. | Expert opinion on pharmacotherapy 20100401 |
| Atorvastatin inhibits homocysteine-induced dysfunction and apoptosis in endothelial progenitor cells. | Acta pharmacologica Sinica 20100401 |
| Atorvastatin protects renal function in the rat with acute unilateral ureteral obstruction. | Urology 20100401 |
| A multicenter, eight-week treatment, single-step titration, open-label study assessing the percentage of Korean dyslipidemic patients achieving LDL cholesterol target with atorvastatin starting doses of 10 mg, 20 mg and 40 mg. | Cardiovascular drugs and therapy 20100401 |
| Comparison of effects of simvastatin versus atorvastatin on oxidative stress in patients with coronary heart disease. | Clinical cardiology 20100401 |
| Texture analysis of carotid artery atherosclerosis from three-dimensional ultrasound images. | Medical physics 20100401 |
| In vitro modulation of peroxisome proliferator-activated receptor-gamma and its genes by C-reactive protein. Role of atorvastatin. | Archives of medical research 20100401 |
| Effects of atorvastatin on arterial stiffness in chronic kidney disease: a randomised controlled trial. | Journal of atherosclerosis and thrombosis 20100331 |
| Clinical trial efforts in Alzheimer disease: why test statins? | Neurology 20100323 |
| Randomized controlled trial of atorvastatin in mild to moderate Alzheimer disease: LEADe. | Neurology 20100323 |
| Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients. | Journal of the American College of Cardiology 20100323 |
| Statins in acute coronary syndromes and genetic insight. | Journal of the American College of Cardiology 20100323 |
| Up-regulating PPAR-γ expression and NO concentration, and down-regulating PAI-1 concentration in a rabbit atherosclerotic model: the possible antiatherogenic and antithrombotic effects of atorvastatin. | International journal of cardiology 20100318 |
| Letter by Superko and King regarding article, 'Lipid Treatment Assessment Project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals'. | Circulation 20100309 |
| Atorvastatin protects rat brains against permanent focal ischemia and downregulates HMGB1, HMGB1 receptors (RAGE and TLR4), NF-kappaB expression. | Neuroscience letters 20100308 |
| Effects of atorvastatin on serum soluble receptors for advanced glycation end-products in type 2 diabetes. | Atherosclerosis 20100301 |
| Statins have beneficial effects on platelet free radical activity and intracellular distribution of GTPases in hyperlipidaemia. | Clinical science (London, England : 1979) 20100301 |
| Effect of total saponins of 'panax notoginseng root' on aortic intimal hyperplasia and the expressions of cell cycle protein and extracellular matrix in rats. | Phytomedicine : international journal of phytotherapy and phytopharmacology 20100301 |
| Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment. | Atherosclerosis 20100301 |
| Anti-inflammatory effect of atorvastatin ameliorates insulin resistance in monosodium glutamate-treated obese mice. | Metabolism: clinical and experimental 20100301 |
| Pleiotropic effects of atorvastatin on monocytes in atherosclerotic patients. | Journal of clinical pharmacology 20100301 |
| 2-methoxyestradiol inhibits atorvastatin-induced rounding of human vascular smooth muscle cells. | Journal of cellular physiology 20100301 |
| Atorvastatin-induced cell toxicity in yeast is linked to disruption of protein isoprenylation. | FEMS yeast research 20100301 |
| Beneficial changes of serum calcification markers and contralateral carotid plaques echogenicity after combined carotid artery stenting plus intensive lipid-lowering therapy in patients with bilateral carotid stenosis. | European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 20100301 |
| Atorvastatin attenuates murine anti-glomerular basement membrane glomerulonephritis. | Kidney international 20100301 |
| HMG CoA reductase inhibition and endothelial function in children with chronic kidney disease (CKD)--a pilot study. | Acta paediatrica (Oslo, Norway : 1992) 20100301 |
| Persistent regional diastolic dysfunction after myocardial ischemia and the effect of statin treatment: assessment with two-dimensional radial strain rate. | Echocardiography (Mount Kisco, N.Y.) 20100301 |
| Coronary heart disease risk in patients with stroke or transient ischemic attack and no known coronary heart disease: findings from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. | Stroke 20100301 |
| Comparison of the effects of atorvastatin and simvastatin in women with polycystic ovary syndrome: A prospective, randomized study. | Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20100301 |
| Ezetimibe added to atorvastatin compared with doubling the atorvastatin dose in patients at high risk for coronary heart disease with diabetes mellitus, metabolic syndrome or neither. | Diabetes, obesity & metabolism 20100301 |
| Mechanism of the inhibitory effect of atorvastatin on endoglin expression induced by transforming growth factor-beta1 in cultured cardiac fibroblasts. | European journal of heart failure 20100301 |
| Atorvastatin-induced modulation of monocyte respiratory burst in vivo in patients with IgA nephropathy: a chronic inflammatory kidney disease. | Clinical nephrology 20100301 |
| Comparative efficacy and safety of low-dose pitavastatin versus atorvastatin in patients with hypercholesterolemia. | The Annals of pharmacotherapy 20100301 |
| Distribution of traditional and novel risk factors and their relation to subsequent cardiovascular events in patients with acute coronary syndromes (from the PROVE IT-TIMI 22 trial). | The American journal of cardiology 20100301 |
| Safety and efficacy of ezetimibe added to atorvastatin versus up titration of atorvastatin to 40 mg in Patients > or = 65 years of age (from the ZETia in the ELDerly [ZETELD] study). | The American journal of cardiology 20100301 |
| Atorvastatin attenuates oxidative stress in patients with chronic kidney disease. | Medical science monitor : international medical journal of experimental and clinical research 20100301 |
| Comparative study of low doses of rosuvastatin and atorvastatin on lipid and glycemic control in patients with metabolic syndrome and hypercholesterolemia. | The Korean journal of internal medicine 20100301 |
| Design and rationale of a real-life study to compare treatment strategies for cardiovascular risk factors: the CRUCIAL study. | Postgraduate medicine 20100301 |
| LDL-C goal attainment in patients who remain on atorvastatin or switch to equivalent or non-equivalent doses of simvastatin: a retrospective matched cohort study in clinical practice. | Postgraduate medicine 20100301 |
| Erythromelalgia: a novel postoperative complication. | Foot & ankle international 20100301 |
| Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial. | JACC. Cardiovascular interventions 20100301 |
| High-dose atorvastatin in acute coronary and cerebrovascular syndromes. | JACC. Cardiovascular interventions 20100301 |
| [Effects of atorfastatin on the cognitive function of patients with vascular cognitive impairment and different apolipoprotein E genotypes]. | Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20100301 |
| Pravastatin treatment before coronary artery bypass grafting for reduction of postoperative atrial fibrillation. | General thoracic and cardiovascular surgery 20100301 |
| Effect of atorvastatin on dendritic cells of tubulointerstitium in diabetic rats. | BMB reports 20100301 |
| [The efficasy of atorvastatin in the case of paroxismal atrial fibrillation in patients with ischemic heart disease]. | Georgian medical news 20100301 |
| Comparison of the efficacy of rosuvastatin versus atorvastatin in reducing apolipoprotein B/apolipoprotein A-1 ratio in patients with acute coronary syndrome: results of the CENTAURUS study. | Archives of cardiovascular diseases 20100301 |
| Sensitivity and proportionality assessment of metabolites from microdose to high dose in rats using LC-MS/MS. | Bioanalysis 20100301 |
| Rhabdomyolysis following co-prescription of fusidic acid and atorvastatin. | The journal of the Royal College of Physicians of Edinburgh 20100301 |
| Discovery of safety biomarkers for atorvastatin in rat urine using mass spectrometry based metabolomics combined with global and targeted approach. | Analytica chimica acta 20100219 |
| Effects of atorvastatin 80 mg daily on indices of matrix remodelling in 'high-risk' patients with ischemic heart disease. | International journal of cardiology 20100218 |
| Synergistic actions of atorvastatin with gamma-tocotrienol and celecoxib against human colon cancer HT29 and HCT116 cells. | International journal of cancer 20100215 |
| [Statin-induced dysphagia]. | Ugeskrift for laeger 20100215 |
| Human skeletal muscle drug transporters determine local exposure and toxicity of statins. | Circulation research 20100205 |
| Can statins suppress the development of abdominal aortic aneurysms? A review of the current evidence. | Angiology 20100201 |
| The influence of SLCO1B1 (OATP1B1) gene polymorphisms on response to statin therapy. | The pharmacogenomics journal 20100201 |
| Lack of robust neurologic benefits with simvastatin or atorvastatin treatment after acute thoracic spinal cord contusion injury. | Experimental neurology 20100201 |
| Atorvastatin inhibits gp91phox circulating levels in patients with hypercholesterolemia. | Arteriosclerosis, thrombosis, and vascular biology 20100201 |
| Atorvastatin modulates matrix metalloproteinase expression, activity, and signaling in abdominal aortic aneurysms. | Vascular and endovascular surgery 20100201 |
| Sympathoinhibition induced by centrally administered atorvastatin is associated with alteration of NAD(P)H and Mn superoxide dismutase activity in rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats. | Journal of cardiovascular pharmacology 20100201 |
| Comparison of 80 versus 10 mg of atorvastatin on occurrence of cardiovascular events after the first event (from the Treating to New Targets [TNT] trial). | The American journal of cardiology 20100201 |
| Usefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal disease. | The American journal of cardiology 20100201 |
| Atorvastatin causes regression of endometriotic implants in a rat model. | Reproductive biomedicine online 20100201 |
| Effects of prescription omega-3-acid ethyl esters on non--high-density lipoprotein cholesterol when coadministered with escalating doses of atorvastatin. | Mayo Clinic proceedings 20100201 |
| Achieving cholesterol targets by individualizing starting doses of statin according to baseline low-density lipoprotein cholesterol and coronary artery disease risk category: the CANadians Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (CanACTFAST) study. | The Canadian journal of cardiology 20100201 |
| Atorvastatin increases blood ratios of vitamin E/low-density lipoprotein cholesterol and coenzyme Q10/low-density lipoprotein cholesterol in hypercholesterolemic patients. | Nutrition research (New York, N.Y.) 20100201 |
| [Atorvastatin use and coronary flow reserve in patients with coronary slow flow]. | Zhonghua xin xue guan bing za zhi 20100201 |
| Noninferiority of pitavastatin in intravascular ultrasound findings. | Journal of the American College of Cardiology 20100119 |
| Concerns about heparin therapy for hypertriglyceridemia. | Archives of internal medicine 20100111 |
| Modulating effect of atorvastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy. | Journal of diabetes and its complications 20100101 |
| Protective effect of atorvastatin in cultured osteoarthritic chondrocytes. | Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20100101 |
| Atorvastatin reverses cardiac remodeling possibly through regulation of protein kinase D/myocyte enhancer factor 2D activation in spontaneously hypertensive rats. | Pharmacological research 20100101 |
| Submaximal exercise coronary artery flow increases in postmenopausal women without coronary artery disease after estrogen and atorvastatin. | Menopause (New York, N.Y.) 20100101 |
| Switching from atorvastatin to simvastatin in patients at high cardiovascular risk: effects on low-density lipoprotein cholesterol. | American journal of therapeutics 20100101 |
| FDG-PET can distinguish inflamed from non-inflamed plaque in an animal model of atherosclerosis. | The international journal of cardiovascular imaging 20100101 |
| Comparison of the effects of simvastatin versus atorvastatin on oxidative stress in patients with type 2 diabetes mellitus. | Journal of cardiovascular pharmacology 20100101 |
| UDP-glucuronosyltransferase (UGT) polymorphisms affect atorvastatin lactonization in vitro and in vivo. | Clinical pharmacology and therapeutics 20100101 |
| Atorvastatin treatment lowers fasting remnant-like particle cholesterol and LDL subfraction cholesterol without affecting LDL size in type 2 diabetes mellitus: Relevance for non-HDL cholesterol and apolipoprotein B guideline targets. | Biochimica et biophysica acta 20100101 |
| Influence of genetic variation in CYP3A4 and ABCB1 on dose decrease or switching during simvastatin and atorvastatin therapy. | Pharmacoepidemiology and drug safety 20100101 |
| Atorvastatin inhibits inflammatory angiogenesis in mice through down regulation of VEGF, TNF-alpha and TGF-beta1. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20100101 |
| Atorvastatin increases the number of endothelial progenitor cells after cardiac surgery: a randomized control study. | Journal of cardiovascular pharmacology 20100101 |
| Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization. | Journal of vascular surgery 20100101 |
| Atorvastatin improves the response to sildenafil in hypercholesterolemic men with erectile dysfunction not initially responsive to sildenafil. | International journal of impotence research 20100101 |
| Three-dimensional carotid ultrasound segmentation variability dependence on signal difference and boundary orientation. | Ultrasound in medicine & biology 20100101 |
| New translational research on novel drugs for hepatitis C virus 1b infection by using a replicon system and human induced pluripotent stem cells. | Hepatology (Baltimore, Md.) 20100101 |
| Year two assessment of fenofibric acid and moderate-dose statin combination: a phase 3, open-label, extension study. | Clinical drug investigation 20100101 |
| Atorvastatin improves insulin sensitivity in mice with obesity induced by monosodium glutamate. | Acta pharmacologica Sinica 20100101 |
| Effects of SLCO1B1 and ABCB1 genotypes on the pharmacokinetics of atorvastatin and 2-hydroxyatorvastatin in healthy Korean subjects. | International journal of clinical pharmacology and therapeutics 20100101 |
| Atorvastatin and celecoxib in combination inhibits the progression of androgen-dependent LNCaP xenograft prostate tumors to androgen independence. | Cancer prevention research (Philadelphia, Pa.) 20100101 |
| Cost effectiveness of atorvastatin in patients with type 2 diabetes mellitus: a pharmacoeconomic analysis of the collaborative atorvastatin diabetes study in the belgian population. | Clinical drug investigation 20100101 |
| Monocyte expression of adhesion molecules during low- and high-flux polysulfone hemodialysis and the effect of atorvastatin administration. | Blood purification 20100101 |
| Inflammatory signaling in pulmonary arterial hypertension: the controversial role of CRP, and the search for new therapies. | Cardiovascular therapeutics 20100101 |
| Atorvastatin decreases C-reactive protein-induced inflammatory response in pulmonary artery smooth muscle cells by inhibiting nuclear factor-kappaB pathway. | Cardiovascular therapeutics 20100101 |
| Meta-analysis of comparative efficacy of increasing dose of Atorvastatin versus Rosuvastatin versus Simvastatin on lowering levels of atherogenic lipids (from VOYAGER). | The American journal of cardiology 20100101 |
| Efficacy and safety of fenofibric acid co-administered with low- or moderate-dose statin in patients with mixed dyslipidemia and type 2 diabetes mellitus: results of a pooled subgroup analysis from three randomized, controlled, double-blind trials. | American journal of cardiovascular drugs : drugs, devices, and other interventions 20100101 |
| [Non-ST-elevation acute coronary syndrome. Comparison of effects of atorvastatin and rosuvastatin on blood levels of lipids and markers of inflammation]. | Kardiologiia 20100101 |
| Atorvastatin-induced prolonged cholestasis with bile duct damage. | Clinical drug investigation 20100101 |
| Influence of co-existing atrial fibrillation on the efficacy of atorvastatin treatment in patients with dilated cardiomyopathy: a pilot study. | Lipids in health and disease 20100101 |
| Atorvastatin reduces plaque vulnerability in an atherosclerotic rabbit model by altering the 5-lipoxygenase pathway. | Cardiology 20100101 |
| Effects of statins on regeneration of olfactory epithelium. | American journal of rhinology & allergy 20100101 |
| Genome-wide association of lipid-lowering response to statins in combined study populations. | PloS one 20100101 |
| Role of glucagon-like peptide- 1 in vascular endothelial dysfunction. | Indian journal of experimental biology 20100101 |
| Effect of atorvastatin on cellular adhesion molecules on leukocytes in patients with normocholesterolemic coronary artery disease. | In vivo (Athens, Greece) 20100101 |
| [Analysis of the budget impact for the Spanish National Health System of the fixed combination of amlodipine 5 or 10mg and atorvastatin 10mg]. | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20100101 |
| Does a single-pill antihypertensive/lipid-lowering regimen improve adherence in US managed care enrolees? A non-randomized, observational, retrospective study. | American journal of cardiovascular drugs : drugs, devices, and other interventions 20100101 |
| Atorvastatin in stroke: a review of SPARCL and subgroup analysis. | Vascular health and risk management 20100101 |
| Cardiovascular computed tomographic assessment of the effect of combination lipoprotein therapy on coronary arterial plaque: rationale and design of the AFRICA (Atorvastatin plus Fenofibric acid in the Reduction of Intermediate Coronary Atherosclerosis) study. | Journal of cardiovascular computed tomography 20100101 |
| Recent trials in critical care nephrology. | Contributions to nephrology 20100101 |
| Effect of atorvastatin on haemostasis, fibrinolysis and inflammation in normocholesterolaemic patients with coronary artery disease: a post hoc analysis of data from a prospective, randomized, double-blind study. | Clinical drug investigation 20100101 |
| [Investigation of the in vitro antibacterial effects of statins]. | Mikrobiyoloji bulteni 20100101 |
| [Possibilities of atorvastatin in complex management of extensive psoriasis in patients with arterial hypertension]. | Kardiologiia 20100101 |
| Pitavastatin: the newest HMG-CoA reductase inhibitor. | Reviews in cardiovascular medicine 20100101 |
| Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against Plasmodium falciparum. | Malaria journal 20100101 |
| Atorvastatin for diabetic macular edema in patients with diabetes mellitus and elevated serum cholesterol. | Ophthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye 20100101 |
| From CARDS to AURORA: one disease, two responses. | Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese 20100101 |
| Association between adherence to calcium-channel blocker and statin medications and likelihood of cardiovascular events among US managed care enrollees. | BMC cardiovascular disorders 20100101 |
| Effect of genetic variant (rs11887534) in ABCG8 gene in coronary artery disease and response to atorvastatin therapy. | Disease markers 20100101 |
| A randomized clinical trial to assess the effect of statins on skeletal muscle function and performance: rationale and study design. | Preventive cardiology 20100101 |
| Development and validation of a reversed-phase high-performance thin-layer chromatography-densitometric method for determination of atorvastatin calcium in bulk drug and tablets. | Journal of AOAC International 20100101 |
| Immediate effect of intensive atorvastatin therapy on lipid parameters in patients with acute coronary syndrome. | Lipids in health and disease 20100101 |
| [How to increase the adherence to treatment of patients with arterial hypertension and dyslipidemia: focus on fixed combination of amlodipine and atorvastatin]. | Kardiologiia 20100101 |
| Atorvastatin induced multiple organ failure. | The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society 20100101 |
| Clinical implications of the cytokine hypothesis of depression: the association between use of statins and aspirin and the risk of major depression. | Psychotherapy and psychosomatics 20100101 |
| The effect of early and intensive statin therapy on ventricular premature beat or non-sustained ventricular tachycardia in patients with acute coronary syndrome. | Cardiology journal 20100101 |
| Atorvastatin pretreatment diminishes the levels of myocardial ischemia markers early after CABG operation: an observational study. | Journal of cardiothoracic surgery 20100101 |
| Effect of atorvastatin on aldosterone production induced by glucose, LDL or angiotensin II in human renal mesangial cells. | Arzneimittel-Forschung 20100101 |
| [Effect of atorvastatin on hemorheological parameters in patients with arterial hypertension with dyslipidemia]. | Kardiologiia 20100101 |
| Changes in cognition and amyloid-β processing with long term cholesterol reduction using atorvastatin in aged dogs. | Journal of Alzheimer's disease : JAD 20100101 |
| Comprehension and informed consent: assessing the effect of a short consent form. | IRB 20100101 |
| Effects of atorvastatin on development of peritoneal fibrosis in rats on peritoneal dialysis. | Renal failure 20100101 |
| Protective effect of atorvastatin on radiation-induced vascular endothelial cell injury in vitro. | Journal of radiation research 20100101 |
| [Effect of atorvastatin (liptonorm) on indicators of the lipid spectrum of blood in patients with the metabolic syndrome]. | Advances in gerontology = Uspekhi gerontologii 20100101 |
| Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol. | PloS one 20100101 |
| Atorvastatin improves tubular status in non-diabetic patients with chronic kidney disease - placebo controlled, randomized, cross-over study. | Acta biochimica Polonica 20100101 |
| Effects of atorvastatin and losartan on monocrotaline-induced pulmonary artery remodeling in rats. | Clinical and experimental hypertension (New York, N.Y. : 1993) 20100101 |
| Hypotensive effect of atorvastatin is not related to changes in inflammation and oxidative stress. | Pharmacological reports : PR 20100101 |
| [Individual pharmacotherapy safety in the assessment of cytochrome P-450 3A4 (CYP3A4) isoenzyme activity]. | Klinicheskaia meditsina 20100101 |
| [Atorvastatin in the treatment of high risk patients with ischemic heart disease and dyslipidemia. Safety assessment in the Russian Multicenter Study ATLANTIKA]. | Kardiologiia 20100101 |
| Are post-treatment low-density lipoprotein subclass pattern analyses potentially misleading? | Lipids in health and disease 20100101 |
| Re: Superiority of apolipoprotein B (apoB) over low-density lipoprotein cholesterol (LDL-C) in treatment of hyperlipidemia. | Journal of clinical lipidology 20100101 |
| Switching from high-efficacy lipid-lowering therapies to simvastatin and low-density lipoprotein cholesterol goal attainment in coronary heart disease/coronary heart disease-equivalent patients. | Journal of clinical lipidology 20100101 |
| Pitavastatin approved for treatment of primary hypercholesterolemia and combined dyslipidemia. | Vascular health and risk management 20100101 |
| Simultaneous determination of atorvastatin calcium and ramipril in capsule dosage forms by high-performance liquid chromatography and high-performance thin layer chromatography. | Journal of AOAC International 20100101 |
| Atorvastatin reduces proteinuria in non-diabetic chronic kidney disease patients partly via lowering serum levels of advanced glycation end products (AGEs). | Oxidative medicine and cellular longevity 20100101 |
| Atorvastatin improves survival in septic rats: effect on tissue inflammatory pathway and on insulin signaling. | PloS one 20100101 |
| Statins inhibit angiotensin II/Smad pathway and related vascular fibrosis, by a TGF-β-independent process. | PloS one 20100101 |
| Long term observation of thin-cap fibroatheroma by optical coherence tomography. | Cardiology journal 20100101 |
| Atorvastatin prevents left ventricular remodeling in spontaneously hypertensive rats. | International heart journal 20100101 |
| Combination of niacin extended-release and simvastatin results in a less atherogenic lipid profile than atorvastatin monotherapy. | Vascular health and risk management 20100101 |
| Effect of Atorvastatin in radiographic density on alveolar bone loss in wistar rats. | Brazilian dental journal 20100101 |
| Anti-inflammatory effect of atorvastatin in patients with aortic sclerosis or mild aortic stenosis independent of hypercholesterolemia. | Pharmacological reports : PR 20100101 |
| Short-term therapy with high dose atorvastatin in patients with coronary artery disease can reduce inflammatory process. | Acta medica Iranica 20100101 |
| Hypocholesterolemia secondary to atrovastatin therapy. | Journal of Ayub Medical College, Abbottabad : JAMC 20100101 |
| Atorvastatin-related thrombocytopenic purpura. | BMJ case reports 20100101 |
| Quantitation of atorvastatin in human plasma using directly suspended acceptor droplet in liquid-liquid-liquid microextraction and high-performance liquid chromatography-ultraviolet detection. | Talanta 20091215 |
| Effect of atorvastatin on platelet thromboxane A(2) synthesis in aspirin-treated patients with acute myocardial infarction. | The American journal of cardiology 20091215 |
| Total cardiovascular disease burden: comparing intensive with moderate statin therapy insights from the IDEAL (Incremental Decrease in End Points Through Aggressive Lipid Lowering) trial. | Journal of the American College of Cardiology 20091215 |
| Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) trial. | Journal of the American College of Cardiology 20091215 |
| Cardiovascular outcomes in randomized trials: should time to first event for 'hard' end points remain the standard approach? | Journal of the American College of Cardiology 20091215 |
| Effect of intensive statin therapy on clinical outcomes among patients undergoing percutaneous coronary intervention for acute coronary syndrome. PCI-PROVE IT: A PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) Substudy. | Journal of the American College of Cardiology 20091208 |
| Isolation and structure determination of oxidative degradation products of atorvastatin. | Journal of pharmaceutical and biomedical analysis 20091205 |
| Novel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarction. | Journal of the American College of Cardiology 20091201 |
| Atorvastatin restores the impaired vascular endothelium-dependent relaxations mediated by nitric oxide and endothelium-derived hyperpolarizing factors but not hypotension in sepsis. | Journal of cardiovascular pharmacology 20091201 |
| Angiotensin type 1 receptor expression and interleukin-8 production in polymorphonuclear leukocytes of patients with peripheral arterial disease. | Journal of cardiovascular pharmacology 20091201 |
| Effect of preoperative atorvastatin therapy on atrial fibrillation following off-pump coronary artery bypass grafting. | Circulation journal : official journal of the Japanese Circulation Society 20091201 |
| Usefulness of aggressive lipid-lowering therapy with rosuvastatin in hypercholesterolemic patients with concomitant type 2 diabetes. | Endocrine 20091201 |
| Low-density lipoprotein cholesterol reduction and goal achievement with ezetimibe/simvastatin versus atorvastatin or rosuvastatin in patients with diabetes, metabolic syndrome, or neither disease, stratified by National Cholesterol Education Program risk category. | Metabolic syndrome and related disorders 20091201 |
| Dual effect of statin medication on the periodontium. | Journal of clinical periodontology 20091201 |
| The influence of atorvastatin on parameters of inflammation and function of the left ventricle in patients with dilated cardiomyopathy. | Medical science monitor : international medical journal of experimental and clinical research 20091201 |
| Is initiation of atorvastatin for employees a good buy for employers? | Mayo Clinic proceedings 20091201 |
| Cardiovascular and economic outcomes after initiation of lipid-lowering therapy with atorvastatin vs simvastatin in an employed population. | Mayo Clinic proceedings 20091201 |
| Efflux transporter-mediated interactions with atorvastatin--interesting findings with multiple substrates: istradefylline, verapamil, and rifampicin. | Journal of clinical pharmacology 20091201 |
| Montelukast inhibits matrix metalloproteinases expression in atherosclerotic rabbits. | Cardiovascular drugs and therapy 20091201 |
| Assessment of arterial stiffness affected by atorvastatin in coronary artery disease using pulse wave velocity. | Clinical and investigative medicine. Medecine clinique et experimentale 20091201 |
| Efficacy of combination drug pulse therapy in maintaining lipid levels in patients intolerant of daily statin use. | Journal of clinical hypertension (Greenwich, Conn.) 20091201 |
| Omega-3 fatty acids and atorvastatin affect connexin 43 expression in the aorta of hereditary hypertriglyceridemic rats. | Canadian journal of physiology and pharmacology 20091201 |
| Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: a 12-week, multicenter, double-blind, randomized, parallel-group study. | Clinical therapeutics 20091201 |
| Unexplained high fever in an elderly patient treated with clonidine, duloxetine, and atorvastatin. | Clinical therapeutics 20091201 |
| [Effect of atorvastatin on postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting]. | Zhonghua yi xue za zhi 20091117 |
| Multi-residue method for trace level determination of pharmaceuticals in solid samples using pressurized liquid extraction followed by liquid chromatography/quadrupole-linear ion trap mass spectrometry. | Talanta 20091115 |
| Atorvastatin attenuates NF-kappaB activation in trigeminal nucleus caudalis in a rat model of migraine. | Neuroscience letters 20091106 |
| Additive beneficial effects of amlodipine and atorvastatin in reversing advanced cardiac hypertrophy in elderly spontaneously hypertensive rats. | Clinical and experimental pharmacology & physiology 20091101 |
| Regulation of steroid 5-alpha reductase type 2 (Srd5a2) by sterol regulatory element binding proteins and statin. | Experimental cell research 20091101 |
| Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS). | American journal of kidney diseases : the official journal of the National Kidney Foundation 20091101 |
| Statins inhibit Akt/PKB signaling via P2X7 receptor in pancreatic cancer cells. | Biochemical pharmacology 20091101 |
| Influence of statin treatment on platelet inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment. | Journal of internal medicine 20091101 |
| Population analyses of atorvastatin clearance in patients living in the community and in nursing homes. | Clinical pharmacology and therapeutics 20091101 |
| Serum adiponectin is decreased in patients with familial combined hyperlipidemia and normolipaemic relatives and is influenced by lipid-lowering treatment. | Nutrition, metabolism, and cardiovascular diseases : NMCD 20091101 |
| Atorvastatin extends the therapeutic window for tPA to 6 h after the onset of embolic stroke in rats. | Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20091101 |
| Three-dimensional ultrasound quantification of intensive statin treatment of carotid atherosclerosis. | Ultrasound in medicine & biology 20091101 |
| Regulatory effects of fenofibrate and atorvastatin on lipoprotein A-I and lipoprotein A-I:A-II kinetics in the metabolic syndrome. | Diabetes care 20091101 |
| Atorvastatin treatment is associated with less augmentation of the carotid pressure waveform in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT). | Hypertension (Dallas, Tex. : 1979) 20091101 |
| Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20091101 |
| A multi-center, open label, crossover designed prospective study evaluating the effects of lipid lowering treatment on steroid synthesis in patients with Type 2 diabetes (MODEST Study). | Journal of endocrinological investigation 20091101 |
| Drug-induced liver injury associated with statins. | Seminars in liver disease 20091101 |
| Reporter gene PET for monitoring survival of transplanted endothelial progenitor cells in the rat heart after pretreatment with VEGF and atorvastatin. | Journal of nuclear medicine : official publication, Society of Nuclear Medicine 20091101 |
| Occurrence and fate of rosuvastatin, rosuvastatin lactone, and atorvastatin in Canadian sewage and surface water samples. | Chemosphere 20091101 |
| NADPH oxidase isoforms and anti-hypertensive effects of atorvastatin demonstrated in two animal models. | Journal of pharmacological sciences 20091101 |
| Economic evaluation of high-dose (80 mg/day) atorvastatin treatment compared with standard-dose (20 mg/day to 40 mg/day) simvastatin treatment in Canada based on the Incremental Decrease in End-Points Through Aggressive Lipid-Lowering (IDEAL) trial. | The Canadian journal of cardiology 20091101 |
| Impact of chronic anticholesterol therapy on development of microvascular rarefaction in the metabolic syndrome. | Microcirculation (New York, N.Y. : 1994) 20091101 |
| Atorvastatin mediates increases in intralesional BAX and BAK expression in human end-stage abdominal aortic aneurysms. | Canadian journal of physiology and pharmacology 20091101 |
| Atorvastatin improves the impaired baroreflex sensitivity via anti-oxidant effect in the rostral ventrolateral medulla of SHRSP. | Clinical and experimental hypertension (New York, N.Y. : 1993) 20091101 |
| Efficacy of low dose atorvastatin in diabetic dyslipidaemia. | Journal of the Indian Medical Association 20091101 |
| The SLCO1B1*5 genetic variant is associated with statin-induced side effects. | Journal of the American College of Cardiology 20091020 |
| Endogenous tissue plasminogen activator and risk of recurrent cardiac events after an acute coronary syndrome in the MIRACL study. | Atherosclerosis 20091001 |
| Short-term 20-mg atorvastatin therapy reduces key inflammatory factors including c-Jun N-terminal kinase and dendritic cells and matrix metalloproteinase expression in human abdominal aortic aneurysmal wall. | Atherosclerosis 20091001 |
| Counter-regulation by atorvastatin of gene modulations induced by L-NAME hypertension is associated with vascular protection. | Vascular pharmacology 20091001 |
| Atorvastatin improves endothelial function and cardiac performance in patients with dilated cardiomyopathy: the role of inflammation. | Cardiovascular drugs and therapy 20091001 |
| Simvastatin and atorvastatin improve neurological outcome after experimental intracerebral hemorrhage. | Stroke 20091001 |
| Arterial destiffening with atorvastatin in overweight and obese middle-aged and older adults. | Hypertension (Dallas, Tex. : 1979) 20091001 |
| Atorvastatin ameliorates tubulointerstitial fibrosis and protects renal function in chronic partial ureteral obstruction cases. | The Journal of urology 20091001 |
| Atorvastatin and fenofibrate increase apolipoprotein AV and decrease triglycerides by up-regulating peroxisome proliferator-activated receptor-alpha. | British journal of pharmacology 20091001 |
| Atorvastatin attenuates homocysteine-induced apoptosis in human umbilical vein endothelial cells via inhibiting NADPH oxidase-related oxidative stress-triggered p38MAPK signaling. | Acta pharmacologica Sinica 20091001 |
| Rationale and design of China intensive lipid lowering with statins in acute coronary syndrome: the CHILLAS study. | American heart journal 20091001 |
| Atorvastatin enhances humoral immune responses but does not alter renal injury in experimental crescentic glomerulonephritis. | Nephrology (Carlton, Vic.) 20091001 |
| Amlodipine/Atorvastatin single-pill therapy for blood pressure and lipid goals in African Americans: influence of the metabolic syndrome and type 2 diabetes mellitus. | Journal of clinical hypertension (Greenwich, Conn.) 20091001 |
| 18F-4V for PET-CT imaging of VCAM-1 expression in atherosclerosis. | JACC. Cardiovascular imaging 20091001 |
| Results of a Markov model analysis to assess the cost-effectiveness of a single tablet of fixed-dose amlodipine and atorvastatin for the primary prevention of cardiovascular disease in Korea. | Clinical therapeutics 20091001 |
| [The last round about statins: there is the fact that 80 mg simvastatin daily results in high risk of myopathy]. | Lakartidningen 20091001 |
| [Effects of atorvastatin, alone and in combination with probucol on endothelial function in patients with acute coronary syndrome]. | Zhonghua xin xue guan bing za zhi 20091001 |
| Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis. | Neurology 20090929 |
| [The ram and the oat bag]. | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20090924 |
| Acute effects of statin therapy on coronary atherosclerosis following an acute coronary syndrome. | The American journal of cardiology 20090915 |
| Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack. | Neurology 20090908 |
| The results support the use of atorvastatin in elderly patients with recent stroke or TIA. | Neurology 20090908 |
| Markers of inflammation, thrombosis and endothelial activation correlate with carotid IMT regression in stable coronary disease after atorvastatin treatment. | Nutrition, metabolism, and cardiovascular diseases : NMCD 20090901 |
| Beneficial effect of atorvastatin on erythropoietin responsiveness in maintenance haemodialysis patients. | Nephrology (Carlton, Vic.) 20090901 |
| Protein extraction of formalin-fixed, paraffin-embedded tissue enables robust proteomic profiles by mass spectrometry. | The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 20090901 |
| Selective prescribing of simvastatin and atorvastatin by patient characteristics at treatment initiation over a 7-year period in Finland. | European journal of clinical pharmacology 20090901 |
| Economic evaluation of atorvastatin for prevention of recurrent stroke based on the SPARCL trial. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20090901 |
| Significantly altered systemic exposure to atorvastatin acid following gastric bypass surgery in morbidly obese patients. | Clinical pharmacology and therapeutics 20090901 |
| Effect of ezetimibe/simvastatin compared with atorvastatin on lipoprotein subclasses in patients with type 2 diabetes and hypercholesterolaemia. | Diabetes, obesity & metabolism 20090901 |
| Statins and gender-related difference in endothelial function in cerebral small vessel disease. | Stroke 20090901 |
| Placebo-controlled trial of high-dose atorvastatin in patients with severe cerebral small vessel disease. | Stroke 20090901 |
| Atorvastatin induces thrombomodulin expression in the aorta of cholesterol-fed rabbits and in TNFalpha-treated human aortic endothelial cells. | Histology and histopathology 20090901 |
| Identification of genetic variants associated with response to statin therapy. | Arteriosclerosis, thrombosis, and vascular biology 20090901 |
| Topical atorvastatin in the treatment of diabetic wounds. | The American journal of the medical sciences 20090901 |
| Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study. | The American journal of cardiology 20090901 |
| Seasonal variation in lipids: should we consider it more? | The American journal of cardiology 20090901 |
| Rhabdomyolysis a result of azithromycin and statins: an unrecognized interaction. | British journal of clinical pharmacology 20090901 |
| Effect of atorvastatin on activities of matrix metalloproteinases and chitotriosidase in male and female mice with experimental hyperlipidemia. | Bulletin of experimental biology and medicine 20090901 |
| Diabetic foot ulcer burden may be modified by high-dose atorvastatin: A 6-month randomized controlled pilot trial. | Journal of diabetes 20090901 |
| Assessing the matrix effects of hemolyzed samples in bioanalysis. | Bioanalysis 20090901 |
| [Comparison on long-term effects of atorvastatin or pravastatin combined with clopidogrel for patients undergoing coronary stenting: a randomized controlled trial]. | Zhonghua yi xue za zhi 20090825 |
| Facile preparation of monodisperse pharmaceutical colloidal spheres of atorvastatin calcium via self-assembly. | Small (Weinheim an der Bergstrasse, Germany) 20090817 |
| Heparin treatment for severe hypertriglyceridemia in diabetic ketoacidosis. | Archives of internal medicine 20090810 |
| Efficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Damage During Angioplasty) Randomized Trial. | Journal of the American College of Cardiology 20090804 |
| Comparative effects of atorvastatin and simvastatin on the plasma total homocysteine levels in women with polycystic ovary syndrome: a prospective randomized study. | Fertility and sterility 20090801 |
| Atorvastatin efficiency after traumatic brain injury in rats. | Surgical neurology 20090801 |
| Statins inhibit Rho kinase activity in patients with atherosclerosis. | Atherosclerosis 20090801 |
| Plasma pre beta-HDL formation is decreased by atorvastatin treatment in type 2 diabetes mellitus: Role of phospholipid transfer protein. | Biochimica et biophysica acta 20090801 |
| Statins normalize vascular lysyl oxidase down-regulation induced by proatherogenic risk factors. | Cardiovascular research 20090801 |
| International open-label studies to assess the efficacy and safety of single-pill amlodipine/atorvastatin in attaining blood pressure and lipid targets recommended by country-specific guidelines: the JEWEL programme. | European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 20090801 |
| [Metabolic rhabdomyolysis during statin therapy]. | La Revue de medecine interne 20090801 |
| ABCG2 polymorphism markedly affects the pharmacokinetics of atorvastatin and rosuvastatin. | Clinical pharmacology and therapeutics 20090801 |
| Early atorvastatin reduces hemorrhage after acute cerebral ischemia in diabetic rats. | The Journal of pharmacology and experimental therapeutics 20090801 |
| Atorvastatin prevents hippocampal cell death due to quinolinic acid-induced seizures in mice by increasing Akt phosphorylation and glutamate uptake. | Neurotoxicity research 20090801 |
| Autocrine amplification loop in statin-induced apoptosis of human melanoma cells. | British journal of pharmacology 20090801 |
| Fluvastatin inhibits expression of the chemokine MDC/CCL22 induced by interferon-gamma in HaCaT cells, a human keratinocyte cell line. | British journal of pharmacology 20090801 |
| Aortic and mitral valve replacement with reconstruction of the intervalvular fibrous body in familial hypercholesterolemia. | The Thoracic and cardiovascular surgeon 20090801 |
| Rationale and design of assessment of lipophilic vs. hydrophilic statin therapy in acute myocardial infarction (the ALPS-AMI) study. | Journal of cardiology 20090801 |
| Right ventricular function in ST elevation myocardial infarction: effect of reperfusion. | Clinical and investigative medicine. Medecine clinique et experimentale 20090801 |
| Atorvastatin modulates Th1/Th2 response in patients with chronic heart failure. | Journal of cardiac failure 20090801 |
| Effects of atorvastatin on angiogenesis in hindlimb ischemia and endothelial progenitor cell formation in rats. | Journal of atherosclerosis and thrombosis 20090801 |
| [Effects of probucol, aspirin and atorvastatin combination therapy upon atherosclerosis]. | Zhonghua yi xue za zhi 20090728 |
| Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study). | Journal of the American College of Cardiology 20090721 |
| Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack. | Neurology 20090721 |
| Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack. | Neurology 20090721 |
| Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats. | Maturitas 20090720 |
| Combined use of extended-release niacin and atorvastatin: safety and effects on lipid modification. | Chinese medical journal 20090720 |
| Antihyperlipidemic effect of the methanolic extract from Lagenaria siceraria Stand. fruit in hyperlipidemic rats. | Journal of ethnopharmacology 20090715 |
| Ultra high performance liquid chromatography tandem mass spectrometric detection in clinical analysis of simvastatin and atorvastatin. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20090715 |
| Hypothyroidism misdiagnosed as statin intolerance. | Annals of internal medicine 20090707 |
| Changes in adiponectin multimer distribution in response to atorvastatin treatment in patients with type 2 diabetes. | Clinical endocrinology 20090701 |
| Cost-effectiveness of intensive atorvastatin therapy in secondary cardiovascular prevention in the United Kingdom, Spain, and Germany, based on the Treating to New Targets study. | The European journal of health economics : HEPAC : health economics in prevention and care 20090701 |
| Regression of Achilles tendon thickness after statin treatment in patients with familial hypercholesterolemia: an ultrasonographic study. | Atherosclerosis 20090701 |
| Anti-atherogenic effects of montelukast associated with reduced MCP-1 expression in a rabbit carotid balloon injury model. | Atherosclerosis 20090701 |
| Flow-mediated dilation in patients with coronary artery disease is enhanced by high dose atorvastatin compared to combined low dose atorvastatin and ezetimibe: results of the CEZAR study. | Atherosclerosis 20090701 |
| Effects of cholesteryl ester transfer protein inhibition on apolipoprotein A-II-containing HDL subspecies and apolipoprotein A-II metabolism. | Journal of lipid research 20090701 |
| Effects of intensive atorvastatin and rosuvastatin treatment on apolipoprotein B-48 and remnant lipoprotein cholesterol levels. | Atherosclerosis 20090701 |
| Ezetimibe and atorvastatin both immunoregulate CD4+ T cells from cardiac transplant recipients invitro. | Transplant immunology 20090701 |
| Rifampicin alters atorvastatin plasma concentration on the basis of SLCO1B1 521T>C polymorphism. | Clinica chimica acta; international journal of clinical chemistry 20090701 |
| Statin effects on LDL and HDL cholesterol in South Asian and white populations. | Journal of clinical pharmacology 20090701 |
| Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress. | Hypertension (Dallas, Tex. : 1979) 20090701 |
| Relative and cumulative effects of lipid and blood pressure control in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels trial. | Stroke 20090701 |
| Review of the SPARCL trial and its subanalyses. | Current atherosclerosis reports 20090701 |
| Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein. | Expert opinion on therapeutic targets 20090701 |
| Determination of atorvastatin and its metabolite ortho-hydroxyatorvastatin in human plasma by on-line anion-exchange solid-phase extraction and liquid chromatography tandem mass spectrometry. | Analytical and bioanalytical chemistry 20090701 |
| The expression of efflux and uptake transporters are regulated by statins in Caco-2 and HepG2 cells. | Acta pharmacologica Sinica 20090701 |
| Lipid reduction in acute coronary syndrome: how much, when, and how? | Current cardiology reports 20090701 |
| Renal and liver tumors in Tsc2(+/-) mice, a model of tuberous sclerosis complex, do not respond to treatment with atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. | Molecular cancer therapeutics 20090701 |
| Lipid profile changes associated with changing available formulary statins: removing higher potency agents. | The American journal of managed care 20090701 |
| Serum levels of lipoprotein(a) and homocysteine in patients on hemodialysis who take hydroxymethylglutaryl-CoA reductase inhibitors, vitamin B6, and folic acid. | Iranian journal of kidney diseases 20090701 |
| [Effect of atorvastatin on inflammatory infiltration in the lung of rabbits with hypercholesterolemia]. | Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20090701 |
| I've heard that high-fat foods and alcohol can raise triglyceride levels. I take Lipitor for high cholesterol, don't eat high-fat foods and don't drink alcohol except for half a glass of wine a few times a month. My triglycerides are always high when checked--my last reading was 222. What else can I do to help lower my triglycerides? | DukeMedicine healthnews 20090701 |
| Case of the month. Idiopathic dilated cardiomyopathy. | JAAPA : official journal of the American Academy of Physician Assistants 20090701 |
| Effect of preoperative atorvastatin therapy on paraoxonase activity and oxidative stress after coronary artery bypass grafting. | Perfusion 20090701 |
| The relationship between nonalcoholic fatty liver disease and the severity of coronary artery disease in patients with metabolic syndrome. | Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir 20090701 |
| Cholestatic jaundice induced by atorvastatin: a possible association with antimitochondrial antibodies. | The Israel Medical Association journal : IMAJ 20090701 |
| Decreased ABCB1 mRNA expression induced by atorvastatin results from enhanced mRNA degradation in HepG2 cells. | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20090628 |
| Coronary heart disease benefits from blood pressure and lipid-lowering. | International journal of cardiology 20090626 |
| Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: a randomized trial. | Annals of internal medicine 20090616 |
| Lipid-altering efficacy and safety of ezetimibe/simvastatin versus atorvastatin in patients with hypercholesterolemia and the metabolic syndrome (from the VYMET study). | The American journal of cardiology 20090615 |
| Relationship of oxidized phospholipids and biomarkers of oxidized low-density lipoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes: Results from the MIRACL (Myocardial Ischemia Reduction With Aggressive Cholesterol Lowering) trial. | Journal of the American College of Cardiology 20090609 |
| Micronization of atorvastatin calcium by antisolvent precipitation process. | International journal of pharmaceutics 20090605 |
| The ATHEROMA (Atorvastatin Therapy: Effects on Reduction of Macrophage Activity) Study. Evaluation using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging in carotid disease. | Journal of the American College of Cardiology 20090602 |
| Iron oxide magnetic resonance imaging for atherosclerosis therapeutic evaluation: still 'rusty?'. | Journal of the American College of Cardiology 20090602 |
| Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis. | Neurology 20090602 |
| Baseline blood pressure, low- and high-density lipoproteins, and triglycerides and the risk of vascular events in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. | Atherosclerosis 20090601 |
| Novel management of isotretinoin-induced hypertriglyceridemia in an adolescent with severe acne. | Clinical pediatrics 20090601 |
| Effects of one year simvastatin and atorvastatin treatments on acute phase reactants in uncontrolled type 2 diabetic patients. | Endocrine 20090601 |
| Effects of rosuvastatin and atorvastatin on LDL and HDL particle concentrations in patients with metabolic syndrome: a randomized, double-blind, controlled study. | Diabetes care 20090601 |
| Cyclooxygenase-2 induced by zymosan in human monocyte-derived dendritic cells shows high stability, and its expression is enhanced by atorvastatin. | The Journal of pharmacology and experimental therapeutics 20090601 |
| Adherence-adjusted efficacy with intensive versus standard statin therapy in patients with acute myocardial infarction in the IDEAL study. | European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 20090601 |
| Statin-induced liver injury involves cross-talk between cholesterol and selenoprotein biosynthetic pathways. | Molecular pharmacology 20090601 |
| Comparison of low vs moderate dose of atorvastatin in clopidogrel resistance after coronary stenting in Korean patients with acute coronary syndrome. | Circulation journal : official journal of the Japanese Circulation Society 20090601 |
| Glucose promotes membrane cholesterol crystalline domain formation by lipid peroxidation. | Biochimica et biophysica acta 20090601 |
| Atorvastatin prevents endothelial dysfunction in mesenteric arteries from spontaneously hypertensive rats: role of cyclooxygenase 2-derived contracting prostanoids. | Hypertension (Dallas, Tex. : 1979) 20090601 |
| [Effect of intensive treatment with atorvastatin versus standard doses of statins on the risk of stroke. A meta-analysis from five randomized trials including 25,709 patients]. | Revista de neurologia 20090601 |
| Atorvastatin might improve ventricular electrostability and decelerate the deterioration of renal function in patients with heart failure and diabetes mellitus. | Journal of cardiology 20090601 |
| Atorvastatin reduces the expression of aldo-keto reductases in HUVEC and PTEC. A new approach to influence the polyol pathway. | Clinical and investigative medicine. Medecine clinique et experimentale 20090601 |
| Conversion to tacrolimus and atorvastatin in cyclosporine-treated heart transplant recipients with dyslipidemia refractory to fluvastatin. | The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20090601 |
| Synergistic action of statins and nitrogen-containing bisphosphonates in the development of rhabdomyolysis in L6 rat skeletal myoblasts. | The Journal of pharmacy and pharmacology 20090601 |
| Atorvastatin Increases Endoglin, SMAD2, Phosphorylated SMAD2/3 and eNOS Expression in ApoE/LDLR Double Knockout Mice. | Journal of atherosclerosis and thrombosis 20090601 |
| Influence of statins on glucose tolerance in patients with type 2 diabetes mellitus: subanalysis of the collaborative study on hypercholesterolemia drug intervention and their benefits for atherosclerosis prevention (CHIBA study). | Journal of atherosclerosis and thrombosis 20090601 |
| Crystal forms of atorvastatin. | Archives of pharmacal research 20090601 |
| Atorvastatin reduces sympathetic activity and increases baroreceptor reflex sensitivity in patients with hypercholesterolaemia and systemic arterial hypertension. | Kardiologia polska 20090601 |
| The functional changes of the perivascular adipose tissue in spontaneously hypertensive rats and the effects of atorvastatin therapy. | Clinical and experimental hypertension (New York, N.Y. : 1993) 20090601 |
| [Atorvastatin dreduces sympathetic activity and improves baroreceptor reflex sensitivity in patients with hypercholesterolemia and hypertension]. | Kardiologia polska 20090601 |
| A multicenter study in Malaysia to determine the efficacy and safety of a generic atorvastatin. | The Medical journal of Malaysia 20090601 |
| Comparison of UV and charged aerosol detection approach in pharmaceutical analysis of statins. | Talanta 20090515 |
| Comparative effect of atorvastatin (80 mg) versus simvastatin (20 to 40 mg) in preventing hospitalizations for heart failure in patients with previous myocardial infarction. | The American journal of cardiology 20090515 |
| Effect of exposure to small pharmaceutical promotional items on treatment preferences. | Archives of internal medicine 20090511 |
| Statins induce apoptosis in ovarian cancer cells through activation of JNK and enhancement of Bim expression. | Cancer chemotherapy and pharmacology 20090501 |
| Effects of atorvastatin on calcium-regulating proteins: a possible mechanism to repair cardiac dysfunction in spontaneously hypertensive rats. | Basic research in cardiology 20090501 |
| Effect of intensive lipid-lowering therapy on telomere erosion in endothelial progenitor cells obtained from patients with coronary artery disease. | Clinical science (London, England : 1979) 20090501 |
| Muscle microvascular dysfunction in central obesity is related to muscle insulin insensitivity but is not reversed by high-dose statin treatment. | Diabetes 20090501 |
| Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20090501 |
| Human platelets express organic anion-transporting peptide 2B1, an uptake transporter for atorvastatin. | Drug metabolism and disposition: the biological fate of chemicals 20090501 |
| Effect of atorvastatin on expression of IL-10 and TNF-alpha mRNA in myocardial ischemia-reperfusion injury in rats. | Biochemical and biophysical research communications 20090501 |
| Placebo-controlled trial of high-dose atorvastatin in patients with severe cerebral small vessel disease. | Stroke 20090501 |
| Plasma tetrahydrobiopterin/dihydrobiopterin ratio: a possible marker of endothelial dysfunction. | Circulation journal : official journal of the Japanese Circulation Society 20090501 |
| Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension. | Journal of hypertension 20090501 |
| Effect of atorvastatin on microRNA 221 / 222 expression in endothelial progenitor cells obtained from patients with coronary artery disease. | European journal of clinical investigation 20090501 |
| Effects of statins on the pharmacokinetics of midazolam in healthy volunteers. | Journal of clinical pharmacology 20090501 |
| Medicinal chemistry strategies in follow-on drug discovery. | Drug discovery today 20090501 |
| Impact of high-dose atorvastatin in coronary heart disease patients age 65 to 78 years. | Clinical cardiology 20090501 |
| The influence of atorvastatin on walking performance in peripheral arterial disease. | VASA. Zeitschrift fur Gefasskrankheiten 20090501 |
| Efficacy and safety of atorvastatin during early hospitalization in elderly patients with unstable angina. | Clinical and experimental pharmacology & physiology 20090501 |
| [Atorvastatin attenuated contrast induced renal function damage]. | Zhonghua xin xue guan bing za zhi 20090501 |
| [Efficacy of high dose atorvastatin on preventing contrast induced nephropathy in patients underwent coronary angiography]. | Zhonghua xin xue guan bing za zhi 20090501 |
| [Effects of different statin regimens on lipid profile and serum metalloproteinases in patients with coronary heart disease]. | Zhonghua xin xue guan bing za zhi 20090501 |
| Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. | Neurology 20090421 |
| Seasonal variation in lipids in patients following acute coronary syndrome on fixed doses of Pravastatin (40 mg) or Atorvastatin (80 mg) (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22 [PROVE IT-TIMI 22] Study). | The American journal of cardiology 20090415 |
| Early initiation of low-dose atorvastatin treatment after an acute ST-elevated myocardial infarction, decreases inflammatory process and prevents endothelial injury and activation. | International journal of cardiology 20090403 |
| A preliminary study of atorvastatin plasma concentrations in critically ill patients with sepsis. | Intensive care medicine 20090401 |
| Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers. | Journal of lipid research 20090401 |
| Coronary plaque stabilization followed by Color Code Plaque analysis with 64-slice multidetector row computed tomography. | Circulation journal : official journal of the Japanese Circulation Society 20090401 |
| Effect of atorvastatin versus rosuvastatin on levels of serum lipids, inflammatory markers and adiponectin in patients with hypercholesterolemia. | Pharmaceutical research 20090401 |
| eNOS T-786C polymorphism affects atorvastatin-induced changes in erythrocyte membrane fluidity. | European journal of clinical pharmacology 20090401 |
| Statin therapy is associated with lower total but not bioavailable or free testosterone in men with type 2 diabetes. | Diabetes care 20090401 |
| [Pubalgia in athlete treated by atorvastatin]. | Presse medicale (Paris, France : 1983) 20090401 |
| Treatment with atorvastatin partially protects the rat heart from harmful catecholamine effects. | Cardiovascular research 20090401 |
| Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study. | European heart journal 20090401 |
| In vivo confirmation of the role of statins in reducing nitric oxide and C-reactive protein levels in peripheral arterial disease. | European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 20090401 |
| Statins and fenofibrate affect skeletal muscle chloride conductance in rats by differently impairing ClC-1 channel regulation and expression. | British journal of pharmacology 20090401 |
| Atorvastatin restores endothelial function in offspring of protein-restricted rats in a cholesterol-independent manner. | Hypertension (Dallas, Tex. : 1979) 20090401 |
| Qualitative and quantitative changes in coronary plaque associated with atorvastatin therapy. | Circulation journal : official journal of the Japanese Circulation Society 20090401 |
| Anti-atherogenic effect of statins: role of nitric oxide, peroxynitrite and haem oxygenase-1. | British journal of pharmacology 20090401 |
| Preoperative statin use and infection after cardiac surgery: a cohort study. | Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20090401 |
| Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by stroke subtypes. | Stroke 20090401 |
| Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques: a 2-year follow-up by noninvasive MRI. | European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 20090401 |
| An association study between catalase -262C>T gene polymorphism, sodium-lithium countertransport activity, insulin resistance, blood lipid parameters and their response to atorvastatin, in Greek dyslipidaemic patients and normolipidaemic controls. | Free radical research 20090401 |
| Potentiated cytotoxic effects of statins and ajoene in murine melanoma cells. | Melanoma research 20090401 |
| Atorvastatin modifies the protein profile of circulating human monocytes after an acute coronary syndrome. | Proteomics 20090401 |
| Eugenosedin-A prevents hyperglycaemia, hyperlipidaemia and lipid peroxidation in C57BL/6J mice fed a high-fat diet. | The Journal of pharmacy and pharmacology 20090401 |
| Atorvastatin effect on the distribution of high-density lipoprotein subfractions and human paraoxonase activity. | Translational research : the journal of laboratory and clinical medicine 20090401 |
| Statin-induced structural changes in coronary plaques evaluated by intracoronary imaging. | Circulation journal : official journal of the Japanese Circulation Society 20090401 |
| Moving from A to Z: successful implementation of a statin switch program by a large physician group. | The American journal of managed care 20090401 |
| Statins for sepsis: a critical and updated review. | Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 20090401 |
| Effects of atorvastatin therapy on protein oxidation and oxidative DNA damage in hypercholesterolemic rabbits. | Pharmacological research 20090401 |
| [Pfizer: TLV decision about antilipemic agents is founded on wrong basis]. | Lakartidningen 20090401 |
| [The statin dosage for achieving goal of cholesterol-lowering based on risk stratification in patients with ischemic cerebrovascular diseases]. | Zhonghua nei ke za zhi 20090401 |
| Statins and fibrate target ClC-1 - from side effects to CLC pharmacology. | British journal of pharmacology 20090401 |
| Comprehensive whole-genome and candidate gene analysis for response to statin therapy in the Treating to New Targets (TNT) cohort. | Circulation. Cardiovascular genetics 20090401 |
| Atorvastatin prevents early apoptosis after thoracic spinal cord contusion injury and promotes locomotion recovery. | Neuroscience letters 20090327 |
| Atorvastatin-induced hemorrhagic cystitis: a case report. | Urology 20090301 |
| High glucose induced endothelial cell growth inhibition is associated with an increase in TGFbeta1 secretion and inhibition of Ras prenylation via suppression of the mevalonate pathway. | The international journal of biochemistry & cell biology 20090301 |
| Single-pill amlodipine/atorvastatin helps patients of diverse ethnicity attain recommended goals for blood pressure and lipids (the Gemini-AALA study). | Journal of human hypertension 20090301 |
| A role for atorvastatin and insulin combination in protecting from liver injury in a model of type 2 diabetes with hyperlipidemia. | Naunyn-Schmiedeberg's archives of pharmacology 20090301 |
| Tuberculosis in a patient on temozolomide: a case report. | Journal of neuro-oncology 20090301 |
| (TTA)n polymorphism in 3-hydroxy-3-methylglutaryl-coenzyme A and response to atorvastatin in coronary artery disease patients. | Basic & clinical pharmacology & toxicology 20090301 |
| Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22. | Arteriosclerosis, thrombosis, and vascular biology 20090301 |
| The TNT study, women and cancer. | Heart (British Cardiac Society) 20090301 |
| Targeting targets for LDL-lowering therapy: lessons from the Collaborative Atorvastatin Diabetes Study (CARDS). | Clinical chemistry 20090301 |
| Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS). | Clinical chemistry 20090301 |
| Variability in pharmacy interpretations of physician prescriptions. | Medical care 20090301 |
| Statins reduce the neurofibrillary tangle burden in a mouse model of tauopathy. | Journal of neuropathology and experimental neurology 20090301 |
| Comparison of efficacy and safety of atorvastatin (80 mg) to simvastatin (20 to 40 mg) in patients aged <65 versus >or=65 years with coronary heart disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] study). | The American journal of cardiology 20090301 |
| Regulation of leukemic cell differentiation and retinoid-induced gene expression by statins. | Molecular cancer therapeutics 20090301 |
| Atorvastatin modulates Th1/Th2 response in patients with chronic heart failure. | Journal of cardiac failure 20090301 |
| Effects of atorvastatin on nuclear magnetic resonance-defined lipoprotein subclasses and inflammatory markers in patients with hypercholesterolemia. | Journal of atherosclerosis and thrombosis 20090301 |
| Regression and shift in composition of coronary atherosclerotic plaques by pioglitazone: insight from an intravascular ultrasound analysis. | Journal of cardiovascular medicine (Hagerstown, Md.) 20090301 |
| Drug-drug interaction studies in preclinical species: should metabolite(s) kinetics be studied? | Xenobiotica; the fate of foreign compounds in biological systems 20090301 |
| Metformin and atorvastatin reduce adhesion formation in a rat uterine horn model. | Reproductive biomedicine online 20090301 |
| Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile. | European journal of internal medicine 20090301 |
| Comparison of atorvastatin and simvastatin in prevention of atrial fibrillation after successful cardioversion. | International heart journal 20090301 |
| [Dyslipidemia, atherosclerosis, and vulnerable plaques: the effect of atorvastatin on atherosclerosis and plaque structure]. | Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir 20090301 |
| [Atorvastatin in primary prevention]. | Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir 20090301 |
| [Atorvastatin in secondary prevention]. | Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir 20090301 |
| Atorvastatin attenuates TLR4-mediated NF-kappaB activation in a MyD88-dependent pathway. | Asian Pacific journal of allergy and immunology 20090301 |
| AMP-activated protein kinase functionally phosphorylates endothelial nitric oxide synthase Ser633. | Circulation research 20090227 |
| Effect of atorvastatin in elderly patients with a recent stroke or transient ischemic attack. | Neurology 20090224 |
| Statins: not just for the young or the faint of heart. | Neurology 20090224 |
| Phospholipase A2 inhibitors in atherosclerosis: the race is on. | Lancet (London, England) 20090221 |
| Comparison of effects of rosuvastatin (10 mg) versus atorvastatin (40 mg) on rho kinase activity in caucasian men with a previous atherosclerotic event. | The American journal of cardiology 20090215 |
| Efficacy and safety of ABT-335 (fenofibric acid) in combination with atorvastatin in patients with mixed dyslipidemia. | The American journal of cardiology 20090215 |
| [Statin therapy and muscle disorders]. | Orvosi hetilap 20090208 |
| [Comment from the cardiologic viewpoint]. | Praxis 20090204 |
| 3-Hydroxy-3-methylglutaryl (HMG)-COA reductase inhibitors and phosphodiesterase type V inhibitors attenuate right ventricular pressure and remodeling in a rat model of pulmonary hypertension. | Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20090204 |
| Does atorvastatin affect androgen levels in men in the era of very-low LDL targeting therapy? | Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20090201 |
| Statins, regulatory T cells, and pediatric graft coronary artery disease. | Pediatric transplantation 20090201 |
| The effect of exogenous cholesterol and lipid-modulating agents on enterocytic amyloid-beta abundance. | The British journal of nutrition 20090201 |
| Effects of vitamin D supplementation in atorvastatin-treated patients: a new drug interaction with an unexpected consequence. | Clinical pharmacology and therapeutics 20090201 |
| Atorvastatin may have no effect on acute phase reaction in children after intravenous bisphosphonate infusion. | Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20090201 |
| Drug interaction potential of 2-((3,4-dichlorophenethyl)(propyl)amino)-1-(pyridin-3-yl)ethanol (LK-935), the novel nonstatin-type cholesterol-lowering agent. | Drug metabolism and disposition: the biological fate of chemicals 20090201 |
| Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS). | Diabetologia 20090201 |
| Atorvastatin decreases stearoyl-CoA desaturase gene expression in THP-1 macrophages incubated with oxidized LDL. | Lipids 20090201 |
| Torcetrapib differentially modulates the biological activities of HDL2 and HDL3 particles in the reverse cholesterol transport pathway. | Arteriosclerosis, thrombosis, and vascular biology 20090201 |
| Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver. | American journal of physiology. Gastrointestinal and liver physiology 20090201 |
| Coadministered amlodipine and atorvastatin produces early improvements in arterial wall compliance in hypertensive patients with dyslipidemia. | American journal of hypertension 20090201 |
| Importance of Rac1 signaling pathway inhibition in the pleiotropic effects of HMG-CoA reductase inhibitors. | Circulation journal : official journal of the Japanese Circulation Society 20090201 |
| The cost of stroke prevention. | Stroke 20090201 |
| Should high creatine kinase discourage the initiation or continuance of statins for the treatment of hypercholesterolemia? | Metabolism: clinical and experimental 20090201 |
| Electrocardiography and outcome in patients with diabetes mellitus on maintenance hemodialysis. | Clinical journal of the American Society of Nephrology : CJASN 20090201 |
| Early atorvastatin therapy improves cardiac function in patients with acute myocardial infarction. | Journal of cardiology 20090201 |
| Letter to editor in response to 'Prevention of pediatric graft coronary artery disease: atorvastatin', by Chin et al. | Pediatric transplantation 20090201 |
| Thyroid hormone beta receptor activation has additive cholesterol lowering activity in combination with atorvastatin in rabbits, dogs and monkeys. | British journal of pharmacology 20090201 |
| Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministered with atorvastatin in dyslipidemic patients. | American heart journal 20090201 |
| Lack of efficacy of the statins atorvastatin and lovastatin in rodent mammary carcinogenesis. | Cancer prevention research (Philadelphia, Pa.) 20090201 |
| [Effect of atorvastatin on lipopolysaccharide-induced expression of C-reactive protein in human pulmonary epithelial cells]. | Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20090201 |
| Effect of lipid-lowering therapy on the progression of intracranial arterial stenosis. | Journal of neurology 20090201 |
| Unexpected and abnormally low HDL cholesterol levels on combination hypolipidemic therapy. | The Journal of the Association of Physicians of India 20090201 |
| Quantification of atorvastatin calcium in tablets by FT-Raman spectroscopy. | Journal of pharmaceutical and biomedical analysis 20090115 |
| Impact of statin therapy on central aortic pressures and hemodynamics: principal results of the Conduit Artery Function Evaluation-Lipid-Lowering Arm (CAFE-LLA) Study. | Circulation 20090106 |
| Effect of high dose statin therapy on platelet function; statins reduce aspirin-resistant platelet aggregation in patients with coronary heart disease. | Journal of thrombosis and thrombolysis 20090101 |
| Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction. | Clinical science (London, England : 1979) 20090101 |
| Models for the analysis of C-reactive protein in statin trials. | Pharmaceutical statistics 20090101 |
| Inhibition of development of experimental aortic abdominal aneurysm in rat model by atorvastatin through inhibition of macrophage migration. | Atherosclerosis 20090101 |
| Short-term evolution (9 months) of aortic atheroma in patients with or without embolic events: a follow-up transoesophageal echocardiographic study. | European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 20090101 |
| Prevention of calcific aortic valve stenosis-fact or fiction? | Annals of medicine 20090101 |
| Effects of atorvastatin on vascular intimal hyperplasia: an experimental rodent model. | Angiology 20090101 |
| The influence of simvastatin, atorvastatin and high-cholesterol diet on acetylcholinesterase activity, amyloid beta and cholesterol synthesis in rat brain. | Steroids 20090101 |
| Statins alter neutrophil migration by modulating cellular Rho activity--a potential mechanism for statins-mediated pleotropic effects? | Journal of leukocyte biology 20090101 |
| ABCB1 and ABCC1 expression in peripheral mononuclear cells is influenced by gene polymorphisms and atorvastatin treatment. | Biochemical pharmacology 20090101 |
| Clopidogrel: review of bioanalytical methods, pharmacokinetics/pharmacodynamics, and update on recent trends in drug-drug interaction studies. | Biomedical chromatography : BMC 20090101 |
| The effect of atorvastatin in patients with polycystic ovary syndrome: a randomized double-blind placebo-controlled study. | The Journal of clinical endocrinology and metabolism 20090101 |
| Statins for heart failure: still caught in no man's land? | Clinical science (London, England : 1979) 20090101 |
| Atorvastatin increases erythropoietin-stimulating agent hyporesponsiveness in maintenance hemodialysis patients: role of anti-inflammation effects. | American journal of nephrology 20090101 |
| A mechanistic study on the phototoxicity of atorvastatin: singlet oxygen generation by a phenanthrene-like photoproduct. | Chemical research in toxicology 20090101 |
| Atorvastatin in Factorial with Omega-3 EE90 Risk Reduction in Diabetes (AFORRD): a randomised controlled trial. | Diabetologia 20090101 |
| Atorvastatin and BMD in coronary syndrome. Role of Lys656Asn polymorphism of leptin receptor gene. | Endocrine journal 20090101 |
| Glomerular filtration rate and blood pressure are unchanged by increased sodium intake in atorvastatin-treated healthy men. | Scandinavian journal of clinical and laboratory investigation 20090101 |
| Diabetes reduces bone marrow and circulating porcine endothelial progenitor cells, an effect ameliorated by atorvastatin and independent of cholesterol. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20090101 |
| Atorvastatin prevents carbohydrate response element binding protein activation in the fructose-fed rat by activating protein kinase A. | Hepatology (Baltimore, Md.) 20090101 |
| The use of a single-pill calcium channel blocker/statin combination in the management of hypertension and dyslipidemia: a randomized, placebo-controlled, multicenter study. | Journal of clinical hypertension (Greenwich, Conn.) 20090101 |
| Polycystic ovary syndrome, inflammation, and statins: do we have the right target? | The Journal of clinical endocrinology and metabolism 20090101 |
| Atorvastatin pleiotropic effects mediated via suppression of TNF-alpha in congestive heart failure patients with initial normal TNF-alpha levels. | The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20090101 |
| Atorvastatin ameliorates cerebral vasospasm and early brain injury after subarachnoid hemorrhage and inhibits caspase-dependent apoptosis pathway. | BMC neuroscience 20090101 |
| Atorvastatin ameliorates sildenafil-induced penile erections in experimental diabetes by inhibiting diabetes-induced RhoA/Rho-kinase signaling hyperactivation. | The journal of sexual medicine 20090101 |
| [Atorvastatin-induced drug reaction with eosinophilia and systemic symptoms (DRESS)]. | Annales de dermatologie et de venereologie 20090101 |
| Coadministration of dabigatran etexilate and atorvastatin: assessment of potential impact on pharmacokinetics and pharmacodynamics. | American journal of cardiovascular drugs : drugs, devices, and other interventions 20090101 |
| Domino liver transplantation using a graft from a donor with familial hypercholesterolemia: seven-yr follow-up. | Clinical transplantation 20090101 |
| Role of plasma adiponectin on the HDL-cholesterol raising effect of atorvastatin in patients with type 2 diabetes. | Current medical research and opinion 20090101 |
| Cardiovascular conditions in hemodialysis patients may be worsened by extensive interdialytic weight gain. | Hemodialysis international. International Symposium on Home Hemodialysis 20090101 |
| Anti-inflammatory effects of atorvastatin on peripheral blood mononuclear cells and synovial fibroblasts in rheumatoid arthritis. | Scandinavian journal of rheumatology 20090101 |
| Atorvastatin and amlodipine: the successful duet that led to Caduet. | Cardiovascular journal of Africa 20090101 |
| Pediatric Atorvastatin in Diabetes Trial (PADIT): a pilot study to determine the effect of atorvastatin on arterial stiffness and endothelial function in children with type 1 diabetes mellitus. | Journal of pediatric endocrinology & metabolism : JPEM 20090101 |
| The lifetime cost effectiveness of amlodipine-based therapy plus atorvastatin compared with atenolol plus atorvastatin, amlodipine-based therapy alone and atenolol-based therapy alone: results from ASCOT1. | PharmacoEconomics 20090101 |
| Rapamycin weekly maintenance dosing and the potential efficacy of combination sorafenib plus rapamycin but not atorvastatin or doxycycline in tuberous sclerosis preclinical models. | BMC pharmacology 20090101 |
| Impact of ezetimibe on cholesterol subfractions in dyslipidemic cardiac transplant recipients receiving statin therapy. | Clinical transplantation 20090101 |
| Clinical insights from the Treating to New Targets trial. | Progress in cardiovascular diseases 20090101 |
| Atorvastatin reduces plasma levels of chemokine (CXCL10) in patients with Crohn's disease. | PloS one 20090101 |
| [Effect of various approaches to therapy with statins in high risk patients from the point of view of vascular endothelium]. | Kardiologiia 20090101 |
| Mechanism of inhibitory effect of atorvastatin on resistin expression induced by tumor necrosis factor-alpha in macrophages. | Journal of biomedical science 20090101 |
| Fixed combination of amlodipine and atorvastatin in cardiovascular risk management: patient perspectives. | Vascular health and risk management 20090101 |
| Long-term statin therapy and CSF cholesterol levels: implications for Alzheimer's disease. | Dementia and geriatric cognitive disorders 20090101 |
| Effect of atorvastatin on PM10-induced cytokine production by human alveolar macrophages and bronchial epithelial cells. | International journal of toxicology 20090101 |
| HIF-1 attenuates Ref-1 expression in endothelial cells: reversal by siRNA and inhibition of geranylgeranylation. | Vascular pharmacology 20090101 |
| Cost-effectiveness of intensive lipid lowering therapy with 80 mg of atorvastatin, versus 10 mg of atorvastatin, for secondary prevention of cardiovascular disease in Canada. | The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique 20090101 |
| Reducing morbidity and mortality in high risk patients with statins. | Vascular health and risk management 20090101 |
| Preparation, characterization and in vitro intestinal absorption of a dry emulsion formulation containing atorvastatin calcium. | Drug delivery 20090101 |
| Long-term beneficial effects of statins on vascular manifestations in patients with systemic sclerosis. | Modern rheumatology 20090101 |
| Effects of atorvastatin on carotid atherosclerotic plaques: a randomized trial for quantitative tissue characterization of carotid atherosclerotic plaques with integrated backscatter ultrasound. | Cerebrovascular diseases (Basel, Switzerland) 20090101 |
| Effect of low doses of atorvastatin on the urinary peptide profile of kidney transplant patients. | Transplantation proceedings 20090101 |
| Headache as the sole presenting symptom of acute myocardial infarction. | The Journal of the Association of Physicians of India 20090101 |
| Statins and ezetimibe modulate plasma proprotein convertase subtilisin kexin-9 (PCSK9) levels. | Transactions of the American Clinical and Climatological Association 20090101 |
| [The use of atorvastatin in patients with rheumatoid arthritis with hyperlipidemia]. | Kardiologiia 20090101 |
| Molecular imaging of cathepsin B proteolytic enzyme activity reflects the inflammatory component of atherosclerotic pathology and can quantitatively demonstrate the antiatherosclerotic therapeutic effects of atorvastatin and glucosamine. | Molecular imaging 20090101 |
| [The role of changes in matrix metalloproteases and chitotriosidase in the mechanism of protective effect of atorvastatin in experimental murine lipemia]. | Eksperimental'naia i klinicheskaia farmakologiia 20090101 |
| Study of plasma level of atorvastatin and its effect on lipid profile. | Indian journal of physiology and pharmacology 20090101 |
| Atorvastatin prevents gentamicin-induced renal damage in rats through the inhibition of p38-MAPK and NF-kappaB pathways. | Renal failure 20090101 |
| Reduced intimal hyperplasia in rabbits via medical therapy after carotid venous bypass. | Texas Heart Institute journal 20090101 |
| [Proximal myopathy secondary to statin treatment in a patient with Hashimoto thyroiditis]. | Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion 20090101 |
| Effect of atorvastatin on paraoxonase1 (PON1) and oxidative status. | Pharmacological reports : PR 20090101 |
| Atorvastatin treatment attenuates motor neuron degeneration in wobbler mice. | Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases 20090101 |
| Antimicrobial action of atorvastatin and rosuvastatin. | Pathology 20090101 |
| SWiss Atorvastatin and interferon Beta-1b trial In Multiple Sclerosis (SWABIMS)--rationale, design and methodology. | Trials 20090101 |
| Comparison of the efficacy of administering a combination of ezetimibe plus fenofibrate versus atorvastatin monotherapy in the treatment of dyslipidemia. | Lipids in health and disease 20090101 |
| Adolescent type 1 Diabetes Cardio-renal Intervention Trial (AdDIT). | BMC pediatrics 20090101 |
| Solubility and stability enhancement of atorvastatin by cyclodextrin complexation. | PDA journal of pharmaceutical science and technology 20090101 |
| Effect of atorvastatin and fenofibric acid on adipokine release from visceral and subcutaneous adipose tissue of patients with mixed dyslipidemia and normolipidemic subjects. | Pharmacological reports : PR 20090101 |
| [Inhibition of CD40L induced E-selectin expression in endothelial cells through extracellular signal-regulated kinase signaling pathway]. | Zhonghua yi xue za zhi 20081230 |
| Safety and efficacy of statin therapy in patients switched from cyclosporine a to sirolimus after cardiac transplantation. | Transplantation 20081227 |
| Atorvastatin enhances hypothermia-induced neuroprotection after stroke. | Journal of the neurological sciences 20081215 |
| Comparison of benefits and risks of rosuvastatin versus atorvastatin from a meta-analysis of head-to-head randomized controlled trials. | The American journal of cardiology 20081215 |
| Cholesteryl ester transfer protein inhibition, high-density lipoprotein raising, and progression of coronary atherosclerosis: insights from ILLUSTRATE (Investigation of Lipid Level Management Using Coronary Ultrasound to Assess Reduction of Atherosclerosis by CETP Inhibition and HDL Elevation). | Circulation 20081209 |
| Cholesteryl ester transfer protein inhibitor torcetrapib and off-target toxicity: a pooled analysis of the rating atherosclerotic disease change by imaging with a new CETP inhibitor (RADIANCE) trials. | Circulation 20081209 |
| Multicenter collaborative randomized parallel group comparative study of pitavastatin and atorvastatin in Japanese hypercholesterolemic patients: collaborative study on hypercholesterolemia drug intervention and their benefits for atherosclerosis prevention (CHIBA study). | Atherosclerosis 20081201 |
| Statin cost-effectiveness comparisons using real-world effectiveness data: formulary implications. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20081201 |
| Hydroxychloroquine-induced hyperpigmentation: the staining pattern. | Journal of cutaneous pathology 20081201 |
| CYP3A53A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia. | Clinica chimica acta; international journal of clinical chemistry 20081201 |
| Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma. | Thorax 20081201 |
| Use of atorvastatin as an anti-inflammatory treatment in Crohn's disease. | British journal of pharmacology 20081201 |
| Effect of atorvastatin on inflammation and outcome in patients with type 2 diabetes mellitus on hemodialysis. | Kidney international 20081201 |
| A case of ANCA-associated systemic vasculitis induced by atorvastatin. | Clinical rheumatology 20081201 |
| Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. | Stroke 20081201 |
| Effect of omega-3-acid ethyl esters on steady-state plasma pharmacokinetics of atorvastatin in healthy adults. | Expert opinion on pharmacotherapy 20081201 |
| Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia. | Metabolism: clinical and experimental 20081201 |
| Modulation of clopidogrel pharmacodynamic response. | Pharmacotherapy 20081201 |
| Effect of atorvastatin on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel in healthy subjects. | Pharmacotherapy 20081201 |
| Efficacy and safety of ezetimibe added on to atorvastatin (20 mg) versus uptitration of atorvastatin (to 40 mg) in hypercholesterolemic patients at moderately high risk for coronary heart disease. | The American journal of cardiology 20081201 |
| Efficacy and safety of ezetimibe added on to atorvastatin (40 mg) compared with uptitration of atorvastatin (to 80 mg) in hypercholesterolemic patients at high risk of coronary heart disease. | The American journal of cardiology 20081201 |
| Intensive lipid-lowering therapy for patients with aortic stenosis. | The American journal of cardiology 20081201 |
| Atorvastatin decreases elevated soluble CD40L in subjects at high cardiovascular risk. Atorvastatin on inflammatory markers study: a substudy of ACTFAST. | Kidney international. Supplement 20081201 |
| Treatment with amlodipine and atorvastatin has additive effect on blood and plaque inflammation in hypertensive patients with carotid atherosclerosis. | Kidney international. Supplement 20081201 |
| Pharmacoeconomic analysis of hypertriglyceridemia treatment at medical institutions. | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20081201 |
| Comparison of cardiovascular event rates in patients without cardiovascular disease in whom atorvastatin or simvastatin was newly initiated. | Mayo Clinic proceedings 20081201 |
| Superior benefit of aggressive lipid-lowering therapy for high- risk patients using statins: the SUBARU study--more hypercholesterolemic patients achieve Japan Atherosclerosis Society LDL-C goals with rosuvastatin therapy than with atorvastatin therapy. | Journal of atherosclerosis and thrombosis 20081201 |
| Apoptotic signaling pathways as a target for the treatment of liver diseases. | Mini reviews in medicinal chemistry 20081201 |
| On call. I am pretty healthy for a 73-year-old, but my cholesterol is 280, and my doctor wants me to take Lipitor. I'm willing to do so, but I need to know what tests I should have to be sure I'm not getting side effects. What do you suggest? | Harvard men's health watch 20081201 |
| The comparison of the effects of standard 20 mg atorvastatin daily and 20 mg atorvastatin every other day on serum LDL-cholesterol and high sensitive C-reactive protein levels. | Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology 20081201 |
| Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study. | Clinical therapeutics 20081201 |
| What's new in stroke? The top 10 studies of 2006-2008. Part II. | Polskie Archiwum Medycyny Wewnetrznej 20081201 |
| Effect of very low LDL-cholesterol on cortisol synthesis. | Journal of endocrinological investigation 20081201 |
| Pharmacogenetic predictors of statin-mediated low-density lipoprotein cholesterol reduction and dose response. | Circulation. Cardiovascular genetics 20081201 |
| Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial. | International journal of cardiology 20081128 |
| [High dosage stain protects heart and brain from recurrence]. | MMW Fortschritte der Medizin 20081127 |
| Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients. | Journal of the American College of Cardiology 20081125 |
| Comparison of effectiveness of atorvastatin 10 mg versus 80 mg in reducing major cardiovascular events and repeat revascularization in patients with previous percutaneous coronary intervention (post hoc analysis of the Treating to New Targets [TNT] Study). | The American journal of cardiology 20081115 |
| Comparison of treatment of severe high-density lipoprotein cholesterol deficiency in men with daily atorvastatin (20 mg) versus fenofibrate (200 mg) versus extended-release niacin (2 g). | The American journal of cardiology 20081115 |
| Quantitative effect of atorvastatin on size and content of non-calcified plaques of coronary arteries 1 year after atorvastatin treatment by multislice computed tomography. | International journal of cardiology 20081112 |
| Blockade of the RhoA-JNK-c-Jun-MMP2 cascade by atorvastatin reduces osteosarcoma cell invasion. | The Journal of biological chemistry 20081107 |
| The influence of statin medications on prostate-specific antigen levels. | Journal of the National Cancer Institute 20081105 |
| Lipoprotein profile changes in children after renal transplantation in the modern immunosuppression era. | Pediatric transplantation 20081101 |
| Dual drug interactions via P-glycoprotein (P-gp)/ cytochrome P450 (CYP3A4) interplay: recent case study of oral atorvastatin and verapamil. | European journal of clinical pharmacology 20081101 |
| Assessment of regional systolic and diastolic functions affected by atorvastatin in coronary artery disease using tissue Doppler imaging. | Clinical cardiology 20081101 |
| Impact of adherence to statins on chronic heart failure in primary prevention. | British journal of clinical pharmacology 20081101 |
| IFNalpha treatment generates antigen-presenting cells insensitive to atorvastatin inhibition of MHC-II expression. | Clinical immunology (Orlando, Fla.) 20081101 |
| Pharmacokinetics of the oral direct renin inhibitor aliskiren in combination with digoxin, atorvastatin, and ketoconazole in healthy subjects: the role of P-glycoprotein in the disposition of aliskiren. | Journal of clinical pharmacology 20081101 |
| Atorvastatin inhibits renal crystal retention in a rat stone forming model. | The Journal of urology 20081101 |
| Hemorrhagic stroke in the SPARCL study. | Stroke 20081101 |
| Human CYP3A4-introduced HepG2 cells: in vitro screening system of new chemicals for the evaluation of CYP3A4-inhibiting activity. | Xenobiotica; the fate of foreign compounds in biological systems 20081101 |
| A possible negative effect of co-administered amlodipine and atorvastatin on semen volume and spermatozoa in men. | The Journal of pharmacy and pharmacology 20081101 |
| Investigation of the vascular and pleiotropic effects of atorvastatin and pioglitazone in a population at high cardiovascular risk. | Diabetes & vascular disease research 20081101 |
| Binder wars. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20081101 |
| Rosuvastatin, pravastatin, and atorvastatin for the treatment of hypercholesterolaemia in HIV-infected patients receiving protease inhibitors. | Current HIV research 20081101 |
| The efficacy and safety of ezetimibe for treatment of dyslipidemia after heart transplantation. | Transplantation proceedings 20081101 |
| Cholesterol synthesis in central nervous system of rat is affected by simvastatin as well as by atorvastatin. | Die Pharmazie 20081101 |
| [High-dose statin in ischemic stroke reduces the risk of recurrent stroke]. | Lakartidningen 20081101 |
| Effect of statins on fibroblasts from human nasal polyps and turbinates. | European annals of allergy and clinical immunology 20081101 |
| Atorvastatin improves arterial stiffness in normotensive normolipidaemic persons with type 2 diabetes. | Journal of the Indian Medical Association 20081101 |
| Combining beta interferon and atorvastatin may increase disease activity in multiple sclerosis. | Neurology 20081028 |
| [Statins and stroke]. | Medicina clinica 20081025 |
| Advertisements for atorvastatin were misleading to women. | BMJ (Clinical research ed.) 20081022 |
| DFT study on hydroxy acid-lactone interconversion of statins: the case of atorvastatin. | Organic & biomolecular chemistry 20081007 |
| Statins activate GATA-6 and induce differentiated vascular smooth muscle cells. | Biochemical and biophysical research communications 20081003 |
| Short term effects of atorvastatin on endothelial functions and oxidized LDL levels in patients with type 2 diabetes. | Endocrine journal 20081001 |
| Atorvastatin and fenofibrate have comparable effects on VLDL-apolipoprotein C-III kinetics in men with the metabolic syndrome. | Arteriosclerosis, thrombosis, and vascular biology 20081001 |
| Pharmacological modulation of epithelial mesenchymal transition caused by angiotensin II. Role of ROCK and MAPK pathways. | Pharmaceutical research 20081001 |
| Statins and congestive heart failure. | Current atherosclerosis reports 20081001 |
| Ptosis, diplopia and statins: an association? | European journal of neurology 20081001 |
| Differences in cardiovascular event rates between atorvastatin and simvastatin among new users: managed-care experience. | Current medical research and opinion 20081001 |
| Evaluation cardioprotective effects of atorvastatin in rats by real time myocardial contrast echocardiography. | Echocardiography (Mount Kisco, N.Y.) 20081001 |
| A large observational study of cardiovascular outcomes associated with atorvastatin or simvastatin therapy in diabetic patients without prior cardiovascular disease. | Diabetes research and clinical practice 20081001 |
| Kinetic studies of the metabolism of rapidly exchangeable apolipoproteins may leave investigators and readers with exchangeable results. | Arteriosclerosis, thrombosis, and vascular biology 20081001 |
| Statins: under investigation for increasing bone mineral density and augmenting fracture healing. | Expert opinion on investigational drugs 20081001 |
| Tissue-specific effects of atorvastatin on 3-hydroxy-3-methylglutarylcoenzyme A reductase expression and activity in spontaneously hypertensive rats. | Acta pharmacologica Sinica 20081001 |
| Effects of cyclosporin A and itraconazole on the pharmacokinetics of atorvastatin in rats. | Acta pharmacologica Sinica 20081001 |
| Bilayer tablets of atorvastatin calcium and nicotinic acid: formulation and evaluation. | Chemical & pharmaceutical bulletin 20081001 |
| Comparative gene expression profiling in three primary human cell lines after treatment with a novel inhibitor of Rho kinase or atorvastatin. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20081001 |
| Characterization of low-density lipoprotein cholesterol-lowering efficacy for atorvastatin in a population-based DNA biorepository. | Basic & clinical pharmacology & toxicology 20081001 |
| Ezetimibe 5 and 10 mg for lowering LDL-C: potential billion-dollar savings with improved tolerability. | The American journal of managed care 20081001 |
| How to reach LDL targets quickly in patients with diabetes or metabolic syndrome. | The Journal of family practice 20081001 |
| Effects of atorvastatin on warfarin-induced aortic medial calcification and systolic blood pressure in rats. | Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20081001 |
| Atorvastatin therapy is associated with reduced levels of N-terminal prohormone brain natriuretic peptide and improved cardiac function in patients with heart failure. | Clinical cardiology 20081001 |
| Vascular and metabolic response to statin in the mildly hypertensive hypercholesterolemic elderly. | Clinics (Sao Paulo, Brazil) 20081001 |
| Long-term economic outcomes associated with intensive versus moderate lipid-lowering therapy in coronary artery disease: results from the Treating to New Targets (TNT) Trial. | American heart journal 20081001 |
| Influence of pitavastatin on glucose tolerance in patients with type 2 diabetes mellitus. | Journal of atherosclerosis and thrombosis 20081001 |
| Anti-atherosclerotic effect of atorvastatin and clopidogrel alone and in combination in rats. | Indian journal of experimental biology 20081001 |
| Statin therapy works for patients who have type 2 diabetes. | JAAPA : official journal of the American Academy of Physician Assistants 20081001 |
| [Brain hypoperfusion revealed by an ocular ischemic syndrome]. | Journal francais d'ophtalmologie 20081001 |
| ABCB1 haplotypes differentially affect the pharmacokinetics of the acid and lactone forms of simvastatin and atorvastatin. | Clinical pharmacology and therapeutics 20081001 |
| Effects of gemfibrozil and atorvastatin on the pharmacokinetics of repaglinide in relation to SLCO1B1 polymorphism. | Clinical pharmacology and therapeutics 20081001 |
| [Combined antihypertensive and antilipemic therapy as one of the pillars in the poly-pharmacologic preventive strategy for patients with high cardiovascular risk]. | Orvosi hetilap 20080928 |
| Prognosis and risk factors in patients with asymptomatic aortic stenosis and their modulation by atorvastatin (20 mg). | The American journal of cardiology 20080915 |
| Amelioration of human allograft arterial injury by atorvastatin or simvastatin correlates with reduction of interferon-gamma production by infiltrating T cells. | Transplantation 20080915 |
| Atorvastatin down-regulates the primate cellular response to porcine aortic endothelial cells in vitro. | Transplantation 20080915 |
| Stability indicating UPLC method for simultaneous determination of atorvastatin, fenofibrate and their degradation products in tablets. | Journal of pharmaceutical and biomedical analysis 20080910 |
| Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysis. | Journal of the American College of Cardiology 20080909 |
| Effect of atorvastatin on endothelial function and inflammation in long-duration type 1 diabetic patients without coronary heart disease and arterial hypertension. | Diabetes, obesity & metabolism 20080901 |
| The creatine kinase response to eccentric exercise with atorvastatin 10 mg or 80 mg. | Atherosclerosis 20080901 |
| Statin therapy increases carotid plaque echogenicity in hypercholesterolemic patients. | Ultrasound in medicine & biology 20080901 |
| Effects of atorvastatin and pravastatin on glucose tolerance, adipokine levels and inflammatory markers in hypercholesterolaemic patients. | Clinical and experimental pharmacology & physiology 20080901 |
| The human paraoxonase-1 phenotype modifies the effect of statins on paraoxonase activity and lipid parameters. | British journal of clinical pharmacology 20080901 |
| CYP3A4*1G polymorphism is associated with lipid-lowering efficacy of atorvastatin but not of simvastatin. | European journal of clinical pharmacology 20080901 |
| Celecoxib but not the combination of celecoxib+atorvastatin prevents the development of monocrotaline-induced pulmonary hypertension in the rat. | Naunyn-Schmiedeberg's archives of pharmacology 20080901 |
| Combination regimen with statins and NSAIDs: a promising strategy for cancer chemoprevention. | International journal of cancer 20080901 |
| A study of the pharmacokinetic interaction of istradefylline, a novel therapeutic for Parkinson's disease, and atorvastatin. | Journal of clinical pharmacology 20080901 |
| Effects of atorvastatin on progression-regression of renal injury in hyperlipidemic chickens. | Histology and histopathology 20080901 |
| Relative effects of statin therapy on stroke and cardiovascular events in men and women: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study. | Stroke 20080901 |
| Efficacy of atorvastatin for achieving cholesterol targets after LDL-cholesterol based dose selection in patients with type 2 diabetes. | Journal of cardiovascular pharmacology and therapeutics 20080901 |
| Effect of atorvastatin on hs-CRP in acute coronary syndrome. | British journal of clinical pharmacology 20080901 |
| Lipidomic approach to evaluate rosuvastatin and atorvastatin at various dosages: investigating differential effects among statins. | Current medical research and opinion 20080901 |
| Statins: potentially useful in therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers. | The Journal of rheumatology 20080901 |
| Phosphorylation of 5-lipoxygenase at ser523 by protein kinase A determines whether pioglitazone and atorvastatin induce proinflammatory leukotriene B4 or anti-inflammatory 15-epi-lipoxin a4 production. | Journal of immunology (Baltimore, Md. : 1950) 20080901 |
| Contribution of cytochrome P450 3A4 and 3A5 to the metabolism of atorvastatin. | Xenobiotica; the fate of foreign compounds in biological systems 20080901 |
| Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials). | The American journal of cardiology 20080901 |
| [Hypertension--does it matter how blood pressure is lowered?]. | Ugeskrift for laeger 20080901 |
| The safety and tolerability of atorvastatin 10 mg in the Collaborative Atorvastatin Diabetes Study (CARDS). | Diabetes & vascular disease research 20080901 |
| Ischemic stroke: a cardiovascular risk equivalent? Lessons learned from the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. | The Canadian journal of cardiology 20080901 |
| [Vascular prevention after cerebral infarct or transient ischemic accident. Recommendations. March, 2008]. | Revue neurologique 20080901 |
| [Impact of statins on clopidogrel platelet inhibition in patients with acute coronary syndrome or stable angina]. | Zhonghua xin xue guan bing za zhi 20080901 |
| Last fall I began taking daily doses of 1,500 mg of niacin, in addition to the 40 mg of Lipitor I've been taking for several years. Within six months, my LDL and triglycerides were down significantly and my HDL was higher. If my next bi-annual blood test shows the same types of results, should I discontinue the Lipitor and niacin? | Heart advisor 20080901 |
| Antiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosis. | JACC. Cardiovascular imaging 20080901 |
| Theranostic strategy against plaque angiogenesis. | JACC. Cardiovascular imaging 20080901 |
| Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients: the MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin) trial. | Journal of the American College of Cardiology 20080819 |
| Early effects of low versus high dose atorvastatin treatment on coagulation and inflammation parameters in patients with acute coronary syndromes. | International journal of cardiology 20080818 |
| Impact of blood circulation on reendothelialization, restenosis and atrovastatin's restenosis prevention effects. | International journal of cardiology 20080818 |
| Cytogenetic status and oxidative DNA-damage induced by atorvastatin in human peripheral blood lymphocytes: standard and Fpg-modified comet assay. | Toxicology and applied pharmacology 20080815 |
| Failure of atorvastatin to modulate CSF HIV-1 infection: results of a pilot study. | Neurology 20080812 |
| A novel membrane-based anti-diabetic action of atorvastatin. | Biochemical and biophysical research communications 20080808 |
| Statin inhibits kainic acid-induced seizure and associated inflammation and hippocampal cell death. | Neuroscience letters 20080808 |
| Detection of Lipitor counterfeits: a comparison of NIR and Raman spectroscopy in combination with chemometrics. | Journal of pharmaceutical and biomedical analysis 20080805 |
| Synergistic effect of amlodipine and atorvastatin in reversing LDL-induced endothelial dysfunction. | Pharmaceutical research 20080801 |
| Caffeinated coffee blunts the myocardial protective effects of statins against ischemia-reperfusion injury in the rat. | Cardiovascular drugs and therapy 20080801 |
| Effect of APOE genotype on lipid levels in patients with coronary heart disease during a 3-week inpatient rehabilitation program. | Clinical pharmacology and therapeutics 20080801 |
| Wake up and smell the coffee: yet another no go for cardiac patients? : editorial to 'caffeinated coffee blunts the myocardial protective effects of statins against ischemia-reperfusion injury in the rat' by Ye et al. | Cardiovascular drugs and therapy 20080801 |
| Functional consequences of active hepatic uptake on cytochrome P450 inhibition in rat and human hepatocytes. | Drug metabolism and disposition: the biological fate of chemicals 20080801 |
| Atorvastatin and celecoxib: a future role in cancer chemoprevention. | International journal of cancer 20080801 |
| Possible involvement of advanced glycation end products in carry-over benefits of atorvastatin in ASCOT-BPLA. | European heart journal 20080801 |
| Hypercholesterolaemia exacerbates ventricular remodelling after myocardial infarction in the rat: role of angiotensin II type 1 receptors. | British journal of pharmacology 20080801 |
| Atorvastatin decreases high-sensitivity C-reactive protein in multiple sclerosis. | Multiple sclerosis (Houndmills, Basingstoke, England) 20080801 |
| Statin-induced inhibition of MCF-7 breast cancer cell proliferation is related to cell cycle arrest and apoptotic and necrotic cell death mediated by an enhanced oxidative stress. | Cancer investigation 20080801 |
| Effects of ezetimibe, either alone or in combination with atorvastatin, on serum visfatin levels: a pilot study. | Expert opinion on pharmacotherapy 20080801 |
| Comparison effect of atorvastatin (10 versus 80 mg) on biomarkers of inflammation and oxidative stress in subjects with metabolic syndrome. | The American journal of cardiology 20080801 |
| Lipophilicity and cardiovascular outcome in patients with CHF. | American heart journal 20080801 |
| The effects of atorvastatin on the occurrence of postoperative atrial fibrillation after off-pump coronary artery bypass grafting surgery. | American heart journal 20080801 |
| Serum uric acid level reduction, cardiovascular outcome, and mortality: comment on the article by Ioachimescu et al. | Arthritis and rheumatism 20080801 |
| Intensive lipid intervention in the post-ENHANCE era. | Mayo Clinic proceedings 20080801 |
| Intensive lipid lowering with atorvastatin in patients with coronary artery disease, diabetes, and chronic kidney disease. | Mayo Clinic proceedings 20080801 |
| Synergistic inhibition of lung tumorigenesis by a combination of green tea polyphenols and atorvastatin. | Clinical cancer research : an official journal of the American Association for Cancer Research 20080801 |
| Monocyte gene-expression profile in men with familial combined hyperlipidemia and its modification by atorvastatin treatment. | Pharmacogenomics 20080801 |
| Effect of atorvastatin on LDL & hs-CRP in a selected Thai population. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20080801 |
| Effect of intensive statin therapy on arterial elasticity in patients with coronary artery disease. | Acta cardiologica 20080801 |
| Discovery Belux: comparison of rosuvastatin with atorvastatin in hypercholesterolaemia. | Acta cardiologica 20080801 |
| Familial dysbetalipoproteinemia: a potentially fatal disorder. | Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20080801 |
| Variability of lipids in patients with Type 2 diabetes taking statin treatment: implications for target setting. | Diabetic medicine : a journal of the British Diabetic Association 20080801 |
| [Important aim of statin therapy: ischemic cardiovascular event (stroke)]. | Ideggyogyaszati szemle 20080730 |
| Atorvastatin effects on SREBF1a and SCAP gene expression in mononuclear cells and its relation with lowering-lipids response. | Clinica chimica acta; international journal of clinical chemistry 20080717 |
| LC and LC-MS methods for the investigation of polypills for the treatment of cardiovascular diseases. Part 1. Separation of active components and classification of their interaction/degradation products. | Journal of pharmaceutical and biomedical analysis 20080715 |
| Physicochemical properties and oral bioavailability of amorphous atorvastatin hemi-calcium using spray-drying and SAS process. | International journal of pharmaceutics 20080709 |
| Variation in Niemann-Pick C1-like 1 gene as a determinant of apolipoprotein B-100 kinetics and response to statin therapy in centrally obese men. | Clinical endocrinology 20080701 |
| High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins. | Cardiovascular research 20080701 |
| Atorvastatin does not improve liver biochemistries or Mayo Risk Score in primary biliary cirrhosis. | Digestive diseases and sciences 20080701 |
| Prediction of the pharmacokinetics of atorvastatin, cerivastatin, and indomethacin using kinetic models applied to isolated rat hepatocytes. | Drug metabolism and disposition: the biological fate of chemicals 20080701 |
| Statins, leptin and regulatory T cells. | Nutrition, metabolism, and cardiovascular diseases : NMCD 20080701 |
| Renoprotection by statins is linked to a decrease in renal oxidative stress, TGF-beta, and fibronectin with concomitant increase in nitric oxide bioavailability. | American journal of physiology. Renal physiology 20080701 |
| The role of eNOS, iNOS, and NF-kappaB in upregulation and activation of cyclooxygenase-2 and infarct size reduction by atorvastatin. | American journal of physiology. Heart and circulatory physiology 20080701 |
| Effect of interferon-beta and atorvastatin on Th1/Th2 cytokines in multiple sclerosis. | Neurochemistry international 20080701 |
| Persistence of atorvastatin and simvastatin among patients with and without prior cardiovascular diseases: a US managed care study. | Current medical research and opinion 20080701 |
| Effect of intensive atorvastatin therapy on prostaglandin E2 levels and metalloproteinase-9 activity in the plasma of patients with non-ST-elevation acute coronary syndrome. | The American journal of cardiology 20080701 |
| Failure of oral atorvastatin to modulate a murine model of systemic lupus erythematosus. | Arthritis and rheumatism 20080701 |
| Relationship between biomarkers of oxidized low-density lipoprotein, statin therapy, quantitative coronary angiography, and atheroma: volume observations from the REVERSAL (Reversal of Atherosclerosis with Aggressive Lipid Lowering) study. | Journal of the American College of Cardiology 20080701 |
| Atorvastatin prevents atrial fibrillation in patients with bradyarrhythmias and implantation of an atrial-based or dual-chamber pacemaker: a prospective randomized trial. | American heart journal 20080701 |
| Lipid management: considerations in acute coronary syndrome. | Current cardiology reports 20080701 |
| Simultaneous estimation of atorvastatin and ramipril by RP-HPLC and spectroscopy. | Pakistan journal of pharmaceutical sciences 20080701 |
| Atorvastatin induces associated reductions in platelet P-selectin, oxidized low-density lipoprotein, and interleukin-6 in patients with coronary artery diseases. | Heart and vessels 20080701 |
| Cost-effectiveness analysis of rosuvastatin versus atorvastatin, simvastatin, and pravastatin from a Canadian health system perspective. | Clinical therapeutics 20080701 |
| Atorvastatin-induced changes in plasma coenzyme q10 and brain natriuretic peptide in patients with coronary artery disease. | International heart journal 20080701 |
| Assessment of the efficacy and tolerability of a fixed dose combination of atorvastatin 10 mg + metformin SR 500 mg in diabetic dyslipidaemia in adult Indian patients. | Journal of the Indian Medical Association 20080701 |
| [Intensive atorvastatin therapy in patients with acute myocardial infarction]. | Zhonghua xin xue guan bing za zhi 20080701 |
| [Effect of atorvastatin treatment on the hemorheologic and hemostatic parameters in chronic cerebrovascular patients]. | Orvosi hetilap 20080615 |
| Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. | Neurology 20080610 |
| [Dual cholesterol inhibition. More high risk patients achieve LDL cholesterol values below 100 mg/dl]. | MMW Fortschritte der Medizin 20080605 |
| Behçet's disease complicated by IgA nephropathy with nephrotic syndrome. | Clinical and experimental nephrology 20080601 |
| Glutathione S-transferase null and cholesteryl ester transfer protein TaqI B polymorphisms and lipid response to atorvastatin in Greek dyslipidaemic patients. | Basic & clinical pharmacology & toxicology 20080601 |
| Cholesterol synthesis inhibition elicits an integrated molecular response in human livers including decreased ACAT2. | Arteriosclerosis, thrombosis, and vascular biology 20080601 |
| Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process. | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20080601 |
| Atorvastatin and uptake of ultrasmall superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) in human monocyte-macrophages: implications for magnetic resonance imaging. | Biomaterials 20080601 |
| Intensive lipid-lowering therapy ameliorates novel calcification markers and GSM score in patients with carotid stenosis. | European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 20080601 |
| A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20080601 |
| Effects of statin treatment in men and women with stable coronary heart disease: a subgroup analysis of the GREACE Study. | Current medical research and opinion 20080601 |
| Statin treatment improves cerebral more than systemic endothelial dysfunction in patients with arterial hypertension. | American journal of hypertension 20080601 |
| Atorvastatin treatment improves survival and effects of implanted mesenchymal stem cells in post-infarct swine hearts. | European heart journal 20080601 |
| Real-time detection and identification of aqueous chlorine transformation products using QTOF MS. | Analytical chemistry 20080601 |
| Prevention of pediatric graft coronary artery disease: atorvastatin. | Pediatric transplantation 20080601 |
| Efficacy of lipid-lowering medications in patients treated with clozapine: a naturalistic study. | Journal of clinical psychopharmacology 20080601 |
| Re: Statins and sepsis. | British journal of anaesthesia 20080601 |
| Cost-effectiveness of statins in the prevention of coronary heart disease events in middle-aged Finnish men. | Current medical research and opinion 20080601 |
| Specific amelioration of cerebral endothelial dysfunction in hypertensive patients treated with atorvastatin. | American journal of hypertension 20080601 |
| Von Willebrand disease and angiodysplasia responding to atorvastatin. | British journal of haematology 20080601 |
| The relation between extent of coronary artery disease measured by quantitative coronary angiography and changes in lipid profile: insights from trials of atherosclerosis regression. | The Journal of invasive cardiology 20080601 |
| Atorvastatin administration after percutaneous coronary intervention in patients with coronary artery disease and normal lipid profiles: impact on plasma adiponectin level. | Clinical cardiology 20080601 |
| Expanding roles for atorvastatin. | Drugs of today (Barcelona, Spain : 1998) 20080601 |
| Effects of statin on small dense low-density lipoprotein cholesterol and remnant-like particle cholesterol in heterozygous familial hypercholesterolemia. | Journal of atherosclerosis and thrombosis 20080601 |
| A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance. | Clinical therapeutics 20080601 |
| Rhabdomyolysis with atorvastatin and fusidic acid. | Postgraduate medical journal 20080601 |
| Atorvastatin and cardiovascular risk in the elderly--patient considerations. | Clinical interventions in aging 20080601 |
| [Pleiotropic effects of statins]. | Revista medica de Chile 20080601 |
| Statin, the black box. | Archives of cardiovascular diseases 20080601 |
| Effects of rosuvastatin and atorvastatin on the apolipoprotein B/apolipoprotein A-1 ratio in patients with an acute coronary syndrome: The CENTAURUS trial design. | Archives of cardiovascular diseases 20080601 |
| Relative safety profiles of high dose statin regimens. | Vascular health and risk management 20080601 |
| Adherence with single-pill amlodipine/atorvastatin vs a two-pill regimen. | Vascular health and risk management 20080601 |
| Cholesterol-induced stimulation of postinflammatory liver fibrosis. | Bulletin of experimental biology and medicine 20080601 |
| Adiponectin plasma levels are increased by atorvastatin treatment in subjects at high cardiovascular risk. | European journal of pharmacology 20080531 |
| Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgery. | Journal of the American College of Cardiology 20080520 |
| Torcetrapib does not reduce atherosclerosis beyond atorvastatin and induces more proinflammatory lesions than atorvastatin. | Circulation 20080513 |
| [Difficulties in detecting the causative agent of an adverse drug reaction in a complicated case]. | Orvosi hetilap 20080511 |
| E-selectin and TFPI are associated with carotid intima-media thickness in stable IHD patients: the baseline findings of the MIAMI study. | Nutrition, metabolism, and cardiovascular diseases : NMCD 20080501 |
| Comparison of effects of pitavastatin and atorvastatin on plasma coenzyme Q10 in heterozygous familial hypercholesterolemia: results from a crossover study. | Clinical pharmacology and therapeutics 20080501 |
| Zooplankton chitobiase activity as an endpoint of pharmaceutical effect. | Archives of environmental contamination and toxicology 20080501 |
| Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus. | Atherosclerosis 20080501 |
| Effects of statins on renal sodium and water handling: acute and short-term effects of atorvastatin on renal haemodynamics, tubular function, vasoactive hormones, blood pressure and pulse rate in healthy, normocholesterolemic humans. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20080501 |
| Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells. | International journal of cancer 20080501 |
| Drug interaction between oral atorvastatin and verapamil in healthy subjects: effects of atorvastatin on the pharmacokinetics of verapamil and norverapamil. | European journal of clinical pharmacology 20080501 |
| Statin-induced inhibition of 3-hydroxy-3-methyl glutaryl coenzyme a reductase sensitizes human osteosarcoma cells to anticancer drugs. | The Journal of pharmacology and experimental therapeutics 20080501 |
| Atorvastatin does not alter serum levels of sCD95 and sCD95L in multiple sclerosis. | Clinical and experimental immunology 20080501 |
| Combined treatment with atorvastatin and minocycline suppresses severity of EAE. | Experimental neurology 20080501 |
| Atorvastatin monotherapy vs. combination therapy in the management of patients with combined hyperlipidemia. | European journal of internal medicine 20080501 |
| Effect of atorvastatin on plasma levels of asymmetric dimethylarginine in patients with non-ischaemic heart failure. | European journal of heart failure 20080501 |
| High-dose atorvastatin does not negatively influence clinical outcomes among clopidogrel treated acute coronary syndrome patients--a Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) analysis. | American heart journal 20080501 |
| Atorvastatin downregulates BMP-2 expression induced by oxidized low-density lipoprotein in human umbilical vein endothelial cells. | Circulation journal : official journal of the Japanese Circulation Society 20080501 |
| Dose-related effect of statins on atrial fibrillation after cardiac surgery. | The Annals of thoracic surgery 20080501 |
| Leukocyte, plasma, and organ-associated cytokine profiles in an animal model of acute inflammation. | APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 20080501 |
| The benefits of intensive lipid lowering in patients with stable coronary heart disease with normal or high systolic blood pressure: an analysis of the Treating to New Targets (TNT) study. | Journal of clinical hypertension (Greenwich, Conn.) 20080501 |
| [Stroke due to spontaneous calcified cerebral embolus as presenting feature of calcified aortic stenosis]. | Journal des maladies vasculaires 20080501 |
| Effects of atorvastatin and pravastatin on signal transduction related to glucose uptake in 3T3L1 adipocytes. | Journal of pharmacological sciences 20080501 |
| Atorvastatin does not alter interferon Beta-induced changes of serum matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 in patients with multiple sclerosis. | Archives of neurology 20080501 |
| HMG-CoA reductase inhibitors deplete circulating classical and non-classical monocytes following human heart transplantation. | Transplant immunology 20080501 |
| [Changes of blood lipids in colorectal cancer patients with coronary heart disease and value of lipid-lowering therapy with statins]. | Nan fang yi ke da xue xue bao = Journal of Southern Medical University 20080501 |
| [Effect of atorvastatin on ACE2 expression in pressure overload induced cardiac hypertrophy in rats]. | Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20080501 |
| [2008 National Cardiology Guidelines: Prioritization requires consideration to other factors than scientific studies alone]. | Lakartidningen 20080501 |
| Commentary on 'the Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics'. | Alzheimer's & dementia : the journal of the Alzheimer's Association 20080501 |
| Cost-effectiveness of atorvastatin in the prevention of cardiovascular events in diabetic patients: a French adaptation of CARDS. | Archives of cardiovascular diseases 20080501 |
| The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study. | Journal of the American College of Cardiology 20080429 |
| The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans. | Journal of the American College of Cardiology 20080429 |
| Systemic evaluation of gene expression changes in major target organs induced by atorvastatin. | European journal of pharmacology 20080428 |
| Torcetrapib and coronary events. | The New England journal of medicine 20080424 |
| Statin induced myotoxicity: the lactone forms are more potent than the acid forms in human skeletal muscle cells in vitro. | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20080423 |
| Lipid levels after acute coronary syndromes. | Journal of the American College of Cardiology 20080415 |
| Lipid levels in the post-acute coronary syndrome setting: destabilizing another myth? | Journal of the American College of Cardiology 20080415 |
| Intensive lipid lowering with atorvastatin in patients with coronary heart disease and chronic kidney disease: the TNT (Treating to New Targets) study. | Journal of the American College of Cardiology 20080415 |
| The effect of HMG-CoA reductase inhibitors on naturally occurring CD4+CD25+ T cells. | Atherosclerosis 20080401 |
| Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) study. | Heart (British Cardiac Society) 20080401 |
| Drug-screening platform based on the contractility of tissue-engineered muscle. | Muscle & nerve 20080401 |
| 3-Hydroxy-3-methylglutaryl coenzyme A reductase in rainbow trout: effects of fasting and statin drugs on activities and mRNA transcripts. | Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 20080401 |
| Effects of traditional chinese medicine on endotoxin and its receptors in rats with non-alcoholic steatohepatitis. | Inflammation 20080401 |
| Determinants of CRP level in statin-treated patients. | Current medical research and opinion 20080401 |
| Atorvastatin induces apoptosis by a caspase-9-dependent pathway: an in vitro study on activated rat hepatic stellate cells. | Liver international : official journal of the International Association for the Study of the Liver 20080401 |
| Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care. | Expert opinion on pharmacotherapy 20080401 |
| Cumulative clinical trial data on atorvastatin for reducing cardiovascular events: the clinical impact of atorvastatin. | Current medical research and opinion 20080401 |
| Gynecomastia possibly induced by rosuvastatin. | Pharmacotherapy 20080401 |
| Pleiotropic effects of atorvastatin in heart failure: role in oxidative stress, inflammation, endothelial function, and exercise capacity. | The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20080401 |
| The failure of torcetrapib: is there a case for independent preclinical and clinical testing? | Expert opinion on pharmacotherapy 20080401 |
| Effects of statin treatment on serum sex steroids levels and autonomic and erectile function. | Urology 20080401 |
| Biphasic effects of atorvastatin on inflammation. | Pakistan journal of pharmaceutical sciences 20080401 |
| [Influence of statins on the antiplatelet effect of clopidogrel and on cardiovascular outcome in patients after coronary intervention]. | Deutsche medizinische Wochenschrift (1946) 20080401 |
| [Cost-effectiveness of managing familial hypercholesterolemia using atorvastatin-based preventive therapy]. | Revista espanola de cardiologia 20080401 |
| Adjunctive interventions in myocardial infarction: the role of statin therapy. | Current atherosclerosis reports 20080401 |
| Intensive statin therapy in acute coronary syndromes. | Current atherosclerosis reports 20080401 |
| Atorvastatin inhibits ABCA1 expression and cholesterol efflux in THP-1 macrophages by an LXR-dependent pathway. | Journal of cardiovascular pharmacology 20080401 |
| Efficient tirofiban infusion resulting in resolution of intracoronary thrombus. | Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir 20080401 |
| Comparisons of short- and intermediate-term effects of pitavastatin versus atorvastatin on lipid profiles, fibrinolytic parameter, and endothelial function. | International journal of cardiology 20080328 |
| Atorvastatin has hypolipidemic and anti-inflammatory effects in apoE/LDL receptor-double-knockout mice. | Life sciences 20080326 |
| Pfizer ends advertisements featuring inventor of artificial heart. | BMJ (Clinical research ed.) 20080308 |
| Activatable magnetic resonance imaging agent reports myeloperoxidase activity in healing infarcts and noninvasively detects the antiinflammatory effects of atorvastatin on ischemia-reperfusion injury. | Circulation 20080304 |
| Gender differences in short-term effects of atorvastatin on lipid profile, fibrinolytic parameters, and endothelial function. | Nutrition, metabolism, and cardiovascular diseases : NMCD 20080301 |
| Modulation of arterial reactivity using amlodipine and atorvastatin measured by ultrasound examination (MARGAUX). | Atherosclerosis 20080301 |
| A dose-titration and comparative study of rosuvastatin and atorvastatin in patients with homozygous familial hypercholesterolaemia. | Atherosclerosis 20080301 |
| Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP mice. | Atherosclerosis 20080301 |
| Dual mode of HMG-CoA reductase inhibition on dendritic cell invasion. | Atherosclerosis 20080301 |
| Atorvastatin attenuates mitochondrial toxin-induced striatal degeneration, with decreasing iNOS/c-Jun levels and activating ERK/Akt pathways. | Journal of neurochemistry 20080301 |
| Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on VLDL apolipoprotein E metabolism. | Journal of lipid research 20080301 |
| Genetic modulation of anti-inflammatory effects of atorvastatin; probably a multi-gene condition. | Atherosclerosis 20080301 |
| Estimating the extent of reporting to FDA: a case study of statin-associated rhabdomyolysis. | Pharmacoepidemiology and drug safety 20080301 |
| High-density lipoprotein mass, cholesteryl ester transport protein, and macrophage reverse cholesterol transport: from the bedside back to the bench. | Cardiovascular research 20080301 |
| Oral nanoparticulate atorvastatin calcium is more efficient and safe in comparison to Lipicure in treating hyperlipidemia. | Lipids 20080301 |
| Evaluation of the clinical outcomes of switching patients from atorvastatin to simvastatin and losartan to candesartan in a primary care setting: 2 years on. | International journal of clinical practice 20080301 |
| Effects of atorvastatin on red-blood cell Na(+)/Li(+) countertransport in hyperlipidemic patients with and without hypertension. | American journal of hypertension 20080301 |
| The efficacy of statin monotherapy uptitration versus switching to ezetimibe/simvastatin: results of the EASEGO study. | Current medical research and opinion 20080301 |
| Comment on: Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: an 8 week controlled trial. | Rheumatology (Oxford, England) 20080301 |
| Differential effect of atorvastatin and fenofibrate on plasma oxidized low-density lipoprotein, inflammation markers, and cell adhesion molecules in patients with type 2 diabetes mellitus. | Metabolism: clinical and experimental 20080301 |
| Pretreatment with high-dose statin, but not low-dose statin, ezetimibe, or the combination of low-dose statin and ezetimibe, limits infarct size in the rat. | Journal of cardiovascular pharmacology and therapeutics 20080301 |
| Atorvastatin therapy may reduce the incidence of sudden cardiac death in patients with advanced chronic heart failure. | Journal of cardiac failure 20080301 |
| Atorvastatin attenuates cardiomyocyte loss in adult rats from protein-restricted dams. | Journal of cardiac failure 20080301 |
| Flexible initial dosing of atorvastatin based upon initial low-density lipoprotein cholesterol levels in type 2 diabetic patients. | The Korean journal of internal medicine 20080301 |
| Synergistic effect of amlodipine and atorvastatin on blood pressure, left ventricular remodeling, and C-reactive protein in hypertensive patients with primary hypercholesterolemia. | Heart and vessels 20080301 |
| Behavioral changes with paranoia in an elderly woman taking atorvastatin. | The American journal of geriatric pharmacotherapy 20080301 |
| Hippocampal volume change in the Alzheimer Disease Cholesterol-Lowering Treatment trial. | Cleveland Clinic journal of medicine 20080301 |
| The Atorvastatin/Donepezil in Alzheimer's Disease Study (LEADe): design and baseline characteristics. | Alzheimer's & dementia : the journal of the Alzheimer's Association 20080301 |
| Strategies for statins: The CASE for fire and forget. | BMJ (Clinical research ed.) 20080223 |
| Monocyte chemoattractant protein-1 expression is enhanced by granulocyte-macrophage colony-stimulating factor via Jak2-Stat5 signaling and inhibited by atorvastatin in human monocytic U937 cells. | The Journal of biological chemistry 20080222 |
| Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial. | Journal of the American College of Cardiology 20080219 |
| Analyzing the results of the treating to new targets study. | Annals of internal medicine 20080219 |
| Analyzing the results of the treating to new targets study. | Annals of internal medicine 20080219 |
| Analyzing the results of the treating to new targets study. | Annals of internal medicine 20080219 |
| Effectiveness of ezetimibe alone or in combination with twice a week Atorvastatin (10 mg) for statin intolerant high-risk patients. | The American journal of cardiology 20080215 |
| Effect of atorvastatin on energy expenditure and skeletal muscle oxidative metabolism at rest and during exercise. | Clinical pharmacology and therapeutics 20080201 |
| Effect of acute changes in oxygen tension on flow-mediated dilation. Relation to cardivascular risk. | Scandinavian cardiovascular journal : SCJ 20080201 |
| Atorvastatin increases human serum levels of proprotein convertase subtilisin/kexin type 9. | Journal of lipid research 20080201 |
| Hepatoselectivity of statins: design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitors. | Bioorganic & medicinal chemistry letters 20080201 |
| The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: extended observations 2 years after trial closure. | European heart journal 20080201 |
| Differential effect of fenofibrate and atorvastatin on in vivo kinetics of apolipoproteins B-100 and B-48 in subjects with type 2 diabetes mellitus with marked hypertriglyceridemia. | Metabolism: clinical and experimental 20080201 |
| A 6 month randomized, double blind, placebo controlled, multi-center trial of high dose atorvastatin on myocardial perfusion abnormalities by positron emission tomography in coronary artery disease. | American heart journal 20080201 |
| Effect of statin dose on incidence of atrial fibrillation: data from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) and Aggrastat to Zocor (A to Z) trials. | American heart journal 20080201 |
| Class effects of statins in elderly patients with congestive heart failure: a population-based analysis. | American heart journal 20080201 |
| Usefulness of statin pretreatment to prevent contrast-induced nephropathy and to improve long-term outcome in patients undergoing percutaneous coronary intervention. | The American journal of cardiology 20080201 |
| Effects of maximal doses of atorvastatin versus rosuvastatin on small dense low-density lipoprotein cholesterol levels. | The American journal of cardiology 20080201 |
| Impact of systemic hypertension on the cardiovascular benefits of statin therapy--a meta-analysis. | The American journal of cardiology 20080201 |
| Anti-inflammatory effects of combined treatment with acetyl salicylic acid and atorvastatin in haemodialysis patients affected by Normal Weight Obese syndrome. | Pharmacological research 20080201 |
| Toxicity of human pharmaceuticals and personal care products to benthic invertebrates. | Environmental toxicology and chemistry 20080201 |
| Atorvastatin slows the progression of cardiac remodeling in mice with pressure overload and inhibits epidermal growth factor receptor activation. | Hypertension research : official journal of the Japanese Society of Hypertension 20080201 |
| [Effects of atorvastatin on p27 protein expression and cardiomyocytes apoptosis in spontaneously hypertensive rats]. | Zhongguo ying yong sheng li xue za zhi = Zhongguo yingyong shenglixue zazhi = Chinese journal of applied physiology 20080201 |
| Polymorphism in KIF6 gene and benefit from statins after acute coronary syndromes: results from the PROVE IT-TIMI 22 study. | Journal of the American College of Cardiology 20080129 |
| A pivotal role for interleukin-4 in atorvastatin-associated neuroprotection in rat brain. | The Journal of biological chemistry 20080125 |
| Inhibition of dipeptidyl peptidase-IV (DPP-IV) by atorvastatin. | Bioorganic & medicinal chemistry letters 20080115 |
| Identification and quantitative determination of atorvastatin calcium polymorph in tablets using FT-Raman spectroscopy. | Talanta 20080115 |
| Statins enhance circulating vitamin E. | International journal of cardiology 20080111 |
| HMG-CoA reductase inhibition improves anti-aging klotho protein expression and arteriosclerosis in rats with chronic inhibition of nitric oxide synthesis. | International journal of cardiology 20080111 |
| Statins and ATP regulate nuclear pAkt via the P2X7 purinergic receptor in epithelial cells. | Biochemical and biophysical research communications 20080104 |
| Short- and long-term elevation of autoantibody titers against oxidized LDL in patients with acute coronary syndromes. Role of the lipoprotein-associated phospholipase A2 and the effect of atorvastatin treatment. | Atherosclerosis 20080101 |
| Leukocyte and endothelial adhesion molecules in patients with hypercholesterolemia: the effect of atorvastatin treatment. | Physiological research 20080101 |
| Automated enzyme inhibition assay method for the determination of atorvastatin-derived HMG-CoA reductase inhibitors in human plasma using radioactivity detection. | Journal of pharmacological and toxicological methods 20080101 |
| Atorvastatin but not elocalcitol increases sildenafil responsiveness in spontaneously hypertensive rats by regulating the RhoA/ROCK pathway. | Journal of andrology 20080101 |
| Mapping spatial and temporal changes in carotid atherosclerosis from three-dimensional ultrasound images. | Ultrasound in medicine & biology 20080101 |
| Hydrophobic but not hydrophilic statins enhance phagocytosis and decrease apoptosis of human peripheral blood cells in vitro. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20080101 |
| Modulation of calcification of vascular smooth muscle cells in culture by calcium antagonists, statins, and their combination. | Molecular and cellular biochemistry 20080101 |
| Effect of atorvastatin on the intravenous and oral pharmacokinetics of verapamil in rats. | Biopharmaceutics & drug disposition 20080101 |
| Inhibition of CETP by torcetrapib attenuates the atherogenicity of postprandial TG-rich lipoproteins in type IIB hyperlipidemia. | Arteriosclerosis, thrombosis, and vascular biology 20080101 |
| Inflammation, statin therapy, and risk of stroke after an acute coronary syndrome in the MIRACL study. | Arteriosclerosis, thrombosis, and vascular biology 20080101 |
| Effects of atorvastatin on Lp(a) and lipoprotein profiles in hemodialysis patients. | The Annals of pharmacotherapy 20080101 |
| Atorvastatin inhibits GSK-3beta phosphorylation by cardiac hypertrophic stimuli. | Biochimica et biophysica acta 20080101 |
| Atorvastatin promotes presenilin-1 expression and Notch1 activity and increases neural progenitor cell proliferation after stroke. | Stroke 20080101 |
| Early decrease of oxidative stress by atorvastatin in hypercholesterolaemic patients: effect on circulating vitamin E. | European heart journal 20080101 |
| Statin therapy in peritoneal dialysis patients: effects beyond lipid lowering. | International urology and nephrology 20080101 |
| The interscan variation of CT coronary artery calcification score: analysis of the Calcium Acetate Renagel Comparison (CARE)-2 study. | Academic radiology 20080101 |
| Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Therapy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) trial. | American heart journal 20080101 |
| Pregnancy-associated plasma protein-A elevation in patients with acute coronary syndrome and subsequent atorvastatin therapy. | The American journal of cardiology 20080101 |
| High-dose statin therapy for secondary prevention of stroke: stroke prevention by aggressive reduction in cholesterol levels study review. | The Journal of cardiovascular nursing 20080101 |
| Atorvastatin accelerates extracellular nucleotide degradation in human endothelial cells. | Molecular and cellular biochemistry 20080101 |
| Application of cytogenetic endpoints and comet assay on human lymphocytes treated with atorvastatin in vitro. | Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering 20080101 |
| Genetic influence in antithrombotic actions of atorvastatin in hypercholesterolaemia. | European journal of clinical investigation 20080101 |
| Improved attainment of blood pressure and cholesterol goals using single-pill amlodipine/atorvastatin in African Americans: the CAPABLE trial. | Mayo Clinic proceedings 20080101 |
| American Heart Association--Scientific Sessions 2007. Part 1. | IDrugs : the investigational drugs journal 20080101 |
| Atorvastatin impairs the myocardial angiogenic response to chronic ischemia in normocholesterolemic swine. | The Journal of thoracic and cardiovascular surgery 20080101 |
| Lowering LDL-C for optimal protection in high-risk patients. | The American journal of managed care 20080101 |
| Disease modifying effect of statins in dextran sulfate sodium model of mouse colitis. | Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20080101 |
| Atorvastatin reduces oxidative stress in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats. | Clinical and experimental hypertension (New York, N.Y. : 1993) 20080101 |
| Impact of cytochrome P450 3A4-metabolized statins on the antiplatelet effect of a 600-mg loading dose clopidogrel and on clinical outcome in patients undergoing elective coronary stent placement. | Thrombosis and haemostasis 20080101 |
| High-dose atorvastatin in peripheral arterial disease (PAD): effect on endothelial function, intima-media-thickness and local progression of PAD. An open randomized controlled pilot trial. | Thrombosis and haemostasis 20080101 |
| Liquid chromatography/mass spectrometric studies on atorvastatin and its stress degradation products. | Rapid communications in mass spectrometry : RCM 20080101 |
| [Clopidogrel and statins or once more on the danger of direct transfer of results of experimental studies in clinical practice]. | Kardiologiia 20080101 |
| Atorvastatin does not affect insulin sensitivity and the adiponectin or leptin levels in hyperlipidemic Type 2 diabetes. | Journal of endocrinological investigation 20080101 |
| Amlodipine/atorvastatin fixed-dose combination: a review of its use in the prevention of cardiovascular disease and in the treatment of hypertension and dyslipidemia. | American journal of cardiovascular drugs : drugs, devices, and other interventions 20080101 |
| Extended ASCOT - lipid lowering (ASCOT-LLA) study shows positive results of atorvastatin. | Cardiovascular journal of Africa 20080101 |
| First head-to-head study comparing rosuvastatin and atorvastatin effects on the treatment of atherosclerosis. | Cardiovascular journal of Africa 20080101 |
| Efficacy and safety of intensive statin therapy in the elderly. | The American journal of geriatric cardiology 20080101 |
| High-dose atorvastatin after stroke or transient ischemic attack: The Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. | Journal of the cardiometabolic syndrome 20080101 |
| Cardiovascular outcomes among patients newly initiating atorvastatin or simvastatin therapy: a large database analysis of managed care plans in the United States. | Clinical therapeutics 20080101 |
| The Lipid lowering and Onset of Renal Disease (LORD) Trial: a randomized double blind placebo controlled trial assessing the effect of atorvastatin on the progression of kidney disease. | BMC nephrology 20080101 |
| An economic evaluation of atorvastatin for primary prevention of cardiovascular events in type 2 diabetes. | PharmacoEconomics 20080101 |
| The effect of atorvastatin treatment on lipid profile and adhesion molecule levels in hypercholesterolemic patients: relation to low-density lipoprotein receptor gene polymorphism. | Cardiology 20080101 |
| Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosis. | PloS one 20080101 |
| Bexarotene combination therapy for patients with Sézary syndrome. | Dermatologic clinics 20080101 |
| Efficacy and tolerability of rosuvastatin and atorvastatin when force-titrated in patients with primary hypercholesterolemia: results from the ECLIPSE study. | Cardiology 20080101 |
| Scientific rationale for combination of a calcium channel antagonist and an HMG-CoA reductase inhibitor: a new approach to risk factor management. | Drugs 20080101 |
| Hypertriglyceridemia and hypercholesterolemia: effects of drug treatment on fatty acid composition of plasma lipids and membranes. | Prostaglandins, leukotrienes, and essential fatty acids 20080101 |
| [A new approach to the treatment of dyslipidemia]. | Medicina (Kaunas, Lithuania) 20080101 |
| Plasma PCSK9 levels are significantly modified by statins and fibrates in humans. | Lipids in health and disease 20080101 |
| Risk management of simvastatin or atorvastatin interactions with CYP3A4 inhibitors. | Drug safety 20080101 |
| Lipid-altering therapy and atrial fibrillation. | Cardiology in review 20080101 |
| DUAAL: atorvastatin provided an unexpectedly potent heart benefit in patients with chronic stable angina. | Cardiovascular journal of Africa 20080101 |
| Effect of atorvastatin on bone mineral density in patients with acute coronary syndrome. | European review for medical and pharmacological sciences 20080101 |
| Atorvastatin at conventional dose did not reduce C-reactive protein in patients on peritoneal dialysis. | Journal of nephrology 20080101 |
| Effect of NCB-02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: a randomized, parallel-group, placebo-controlled, 8-week study. | Drugs in R&D 20080101 |
| Effects of atherogenic diet and atorvastatin treatment on gene expression profiles in the C57BL/6J mouse liver. | Gene expression 20080101 |
| Atorvastatin increases myocardial indices of oxidative stress in a porcine model of hypercholesterolemia and chronic ischemia. | Journal of cardiac surgery 20080101 |
| The antiplatelet effect of atorvastatin in patients with acute coronary syndrome depends on the hs-CRP level. | Acute cardiac care 20080101 |
| Effect of correcting serum cholesterol levels on erectile function in patients with vasculogenic erectile dysfunction. | Scandinavian journal of urology and nephrology 20080101 |
| Does knowledge of medication prices predict physicians' support for cost effective prescribing policies. | The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique 20080101 |
| Effects of low-dose atorvastatin and rosuvastatin on plasma lipid profiles: a long-term, randomized, open-label study in patients with primary hypercholesterolemia. | American journal of cardiovascular drugs : drugs, devices, and other interventions 20080101 |
| Ameliorative role of Atorvastatin and Pitavastatin in L-Methionine induced vascular dementia in rats. | BMC pharmacology 20080101 |
| Therapeutic association of atorvastatin and insulin in cardiac ischemia: study in a model of type 2 diabetes with hyperlipidemia. | Pharmacological research 20080101 |
| Molecule of the month. | Current topics in medicinal chemistry 20080101 |
| The influence of low dose atorvastatin on inflammatory marker levels in patients with acute coronary syndrome and its potential clinical value. | Cardiology journal 20080101 |
| Epithelial neutrophil-activating peptide (ENA-78), acute coronary syndrome prognosis, and modulatory effect of statins. | PloS one 20080101 |
| Evaluation of a new formulation of fenofibric acid, ABT-335, co-administered with statins : study design and rationale of a phase III clinical programme. | Clinical drug investigation 20080101 |
| [Chronic transplant nephropathy]. | Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20080101 |
| Benfotiamine attenuates nicotine and uric acid-induced vascular endothelial dysfunction in the rat. | Pharmacological research 20080101 |
| Determination of etofibrate, fenofibrate, and atorvastatin in pharmaceutical preparations and plasma using differential pulse polarographic and square wave voltammetric techniques. | Journal of AOAC International 20080101 |
| [Comparative assessment of antiinflammatory action of atorvastatin in ischemic heart disease and rheumatoid arthritis]. | Kardiologiia 20080101 |
| Effect of the TNFalpha-308 G/A polymorphism on the changes produced by atorvastatin in bone mineral density in patients with acute coronary syndrome. | Annals of nutrition & metabolism 20080101 |
| Efficacy of statins in familial hypercholesterolaemia: a long term cohort study. | BMJ (Clinical research ed.) 20080101 |
| Quantitative determination of atorvastatin and para-hydroxy atorvastatin in human plasma by LC-MS-MS. | Journal of chromatographic science 20080101 |
| Short-term effect of atorvastatin on endothelial function in healthy offspring of parents with type 2 diabetes mellitus. | Cardiovascular therapeutics 20080101 |
| [Atorvastatin in treatment of patients with coronary heart disease and dislipidemiya and high general risk: efficiency and safety estimation. Design and main results of ATLANTIKA]. | Kardiologiia 20080101 |
| Essential role of TGF-beta/Smad pathway on statin dependent vascular smooth muscle cell regulation. | PloS one 20080101 |
| Pre-operative atorvastatin therapy to decrease the systemic inflammatory response after coronary artery bypass grafting. | The Journal of international medical research 20080101 |
| Short-term effects of atorvastatin on hemorheologic parameters and endothelial dysfunction in patients with hypercholesterolemia. Lower is better? | Clinical hemorheology and microcirculation 20080101 |
| Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease. Insights from the Incremental Decrease In End-points Through Aggressive Lipid-lowering Trial (IDEAL). | Annals of medicine 20080101 |
| Severe acute cholestatic hepatitis with prolonged cholestasis and bile-duct injury following atorvastatin therapy: a case report. | Acta gastro-enterologica Belgica 20080101 |
| Antitumor and apoptosis promoting properties of atorvastatin, an inhibitor of HMG-CoA reductase, against Dalton's Lymphoma Ascites tumor in mice. | Journal of experimental therapeutics & oncology 20080101 |
| [Comparison of the effects of carbohydrate metabolism compensation and atorvastatin treatment on lipid metabolism and C-reactive protein in type 2 diabetes mellitus]. | Terapevticheskii arkhiv 20080101 |
| Efficacy and safety of combination of extended release niacin and atorvastatin in patients with low levels of high density lipoprotein cholesterol. | Indian heart journal 20080101 |
| Cost-effectiveness of intensive atorvastatin treatment in high-risk patients compared with usual care in a postgeneric statin market: economic analysis of the Aggressive Lipid-lowering Initiation Abates New Cardiac Events (ALLIANCE) study. | Clinical therapeutics 20080101 |
| Phenotyping of cytochrome P450 3A enzyme in Gujarat population. | Drug metabolism letters 20080101 |
| Platelet aggregation inhibition in patients receiving statins either fully or partially metabolized by CYP3A4. | Proceedings of the Western Pharmacology Society 20080101 |
| Aspirin and hormone therapy for prostate cancer. | The New England journal of medicine 20071227 |
| Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity. | Blood 20071215 |
| Synthesis and HMG CoA reductase inhibition of 4-thiophenyl quinolines as potential hypocholesterolemic agents. | Bioorganic & medicinal chemistry 20071215 |
| Different effects of SLCO1B1 polymorphism on the pharmacokinetics of atorvastatin and rosuvastatin. | Clinical pharmacology and therapeutics 20071201 |
| Protective effects of atorvastatin on chronic allograft nephropathy in rats. | The Journal of surgical research 20071201 |
| Effects of CoQ10 supplementation on plasma lipoprotein lipid, CoQ10 and liver and muscle enzyme levels in hypercholesterolemic patients treated with atorvastatin: a randomized double-blind study. | Atherosclerosis 20071201 |
| Effects of atorvastatin on bone in postmenopausal women with dyslipidemia: a double-blind, placebo-controlled, dose-ranging trial. | The Journal of clinical endocrinology and metabolism 20071201 |
| Inflammatory activation during coronary artery surgery and its dose-dependent modulation by statin/ACE-inhibitor combination. | Arteriosclerosis, thrombosis, and vascular biology 20071201 |
| Stroke prediction and stroke prevention with atorvastatin in the Collaborative Atorvastatin Diabetes Study (CARDS). | Diabetic medicine : a journal of the British Diabetic Association 20071201 |
| Statin-mediated cytoprotection of human vascular endothelial cells: a role for Kruppel-like factor 2-dependent induction of heme oxygenase-1. | Journal of thrombosis and haemostasis : JTH 20071201 |
| Serum from hypercholesterolemic patients treated with atorvastatin or simvastatin inhibits cultured human smooth muscle cell proliferation. | Pharmacological research 20071201 |
| Impact of patient and plan design factors on switching to preferred statin therapy. | The Annals of pharmacotherapy 20071201 |
| Higher dose of statin medication may be better for older adults. | Mayo Clinic women's healthsource 20071201 |
| Atorvastatin and statins in the treatment of heart failure. | Expert opinion on pharmacotherapy 20071201 |
| An improved HPLC method with the aid of a chemometric protocol: simultaneous analysis of amlodipine and atorvastatin in pharmaceutical formulations. | Journal of separation science 20071201 |
| Biological consequences of statins in Candida species and possible implications for human health. | Biochemical Society transactions 20071201 |
| Randomized evaluation of atorvastatin in patients with coronary heart disease: a serial intravascular ultrasound study. | Circulation journal : official journal of the Japanese Circulation Society 20071201 |
| The genetic determinants of atorvastatin response. | Current opinion in molecular therapeutics 20071201 |
| Importance of intensive lipid lowering in acute coronary syndrome and percutaneous coronary intervention. | Journal of interventional cardiology 20071201 |
| Improvement in endothelium dysfunction in diabetics treated with statins: a randomized comparison of atorvastatin 20 mg versus rosuvastatin 10 mg. | Journal of interventional cardiology 20071201 |
| A randomized, placebo-controlled trial to evaluate the efficacy, safety, and pharmacodynamic interaction of coadministered amlodipine and atorvastatin in 1660 patients with concomitant hypertension and dyslipidemia: the respond trial. | Journal of clinical pharmacology 20071201 |
| Statins stimulate in vitro membrane FasL expression and lymphocyte apoptosis through RhoA/ROCK pathway in murine melanoma cells. | Neoplasia (New York, N.Y.) 20071201 |
| [Effects of atorvastatin on expression of peroxisome proliferation activated receptor gamma in unilateral ureteral obstruction in rats]. | Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue 20071201 |
| Comparison of low-density lipoprotein cholesterol reduction after switching patients on other statins to rosuvastatin or simvastatin in a real-world clinical practice setting. | The American journal of managed care 20071201 |
| A randomised study comparing the efficacy and safety of rosuvastatin with atorvastatin for achieving lipid goals in clinical practice in Asian patients at high risk of cardiovascular disease (DISCOVERY-Asia study). | Current medical research and opinion 20071201 |
| Effects of statins (atorvastatin) on serum lipoprotein levels in patients with primary hyperlipidemia and coronary heart disease. | Prilozi 20071201 |
| Effects of torcetrapib in patients at high risk for coronary events. | The New England journal of medicine 20071122 |
| Atorvastatin prevents connexin43 remodeling in hypertrophied left ventricular myocardium of spontaneously hypertensive rats. | Chinese medical journal 20071105 |
| Atorvastatin decreases triacylglycerol-associated risk of vascular events in coronary heart disease patients. | Lipids 20071101 |
| The PI3K/Akt pathway mediates the neuroprotective effect of atorvastatin in extending thrombolytic therapy after embolic stroke in the rat. | Arteriosclerosis, thrombosis, and vascular biology 20071101 |
| A novel mechanism of action of atorvastatin against cardiovascular risk: a commentary on 'decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins'. | Free radical biology & medicine 20071101 |
| Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. | Free radical biology & medicine 20071101 |
| Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study. | Clinical journal of the American Society of Nephrology : CJASN 20071101 |
| HMG-CoA reductase inhibitors and renal function. | Clinical journal of the American Society of Nephrology : CJASN 20071101 |
| Comparison of atorvastatin versus fenofibrate in reaching lipid targets and influencing biomarkers of endothelial damage in patients with familial combined hyperlipidemia. | Metabolism: clinical and experimental 20071101 |
| Atorvastatin in prevention of stroke and transient ischaemic attack. | Expert opinion on pharmacotherapy 20071101 |
| HMG CoA reductase inhibition and left ventricular mass in hypertrophic cardiomyopathy: a randomized placebo-controlled pilot study. | European journal of clinical investigation 20071101 |
| Novel delivery systems of atorvastatin should be evaluated for pharmacodynamics instead of pharmacokinetics. | The Journal of pharmacy and pharmacology 20071101 |
| The ARMYDA trials (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) at Campus Bio-Medico University: rationale, results and future horizons. | Fundamental & clinical pharmacology 20071101 |
| SPARCL: the glimmer of statins for stroke risk reduction. | Current atherosclerosis reports 20071101 |
| Efficacy of atorvastatin when not administered daily. | Arquivos brasileiros de cardiologia 20071101 |
| Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia. | Clinical therapeutics 20071101 |
| [Cardioprotective effects of atorvastatin preconditioning via iNOS upregulation in a rabbit ischemia/reperfusion model]. | Zhonghua xin xue guan bing za zhi 20071101 |
| [Influence of atorvastatin on the expression of monocyte chemoattractant protein-1 in peritoneal mesothelial cells by high glucose]. | Zhonghua yi xue za zhi 20071016 |
| Comparison of effectiveness of rosuvastatin versus atorvastatin on the achievement of combined C-reactive protein (<2 mg/L) and low-density lipoprotein cholesterol (< 70 mg/dl) targets in patients with type 2 diabetes mellitus (from the ANDROMEDA study). | The American journal of cardiology 20071015 |
| Selective inhibition of growth of tuberous sclerosis complex 2 null cells by atorvastatin is associated with impaired Rheb and Rho GTPase function and reduced mTOR/S6 kinase activity. | Cancer research 20071015 |
| Effect of clopidogrel on the inflammatory progression of early atherosclerosis in rabbits model. | Atherosclerosis 20071001 |
| Efficacy and safety of rosuvastatin 40 mg versus atorvastatin 80 mg in high-risk patients with hypercholesterolemia: results of the POLARIS study. | Atherosclerosis 20071001 |
| Switching statins in Norway after new reimbursement policy: a nationwide prescription study. | British journal of clinical pharmacology 20071001 |
| The cardioprotective effect of a statin and cilostazol combination: relationship to Akt and endothelial nitric oxide synthase activation. | Cardiovascular drugs and therapy 20071001 |
| Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis. | Blood 20071001 |
| P-glycoprotein has differential effects on the disposition of statin acid and lactone forms in mdr1a/b knockout and wild-type mice. | Drug metabolism and disposition: the biological fate of chemicals 20071001 |
| Atorvastatin decreases lipoprotein lipase and endothelial lipase expression in human THP-1 macrophages. | Journal of lipid research 20071001 |
| Statin therapy, alone or with rapamycin, does not reverse monocrotaline pulmonary arterial hypertension: the rapamcyin-atorvastatin-simvastatin study. | American journal of physiology. Lung cellular and molecular physiology 20071001 |
| Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: an 8 weeks controlled trial. | Rheumatology (Oxford, England) 20071001 |
| Induction of antigen-specific tolerance in multiple sclerosis after immunization with DNA encoding myelin basic protein in a randomized, placebo-controlled phase 1/2 trial. | Archives of neurology 20071001 |
| Interaction between a commercially available St. John's wort product (Movina) and atorvastatin in patients with hypercholesterolemia. | European journal of clinical pharmacology 20071001 |
| Reinforcing a continuum of care: in-hospital initiation of long-term secondary prevention following acute coronary syndromes. | Cardiovascular drugs and therapy 20071001 |
| Discontinuation of statin therapy and clinical outcome after ischemic stroke. | Stroke 20071001 |
| The power of drug co-administration: smaller doses better outcomes. | Cardiovascular drugs and therapy 20071001 |
| Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials). | The American journal of cardiology 20071001 |
| Preoperative lipid-lowering therapy on postoperative outcome. | The American journal of cardiology 20071001 |
| Clinical trials update from the European Society of Cardiology Congress 2007: 3CPO, ALOFT, PROSPECT and statins for heart failure. | European journal of heart failure 20071001 |
| Atorvastatin and portal pressure. | Hepatology (Baltimore, Md.) 20071001 |
| A meta-analysis to evaluate the efficacy of statins in children with familial hypercholesterolemia. | International journal of clinical pharmacology and therapeutics 20071001 |
| Adverse balance of nitric oxide/peroxynitrite in the dysfunctional endothelium can be reversed by statins. | Journal of cardiovascular pharmacology 20071001 |
| Comparison of the efficacies of five different statins on inhibition of human saphenous vein smooth muscle cell proliferation and invasion. | Journal of cardiovascular pharmacology 20071001 |
| Changes of CD4+CD25+ regulatory T cells in patients with acute coronary syndrome and the effects of atorvastatin. | Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20071001 |
| Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? The single pill of amlodipine/atorvastatin. | Vascular health and risk management 20071001 |
| Atorvastatin donor pretreatment prevents ischemia/reperfusion injury in renal transplantation in rats: possible role for aldose-reductase inhibition. | Transplantation 20070927 |
| HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events. | The New England journal of medicine 20070927 |
| Effects of short term atorvastatin treatment on cerebral hemodynamics in CADASIL. | Journal of the neurological sciences 20070915 |
| Atorvastatin inhibits T cell activation through 3-hydroxy-3-methylglutaryl coenzyme A reductase without decreasing cholesterol synthesis. | Journal of immunology (Baltimore, Md. : 1950) 20070915 |
| Atorvastatin and celecoxib inhibit prostate PC-3 tumors in immunodeficient mice. | Clinical cancer research : an official journal of the American Association for Cancer Research 20070915 |
| Effects of long-term administration of HMG-CoA reductase inhibitor, atorvastatin, on stroke events and local cerebral blood flow in stroke-prone spontaneously hypertensive rats. | Brain research 20070912 |
| NCX 6560, a nitric oxide-releasing derivative of atorvastatin, inhibits cholesterol biosynthesis and shows anti-inflammatory and anti-thrombotic properties. | European journal of pharmacology 20070910 |
| Is it time to stop treating dyslipidaemia with fibrates? | The New Zealand medical journal 20070907 |
| Effect of demethylasterriquinone b1 in hypertension associated vascular endothelial dysfunction. | International journal of cardiology 20070903 |
| In vivo coronary plaque histology in patients with stable and acute coronary syndromes: relationships with hyperlipidemic status and statin treatment. | Atherosclerosis 20070901 |
| Serotonin transporter protein in pulmonary hypertensive rats treated with atorvastatin. | American journal of physiology. Lung cellular and molecular physiology 20070901 |
| Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy. | Diabetologia 20070901 |
| Protective effect of atorvastatin on acute systemic inflammation-induced endothelial dysfunction in hypercholesterolaemic subjects. | European heart journal 20070901 |
| Physiogenomic association of statin-related myalgia to serotonin receptors. | Muscle & nerve 20070901 |
| The central role of adenosine in statin-induced ERK1/2, Akt, and eNOS phosphorylation. | American journal of physiology. Heart and circulatory physiology 20070901 |
| Flow cytometric evaluation of synergistic pro-apoptotic effects of statins and clofibrates in IM-9 human lymphoblasts. | Clinical and experimental pharmacology & physiology 20070901 |
| Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid. | Hepatology (Baltimore, Md.) 20070901 |
| [Rhabdomyolysis associated to combined ezetimibe-statin treatment]. | Revista clinica espanola 20070901 |
| Effect of rosuvastatin versus atorvastatin treatment on paraoxonase-1 activity in men with established cardiovascular disease and a low HDL-cholesterol. | Current medical research and opinion 20070901 |
| The dual peroxisome proliferator-activated receptor alpha/gamma agonist tesaglitazar further improves the lipid profile in dyslipidemic subjects treated with atorvastatin. | Metabolism: clinical and experimental 20070901 |
| CYP2D6*4 polymorphism is associated with statin-induced muscle effects. | Pharmacogenetics and genomics 20070901 |
| Safety and efficacy of Atorvastatin-induced very low-density lipoprotein cholesterol levels in Patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study). | The American journal of cardiology 20070901 |
| Effect of a single 20-mg tablet of Atorvastatin on brachial artery blood flow in normolipidemic male smokers versus nonsmokers. | The American journal of cardiology 20070901 |
| Statin therapy reduces serum levels of glycosylphosphatidylinositol-specific phospholipase D. | Translational research : the journal of laboratory and clinical medicine 20070901 |
| Effects of atorvastatin on coronary flow reserve in patients with slow coronary flow. | Clinical cardiology 20070901 |
| Medication use as a confounding factor in the use of the cerebrospinal fluid tau/beta-amyloid42 ratio. | Archives of neurology 20070901 |
| Effects of toll-like receptor-4 gene polymorphisms on soluble P-selectin and von Willebrand factor levels in hypercholesterolemic patients. | Thrombosis and haemostasis 20070901 |
| Effects of atorvastatin on C-reactive protein secretions by adipocytes in hypercholesterolemic rabbits. | Journal of cardiovascular pharmacology 20070901 |
| Atorvastatin treatment in the short term: does it induce renoprotection or vasculoprotection in renal transplantation? | Transplantation proceedings 20070901 |
| Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. | The American journal of geriatric pharmacotherapy 20070901 |
| [Statins--are they potentially useful in rheumatology?]. | Polskie Archiwum Medycyny Wewnetrznej 20070901 |
| [The antiplatelet effect of clopidogrel is not attenuated by statin treatment in patients with acute coronary syndromes undergone coronary stenting]. | Zhonghua xin xue guan bing za zhi 20070901 |
| Use of lipid-modulating drugs in complicated course of coronary heart disease. | Bulletin of experimental biology and medicine 20070901 |
| Statin treatment withdrawal in ischemic stroke: a controlled randomized study. | Neurology 20070828 |
| Low-dose treatment with atorvastatin leads to anti-oxidative and anti-inflammatory effects in diabetes mellitus. | European journal of pharmacology 20070827 |
| [Effect of atorvastatin on carotid intima-medial of thickness of primary hypertension patients of Han nationality in China]. | Zhonghua yi xue za zhi 20070821 |
| Simvastatin and atorvastatin enhance gene expression of collagen type 1 and osteocalcin in primary human osteoblasts and MG-63 cultures. | Journal of cellular biochemistry 20070815 |
| Anti-inflammatory effects of atorvastatin: modulation by the T-786C polymorphism in the endothelial nitric oxide synthase gene. | Atherosclerosis 20070801 |
| Increase in circulating levels of adiponectin after treatment with statin and fibrate in patients with coronary artery disease and hyperlipidemia. | Atherosclerosis 20070801 |
| Atorvastatin treatment for men with lower urinary tract symptoms and benign prostatic enlargement. | European urology 20070801 |
| Comparison of intensive and low-dose atorvastatin therapy in the reduction of carotid intimal-medial thickness in patients with coronary heart disease. | Heart (British Cardiac Society) 20070801 |
| Statins in elderly patients with acute coronary syndrome: an analysis of dose and class effects in typical practice. | Heart (British Cardiac Society) 20070801 |
| Atorvastatin partially prevents an inflammatory barrier breakdown of cultured human brain endothelial cells at a pharmacologically relevant concentration. | Journal of neurochemistry 20070801 |
| Metabolic dysfunction and male pelvic health. | European urology 20070801 |
| Atorvastatin glucuronidation is minimally and nonselectively inhibited by the fibrates gemfibrozil, fenofibrate, and fenofibric acid. | Drug metabolism and disposition: the biological fate of chemicals 20070801 |
| Effects of different doses of atorvastatin on human apolipoprotein B-100, B-48, and A-I metabolism. | Journal of lipid research 20070801 |
| Inhibition of serotonin-induced mitogenesis, migration, and ERK MAPK nuclear translocation in vascular smooth muscle cells by atorvastatin. | American journal of physiology. Lung cellular and molecular physiology 20070801 |
| Atorvastatin treatment and vaccination efficacy. | Journal of clinical pharmacology 20070801 |
| The influence of hospitalisation on drug prescription in primary care--a large-scale follow-up study. | European journal of clinical pharmacology 20070801 |
| Effect of statin therapy on early return of potency after nerve sparing radical retropubic prostatectomy. | The Journal of urology 20070801 |
| Efficacy of atorvastatin after LDL-cholesterol-based dose selection in high risk dyslipidaemic patients: results of the target dose study. | Current medical research and opinion 20070801 |
| A multicentre, open study to assess the effect of individualizing starting doses of atorvastatin according to baseline LDL-C levels on achieving cholesterol targets: the Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration (ACTFAST-2) study. | Current medical research and opinion 20070801 |
| Treatment with atorvastatin reduces serum adipocyte-fatty acid binding protein value in patients with hyperlipidaemia. | European journal of clinical investigation 20070801 |
| Testing the hypothesis of atherosclerotic plaque lipid depletion during lipid therapy by magnetic resonance imaging: study design of Carotid Plaque Composition Study. | American heart journal 20070801 |
| Activation of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) by atorvastatin is mediated by 15-deoxy-delta-12,14-PGJ2. | Prostaglandins & other lipid mediators 20070801 |
| Role of statins for the primary prevention of cardiovascular disease in patients with type 2 diabetes mellitus. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070801 |
| Effects of increasing doses of atorvastatin on the atherogenic lipid subclasses commonly associated with hypertriglyceridemia. | The American journal of cardiology 20070801 |
| On the factors modulating the effect of statins on malignant cell proliferation. | Cancer investigation 20070801 |
| Statins and C-reactive protein levels. | Journal of clinical hypertension (Greenwich, Conn.) 20070801 |
| Impact of statin dosing intensity on transaminase and creatine kinase. | The American journal of medicine 20070801 |
| Ask the doctor. Are Lipitor and Crestor equally good for me? | Harvard heart letter : from Harvard Medical School 20070801 |
| Endothelial expression of endoglin in normocholesterolemic and hypercholesterolemic C57BL/6J mice before and after atorvastatin treatment. | Canadian journal of physiology and pharmacology 20070801 |
| Statin treatment increases formation of carbon monoxide and bilirubin in mice: a novel mechanism of in vivo antioxidant protection. | Canadian journal of physiology and pharmacology 20070801 |
| Prolonged-release nicotinic acid for the management of dyslipidemia: an update including results from the NAUTILUS study. | Vascular health and risk management 20070801 |
| Investigation of electrochemical behavior of lipid lowering agent atorvastatin calcium in aqueous media and its determination from pharmaceutical dosage forms and biological fluids using boron-doped diamond and glassy carbon electrodes. | Combinatorial chemistry & high throughput screening 20070801 |
| Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial. | Journal of the American College of Cardiology 20070724 |
| Effect of statin withdrawal on frequency of cardiac events after vascular surgery. | The American journal of cardiology 20070715 |
| HDL cholesterol and atherosclerosis. | Lancet (London, England) 20070714 |
| Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial. | Lancet (London, England) 20070714 |
| Letter by Rosenberg and Uretsky regarding article, 'Risks associated with statin therapy: a systematic overview of randomized clinical trials'. | Circulation 20070703 |
| Summaries for patients. High- or low-dose atorvastatin in elderly patients with stable coronary artery disease. | Annals of internal medicine 20070703 |
| Outcomes of using high- or low-dose atorvastatin in patients 65 years of age or older with stable coronary heart disease. | Annals of internal medicine 20070703 |
| Enhanced cardioprotection against ischemia-reperfusion injury with a dipyridamole and low-dose atorvastatin combination. | American journal of physiology. Heart and circulatory physiology 20070701 |
| Efficacy of ezetimibe/simvastatin 10/20 and 10/40 mg compared with atorvastatin 20 mg in patients with type 2 diabetes mellitus. | Diabetes, obesity & metabolism 20070701 |
| Simvastatin and atorvastatin improve behavioral outcome, reduce hippocampal degeneration, and improve cerebral blood flow after experimental traumatic brain injury. | Experimental neurology 20070701 |
| Economic impacts attributable to the early clinical benefit of atorvastatin therapy--a US managed care perspective. | Current medical research and opinion 20070701 |
| Effects of high-dose atorvastatin on antiinflammatory properties of high density lipoprotein in patients with rheumatoid arthritis: a pilot study. | The Journal of rheumatology 20070701 |
| Reducing myocardial injury by minimizing imbalance between oxygen supply and demand. | Anesthesiology 20070701 |
| Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase. | Hepatology (Baltimore, Md.) 20070701 |
| Reversal of memory deficits by Atorvastatin and Simvastatin in rats. | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20070701 |
| Statins increase neurogenesis in the dentate gyrus, reduce delayed neuronal death in the hippocampal CA3 region, and improve spatial learning in rat after traumatic brain injury. | Journal of neurotrauma 20070701 |
| [Effects of atorvastatin on endothelium protection in spontaneously hypertensive rats]. | Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20070701 |
| [Results of ARMYDA-ACS trial show good outcome of 80 mg atorvastatin pretreatment in patients with acute coronary syndromes undergoing early percutaneous coronary intervention]. | Kardiologia polska 20070701 |
| [Atorvastatin inhibits scavenger receptor A and monocyte chemoattractant protein-1 expressions in foam cell]. | Zhonghua xin xue guan bing za zhi 20070701 |
| Lectin-like oxidized-LDL receptor-1 (LOX-1) polymorphisms influence cardiovascular events rate during statin treatment. | International journal of cardiology 20070625 |
| Effects of atorvastatin therapy on hypercholesterolemic rabbits with respect to oxidative stress, nitric oxide pathway and homocysteine. | Life sciences 20070620 |
| Long-term prognostic value of neopterin: a novel marker of monocyte activation in patients with acute coronary syndrome. | Circulation 20070619 |
| Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels. | The American journal of cardiology 20070615 |
| Direct adipotropic actions of atorvastatin: differentiation state-dependent induction of apoptosis, modulation of endocrine function, and inhibition of glucose uptake. | European journal of pharmacology 20070614 |
| Relation between local temperature and C-reactive protein levels in patients with coronary artery disease: effects of atorvastatin treatment. | Atherosclerosis 20070601 |
| Impact of atorvastatin treatment on platelet-activating factor acetylhydrolase and 15-F(2trans)-isoprostane in hypercholesterolaemic patients. | British journal of clinical pharmacology 20070601 |
| Comparative effects on lipid levels of combination therapy with a statin and extended-release niacin or ezetimibe versus a statin alone (the COMPELL study). | Atherosclerosis 20070601 |
| Aspirin before reperfusion blunts the infarct size limiting effect of atorvastatin. | American journal of physiology. Heart and circulatory physiology 20070601 |
| Dyslipidaemia as predictor of progressive renal failure and the impact of treatment with atorvastatin. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20070601 |
| Measurement of liver collagen synthesis by heavy water labeling: effects of profibrotic toxicants and antifibrotic interventions. | American journal of physiology. Gastrointestinal and liver physiology 20070601 |
| Cost-effectiveness of high-dose atorvastatin compared with regular dose simvastatin. | European heart journal 20070601 |
| The mechanism underlying vascular smooth muscle cell apoptosis induced by atorvastatin may be mainly associated with down-regulation of survivin expression. | Cardiovascular drugs and therapy 20070601 |
| Oxidative stress-mediated platelet CD40 ligand upregulation in patients with hypercholesterolemia: effect of atorvastatin. | Journal of thrombosis and haemostasis : JTH 20070601 |
| L-arginine plus atorvastatin for prevention of atheroma formation in genetically hypercholesterolaemic rabbits. | The British journal of nutrition 20070601 |
| Upregulation of nitric oxide, inhibition of oxidative stress, and antihypertensive effects of statins. | Hypertension (Dallas, Tex. : 1979) 20070601 |
| Preferable effect of pravastatin compared to atorvastatin on beta cell function in Japanese early-state type 2 diabetes with hypercholesterolemia. | Endocrine journal 20070601 |
| Atorvastatin-induced downregulation of survivin and vascular smooth muscle cell apoptosis: a causal relationship in restenosis? | Cardiovascular drugs and therapy 20070601 |
| Increased asymmetric dimethylarginine concentrations in stimulated peripheral blood mononuclear cells. | Scandinavian journal of immunology 20070601 |
| Effect of atorvastatin on progression of sensorineural hearing loss and tinnitus in the elderly: results of a prospective, randomized, double-blind clinical trial. | Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 20070601 |
| Short-term therapy with atorvastatin or fenofibrate does not affect plasma ghrelin, resistin or adiponectin levels in type 2 diabetic patients with mixed hyperlipoproteinaemia. | Acta diabetologica 20070601 |
| Comparison of rosuvastatin versus atorvastatin in South-Asian patients at risk of coronary heart disease (from the IRIS Trial). | The American journal of cardiology 20070601 |
| High-dose atorvastatin is associated with impaired myocardial angiogenesis in response to vascular endothelial growth factor in hypercholesterolemic swine: relevance to the human situation? | The Journal of thoracic and cardiovascular surgery 20070601 |
| A randomized trial of the effect of statin and fibrate therapy on arterial function in CKD. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20070601 |
| Atorvastatin therapy improves exercise oxygen uptake kinetics in post-myocardial infarction patients. | European journal of clinical investigation 20070601 |
| Long-term effect of atorvastatin on neurohumoral activation and cardiac function in patients with chronic heart failure: a prospective randomized controlled study. | American heart journal 20070601 |
| Cost-effectiveness of high-dose atorvastatin compared with usual-dose simvastatin: less than IDEAL? | European heart journal 20070601 |
| Rosuvastatin reduces interleukin-6-induced expression of C-reactive protein in human hepatocytes in a STAT3- and C/EBP-dependent fashion. | International journal of clinical pharmacology and therapeutics 20070601 |
| Therapeutic dose assessment of patient switching from atorvastatin to simvastatin. | The American journal of managed care 20070601 |
| Effect of pioglitazone and its combination with statins in coronary artery disease patients with hyperinsulinemia. | Canadian journal of physiology and pharmacology 20070601 |
| Attenuation of contractile dysfunction by atorvastatin after intestinal ischemia reperfusion injury in rats. | European journal of pharmacology 20070507 |
| Atorvastatin modulates the profile of proteins released by human atherosclerotic plaques. | European journal of pharmacology 20070507 |
| High-dose atorvastatin causes regression of endometriotic implants: a rat model. | Human reproduction (Oxford, England) 20070501 |
| Fluvastatin and atorvastatin affect calcium homeostasis of rat skeletal muscle fibers in vivo and in vitro by impairing the sarcoplasmic reticulum/mitochondria Ca2+-release system. | The Journal of pharmacology and experimental therapeutics 20070501 |
| Interactions between statins and Penicillium chrysogenum antifungal protein (PAF) to inhibit the germination of sporangiospores of different sensitive Zygomycetes. | FEMS microbiology letters 20070501 |
| Decreased skeletal muscle mitochondrial DNA in patients treated with high-dose simvastatin. | Clinical pharmacology and therapeutics 20070501 |
| Effects of rosuvastatin on lipids, lipoproteins and apolipoproteins in the dyslipidaemia of diabetes. | Diabetic medicine : a journal of the British Diabetic Association 20070501 |
| Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on Inflammatory Markers study: a substudy of Achieve Cholesterol Targets Fast with Atorvastatin Stratified Titration. | American heart journal 20070501 |
| Effects of atorvastatin and simvastatin on atrial plateau currents. | Journal of molecular and cellular cardiology 20070501 |
| Suppressive effects of statins on acute promyelocytic leukemia cells. | Cancer research 20070501 |
| Evaluation of atorvastatin and simvastatin for treatment of multiple sclerosis. | Expert review of neurotherapeutics 20070501 |
| Study highlights need for considered clinical approach to statin switching. | International journal of clinical practice 20070501 |
| Statin wars: emphasis on potency vs event reduction and safety? | Mayo Clinic proceedings 20070501 |
| Achieving low-density lipoprotein cholesterol goals in high-risk patients in managed care: comparison of rosuvastatin, atorvastatin, and simvastatin in the SOLAR trial. | Mayo Clinic proceedings 20070501 |
| Effect of HMGCoA reductase inhibitors on cytochrome P450 expression in endothelial cell line. | Journal of cardiovascular pharmacology 20070501 |
| Effects of atorvastatin on ventricular late potentials and repolarization dispersion in patients with hypercholesterolemia. | The Kaohsiung journal of medical sciences 20070501 |
| Regulation of phospholamban and sarcoplasmic reticulum Ca2+-ATPase by atorvastatin: implication for cardiac hypertrophy. | Archives of pharmacal research 20070501 |
| The effect of rapid lipid lowering with atorvastatin on autonomic parameters in patients with coronary artery disease. | International journal of cardiology 20070425 |
| [CME-Lab 2/Solution. Hypercholesteremia and therapy control]. | Praxis 20070425 |
| Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia. | The New England journal of medicine 20070419 |
| Letter by Padfield et al regarding article, 'Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of Myocardial Dysrhythmia After Cardiac Surgery) study'. | Circulation 20070417 |
| Letter by Shroff and Orlandi regarding article, 'Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of Myocardial Dysrhythmia After Cardiac Surgery) study'. | Circulation 20070417 |
| [Hypercholesterolemia and control with therapy]. | Praxis 20070411 |
| Beneficial effect of statins in multiple sclerosis: is it dose-dependent? | Atherosclerosis 20070401 |
| Atorvastatin inhibits angiotensin-converting enzyme induction in differentiating human macrophages. | American journal of physiology. Heart and circulatory physiology 20070401 |
| Post-trauma Lipitor treatment prevents endothelial dysfunction, facilitates neuroprotection, and promotes locomotor recovery following spinal cord injury. | Journal of neurochemistry 20070401 |
| Cost-effectiveness of primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes: results from the Collaborative Atorvastatin Diabetes Study (CARDS). | Diabetologia 20070401 |
| A novel mechanism of action for statins against diabetes-induced oxidative stress. | Diabetologia 20070401 |
| The effect of aggressive versus conventional lipid-lowering therapy on markers of inflammatory and oxidative stress. | Cardiovascular drugs and therapy 20070401 |
| Construction of atorvastatin dose-response relationships using data from a large population-based DNA biobank. | Basic & clinical pharmacology & toxicology 20070401 |
| Effect of atorvastatin on non-ischemic heart failure and matrix metalloproteinase-2 and 9 in rats. | Acta pharmacologica Sinica 20070401 |
| Atorvastatin-induced early-onset rhabdomyolysis in a patient with nephrotic syndrome. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070401 |
| Use of maximum-dose simvastatin or atorvastatin in an ethnically diverse population. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070401 |
| Inhibition of laser-induced choroidal neovascularization by atorvastatin by downregulation of monocyte chemotactic protein-1 synthesis in mice. | Investigative ophthalmology & visual science 20070401 |
| How to deal with multiple treatment or dose groups in randomized clinical trials? Another approach. | Fundamental & clinical pharmacology 20070401 |
| Atorvastatin does not exhibit antiviral activity against HCV at conventional doses: a pilot clinical trial. | Hepatology (Baltimore, Md.) 20070401 |
| Effects of Atorvastatin on vitamin D levels in patients with acute ischemic heart disease. | The American journal of cardiology 20070401 |
| Efficacy and safety of ezetimibe co-administered with atorvastatin in untreated patients with primary hypercholesterolaemia and coronary heart disease. | Current medical research and opinion 20070401 |
| Designs of RADIANCE 1 and 2: carotid ultrasound studies comparing the effects of torcetrapib/atorvastatin with atorvastatin alone on atherosclerosis. | Current medical research and opinion 20070401 |
| Did a flawed study design affect the results of the VYTAL study? | Mayo Clinic proceedings 20070401 |
| Simultaneous quantitative resolution of atorvastatin calcium and fenofibrate in pharmaceutical preparation by using derivative ratio spectrophotometry and chemometric calibrations. | Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 20070401 |
| Statins alter oxidant-antioxidant status and lower exercise-induced oxidative stress. | International journal of clinical pharmacology and therapeutics 20070401 |
| [Compared with atorvastatin at the dose of 10 mg per day rosuvastatin was more effective to reach an LDL goal of < 1.00 g/l in high cardiovascular risk patients (ARIANE study)]. | Annales de cardiologie et d'angeiologie 20070401 |
| Prophylactic statins as a possible method to decrease bubble formation in diving. | Aviation, space, and environmental medicine 20070401 |
| Lower is better: implications of the Treating to New Targets (TNT) study for Canadian patients. | The Canadian journal of cardiology 20070401 |
| Combination therapy of low-dose atorvastatin and fenofibrate in mixed hyperlipidemia. | Methods and findings in experimental and clinical pharmacology 20070401 |
| [The 2006 American Heart Association selection of the 'top ten advances in heart disease and stroke research']. | Revue medicale de Liege 20070401 |
| Effect of beta-hydroxy-beta-methylglutaryl coenzyme A reductase inhibitor atorvastatin on contractility of the isolated rat heart under normal conditions and during oxidative stress. | Bulletin of experimental biology and medicine 20070401 |
| Effect of torcetrapib on the progression of coronary atherosclerosis. | The New England journal of medicine 20070329 |
| CETP inhibitors to increase HDL cholesterol levels. | The New England journal of medicine 20070329 |
| Effects of a potent and selective PPAR-alpha agonist in patients with atherogenic dyslipidemia or hypercholesterolemia: two randomized controlled trials. | JAMA 20070328 |
| Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial. | Journal of the American College of Cardiology 20070327 |
| Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease. | The American journal of cardiology 20070315 |
| Statin wars following coronary revascularization - evidence-based clinical practice? | The Canadian journal of cardiology 20070315 |
| Treatment with ezetimibe plus low-dose atorvastatin compared with higher-dose atorvastatin alone: is sufficient cholesterol-lowering enough to inhibit platelets? | Journal of the American College of Cardiology 20070313 |
| [Secondary prevention of recurrent stroke by lowering cholesterol levels and blood pressure]. | Nederlands tijdschrift voor geneeskunde 20070303 |
| Effect of individualizing starting doses of a statin according to baseline LDL-cholesterol levels on achieving cholesterol targets: the achieve cholesterol targets fast with atorvastatin stratified titration (ACTFAST) study. | Atherosclerosis 20070301 |
| Enhanced expression of the homeostatic chemokines CCL19 and CCL21 in clinical and experimental atherosclerosis: possible pathogenic role in plaque destabilization. | Arteriosclerosis, thrombosis, and vascular biology 20070301 |
| Inhibition of 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase blunts factor VIIa/tissue factor and prothrombinase activities via effects on membrane phosphatidylserine. | Arteriosclerosis, thrombosis, and vascular biology 20070301 |
| Treatment of experimental autoimmune uveoretinitis with atorvastatin and lovastatin. | Experimental eye research 20070301 |
| Increased plasma levels of oxysterols, in vivo markers of oxidative stress, in patients with familial combined hyperlipidemia: reduction during atorvastatin and fenofibrate therapy. | Free radical biology & medicine 20070301 |
| Effects of high-dose atorvastatin in patients > or =65 years of age with acute coronary syndrome (from the myocardial ischemia reduction with aggressive cholesterol lowering [MIRACL] study). | The American journal of cardiology 20070301 |
| Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteins. | The American journal of cardiology 20070301 |
| Improving catalytic function by ProSAR-driven enzyme evolution. | Nature biotechnology 20070301 |
| Treatment of traumatic brain injury with a combination therapy of marrow stromal cells and atorvastatin in rats. | Neurosurgery 20070301 |
| The combination of atorvastatin and ethanol is not more hepatotoxic to rats than the administration of each drug alone. | Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20070301 |
| Fluvastatin as co-medication in heart transplant recipients with elevated creatine-kinase. | Transplantation proceedings 20070301 |
| Dose-dependent effects of docosahexaenoic acid supplementation on blood lipids in statin-treated hyperlipidaemic subjects. | Lipids 20070301 |
| Therapeutic options in non-alcoholic steatohepatitis (NASH). Are all agents alike? Results of a preliminary study. | Journal of gastrointestinal and liver diseases : JGLD 20070301 |
| A model for assessing the cost-effectiveness of atorvastatin and simvastatin in achieving Canadian low-density lipoprotein cholesterol targets. | Clinical therapeutics 20070301 |
| [The efficacy and safety of rosuvastatin on treating patients with hypercholesterolemia in Chinese: a randomized, double-blind, multi-center clinical trial]. | Zhonghua xin xue guan bing za zhi 20070301 |
| Randomised study to compare the efficacy and safety of isapgol plus atorvastatin versus atorvastatin alone in subjects with hypercholesterolaemia. | Journal of the Indian Medical Association 20070301 |
| [Interaction risk with statin switch]. | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20070215 |
| Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: results of the Study Assessing Goals in the Elderly (SAGE). | Circulation 20070213 |
| Statin therapy and the elderly: SAGE advice? | Circulation 20070213 |
| Atorvastatin reduces tissue factor expression in adipose tissue of atherosclerotic rabbits. | International journal of cardiology 20070207 |
| Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study. | Circulation 20070206 |
| Effects of atorvastatin and vitamin C on forearm hyperaemic blood flow, asymmentrical dimethylarginine levels and the inflammatory process in patients with type 2 diabetes mellitus. | Heart (British Cardiac Society) 20070201 |
| A stability-indicating high performance liquid chromatographic (HPLC) assay for the simultaneous determination of atorvastatin and amlodipine in commercial tablets. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20070201 |
| Short-term effects of atorvastatin on bone turnover in male patients with hypercholesterolemia. | Endocrine journal 20070201 |
| effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers. | Clinical pharmacology and therapeutics 20070201 |
| Statins induce S1P1 receptors and enhance endothelial nitric oxide production in response to high-density lipoproteins. | British journal of pharmacology 20070201 |
| Atorvastatin preserves renal function in chronic complete unilateral ureteral obstruction. | The Journal of urology 20070201 |
| The failure of torcetrapib: was it the molecule or the mechanism? | Arteriosclerosis, thrombosis, and vascular biology 20070201 |
| Diabetes and residual risk of coronary heart disease. | Nature clinical practice. Endocrinology & metabolism 20070201 |
| Progressive myopathy with up-regulation of MHC-I associated with statin therapy. | Neuromuscular disorders : NMD 20070201 |
| Effectiveness of rosuvastatin versus atorvastatin in reducing lipid levels and achieving low-density-lipoprotein cholesterol goals in a usual care setting. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070201 |
| Effect of atorvastatin on cognitive function in patients from the Lipid Lowering and Onset of Renal Disease (LORD) trial. | Pharmacotherapy 20070201 |
| Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart. | Prostaglandins & other lipid mediators 20070201 |
| Effect of atorvastatin and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary stent thrombosis. | The American journal of cardiology 20070201 |
| Safety of lovastatin/extended release niacin compared with lovastatin alone, atorvastatin alone, pravastatin alone, and simvastatin alone (from the United States Food and Drug Administration adverse event reporting system). | The American journal of cardiology 20070201 |
| Stability indicating RP-HPLC method for simultaneous determination of atorvastatin and amlodipine from their combination drug products. | Chemical & pharmaceutical bulletin 20070201 |
| Drug designed to raise HDL levels falls down. | The Journal of clinical investigation 20070201 |
| Amlodipine/atorvastatin for preventing heart disease. | American family physician 20070201 |
| Effect of atorvastatin on peripheral endothelial function and systemic inflammatory markers in patients with stable coronary artery disease. | Wiener medizinische Wochenschrift (1946) 20070201 |
| [Blood lipid-regulation of stilbene glycoside from polygonum multiflorum]. | Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 20070201 |
| A dose-specific meta-analysis of lipid changes in randomized controlled trials of atorvastatin and simvastatin. | Clinical therapeutics 20070201 |
| Antiarrhythmic effect of atorvastatin on autoimmune myocarditis is mediated by improving myocardial repolarization. | Life sciences 20070123 |
| Atorvastatin slows down the deterioration of inner ear function with age in mice. | Neuroscience letters 20070110 |
| Cholesterol lowering in patients with CHD and metabolic syndrome. | Lancet (London, England) 20070106 |
| Cholesterol lowering in patients with CHD and metabolic syndrome. | Lancet (London, England) 20070106 |
| Cholesterol lowering in patients with CHD and metabolic syndrome. | Lancet (London, England) 20070106 |
| Cholesterol lowering in patients with CHD and metabolic syndrome. | Lancet (London, England) 20070106 |
| When the party's over. | Nature 20070104 |
| The logistic transform for bounded outcome scores. | Biostatistics (Oxford, England) 20070101 |
| Atorvastatin has cardiac safety at intensive cholesterol-reducing protocols for long term, yet its cancer-treatment doses with chemotherapy may cause cardiomyopathy even under coenzyme-Q10 protection. | Cell biochemistry and function 20070101 |
| The HMG-CoA reductase inhibitor, atorvastatin, attenuates the effects of acute administration of amyloid-beta1-42 in the rat hippocampus in vivo. | Neuropharmacology 20070101 |
| Effect of atorvastatin on ocular blood flow velocities in patients with diabetic retinopathy. | The British journal of ophthalmology 20070101 |
| Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome: a subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20070101 |
| Statins induce differentiation and cell death in neurons and astroglia. | Glia 20070101 |
| The effect of atorvastatin therapy on lecithin:cholesterol acyltransferase, cholesteryl ester transfer protein and the antioxidant paraoxonase. | Clinical biochemistry 20070101 |
| Increased soluble Fas plasma levels in subjects at high cardiovascular risk: Atorvastatin on Inflammatory Markers (AIM) study, a substudy of ACTFAST. | Arteriosclerosis, thrombosis, and vascular biology 20070101 |
| Statin treatment upregulates vascular neuronal nitric oxide synthase through Akt/NF-kappaB pathway. | Arteriosclerosis, thrombosis, and vascular biology 20070101 |
| Differential effects of statins and alendronate on cholinesterases in serum and brain of rats. | Physiological research 20070101 |
| Impact of high dose statin trials on hospital prescribers. | European journal of clinical pharmacology 20070101 |
| Protective effects of atorvastatin in rat models of acute pulmonary embolism: involvement of matrix metalloproteinase-9. | Critical care medicine 20070101 |
| Differential impact of atorvastatin vs pravastatin on progressive insulin resistance and left ventricular diastolic dysfunction in a rat model of type II diabetes. | Circulation journal : official journal of the Japanese Circulation Society 20070101 |
| Comparison of inhibitory effects of irbesartan and atorvastatin treatment on the renin angiotensin system (RAS) in veins: a randomized double-blind crossover trial in healthy subjects. | Journal of clinical pharmacology 20070101 |
| The pressure is rising. | Critical care medicine 20070101 |
| Probable statin-induced testicular pain. | The Annals of pharmacotherapy 20070101 |
| Effect of decreased plasma cholesterol by atorvastatin treatment on erythrocyte mechanical properties. | Clinical hemorheology and microcirculation 20070101 |
| Evaluation of the cost savings and clinical outcomes of switching patients from atorvastatin to simvastatin and losartan to candesartan in a Primary Care setting. | International journal of clinical practice 20070101 |
| Atorvastatin attenuates transplant-associated coronary arteriosclerosis in a murine model of cardiac transplantation. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20070101 |
| Update on heart disease. Evidence mounts for even lower LDL. | Diabetes self-management 20070101 |
| [Effect of atorvastatin on left ventricular remodeling in spontaneously hypertensive rats]. | Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences 20070101 |
| [Effects of atorvastatin on hyperlipidemia in kidney disease patients]. | Nihon Jinzo Gakkai shi 20070101 |
| Effect of atorvastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, in rats. | Archives of pharmacal research 20070101 |
| A novel pleiotropic effect of atorvastatin on advanced glycation end product (AGE)-related disorders. | Medical hypotheses 20070101 |
| Atorvastatin and amlodipine co-treatment in ASCOT--LLA shows benefit. | Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners 20070101 |
| Intensive Lipitor therapy reduced heart attack and stroke by one-third in patients with chronic kidney disease. | Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners 20070101 |
| [Effect of therapy with atorvastatin on parameters of postprandial lipemia and factors of inflammation in patients with ischemic heart disease]. | Kardiologiia 20070101 |
| [Randomized FARVATER study. Part 2. Effect of atorvastatin on endothelial function, distensibility and stiffness of vascular wall]. | Kardiologiia 20070101 |
| Evaluation of a novel tablet splitter. | Journal of the American Pharmacists Association : JAPhA 20070101 |
| Beneficial effect of atorvastatin on left ventricular remodeling in spontaneously hypertensive rats. | Pharmacology 20070101 |
| Supravalvular and valvular aortic stenosis in heterozygous familial hypercholesterolemia. | Medical principles and practice : international journal of the Kuwait University, Health Science Centre 20070101 |
| Statin's cost-effectiveness: a Canadian analysis of commonly prescribed generic and brand name statins. | The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique 20070101 |
| Ezetimibe is effective when added to maximally tolerated lipid lowering therapy in patients with HIV. | Lipids in health and disease 20070101 |
| Successful intensive lipid-lowering therapy using atorvastatin stabilizes coronary artery plaque as assessed by multi-detector row computed tomography. | Internal medicine (Tokyo, Japan) 20070101 |
| Estimation of atorvastatin calcium and fenofibrate in tablets by derivative spectrophotometry and liquid chromatography. | Journal of AOAC International 20070101 |
| The Atorvastatin Goal Achievement Across Risk Levels: (ATGOAL) study in Thailand. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20070101 |
| Regression of left main coronary artery atherosclerotic stenosis after 12 years of follow-up, despite bypass surgery. | Angiology 20070101 |
| Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease. | BMC medicine 20070101 |
| [Efficiency of early atorvastatine treatment in patients with unstable angina]. | Likars'ka sprava 20070101 |
| Study of ATP-binding cassette transporter A1 (ABCA1)-mediated cellular cholesterol efflux in diabetic golden hamsters. | The Journal of international medical research 20070101 |
| Efficacy of atorvastatin therapy in ischaemic heart disease - effects on oxidized low-density lipoprotein and adiponectin. | The Journal of international medical research 20070101 |
| Atorvastatin does not induce glomerular or tubular dysfunction even at high doses. | Journal of the cardiometabolic syndrome 20070101 |
| Deception in the single-blind run-in phase of clinical trials. | IRB 20070101 |
| Atorvastatin: pharmacological characteristics and lipid-lowering effects. | Drugs 20070101 |
| Effects of atorvastatin on the different phases of atherogenesis. | Drugs 20070101 |
| Atorvastatin efficacy in the primary and secondary prevention of cardiovascular events. | Drugs 20070101 |
| Atorvastatin efficacy in the prevention of cardiovascular events in patients with diabetes mellitus and/or metabolic syndrome. | Drugs 20070101 |
| Atorvastatin: its clinical role in cerebrovascular prevention. | Drugs 20070101 |
| Atorvastatin: a safety and tolerability profile. | Drugs 20070101 |
| Atorvastatin neutralizes the up-regulation of thrombospondin-1 induced by thrombin in human umbilical vein endothelial cells. | Endothelium : journal of endothelial cell research 20070101 |
| Outcomes for the elderly cohort in the treating to New Targets trial. | The American journal of geriatric cardiology 20070101 |
| Atorvastatin: a pharmacoeconomic review of its use in the primary and secondary prevention of cardiovascular events. | PharmacoEconomics 20070101 |
| [Ishikawa diagram and barrier analysis implemented to a medication error that induces rhabdomyolysis]. | Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria 20070101 |
| Aspects of statin prescribing in Norwegian counties with high, average and low statin consumption - an individual-level prescription database study. | BMC clinical pharmacology 20070101 |
| The effects of atorvastatin therapy on endothelial function in patients with coronary artery disease. | Cardiovascular ultrasound 20070101 |
| Physicochemical modifications induced by statins therapy on human erythrocytes membranes. | Wiadomosci lekarskie (Warsaw, Poland : 1960) 20070101 |
| Stability-indicating reversed-phase liquid chromatographic method for simultaneous determination of atorvastatin and ezetimibe from their combination drug products. | Journal of AOAC International 20070101 |
| Stability-indicating high-performance liquid chromatographic assay of atorvastatin with fluorescence detection. | Journal of AOAC International 20070101 |
| [Effect of atorvastatin therapy on the level of secretory phospholipase A2 group IIA and on the modification of low density lipoproteins in patients with ischemic heart disease]. | Kardiologiia 20070101 |
| [Immunoinflammatory factors in unstable angina. Possibility of influence of atorvastatin]. | Kardiologiia 20070101 |
| [Assessment of hypolipidemic efficacy and safety of various doses of atorvastatin]. | Kardiologiia 20070101 |
| Statin therapy alone and in combination with an acyl-CoA:cholesterol O-acyltransferase inhibitor on experimental atherosclerosis. | Pathophysiology of haemostasis and thrombosis 20070101 |
| Integrin expression on monocytes and lymphocytes in unstable angina short term effects of atorvastatin. | Romanian journal of internal medicine = Revue roumaine de medecine interne 20070101 |
| Gender difference of atorvastatin's vasoprotective effect in balloon-injured rat carotid arteries. | European journal of pharmacology 20061228 |
| Statins activate AMP-activated protein kinase in vitro and in vivo. | Circulation 20061212 |
| Cholesterol: the good, the bad, and the stopped trials. | Lancet (London, England) 20061209 |
| The MEGA study. | Lancet (London, England) 20061209 |
| [Immunointervention in newly diagnosed type 1 diabetes]. | Deutsche medizinische Wochenschrift (1946) 20061208 |
| Beyond lipid lowering: What have we learned about the benefits of statins from the acute coronary syndromes trials? | The American journal of cardiology 20061204 |
| Molecular basis of differences among statins and a comparison with antioxidant vitamins. | The American journal of cardiology 20061204 |
| Plant sterol or stanol esters retard lesion formation in LDL receptor-deficient mice independent of changes in serum plant sterols. | Journal of lipid research 20061201 |
| Down-regulation of ABCB1 transporter by atorvastatin in a human hepatoma cell line and in human peripheral blood mononuclear cells. | Biochimica et biophysica acta 20061201 |
| Effect of atorvastatin on soluble CD14, CD40 Ligand, sE- and sP-selectins and MCP-1 in patients with type 2 diabetes mellitus: relationship to cholesterol turnover. | Pharmacological research 20061201 |
| Effects of chronic treatment with statins and fenofibrate on rat skeletal muscle: a biochemical, histological and electrophysiological study. | British journal of pharmacology 20061201 |
| Atorvastatine for chronic synovitis due to massive intra-articular cholesterol monohydrate deposition in long-standing rheumatoid arthritis. | Rheumatology (Oxford, England) 20061201 |
| 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitor Atorvastatin mediated effects depend on the activation status of target cells in PLP-EAE. | Journal of autoimmunity 20061201 |
| Atorvastatin interferes with activation of human CD4(+) T cells via inhibition of small guanosine triphosphatase (GTPase) activity and caspase-independent apoptosis. | Clinical and experimental immunology 20061201 |
| The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin. | Naunyn-Schmiedeberg's archives of pharmacology 20061201 |
| Possible role of exogenous cAMP to improve vascular endothelial dysfunction in hypertensive rats. | Fundamental & clinical pharmacology 20061201 |
| Statin treatment, reduced T-cell content of atherosclerotic plaques and cancer. | Journal of internal medicine 20061201 |
| Bezoar formation requiring endoscopic removal after intentional overdose of extended-release nifedipine. | Pharmacotherapy 20061201 |
| Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS): rationale and design. | Circulation journal : official journal of the Japanese Circulation Society 20061201 |
| Vascular protection of dual therapy (atorvastatin-amlodipine) in hypertensive patients. | Journal of the American Society of Nephrology : JASN 20061201 |
| Effects of atorvastatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease. | Journal of the American Society of Nephrology : JASN 20061201 |
| Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry. | Hepatology (Baltimore, Md.) 20061201 |
| High-dose atorvastatin is associated with impaired myocardial angiogenesis in response to vascular endothelial growth factor in hypercholesterolemic swine. | The Journal of thoracic and cardiovascular surgery 20061201 |
| Ezetimibe/simvastatin vs atorvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia: the VYTAL study. | Mayo Clinic proceedings 20061201 |
| Atorvastatin therapy associated with improvement in left ventricular remodeling in a case of idiopathic dilated cardiomyopathy. | The American journal of the medical sciences 20061201 |
| Organic anion transporting polypeptide 2B1 is a high-affinity transporter for atorvastatin and is expressed in the human heart. | Clinical pharmacology and therapeutics 20061201 |
| Tolerizing DNA vaccines for autoimmune arthritis. | Autoimmunity 20061201 |
| Atorvastatin decreases serum levels of advanced glycation end products (AGEs) in patients with type 2 diabetes. | Clinical and experimental medicine 20061201 |
| Distinct effects of pravastatin, atorvastatin, and simvastatin on insulin secretion from a beta-cell line, MIN6 cells. | Journal of atherosclerosis and thrombosis 20061201 |
| Effects of high-dose statin administered prior to coronary angioplasty on the incidence of cardiac events in patients with acute coronary syndrome. | Kardiologia polska 20061201 |
| [Effect of different doses of atorvastatin on adhesion molecules of the patients undergoing percutaneous coronary intervention]. | Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20061201 |
| Effect of atorvastatin on type 2 diabetic dyslipidemia. | Journal of cardiovascular pharmacology and therapeutics 20061201 |
| [Musculoskeletal adverse effects of levofloxacin]. | Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia 20061201 |
| Effects of atorvastatin and aspirin combined therapy on inflammatory responses in patients undergoing coronary artery bypass grafting. | Cytokine 20061201 |
| [Metabolic syndrome in men of 35-65 years old from rural district of Poltava region and possibility of the prophylactic therapy with atorvastatine]. | Likars'ka sprava 20061201 |
| Statin therapy after stroke or transient ischemic attack. | The New England journal of medicine 20061130 |
| Statin therapy after stroke or transient ischemic attack. | The New England journal of medicine 20061130 |
| Statin therapy after stroke or transient ischemic attack. | The New England journal of medicine 20061130 |
| Statin therapy after stroke or transient ischemic attack. | The New England journal of medicine 20061130 |
| Statin therapy after stroke or transient ischemic attack. | The New England journal of medicine 20061130 |
| [Selection of statin considering the HDL cholesterol level]. | Orvosi hetilap 20061126 |
| Atorvastatin restores Lck expression and lipid raft-associated signaling in T cells from patients with systemic lupus erythematosus. | Journal of immunology (Baltimore, Md. : 1950) 20061115 |
| Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels on a background of atorvastatin. | Journal of the American College of Cardiology 20061107 |
| Effects of high-dose atorvastatin on cerebrovascular events in patients with stable coronary disease in the TNT (treating to new targets) study. | Journal of the American College of Cardiology 20061107 |
| Paradoxical increase in lumen size during progression of coronary atherosclerosis: observations from the REVERSAL trial. | Atherosclerosis 20061101 |
| RhoA GTPase inactivation by statins induces osteosarcoma cell apoptosis by inhibiting p42/p44-MAPKs-Bcl-2 signaling independently of BMP-2 and cell differentiation. | Cell death and differentiation 20061101 |
| Short-term statin treatment improves endothelial function and neurohormonal imbalance in normocholesterolaemic patients with non-ischaemic heart failure. | Heart (British Cardiac Society) 20061101 |
| Atorvastatin protects against cerebral infarction via inhibition of NADPH oxidase-derived superoxide in ischemic stroke. | American journal of physiology. Heart and circulatory physiology 20061101 |
| Comment on 'Effect of atorvastatin on SR-BI expression and HDL-induced cholesterol efflux in adipocytes of hypercholesterolemic rabbits' by Zhao et al. (Clin Chim Acta 2006; 365: 119-24). | Clinica chimica acta; international journal of clinical chemistry 20061101 |
| Effects of atorvastatin and apoA-I/phosphatidylcholine discs on triglyceride-rich lipoprotein subfractions as characterized by capillary isotachophoresis. | Clinica chimica acta; international journal of clinical chemistry 20061101 |
| Atorvastatin and quinapril inhibit blood coagulation in patients with coronary artery disease following 28 days of therapy. | Journal of thrombosis and haemostasis : JTH 20061101 |
| Anti-oxidant effects of atorvastatin in dexamethasone-induced hypertension in the rat. | Clinical and experimental pharmacology & physiology 20061101 |
| Effect of statins on preventing recurrence of atrial fibrillation after electrical cardioversion. | The American journal of cardiology 20061101 |
| Atorvastatin effect on circulating and leukocyte-produced CD40 ligand concentrations in people with normal cholesterol levels: a pilot study. | Pharmacotherapy 20061101 |
| Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS). | Diabetes care 20061101 |
| Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN): response to Knopp. | Diabetes care 20061101 |
| Comparative lipid-lowering effects of policosanol and atorvastatin: a randomized, parallel, double-blind, placebo-controlled trial. | American heart journal 20061101 |
| Statins, fibrates, and melanoma risk: a systematic review and meta-analysis. | Journal of the National Cancer Institute 20061101 |
| Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practice. | The American journal of managed care 20061101 |
| Statins induce mammalian target of rapamycin (mTOR)-mediated inhibition of Akt signaling and sensitize p53-deficient cells to cytostatic drugs. | Molecular cancer therapeutics 20061101 |
| Clinical characteristics and outcomes of Chinese patients with cholesterol crystal embolism after coronary intervention. | Clinical cardiology 20061101 |
| Alternate-day dosing of atorvastatin: effects in treating type 2 diabetic patients with dyslipidaemia. | Acta diabetologica 20061101 |
| Statin effective in preventing recurrent stroke. | DukeMedicine healthnews 20061101 |
| The effects of quinapril and atorvastatin on the responsiveness to sildenafil in men with erectile dysfunction. | Vascular medicine (London, England) 20061101 |
| Short-term effects of low-dose atorvastatin on inflammatory status and lipid profiles in perimenopausal hypercholesterolemic, hypertriglyceridemic women. | International journal of cardiology 20061026 |
| Protection from procedural myocardial injury by atorvastatin is associated with lower levels of adhesion molecules after percutaneous coronary intervention: results from the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-Cell Adhesion Molecules) substudy. | Journal of the American College of Cardiology 20061017 |
| [Vascular pleiosynergism--a new concept?]. | Orvosi hetilap 20061015 |
| [Effects of atorvastatin in N-terminal pro-brain natriuretic peptide plasma levels in hypercholesterolemic patients with or without hypertension]. | Medicina clinica 20061014 |
| [Effectiveness of atorvastatin compared to other statins of usual clinical practice in primary care]. | Medicina clinica 20061014 |
| Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. | Circulation 20061003 |
| Atorvastatin associated liver disease. | Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20061001 |
| Effects of amlodipine-atorvastatin combination on inflammation markers and insulin sensitivity in normocholesterolemic obese hypertensive patients. | European journal of clinical pharmacology 20061001 |
| Influence of atorvastatin treatment on L-arginine cerebrovascular reactivity and flow-mediated dilatation in patients with lacunar infarctions. | Stroke 20061001 |
| Statins and cerebral vasomotor reactivity: implications for a new therapy? | Stroke 20061001 |
| A pharmacogenomic study of atorvastatin effects on eNOS activity: do 'statins' modulate blood nitrite levels and intravascular oxidant stress in susceptible individuals? | Free radical biology & medicine 20061001 |
| eNOS gene T-786C polymorphism modulates atorvastatin-induced increase in blood nitrite. | Free radical biology & medicine 20061001 |
| Effect of food on the bioavailability of amlodipine besylate/atorvastatin calcium combination tablet. | Journal of clinical pharmacology 20061001 |
| Usefulness of follow-up low-density lipoprotein cholesterol level as an independent predictor of changes of coronary atherosclerotic plaque size as determined by intravascular ultrasound analysis after statin (atorvastatin or simvastatin) therapy. | The American journal of cardiology 20061001 |
| Quantifying the effect of antiplatelet therapy: a comparison of the platelet function analyzer (PFA-100) and modified thromboelastography (mTEG) with light transmission platelet aggregometry. | Anesthesiology 20061001 |
| Plasma-soluble CD40 is related to cholesterol metabolism in patients with moderate hypercholesterolemia. | Scandinavian cardiovascular journal : SCJ 20061001 |
| Arterial stiffness and Chlamydia pneumoniae infection in coronary artery disease. Is there a link? | Scandinavian cardiovascular journal : SCJ 20061001 |
| Toxicity of statins on rat skeletal muscle mitochondria. | Cellular and molecular life sciences : CMLS 20061001 |
| Fake drugs: a problem for all. | British journal of hospital medicine (London, England : 2005) 20061001 |
| Neutrophil superoxide anion generation during atorvastatin and fluvastatin therapy used in coronary heart disease primary prevention. | Journal of cardiovascular pharmacology 20061001 |
| Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantation. | Transplantation 20060927 |
| More on switching statins: comments from Pfizer. | BMJ (Clinical research ed.) 20060923 |
| Atorvastatin in nonischemic left ventricular systolic dysfunction. | Journal of the American College of Cardiology 20060919 |
| Letter by Romanens and Miserez regarding article, 'Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial'. | Circulation 20060919 |
| Comparison of rosuvastatin versus atorvastatin in Hispanic-Americans with hypercholesterolemia (from the STARSHIP trial). | The American journal of cardiology 20060915 |
| [Efficacy and safety of extended-release niacin alone or with atorvastatin for lipid profile modification]. | Zhonghua yi xue za zhi 20060912 |
| Atorvastatin for stroke prevention. | The Medical letter on drugs and therapeutics 20060911 |
| Coronary risk factors and inflammation in patients with coronary artery disease and internal cardioverter defibrillator implants. | International journal of cardiology 20060910 |
| Interleukin-6 (IL-6)-174 G/C polymorphism--lack of association with inflammatory and haemostatic variables in patients with coronary heart disease treated with atorvastatin and quinapril. | International journal of cardiology 20060910 |
| Does the metabolic syndrome help to select patients requiring high statin dose? | Lancet (London, England) 20060909 |
| Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study. | Lancet (London, England) 20060909 |
| Media report of rare rhabdomyolysis cases seems to have triggered reluctance among some New Zealanders to use statins. | The New Zealand medical journal 20060908 |
| [Do statins have benefit on migraine]. | Medicina clinica 20060902 |
| Progressive coronary calcification despite intensive lipid-lowering treatment: a randomised controlled trial. | Heart (British Cardiac Society) 20060901 |
| Simultaneous quantification of atorvastatin and active metabolites in human plasma by liquid chromatography-tandem mass spectrometry using rosuvastatin as internal standard. | Biomedical chromatography : BMC 20060901 |
| Myocardial protection by pioglitazone, atorvastatin, and their combination: mechanisms and possible interactions. | American journal of physiology. Heart and circulatory physiology 20060901 |
| Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia. | The Journal of pathology 20060901 |
| Atorvastatin inhibits inflammatory hypernociception. | British journal of pharmacology 20060901 |
| The CARDS trial: diabetic patients dealt a winning hand. | Current atherosclerosis reports 20060901 |
| Growth inhibition of Candida species and Aspergillus fumigatus by statins. | FEMS microbiology letters 20060901 |
| Bioavailability of amlodipine besylate/atorvastatin calcium combination tablet. | Journal of clinical pharmacology 20060901 |
| Statin therapy for patients with chronic heart failure. | The American journal of cardiology 20060901 |
| Validated HPLC-MS-MS method for simultaneous determination of atorvastatin and 2-hydroxyatorvastatin in human plasma-pharmacokinetic study. | Analytical and bioanalytical chemistry 20060901 |
| Autoimmune hepatitis triggered by statins. | Journal of clinical gastroenterology 20060901 |
| Preparation and evaluation of self-microemulsifying drug delivery systems (SMEDDS) containing atorvastatin. | The Journal of pharmacy and pharmacology 20060901 |
| Change in circulating C-reactive protein is not associated with atorvastatin treatment in Alzheimer's disease. | Neurological research 20060901 |
| Effects of statins on bone mineral density. | Saudi medical journal 20060901 |
| Efficacy, safety and tolerability of atorvastatin in dyslipidemic subjects with advanced (non-nephrotic) and endstage chronic renal failure. | Clinical and experimental nephrology 20060901 |
| Pharmacokinetic and bioequivalence testing of atorvastatin formulations in healthy male volunteers. | Die Pharmazie 20060901 |
| The effect of apolipoprotein E polymorphism on the response to lipid-lowering treatment with atorvastatin or fenofibrate. | Journal of cardiovascular pharmacology and therapeutics 20060901 |
| The effect of early statin treatment on inflammation and cardiac events in acute coronary syndrome patients with low-density lipoprotein cholesterol. | Heart and vessels 20060901 |
| API expert consensus document on management of ischemic heart disease. | The Journal of the Association of Physicians of India 20060901 |
| Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients. | Journal of the Indian Medical Association 20060901 |
| Augmentation of myocardial production of 15-epi-lipoxin-a4 by pioglitazone and atorvastatin in the rat. | Circulation 20060829 |
| The effect of atorvastatin on heart rate variability and lipoproteins in patients treated with coronary bypass surgery. | International journal of cardiology 20060828 |
| Vascular endothelial growth factor mediates atorvastatin-induced mammalian achaete-scute homologue-1 gene expression and neuronal differentiation after stroke in retired breeder rats. | Neuroscience 20060825 |
| Atorvastatin inhibits angiotensin II-induced T-type Ca2+ channel expression in endothelial cells. | Biochemical and biophysical research communications 20060825 |
| Differential roles of MAP kinases in atorvastatin-induced VEGF release in cardiac myocytes. | Life sciences 20060815 |
| Pleiotropic effects of statins and early benefit in the PROVE IT-TIMI-22 study. | Journal of the American College of Cardiology 20060815 |
| Herbicidal effects of statin pharmaceuticals in Lemna gibba. | Environmental science & technology 20060815 |
| High-dose atorvastatin after stroke or transient ischemic attack. | The New England journal of medicine 20060810 |
| Stroke--an equal opportunity for the initiation of statin therapy. | The New England journal of medicine 20060810 |
| Atorvastatin reduces plasminogen activator inhibitor-1 expression in adipose tissue of atherosclerotic rabbits. | Clinica chimica acta; international journal of clinical chemistry 20060801 |
| Effects of statins on the adipocyte maturation and expression of glucose transporter 4 (SLC2A4): implications in glycaemic control. | Diabetologia 20060801 |
| Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapy. | Journal of thrombosis and thrombolysis 20060801 |
| Association of statin therapy and increased survival in patients with multiple organ dysfunction syndrome. | Intensive care medicine 20060801 |
| Statin treatment is not associated with consistent alterations in inflammatory status of carotid atherosclerotic plaques: a retrospective study in 378 patients undergoing carotid endarterectomy. | Stroke 20060801 |
| Fn14 is upregulated in cytokine-stimulated vascular smooth muscle cells and is expressed in human carotid atherosclerotic plaques: modulation by atorvastatin. | Stroke 20060801 |
| Intracellular retention of hepatic serpins caused by severe hyperlipidemia. | Liver international : official journal of the International Association for the Study of the Liver 20060801 |
| Effect of atorvastatin on plasma osteopontin levels in patients with hypercholesterolemia. | Arteriosclerosis, thrombosis, and vascular biology 20060801 |
| Golf-inhibiting gynecomastia associated with atorvastatin therapy. | Pharmacotherapy 20060801 |
| Clopidogrel-statin interaction: a mountain or a mole hill? | American heart journal 20060801 |
| A pharmacoepidemiology study of the interaction between atorvastatin and clopidogrel after percutaneous coronary intervention. | American heart journal 20060801 |
| Letter by Schmermund and Erbel regarding article, 'Coronary artery calcium: should we rely on this surrogate marker?'. | Circulation 20060801 |
| Clinical trials update from the European Society of Cardiology heart failure meeting: TNT subgroup analysis, darbepoetin alfa, FERRIC-HF and KW-3902. | European journal of heart failure 20060801 |
| Atorvastatin or fenofibrate on post-prandial lipaemia in type 2 diabetic patients with hyperlipidaemia. | European journal of clinical investigation 20060801 |
| Efficacy and safety of coadministered amlodipine and atorvastatin in patients with hypertension and dyslipidemia: results of the AVALON trial. | Journal of clinical hypertension (Greenwich, Conn.) 20060801 |
| The anti-atherosclerotic effects of lipid lowering with atorvastatin in patients with hypercholesterolemia. | Journal of atherosclerosis and thrombosis 20060801 |
| Effects of atorvastatin on coagulation parameters and homocysteine in patients with primary hypercholesterolemia. | Journal of the National Medical Association 20060801 |
| High-dose statins for diabetes. | Health news (Waltham, Mass.) 20060801 |
| UV-B phototoxic effects induced by atorvastatin. | Archives of dermatology 20060801 |
| The effects of atorvastatin on coronary endothelial function in patients with recent myocardial infarction. | Clinical cardiology 20060801 |
| Statins, especially atorvastatin, may improve survival following brachytherapy for clinically localized prostate cancer. | Urologic nursing 20060801 |
| Lower is better: implications of the Treating to New Targets (TNT) study for Canadian patients. | The Canadian journal of cardiology 20060801 |
| The year in non-ST-segment elevation acute coronary syndromes. | Journal of the American College of Cardiology 20060718 |
| MRI of combination treatment of embolic stroke in rat with rtPA and atorvastatin. | Journal of the neurological sciences 20060715 |
| Chemoprevention of familial adenomatous polyposis by low doses of atorvastatin and celecoxib given individually and in combination to APCMin mice. | Cancer research 20060715 |
| [Effectiveness and tolerance of atorvastatin for antiretroviral therapy-secondary dyslipemia]. | Medicina clinica 20060715 |
| [HIV infection: from Pneumocystis to statins]. | Medicina clinica 20060715 |
| Inhibitory effects of statins on human monocarboxylate transporter 4. | International journal of pharmaceutics 20060706 |
| Atorvastatin increases plasma soluble Fms-like tyrosine kinase-1 and decreases vascular endothelial growth factor and placental growth factor in association with improvement of ventricular function in acute myocardial infarction. | Journal of the American College of Cardiology 20060704 |
| High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response. | Circulation 20060704 |
| Role of human valve interstitial cells in valve calcification and their response to atorvastatin. | Circulation 20060704 |
| A novel role of extracellular nucleotides in valve calcification: a potential target for atorvastatin. | Circulation 20060704 |
| Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth. | European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 20060701 |
| Atorvastatin normalizes endothelial function in healthy smokers. | Clinical science (London, England : 1979) 20060701 |
| Atorvastatin prevents hypoxia-induced inhibition of endothelial nitric oxide synthase expression but does not affect heme oxygenase-1 in human microvascular endothelial cells. | Atherosclerosis 20060701 |
| Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism. | Drug metabolism and disposition: the biological fate of chemicals 20060701 |
| A comparative study on the antimutagenicity of atorvastatin and lovastatin against directly acting mutagens. | Cell biology and toxicology 20060701 |
| Plasma apolipoprotein A5 and triglycerides in type 2 diabetes. | Diabetologia 20060701 |
| Quinine-induced renal failure as a result of rhabdomyolysis, haemolytic uraemic syndrome and disseminated intravascular coagulation. | Internal medicine journal 20060701 |
| Effect of atorvastatin (10 mg/day) on glucose metabolism in patients with the metabolic syndrome. | The American journal of cardiology 20060701 |
| Severe hepatic side effects of ezetimibe. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20060701 |
| Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN). | Diabetes care 20060701 |
| High-dose statin treatment does not alter plasma marker for brain cholesterol metabolism in patients with moderately elevated plasma cholesterol levels. | Journal of clinical pharmacology 20060701 |
| Atorvastatin prevented and reversed dexamethasone-induced hypertension in the rat. | Clinical and experimental hypertension (New York, N.Y. : 1993) 20060701 |
| Persistence and adherence to cholesterol lowering agents: evidence from Régie de l'Assurance Maladie du Québec data. | American heart journal 20060701 |
| Single coronary artery with retroaortic course. An unusual origin of right Valsalva sinus. | Saudi medical journal 20060701 |
| What's in the CARDS? | Diabetic medicine : a journal of the British Diabetic Association 20060701 |
| By the way, doctor. Pomegranate juice is supposed to be a health food, but I've heard that it can interfere with some medications, the way grapefruit juice can. I take Lipitor and wonder if I should be concerned. | Harvard women's health watch 20060701 |
| Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction. | Expert review of cardiovascular therapy 20060701 |
| Atorvastatin has no beneficial effect on cardiovascular outcomes in patients with advanced chronic kidney disease. | Nature clinical practice. Nephrology 20060701 |
| Re-elevation of high-sensitivity C-reactive protein but not the von Willebrand Factor after withdrawing atorvastatin therapy in patients with unstable angina undergoing coronary artery stenting. | International heart journal 20060701 |
| Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial. | Circulation 20060620 |
| Reducing cardiovascular risk in diabetes: beyond glycemic and blood pressure control. | International journal of cardiology 20060616 |
| Can combining different risk interventions into a single formulation contribute to improved cardiovascular disease risk reduction? Rationale and design for an international, open-label program to assess the effectiveness of a single pill (amlodipine/atorvastatin) to attain recommended target levels for blood pressure and lipids (The JEWEL Program). | International journal of cardiology 20060616 |
| [High lowering of lipids can melt coronary plaques -- is coronary disease reversible?]. | MMW Fortschritte der Medizin 20060615 |
| [For coronary disease patients is certain: the lower the LDL the better]. | MMW Fortschritte der Medizin 20060615 |
| [After TIA and stroke: a statin for secondary prevention?]. | MMW Fortschritte der Medizin 20060615 |
| High-dose statins and the IDEAL study. | JAMA 20060607 |
| High-dose statins and the IDEAL study. | JAMA 20060607 |
| High-dose statins and the IDEAL study. | JAMA 20060607 |
| High-dose statins and the IDEAL study. | JAMA 20060607 |
| Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study. | Journal of the American College of Cardiology 20060606 |
| Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappaB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin. | The Journal of biological chemistry 20060602 |
| Effect of atorvastatin on TH1 and TH2 cytokine secreting cells during T cell activation and differentiation. | Atherosclerosis 20060601 |
| Atorvastatin downregulates tissue plasminogen activator-aggravated genes mediating coagulation and vascular permeability in single cerebral endothelial cells captured by laser microdissection. | Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20060601 |
| The effect of atorvastatin on serum myeloperoxidase and CRP levels in patients with acute coronary syndrome. | Clinica chimica acta; international journal of clinical chemistry 20060601 |
| Immunoregulatory effects of atorvastatin on experimental autoimmune myocarditis in Lewis rats. | Immunology and cell biology 20060601 |
| Effects of the cholesteryl ester transfer protein inhibitor torcetrapib on apolipoprotein B100 metabolism in humans. | Arteriosclerosis, thrombosis, and vascular biology 20060601 |
| Use of an indirect effect model to describe the LDL cholesterol-lowering effect by statins in hypercholesterolaemic patients. | Fundamental & clinical pharmacology 20060601 |
| A pilot study of atorvastatin treatment in dyslipemid, non-alcoholic fatty liver patients. | Alimentary pharmacology & therapeutics 20060601 |
| Effects of obesity on lipid-lowering, anti-inflammatory, and antiatherosclerotic benefits of atorvastatin or pravastatin in patients with coronary artery disease (from the REVERSAL Study). | The American journal of cardiology 20060601 |
| Increase in circulating endothelial precursors by atorvastatin in patients with systemic sclerosis. | Arthritis and rheumatism 20060601 |
| Preventing and repairing vascular damage in scleroderma: should we focus beyond vasodilatation to recruitment of endothelial precursor cells? | Arthritis and rheumatism 20060601 |
| Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study. | Diabetes care 20060601 |
| Safety and effects on the lipid and C-reactive protein plasma concentration of the association of ezetimibe plus atorvastatin in renal transplant patients treated by cyclosporine-A: a pilot study. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20060601 |
| Differential effects of different statins on endothelin-1 gene expression and endothelial NOS phosphorylation in porcine aortic endothelial cells. | Experimental biology and medicine (Maywood, N.J.) 20060601 |
| Endothelin-mediated vasoconstriction in early atherosclerosis is markedly increased in ApoE-/- mouse but prevented by atorvastatin. | Experimental biology and medicine (Maywood, N.J.) 20060601 |
| The effects of different doses of atorvastatin on plasma endothelin-1 levels in type 2 diabetic patients with dyslipidemia. | Experimental biology and medicine (Maywood, N.J.) 20060601 |
| Effects of preoperative statin therapy on cytokines after cardiac surgery. | The Thoracic and cardiovascular surgeon 20060601 |
| Exposure of atorvastatin is unchanged but lactone and acid metabolites are increased several-fold in patients with atorvastatin-induced myopathy. | Clinical pharmacology and therapeutics 20060601 |
| The clinical relevance of low-density-lipoproteins size modulation by statins. | Cardiovascular drugs and therapy 20060601 |
| Rapid analysis of atorvastatin calcium using capillary electrophoresis and microchip electrophoresis. | Electrophoresis 20060601 |
| Prevention of myocardial damage during coronary intervention. | Cardiovascular & hematological disorders drug targets 20060601 |
| Effect of long-term atorvastatin treatment on the electrophysiological and mechanical functions of muscle. | International journal of clinical pharmacology and therapeutics 20060601 |
| [Regression of a large lipid-rich pool in the coronary artery during treatment with statin detected by intravascular ultrasound: a case report]. | Journal of cardiology 20060601 |
| Profound regression of coronary atherosclerosis with statins. | The Canadian journal of cardiology 20060601 |
| Statins: beneficial or adverse for glucose metabolism. | Journal of atherosclerosis and thrombosis 20060601 |
| Concurrent use of clopidogrel (Plavix) and atorvastatin (Lipitor) is contraindicated. | South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20060601 |
| Treating to target patients with primary hyperlipidaemia: comparison of the effects of ATOrvastatin and ROSuvastatin (the ATOROS study). | Current medical research and opinion 20060601 |
| Achieving 2003 European lipid goals with rosuvastatin and comparator statins in 6743 patients in real-life clinical practice: DISCOVERY meta-analysis. | Current medical research and opinion 20060601 |
| Tolerability of atorvastatin in a population aged > or =65 years: a retrospective pooled analysis of results from fifty randomized clinical trials. | The American journal of geriatric pharmacotherapy 20060601 |
| Concurrent use of clopidogrel (Plavix) and atorvastatin (Lipitor) is contraindicated. | South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20060601 |
| Effects of atorvastatin and atorvastatin withdrawal on soluble CD40L and adipocytokines in patients with hypercholesterolaemia. | Acta cardiologica 20060601 |
| [Thoughts about the results of the 'IDEAL' study]. | Orvosi hetilap 20060528 |
| Effect of atorvastatin on the recurrence rates of atrial fibrillation after electrical cardioversion. | The American journal of cardiology 20060515 |
| Short-term atorvastatin treatment enhances specific antibody production following tetanus toxoid vaccination in healthy volunteers. | Vaccine 20060508 |
| Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2. | American journal of physiology. Heart and circulatory physiology 20060501 |
| Stress on pleiotropic effects of statins. | European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 20060501 |
| Statins and stroke: current clinical practice. | Stroke 20060501 |
| Statin-induced proinflammatory response in mitogen-activated peripheral blood mononuclear cells through the activation of caspase-1 and IL-18 secretion in monocytes. | Journal of immunology (Baltimore, Md. : 1950) 20060501 |
| Apolipoproteins AI and B as therapeutic targets. | Journal of internal medicine 20060501 |
| Atorvastatin and glatiramer acetate: new hope in MS? | The Lancet. Neurology 20060501 |
| Dose-comparison study of the combination of ezetimibe and simvastatin (Vytorin) versus atorvastatin in patients with hypercholesterolemia: the Vytorin Versus Atorvastatin (VYVA) Study. | American heart journal 20060501 |
| Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II. | American heart journal 20060501 |
| Plasma phospholipid transfer protein activity is decreased in type 2 diabetes during treatment with atorvastatin: a role for apolipoprotein E? | Diabetes 20060501 |
| Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease. | Journal of thrombosis and haemostasis : JTH 20060501 |
| A case of cholesterol embolism confirmed by skin biopsy and successfully treated with statins and steroids. | The American journal of the medical sciences 20060501 |
| Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study. | Current medical research and opinion 20060501 |
| Drug and medical cost effects of a drug formulary change with therapeutic interchange for statin drugs in a multistate managed Medicaid organization. | Journal of managed care pharmacy : JMCP 20060501 |
| Influence of HMG-CoA-reductase inhibitors on the body fat status. | VASA. Zeitschrift fur Gefasskrankheiten 20060501 |
| [Intensive cholesterol lowering therapy to reduce cardiovascular risk]. | Revista medica de Chile 20060501 |
| [Cost-effectiveness analysis of the use of atorvastatin in patients with type 2 diabetes mellitus: a pharmacoeconomic model of the CARDS study]. | Anales de medicina interna (Madrid, Spain : 1984) 20060501 |
| Is atorvastatin superior to other statins? Analysis of the clinical trials with atorvastatin having cardiovascular endpoints. | Reviews on recent clinical trials 20060501 |
| The impact of early administration of low-dose atorvastatin treatment on inflammatory process, in patients with unstable angina and low cholesterol level. | International journal of cardiology 20060428 |
| Hydroxymethylglutaryl-coenzyme A reductase inhibitors induce apoptosis in human cardiac myocytes in vitro. | Biochemical pharmacology 20060428 |
| Statins protect human aortic smooth muscle cells from inorganic phosphate-induced calcification by restoring Gas6-Axl survival pathway. | Circulation research 20060428 |
| Atorvastatin may cause nightmares. | BMJ (Clinical research ed.) 20060422 |
| Prevention of azoxymethane-induced colon cancer by combination of low doses of atorvastatin, aspirin, and celecoxib in F 344 rats. | Cancer research 20060415 |
| Lipoprotein-associated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction) trial. | Circulation 20060411 |
| Active metabolite of atorvastatin inhibits membrane cholesterol domain formation by an antioxidant mechanism. | The Journal of biological chemistry 20060407 |
| Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity. | The Journal of clinical investigation 20060403 |
| Proportion of oxidized LDL relative to plasma apolipoprotein B does not change during statin therapy in patients with heterozygous familial hypercholesterolemia. | Atherosclerosis 20060401 |
| Effect of rosuvastatin or atorvastatin on urinary albumin excretion and renal function in type 2 diabetic patients. | Diabetes research and clinical practice 20060401 |
| Effect of pravastatin, simvastatin and atorvastatin on the phagocytic activity of mouse peritoneal macrophages. | Experimental and molecular pathology 20060401 |
| Down-regulation of autoreactive T-cells by HMG CoA reductase inhibitors. | Clinical immunology (Orlando, Fla.) 20060401 |
| Atorvastatin desensitizes beta-adrenergic signaling in cardiac myocytes via reduced isoprenylation of G-protein gamma-subunits. | FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20060401 |
| Angiogenic transcriptome of human microvascular endothelial cells: Effect of hypoxia, modulation by atorvastatin. | Vascular pharmacology 20060401 |
| Effects of atorvastatin on higher functions. | European journal of clinical pharmacology 20060401 |
| Early effects on endothelial function of atorvastatin 40 mg twice daily and its withdrawal. | The American journal of cardiology 20060401 |
| Atorvastatin fails to prevent the development of autoimmune diabetes despite inhibition of pathogenic beta-cell-specific CD8 T-cells. | Diabetes 20060401 |
| Comparative expression profiling in primary and immortalized endothelial cells: changes in gene expression in response to hydroxy methylglutaryl-coenzyme A reductase inhibition. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20060401 |
| Effects of atorvastatin on high-density lipoprotein apolipoprotein A-I metabolism in dogs. | European journal of clinical investigation 20060401 |
| Atorvastatin prevented and partially reversed adrenocorticotropic hormone-induced hypertension in the rat. | Clinical and experimental pharmacology & physiology 20060401 |
| Systemic infections can decrease the threshold of statin-induced muscle injury. | Southern medical journal 20060401 |
| Concurrent use of clopidogrel (Plavix) and atorvasatin (Lipitor) is contraindicated. | South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20060401 |
| Chinese red rice depletes muscle coenzyme Q10 and maintains muscle damage after discontinuation of statin treatment. | Journal of the American Geriatrics Society 20060401 |
| Influences of statins on glucose tolerance in patients with type 2 diabetes mellitus. | Journal of atherosclerosis and thrombosis 20060401 |
| Efficacy of a low dose of pitavastatin compared with atorvastatin in primary hyperlipidemia: results of a 12-week, open label study. | Journal of atherosclerosis and thrombosis 20060401 |
| In vitro availability of atorvastatin in presence of losartan. | Pakistan journal of pharmaceutical sciences 20060401 |
| [The effects of 40 mg atorvastatin on serum lipids, inflammatory markers and clinical events in ACS patients post PCI]. | Zhonghua xin xue guan bing za zhi 20060401 |
| [Effect of atorvastatin on Fas (CD95/Apo-1) expression in normal or ischemic brain]. | Anales de medicina interna (Madrid, Spain : 1984) 20060401 |
| SREBP inhibits VEGF expression in human smooth muscle cells. | Biochemical and biophysical research communications 20060331 |
| In vivo suppression of major histocompatibility complex class II expression on porcine vascular endothelial cells by an HMG-CoA reductase inhibitor. | Transplantation 20060327 |
| A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22. | Circulation 20060321 |
| Statins and antioxidant vitamins: should co-administration be avoided? | Journal of the American College of Cardiology 20060321 |
| Direct comparison of the A to Z and PROVE IT trials: a second chance to gain a first impression. | Circulation 20060321 |
| MDOC and atorvastatin have potential antiinflammatory effects in vascular endothelium of apoE-/- mouse model of atherosclerosis. | Life sciences 20060320 |
| Effect of statin treatment on coronary collateral development in patients with diabetes mellitus. | The American journal of cardiology 20060315 |
| Usefulness of atorvastatin in patients with heart failure due to inflammatory dilated cardiomyopathy and elevated cholesterol levels. | The American journal of cardiology 20060315 |
| [Effect of statin treatment begun early after acute myocardial infarction on endothelial function in patients with normal levels of cholesterol. VAATOPE Study (VAlue of ATOrvastatin in Postinfarction Endothelium)]. | Medicina clinica 20060311 |
| [Early effect of statins after myocardial infarction. A statin-induced pleiotropic effect?]. | Medicina clinica 20060311 |
| Analysis of five HMG-CoA reductase inhibitors-- atorvastatin, lovastatin, pravastatin, rosuvastatin and simvastatin: pharmacological, pharmacokinetic and analytical overview and development of a new method for use in pharmaceutical formulations analysis and in vitro metabolism studies. | Biomedical chromatography : BMC 20060301 |
| Effect of atorvastatin on SR-BI expression and HDL-induced cholesterol efflux in adipocytes of hypercholesterolemic rabbits. | Clinica chimica acta; international journal of clinical chemistry 20060301 |
| Effects of acid and lactone forms of eight HMG-CoA reductase inhibitors on CYP-mediated metabolism and MDR1-mediated transport. | Pharmaceutical research 20060301 |
| Effects of atorvastatin on lipid metabolism in normolipidemic and hereditary hyperlipidemic, non-laying hens. | Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology 20060301 |
| Effects of various statins on cytokine-dependent growth and IgE-dependent release of histamine in human mast cells. | Allergy 20060301 |
| Composition of coronary plaques obtained by directional atherectomy in stable angina: its relation to serum lipids and statin treatment. | Journal of internal medicine 20060301 |
| Can atorvastatin improve the response to sildenafil in men with erectile dysfunction not initially responsive to sildenafil? Hypothesis and pilot trial results. | The journal of sexual medicine 20060301 |
| Effects of rosiglitazone alone and in combination with atorvastatin on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus. | The American journal of cardiology 20060301 |
| Comments on 'Multiple transporters affect the disposition of atorvastatin and its two active hydroxy metabolites: Application of in vitro and ex situ systems'. | The Journal of pharmacology and experimental therapeutics 20060301 |
| Atorvastatin improves myocardial perfusion in a patient with hypercholesterolemia and single-vessel coronary disease. | Clinical nuclear medicine 20060301 |
| Modulatory effects of atorvastatin on endothelial cell-derived chemokines, cytokines, and angiogenic factors. | Pharmacotherapy 20060301 |
| Low high-density lipoprotein cholesterol and cardiovascular disease: risk reduction with statin therapy. | American heart journal 20060301 |
| Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery. | Critical care medicine 20060301 |
| One-year atorvastatin treatment in hypercholesterolemic patients with or without carotid artery disease. | International angiology : a journal of the International Union of Angiology 20060301 |
| Hydroxymethylglutaryl-CoA reductase inhibitors in older persons with acute myocardial infarction: evidence for an age-statin interaction. | Journal of the American Geriatrics Society 20060301 |
| Comparative studies on hypocholesterolemic effect of different fractions of Hyphaene thebaica (Doum) in experimental animals. | Die Pharmazie 20060301 |
| A single-pill combination of amlodipine besylate and atorvastatin calcium. | Drugs of today (Barcelona, Spain : 1998) 20060301 |
| Short-term atorvastatin treatment does not modify neointimal morphology but reduces MMP-2 expression in normocholesterolemic rabbit stented arteries. | Journal of cardiovascular pharmacology 20060301 |
| Treatment of hypercholesterolemia in patients with metabolic syndrome: how do different statins compare? | Nature clinical practice. Endocrinology & metabolism 20060301 |
| Effects of rosiglitazone and atorvastatin on the expression of genes that control cholesterol homeostasis in differentiating monocytes. | Biochemical pharmacology 20060227 |
| The effect of atorvastatin treatment on HIV-1-infected patients interrupting antiretroviral therapy. | AIDS (London, England) 20060227 |
| [Treatment of hypercholesterolemia--lower is better]. | Ugeskrift for laeger 20060227 |
| Undisclosed conflicts of interest. | Annals of internal medicine 20060207 |
| Atorvastatin induces insulin sensitization in Zucker lean and fatty rats. | Atherosclerosis 20060201 |
| 99mTc-interleukin-2 scintigraphy for the in vivo imaging of vulnerable atherosclerotic plaques. | European journal of nuclear medicine and molecular imaging 20060201 |
| Multiple transporters affect the disposition of atorvastatin and its two active hydroxy metabolites: application of in vitro and ex situ systems. | The Journal of pharmacology and experimental therapeutics 20060201 |
| Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once-daily atorvastatin. | Pharmacoepidemiology and drug safety 20060201 |
| Imaging of a regressive coronary soft plaque under lipid lowering therapy by multi-slice computed tomography. | The international journal of cardiovascular imaging 20060201 |
| Enhanced cardioprotection against ischemia-reperfusion injury with combining sildenafil with low-dose atorvastatin. | Cardiovascular drugs and therapy 20060201 |
| Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention. | American heart journal 20060201 |
| Involvement of Rho-kinase in experimental vascular endothelial dysfunction. | Molecular and cellular biochemistry 20060201 |
| Atorvastatin reduces the expression of COX-2 mRNA in peripheral blood monocytes from patients with acute myocardial infarction and modulates the early inflammatory response. | Clinical chemistry 20060201 |
| LPS-induced release of IL-1 beta, IL-1Ra, IL-6, and TNF-alpha in whole blood from patients with familial hypercholesterolemia: no effect of cholesterol-lowering treatment. | Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 20060201 |
| [Statins in patients with kidney failure: efficacy, tolerance, and prescription guidelines in patients with chronic kidney disease and renal transplant]. | Presse medicale (Paris, France : 1983) 20060201 |
| Probucol and atorvastatin decrease urinary 8-hydroxy-2'-deoxyguanosine in patients with diabetes and hypercholesterolemia. | Journal of atherosclerosis and thrombosis 20060201 |
| Medication costs as a primary cause of nonadherence in the elderly. | The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists 20060201 |
| Synergistic effects of atorvastatin and sildenafil in cardioprotection--role of NO. | Cardiovascular drugs and therapy 20060201 |
| Correlation between inflammation and oxidative stress in normocholesterolemic coronary artery disease patients 'on' and 'off' atorvastatin for short time intervals. | Cardiovascular drugs and therapy 20060201 |
| Torcetrapib and atorvastatin: a novel combination therapy for dyslipidemia. | Drugs of today (Barcelona, Spain : 1998) 20060201 |
| [Time course of G-CSF, estrogen and various doses of atorvastatin on endothelial progenitor cells mobilization]. | Zhonghua xin xue guan bing za zhi 20060201 |
| Lessons learnt from the 4D trial. | Nephrologie & therapeutique 20060201 |
| Does statin therapy improve cardiovascular outcomes in patients with type 2 diabetes receiving hemodialysis? | Nature clinical practice. Nephrology 20060201 |
| Effects of hydroxysterols and atorvastatin on lipopolysaccharide-induced secretion of tumor necrosis factor and interleukin-10 by mouse macrophages. | Bulletin of experimental biology and medicine 20060201 |
| A novel lipoprotein-mediated mechanism controlling sexual attractiveness in a colorful songbird. | Physiology & behavior 20060130 |
| Effects of early administration of atorvastatin treatment on thrombotic process in normocholesterolemic patients with unstable angina. | International journal of cardiology 20060126 |
| Effect of intensive versus standard lipid-lowering treatment with atorvastatin on the progression of calcified coronary atherosclerosis over 12 months: a multicenter, randomized, double-blind trial. | Circulation 20060124 |
| Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure. | Journal of the American College of Cardiology 20060117 |
| Comparison of efficacy and safety of rosuvastatin versus atorvastatin in African-American patients in a six-week trial. | The American journal of cardiology 20060115 |
| Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins. | The American journal of cardiology 20060115 |
| Statins for high-risk patients without heart disease or high cholesterol. | The Medical letter on drugs and therapeutics 20060102 |
| Effect of atorvastatin on in vitro expression of resistin in adipocytes and monocytes/macrophages and effect of atorvastatin treatment on serum resistin levels in patients with type 2 diabetes. | Pharmacology 20060101 |
| Eosinophilic fasciitis secondary to treatment with atorvastatin. | Clinical and experimental dermatology 20060101 |
| Atorvastatin lowers plasma low-density lipoprotein cholesterol and C-reactive protein in Japanese type 2 diabetic patients. | Metabolism: clinical and experimental 20060101 |
| HMG-CoA reductase inhibitors may affect thrombin generation by reducing factor VII activity in hyperlipidemic patients. | Thrombosis research 20060101 |
| Effect of atorvastatin on circulating proinflammatory T-lymphocyte subsets and soluble CD40 ligand in patients with stable coronary artery disease--a randomized, placebo-controlled study. | American heart journal 20060101 |
| Preoperative statin therapy and troponin T predict early complications of coronary artery surgery. | The Annals of thoracic surgery 20060101 |
| Effects of morning versus evening intake of atorvastatin on major cardiac event and restenosis rates in patients undergoing first elective percutaneous coronary intervention. | The American journal of cardiology 20060101 |
| Comparative safety of atorvastatin 80 mg versus 10 mg derived from analysis of 49 completed trials in 14,236 patients. | The American journal of cardiology 20060101 |
| Evolution of lesions over 10 years in a patient with SLE: flowchart approach to the new International Society of Nephrology (ISN)/Renal Pathology Society (RPS) classification of lupus nephritis. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20060101 |
| Cross-over trial of intensive monotherapy with atorvastatin and combined therapy with atorvastatin and colestimide for Japanese familial hypercholesterolemia. | Circulation journal : official journal of the Japanese Circulation Society 20060101 |
| Statins and osteoporosis: new role for old drugs. | The Journal of pharmacy and pharmacology 20060101 |
| [Acute cholestatic hepatitis after atorvastatin reintroduction]. | Gastroenterologia y hepatologia 20060101 |
| Arginine uptake is attenuated through modulation of cationic amino-acid transporter-1, in uremic rats. | Kidney international 20060101 |
| Atorvastatin reduces the expression of prostaglandin E2 receptors in human carotid atherosclerotic plaques and monocytic cells: potential implications for plaque stabilization. | Journal of cardiovascular pharmacology 20060101 |
| Anti-atherosclerotic effect of amlodipine, alone and in combination with atorvastatin, in APOE*3-Leiden/hCRP transgenic mice. | Journal of cardiovascular pharmacology 20060101 |
| Statins decrease serotonin-induced contractions in coronary arteries of swine in vitro. | Pharmacology 20060101 |
| Muscle symptoms associated with statins: a series of twenty patients. | Basic & clinical pharmacology & toxicology 20060101 |
| Short-term lipid-lowering treatment with atorvastatin improves renal function but not renal blood flow indices in patients with peripheral arterial disease. | Angiology 20060101 |
| The influence of low-dose atorvastatin on lipid levels and endothelial vascular function in patients with significant coronary artery stenosis. | Kardiologia polska 20060101 |
| HPLC assay and pharmacokinetic study of atorvastatin in beagle dogs after oral administration of atorvastatin self-microemulsifying drug delivery system. | Die Pharmazie 20060101 |
| Aggressive low-density lipoprotein cholesterol lowering in secondary prevention of coronary heart disease. | Current atherosclerosis reports 20060101 |
| C-reactive protein levels and outcomes after statin therapy. | Current atherosclerosis reports 20060101 |
| Reduction in cardiovascular events with atorvastatin in type 2 diabetes. | Current atherosclerosis reports 20060101 |
| Effect of pravastatin and atorvastatin on glucose metabolism in nondiabetic patients with hypercholesterolemia. | Internal medicine (Tokyo, Japan) 20060101 |
| An open-label, crossover study of the pharmacokinetics of Insoluble Drug Delivery-MicroParticle fenofibrate in combination with atorvastatin, simvastatin, and extended-release niacin in healthy volunteers. | Clinical therapeutics 20060101 |
| [The IDEAL study comparing simvastatin 20-40 mg versus atorvastatin 80 mg for secondary prevention after myocardial infarction: between two ideas of the ideal]. | Revue medicale de Liege 20060101 |
| The statins: drug interactions of significance to the dental practitioner. | Dental update 20060101 |
| Early effects of simvastatin versus atorvastatin on oxidative stress and proinflammatory cytokines in hyperlipidemic subjects. | Angiology 20060101 |
| Effect of atorvastatin treatment on isoproterenol-induced myocardial infarction in rats. | Pharmacology 20060101 |
| Atorvastatin and diabetic vascular complications. | Current pharmaceutical design 20060101 |
| Caring for a woman at high risk for type 2 diabetes. | Journal of midwifery & women's health 20060101 |
| The fading of reported effectiveness. A meta-analysis of randomised controlled trials. | BMC medical research methodology 20060101 |
| Prevention of positive coronary artery remodeling with statin therapy in patients with coronary artery diseases. | Angiology 20060101 |
| Unrecognized side effect of statin treatment: unilateral blepharoptosis. | Ophthalmic plastic and reconstructive surgery 20060101 |
| Rhabdomyolysis in a patient treated with colchicine and atorvastatin. | The Annals of pharmacotherapy 20060101 |
| Cholesterol distribution, not total levels, correlate with altered amyloid precursor protein processing in statin-treated mice. | Neuromolecular medicine 20060101 |
| Cost-effectiveness analysis of cholesterol-lowering therapies in Spain. | American journal of cardiovascular drugs : drugs, devices, and other interventions 20060101 |
| [A case of interstitial lung disease with atorvastatin (Tahor) and a review of the literature about these effects observed under statins]. | Therapie 20060101 |
| Religious attendance: more cost-effective than lipitor? | Journal of the American Board of Family Medicine : JABFM 20060101 |
| Dyslipidemia in older adults. | The American journal of geriatric cardiology 20060101 |
| Statin-induced expression of CD59 on vascular endothelium in hypoxia: a potential mechanism for the anti-inflammatory actions of statins in rheumatoid arthritis. | Arthritis research & therapy 20060101 |
| Circulating cholesterol levels, apolipoprotein E genotype and dementia severity influence the benefit of atorvastatin treatment in Alzheimer's disease: results of the Alzheimer's Disease Cholesterol-Lowering Treatment (ADCLT) trial. | Acta neurologica Scandinavica. Supplementum 20060101 |
| Tubulointerstitial macrophage accumulation is regulated by sequentially expressed osteopontin and macrophage colony-stimulating factor: implication for the role of atorvastatin. | Mediators of inflammation 20060101 |
| Cost effectiveness of adding ezetimibe to atorvastatin therapy in patients not at cholesterol treatment goal in Canada. | PharmacoEconomics 20060101 |
| Renal effects of HMG-CoA reductase inhibition in a rat model of chronic inhibition of nitric oxide synthesis. | Kidney & blood pressure research 20060101 |
| Is rosuvastatin really a more efficient therapeutic option than atorvastatin? | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20060101 |
| How safe is aggressive statin therapy? | Progress in cardiovascular nursing 20060101 |
| Atorvastatin has distinct effects on endothelial markers in different mouse models of atherosclerosis. | Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20060101 |
| Effect of atorvastatin on antibody, interleukin-4 and gamma-interferon production in mice immunized with egg albumin. | Immunopharmacology and immunotoxicology 20060101 |
| High-dose atorvastatin therapy achieves 25% reduction in CV events in TNT substudy of diabetic patients. | Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners 20060101 |
| [Randomized FARVATER Study. Part 1. Effect of 10 and 20 mg/day atorvastatin on levels of lipids, C-reactive protein, and fibrinogen in patients with ischemic heart disease and hyperlipidemia]. | Kardiologiia 20060101 |
| Risk factors for rhabdomyolysis with simvastatin and atorvastatin. | Drug safety 20060101 |
| Stimulatory effects of atorvastatin on extracellular nucleotide degradation in human endothelial cells. | Nucleosides, nucleotides & nucleic acids 20060101 |
| [Effects of atorvastatin and acipimox on the lipid spectrum of blood plasma, endothelial function and a clinical course of unstable angina pectoris]. | Terapevticheskii arkhiv 20060101 |
| Evaluation of lipid-lowering therapy and cholesterol goal attainment in Finland: the National FINRISK Study. | American journal of cardiovascular drugs : drugs, devices, and other interventions 20060101 |
| Risk factors for rhabdomyolysis with simvastatin and atorvastatin. | Drug safety 20060101 |
| [Rhabdomyolysis after treatment with atorvastatin detected by bone scintigraphy]. | Revista espanola de medicina nuclear 20060101 |
| A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle. | PloS one 20060101 |
| [Atorvastatin in correction of metabolic syndrome: clinico-economical assessment of efficacy]. | Kardiologiia 20060101 |
| Atorvastatin attenuating down-regulation of peroxisome proliferator-activated receptor gamma in preventing cardiac hypertrophy of rats in vitro and in vivo. | Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20060101 |
| Endoglin expression in hyper-cholesterolemia and after atorvastatin treatment in apoE-deficient mice. | Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques 20060101 |
| [Hypoadiponectinemia: a cardiovascular risk factor in uremia. A view from the evidence]. | Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia 20060101 |
| [Oxidation stress, insulin resistance and endothelial dysfunction during the treatment of hyperlipidaemia]. | Casopis lekaru ceskych 20060101 |
| Validation of HPLC method for determination of atorvastatin in tablets and for monitoring stability in solid phase. | Acta poloniae pharmaceutica 20060101 |
| Effect of atorvastatin withdrawal on circulating coenzyme Q10 concentration in patients with hypercholesterolemia. | BioFactors (Oxford, England) 20060101 |
| [The effect of statins on lipids peroxidation and activities of antioxidants enzymes in patients with dyslipidemia]. | Przeglad lekarski 20060101 |
| Metabolic syndrome with early aortic atherosclerosis in a child. | Journal of the cardiometabolic syndrome 20060101 |
| Atorvastatin stimulates the production of osteoprotegerin by human osteoblasts. | Journal of cellular biochemistry 20051215 |
| Effect of atorvastatin (80 mg/day) versus pravastatin (40 mg/day) on arterial remodeling at coronary branch points (from the REVERSAL study). | The American journal of cardiology 20051215 |
| The effects of atorvastatin (10 mg) on systemic inflammation in heart failure. | The American journal of cardiology 20051215 |
| Effects of Atorvastatin on Th polarization in patients with acute myocardial infarction. | European journal of heart failure 20051201 |
| Effects of combined administration of low dose atorvastatin and vitamin E on inflammatory markers and endothelial function in patients with heart failure. | European journal of heart failure 20051201 |
| Beneficial effects of atorvastatin on myocardial regions with initially low vasodilatory capacity at various stages of coronary artery disease. | European journal of nuclear medicine and molecular imaging 20051201 |
| A comparative study with rosuvastatin in subjects with metabolic syndrome: results of the COMETS study. | European heart journal 20051201 |
| Lipid-lowering with atorvastatin improves tissue characteristics of carotid plaque. | Atherosclerosis 20051201 |
| Changes in ubiquitin proteasome pathway gene expression in skeletal muscle with exercise and statins. | Arteriosclerosis, thrombosis, and vascular biology 20051201 |
| Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, is elevated in coronary artery disease and is reduced during statin therapy. | Arteriosclerosis, thrombosis, and vascular biology 20051201 |
| Effects of atorvastatin on the Th1/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats. | Journal of autoimmunity 20051201 |
| Effects of atorvastatin on arterial endothelial function in coronary bypass surgery. | European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 20051201 |
| Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS). | Diabetologia 20051201 |
| 3'UTR/T polymorphism of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) is associated with modified anti-platelet activity of atorvastatin in hypercholesterolemic subjects. | Atherosclerosis 20051201 |
| Effects of morning versus evening administration of atorvastatin in patients with hyperlipidemia. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20051201 |
| Early anticoagulant effect of atorvastatin. | Arteriosclerosis, thrombosis, and vascular biology 20051201 |
| Genetic variation in the hepatic lipase gene is associated with combined hyperlipidemia, plasma lipid concentrations, and lipid-lowering drug response. | American heart journal 20051201 |
| Lipid-altering efficacy of switching from atorvastatin 10 mg/day to ezetimibe/simvastatin 10/20 mg/day compared to doubling the dose of atorvastatin in hypercholesterolaemic patients with atherosclerosis or coronary heart disease. | International journal of clinical practice 20051201 |
| Achieving lipid goals in real life: the Dutch DISCOVERY study. | International journal of clinical practice 20051201 |
| Statin use in a 'real-world' clinical setting: aggressive lipid lowering compared with usual care in the Aggressive Lipid-Lowering Initiation Abates New Cardiac Events (ALLIANCE) trial. | The American journal of medicine 20051201 |
| Improved outcome after acute coronary syndromes with an intensive versus standard lipid-lowering regimen: results from the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) trial. | The American journal of medicine 20051201 |
| A rationale for combination therapy in risk factor management: a mechanistic perspective. | The American journal of medicine 20051201 |
| Statins, especially atorvastatin, may favorably influence clinical presentation and biochemical progression-free survival after brachytherapy for clinically localized prostate cancer. | Urology 20051201 |
| Atorvastatin: a potential chemopreventive agent in bladder cancer. | Urology 20051201 |
| Atorvastatin therapy increases heart rate variability, decreases QT variability, and shortens QTc interval duration in patients with advanced chronic heart failure. | Journal of cardiac failure 20051201 |
| Does 'anti-lipid' also mean 'anti-arrhythmic'? | Journal of cardiac failure 20051201 |
| The ability of statins to protect low density lipoprotein from oxidation in hypercholesterolemic patients. | International journal of clinical pharmacology and therapeutics 20051201 |
| Cholesterol, copper and Abeta in controls, MCI, AD and the AD cholesterol-lowering treatment trial (ADCLT). | Current Alzheimer research 20051201 |
| I'm taking Zocor to help lower my cholesterol. The directions say to take it at night. My friend takes Lipitor, but doesn't have to take it at night. Why the difference? | Mayo Clinic health letter (English ed.) 20051201 |
| [The effect of atorvastatin on the expression of CD55, CD59 in patients with hyperlipidemia]. | Zhonghua xin xue guan bing za zhi 20051201 |
| [Atorvastatin upregulates the expression of PPAR alpha/gamma and inhibits the hypertrophy of cardiac myocytes in vitro]. | Zhonghua xin xue guan bing za zhi 20051201 |
| Efficacy and safety of atorvastatin in South Asian patients with dyslipidemia: an open label noncomparative pilot study. | Vascular health and risk management 20051201 |
| High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. | JAMA 20051116 |
| The IDEAL cholesterol: lower is better. | JAMA 20051116 |
| Effect of intensive versus moderate lipid lowering on endothelial function and vascular responsiveness to angiotensin II in stable coronary artery disease. | The American journal of cardiology 20051115 |
| Statin comparisons in controlled clinical trials. | The American journal of cardiology 20051115 |
| [How can lipid therapy be improved? Cardiologists insist on dual cholesterol inhibition]. | MMW Fortschritte der Medizin 20051110 |
| [Cholesterol goals are now easier to reach. Half LDL cholesterol with only one tablet daily]. | MMW Fortschritte der Medizin 20051110 |
| Reducing residual risk for patients on statin therapy: the potential role of combination therapy. | The American journal of cardiology 20051107 |
| Determination of atorvastatin in human serum by reversed-phase high-performance liquid chromatography with UV detection. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20051105 |
| Inflammatory markers and the metabolic syndrome. | Atherosclerosis 20051101 |
| Serum 1H-nuclear magnetic spectroscopy followed by principal component analysis and hierarchical cluster analysis to demonstrate effects of statins on hyperlipidemic patients. | NMR in biomedicine 20051101 |
| The effect of six different statins on the proliferation, migration, and invasion of human smooth muscle cells. | The Journal of surgical research 20051101 |
| Impact of short-term administration of high-density lipoproteins and atorvastatin on atherosclerosis in rabbits. | Arteriosclerosis, thrombosis, and vascular biology 20051101 |
| Use of a treatment algorithm to achieve NCEP ATP III goals with atorvastatin. | Journal of cardiovascular pharmacology 20051101 |
| The pharmaco-economics of peri-operative statin therapy. | Anaesthesia 20051101 |
| The effects of atorvastatin on gluten-induced intestinal T cell responses in coeliac disease. | Clinical and experimental immunology 20051101 |
| Effects of grapefruit juice on the pharmacokinetics of pitavastatin and atorvastatin. | British journal of clinical pharmacology 20051101 |
| The effect of statin therapy on plasma high-density lipoprotein cholesterol levels is modified by paraoxonase-1 in patients with familial hypercholesterolaemia. | Journal of internal medicine 20051101 |
| Intensity of lipid lowering with statins and brachial artery vascular endothelium reactivity after acute coronary syndromes (from the BRAVER trial). | The American journal of cardiology 20051101 |
| Statins and aortic stenosis progression: are biologic targets still an option? | Current cardiology reports 20051101 |
| Statin-induced apoptosis linked with membrane farnesylated Ras small G protein depletion, rather than geranylated Rho protein. | The Journal of pharmacy and pharmacology 20051101 |
| HMG-CoA reductase inhibitors do not improve glucose intolerance in spontaneously diabetic Goto-Kakizaki rats. | Biological & pharmaceutical bulletin 20051101 |
| Differential associations of statin and fibrate treatment with carotid arterial remodeling. | American journal of hypertension 20051101 |
| Effect of C-reactive protein reduction on paroxysmal atrial fibrillation. | American heart journal 20051101 |
| In-hospital initiation of statin therapy in acute coronary syndromes: maximizing the early and long-term benefits. | Chest 20051101 |
| LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study. | Current medical research and opinion 20051101 |
| [Fluctuation of C-reactive protein levels in acute coronary syndrome]. | Georgian medical news 20051101 |
| Effect of low doses of atorvastatin on adiponectin, glucose homeostasis, and clinical inflammatory markers in kidney transplant recipients. | Transplantation proceedings 20051101 |
| Safety of statins when response is carefully monitored: a study of 336 heart recipients. | Transplantation proceedings 20051101 |
| [Preparation and evaluation of self-microemulsifying drug delivery systems containing atorvastatin]. | Yao xue xue bao = Acta pharmaceutica Sinica 20051101 |
| [Atorvastatin reduces the expression of COX-2 mRNA in peripheral blood monocytes in patients with acute myocardial infarction and modulates the early inflammatory response]. | Zhonghua xin xue guan bing za zhi 20051101 |
| Atorvastatin in patients with type 2 diabetes mellitus undergoing dialysis. | The New England journal of medicine 20051027 |
| Atorvastatin in patients with type 2 diabetes mellitus undergoing dialysis. | The New England journal of medicine 20051027 |
| Atorvastatin in patients with type 2 diabetes mellitus undergoing dialysis. | The New England journal of medicine 20051027 |
| [Effects of atorvastatin on plasma hypersensitive C-reactive protein and interleukin-6 in patients with acute cerebral infarction]. | Zhonghua yi xue za zhi 20051026 |
| Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. | Journal of the American College of Cardiology 20051018 |
| Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy. | Journal of the American College of Cardiology 20051018 |
| Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial. | Journal of the American College of Cardiology 20051018 |
| Rosuvastatin is cost-effective compared with atorvastatin in reaching cholesterol goals. | International journal of cardiology 20051010 |
| Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin. | International journal of cardiology 20051010 |
| Torcetrapib and atorvastatin. | The New England journal of medicine 20051006 |
| Torcetrapib and atorvastatin. | The New England journal of medicine 20051006 |
| Torcetrapib and atorvastatin. | The New England journal of medicine 20051006 |
| Atorvastatin reduces serum leptin concentration in hypercholesterolemic rabbits. | Clinica chimica acta; international journal of clinical chemistry 20051001 |
| Influence of atorvastatin on apolipoprotein E and AI kinetics in patients with type 2 diabetes. | The Journal of pharmacology and experimental therapeutics 20051001 |
| In vitro effect of statins on cytokine production and mitogen response of human peripheral blood mononuclear cells. | Clinical immunology (Orlando, Fla.) 20051001 |
| Effects of statins on microglia. | Journal of neuroscience research 20051001 |
| Persistence and determinants of statin therapy among middle-aged patients free of cardiovascular disease. | European journal of clinical pharmacology 20051001 |
| Effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on high-sensitivity C-reactive protein levels. | Pharmacotherapy 20051001 |
| Relation of characteristics of metabolic syndrome to short-term prognosis and effects of intensive statin therapy after acute coronary syndrome: an analysis of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) trial. | Diabetes care 20051001 |
| Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA): response to Server et al. | Diabetes care 20051001 |
| Effect of atorvastatin on spatial memory, neuronal survival, and vascular density in female rats after traumatic brain injury. | Journal of neurosurgery 20051001 |
| [Drug combinations: statins and niacin]. | Arquivos brasileiros de cardiologia 20051001 |
| [ASCOT-BPLA Study raises new questions regarding: which is the best initial antihypertensive drug?]. | MMW Fortschritte der Medizin 20050929 |
| Evaluation of apoptosis and necrosis induced by statins using fluorescence-enhanced flow cytometry. | Journal of pharmaceutical and biomedical analysis 20050915 |
| Atorvastatin prevents peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) downregulation in lipopolysaccharide-stimulated H9c2 cells. | Biochimica et biophysica acta 20050915 |
| Binding thermodynamics of statins to HMG-CoA reductase. | Biochemistry 20050906 |
| Different time course for prevention of coronary and stroke events by atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid-Lowering Arm (ASCOT-LLA). | The American journal of cardiology 20050905 |
| Early time to benefit with intensive statin treatment: could it be the pleiotropic effects? | The American journal of cardiology 20050905 |
| Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial. | The American journal of cardiology 20050905 |
| Safety of high-dose atorvastatin therapy. | The American journal of cardiology 20050905 |
| Supratherapeutic response to ezetimibe administered with cyclosporine. | The Annals of pharmacotherapy 20050901 |
| 3D ultrasound measurement of change in carotid plaque volume: a tool for rapid evaluation of new therapies. | Stroke 20050901 |
| Combined therapy with atorvastatin and calcineurin inhibitors: no interactions with tacrolimus. | American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20050901 |
| REVERSAL and PROVE-IT: are clinically oriented trials really better than 'pure' scientific studies? | International journal of cardiology 20050901 |
| New insights in the treatment of dyslipidemia: a focus on cardiovascular event reduction and the anti-atherosclerotic effects of atorvastatin. | Current atherosclerosis reports 20050901 |
| Margarine phytosterols decrease the secretion of atherogenic lipoproteins from HepG2 liver and Caco2 intestinal cells. | Atherosclerosis 20050901 |
| Combined effects of HMG-CoA-reductase inhibition and renin-angiotensin system blockade on experimental atherosclerosis. | Atherosclerosis 20050901 |
| Effects of 4 weeks of atorvastatin administration on the antiinflammatory cytokine interleukin-10 in patients with unstable angina. | Clinical chemistry 20050901 |
| The effect of low-dose atorvastatin on circulating monocyte chemoattractant protein-1 in patients with type 2 diabetes complicated by hyperlipidemia. | Metabolism: clinical and experimental 20050901 |
| High baseline serum total and LDL cholesterol levels are associated with MDR1 haplotypes in Brazilian hypercholesterolemic individuals of European descent. | Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20050901 |
| Matrix metalloproteinases in isolated hypercholesterolemia. | International angiology : a journal of the International Union of Angiology 20050901 |
| Efficacy and safety of statins in hypercholesterolemia with emphasis on lipoproteins. | Heart and vessels 20050901 |
| Drug-induced acute autoimmune hepatitis during combination therapy with atorvastatin and ezetimibe. | Annals of clinical biochemistry 20050901 |
| In vitro inhibitory effects of atorvastatin on cardiac fibroblasts: implications for ventricular remodelling. | Clinical and experimental pharmacology & physiology 20050901 |
| Conversion to atorvastatin in patients intolerant or refractory to simvastatin therapy: the CAPISH study. | Mayo Clinic proceedings 20050901 |
| [Considerable LDL lowering is advantageous]. | MMW Fortschritte der Medizin 20050901 |
| Torcetrapib/atorvastatin combination therapy. | Expert review of cardiovascular therapy 20050901 |
| High-density lipoproteins and ATP-binding cassette transporters as targets for cardiovascular drug therapy. | Current opinion in investigational drugs (London, England : 2000) 20050901 |
| Torcetrapib + atorvastatin (Pfizer). | Current opinion in investigational drugs (London, England : 2000) 20050901 |
| Differences between statins on clinical endpoints: a population-based cohort study. | Current medical research and opinion 20050901 |
| Atorvastatin affects interleukin-2 signaling by altering the lipid raft enrichment of the interleukin-2 receptor beta chain. | Journal of investigative medicine : the official publication of the American Federation for Clinical Research 20050901 |
| Statins don't stop aortic valve narrowing...or memory loss (yet). | Harvard heart letter : from Harvard Medical School 20050901 |
| Stroke prevention, blood cholesterol and statins. | Acta neurologica Taiwanica 20050901 |
| [Prevention of periprocedural myocardial damage in patients undergoing percutaneous coronary intervention]. | Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology 20050901 |
| A case of familial hypercholesterolemia; secession from LDL-apheresis by the drug treatment with potent statin and resin. | The Tokai journal of experimental and clinical medicine 20050901 |
| Impact of the pravastatin or atorvastatin evaluation and infection therapy-thrombolysis in myocardial infarction 22/Reversal of Atherosclerosis with Aggressive Lipid Lowering trials on trends in intensive versus moderate statin therapy in Ontario, Canada. | Circulation 20050830 |
| Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway. | Circulation 20050830 |
| Dan Ravicher profile. A 'Robin Hood' declares war on lucrative U.S. patents. | Science (New York, N.Y.) 20050826 |
| The effects of quinapril and atorvastatin on artery structure and function in adult spontaneously hypertensive rats. | European journal of pharmacology 20050822 |
| Pharmacologic options for aggressive low-density lipoprotein cholesterol lowering: benefits versus risks. | The American journal of cardiology 20050822 |
| [Statins: for the time being, do not as a rule prescribe the maximum dose]. | Nederlands tijdschrift voor geneeskunde 20050820 |
| [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly]. | MMW Fortschritte der Medizin 20050818 |
| [To lessen the cardiovascular risk of the diabetic patient. Atorvastatin of use for diabetic patients without coronary disease, too]. | MMW Fortschritte der Medizin 20050818 |
| Long-term protective effect of atorvastatin in permanent focal cerebral ischemia. | Brain research 20050809 |
| Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy. | Circulation research 20050805 |
| Atorvastatin reverses age-related reduction in rat hepatic PPARalpha and HNF-4. | British journal of pharmacology 20050801 |
| Comparison of the effects of pravastatin and atorvastatin on fracture incidence in the PROVE IT-TIMI 22 trial--secondary analysis of a randomized controlled trial. | Bone 20050801 |
| Atorvastatin does not decrease or delay diabetes onset in two different mouse models of type 1 diabetes. | Diabetologia 20050801 |
| The effects of prior use of atorvastatin on coronary blood flow after primary percutaneous coronary intervention in patients presenting with acute myocardial infarction. | Coronary artery disease 20050801 |
| The inhibitory potency of clopidogrel on ADP-induced platelet activation is not attenuated when it is co-administered with atorvastatin (20 mg/day) for 5 weeks in patients with acute coronary syndromes. | Platelets 20050801 |
| Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month. | Stroke 20050801 |
| Effect of atorvastatin and fluvastatin on the metabolism of midazolam by cytochrome P450 in vitro. | Anaesthesia 20050801 |
| Remnant lipoproteinemia is a risk factor for endothelial vasomotor dysfunction and coronary artery disease in metabolic syndrome. | Atherosclerosis 20050801 |
| Progesterone abolishes estrogen and/or atorvastatin endothelial dependent vasodilatory effects. | Atherosclerosis 20050801 |
| Statin use after acute myocardial infarction: a nationwide study in Denmark. | British journal of clinical pharmacology 20050801 |
| Statin neuropathy masquerading as diabetic autoimmune polyneuropathy. | Diabetes care 20050801 |
| Effect of atorvastatin on tumor necrosis factor alpha serum concentration and mRNA expression of adipose in hypercholesterolemic rabbits. | Journal of cardiovascular pharmacology 20050801 |
| [Effect of maximum dose of atorvastatin on inflammation, thrombogenesis and fibrinolysis in high-risk patients with ischemic heart disease]. | Revista espanola de cardiologia 20050801 |
| The DISCOVERY PENTA study: a DIrect Statin COmparison of LDL-C Value--an Evaluation of Rosuvastatin therapY compared with atorvastatin. | Current medical research and opinion 20050801 |
| Rifampin markedly decreases and gemfibrozil increases the plasma concentrations of atorvastatin and its metabolites. | Clinical pharmacology and therapeutics 20050801 |
| Plasma low-density lipoprotein reduction and structural effects on coronary atherosclerotic plaques by atorvastatin as clinically assessed with intravascular ultrasound radio-frequency signal analysis: a randomized prospective study. | American heart journal 20050801 |
| Targeting vascular risk in patients with metabolic syndrome but without diabetes. | Metabolism: clinical and experimental 20050801 |
| Not all statins interfere with clopidogrel during antiplatelet therapy. | European journal of clinical investigation 20050801 |
| The antiplatelet effect of clopidogrel is not attenuated by statin treatment in stable patients with ischemic heart disease. | Thrombosis and haemostasis 20050801 |
| New light on statin side effects. What recent research on the cholesterol drugs means to you. | Heart advisor 20050801 |
| Hypotension and eosinophilia with atorvastatin. | Pharmacy world & science : PWS 20050801 |
| Effect of chitosan on lipid levels when administered concurrently with atorvastatin--a placebo controlled study. | Journal of the Indian Medical Association 20050801 |
| Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. | The New England journal of medicine 20050721 |
| Intensive lipid lowering with atorvastatin in coronary disease. | The New England journal of medicine 20050707 |
| Intensive lipid lowering with atorvastatin in coronary disease. | The New England journal of medicine 20050707 |
| Intensive lipid lowering with atorvastatin in coronary disease. | The New England journal of medicine 20050707 |
| Intensive lipid lowering with atorvastatin in coronary disease. | The New England journal of medicine 20050707 |
| Treatment of asymptomatic adults with elevated coronary calcium scores with atorvastatin, vitamin C, and vitamin E: the St. Francis Heart Study randomized clinical trial. | Journal of the American College of Cardiology 20050705 |
| Statins decrease Toll-like receptor 4 expression and downstream signaling in human CD14+ monocytes. | Arteriosclerosis, thrombosis, and vascular biology 20050701 |
| Determination of atorvastatin and metabolites in human plasma with solid-phase extraction followed by LC-tandem MS. | Analytical and bioanalytical chemistry 20050701 |
| Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial. | Diabetes, obesity & metabolism 20050701 |
| Simultaneous treatment of hypertension and dyslipidaemia may help to reduce overall cardiovascular risk: focus on amlodipine/atorvastatin single-pill therapy. | International journal of clinical practice 20050701 |
| Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells. | Pharmacogenetics and genomics 20050701 |
| Atorvastatin therapy lowers circulating cholesterol but not free radical activity in advance of identifiable clinical benefit in the treatment of mild-to-moderate AD. | Current Alzheimer research 20050701 |
| Acute effect of atorvastatin on coronary circulation measured by transthoracic Doppler echocardiography in patients without coronary artery disease by angiography. | The American journal of cardiology 20050701 |
| Effect of efavirenz on the pharmacokinetics of simvastatin, atorvastatin, and pravastatin: results of AIDS Clinical Trials Group 5108 Study. | Journal of acquired immune deficiency syndromes (1999) 20050701 |
| High-dose statins and skeletal muscle metabolism in humans: a randomized, controlled trial. | Clinical pharmacology and therapeutics 20050701 |
| Effects of atorvastatin on inflammation and oxidative stress. | Heart and vessels 20050701 |
| Reply to Al-Shaer, is atorvastatin more appropriate to use in combination with niacin than simvastatin in patients with the metabolic syndrome? (Am Heart J 2005;149:e17.). | American heart journal 20050701 |
| The angiotensin-converting enzyme gene insertion/deletion polymorphism and effects of quinapril and atorvastatin on haemostatic parameters in patients with coronary artery disease. | Thrombosis and haemostasis 20050701 |
| Cholesterol drug may help treat Alzheimer's. | Heart advisor 20050701 |
| Evidence of improved serum fatty acid profile of postmenopausal women receiving atorvastatin and raloxifene. | Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20050701 |
| Torcetrapib and atorvastatin--should marketing drive the research agenda? | The New England journal of medicine 20050623 |
| Volumetric quantitative analysis of tissue characteristics of coronary plaques after statin therapy using three-dimensional integrated backscatter intravascular ultrasound. | Journal of the American College of Cardiology 20050621 |
| [Medical management of primary nonalcoholic fatty liver disease]. | Medicina clinica 20050618 |
| Anti-inflammatory and analgesic effects of atorvastatin in a rat model of adjuvant-induced arthritis. | European journal of pharmacology 20050615 |
| Regulation of macrophage cholesterol efflux through hydroxymethylglutaryl-CoA reductase inhibition: a role for RhoA in ABCA1-mediated cholesterol efflux. | The Journal of biological chemistry 20050610 |
| A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. | The New England journal of medicine 20050609 |
| Statins for aortic stenosis. | The New England journal of medicine 20050609 |
| Images in clinical medicine. A medical mystery--bradycardia. | The New England journal of medicine 20050602 |
| Protective effects of statins involving both eNOS and tPA in focal cerebral ischemia. | Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20050601 |
| Statins reduce interleukin-6-induced C-reactive protein in human hepatocytes: new evidence for direct antiinflammatory effects of statins. | Arteriosclerosis, thrombosis, and vascular biology 20050601 |
| Statin drugs and congenital anomalies. | American journal of medical genetics. Part A 20050601 |
| FOXO-dependent expression of the proapoptotic protein Bim: pivotal role for apoptosis signaling in endothelial progenitor cells. | FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20050601 |
| Atorvastatin inhibits calcification and enhances nitric oxide synthase production in the hypercholesterolaemic aortic valve. | Heart (British Cardiac Society) 20050601 |
| Relative impact of CYP3A genotype and concomitant medication on the severity of atorvastatin-induced muscle damage. | Pharmacogenetics and genomics 20050601 |
| Cost effectiveness of rosuvastatin in treating patients to low-density lipoprotein cholesterol goals compared with atorvastatin, pravastatin, and simvastatin (a US Analysis of the STELLAR Trial). | The American journal of cardiology 20050601 |
| Upregulation of the immune system in primary hypercholesterolaemia: effect of atorvastatin therapy. | Journal of internal medicine 20050601 |
| Cholesterol-lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes -- CORALL study. | Journal of internal medicine 20050601 |
| A promoter polymorphism in cholesterol 7alpha-hydroxylase interacts with apolipoprotein E genotype in the LDL-lowering response to atorvastatin. | Atherosclerosis 20050601 |
| Efficacy and safety of ezetimibe co-administered with ongoing atorvastatin therapy in achieving low-density lipoprotein goal in patients with hypercholesterolemia and coronary heart disease. | International journal of clinical practice 20050601 |
| Statins and CVD prevention in the diabetic population: implications of the CARDS trial. | Current diabetes reports 20050601 |
| The effect of atorvastatin on serum lipoproteins in acromegaly. | Clinical endocrinology 20050601 |
| Atorvastatin and cardiovascular protection: a review and comparison of recent clinical trials. | Expert opinion on pharmacotherapy 20050601 |
| Gabapentin-induced myopathy in 2 patients on short daily hemodialysis. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20050601 |
| Atorvastatin. | Expert opinion on pharmacotherapy 20050601 |
| Hypolipidemic effect of methanolic extract of Dolichos biflorus Linn. in high fat diet fed rats. | Indian journal of experimental biology 20050601 |
| Acute onset and worsening of diabetes concurrent with administration of statins. | Endocrine journal 20050601 |
| [Erythrocyte fluidity in patients with hyperlipidemia during statins therapy]. | Polskie Archiwum Medycyny Wewnetrznej 20050601 |
| Atorvastatin-induced severe gastric ulceration: a case report. | World journal of gastroenterology 20050528 |
| Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients. | Circulation 20050517 |
| Relative efficacy of atorvastatin 80 mg and pravastatin 40 mg in achieving the dual goals of low-density lipoprotein cholesterol <70 mg/dl and C-reactive protein <2 mg/l: an analysis of the PROVE-IT TIMI-22 trial. | Journal of the American College of Cardiology 20050517 |
| Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia. | Journal of the American College of Cardiology 20050517 |
| Letter regarding article by Tsimikas et al, 'high-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial'. | Circulation 20050510 |
| Effects of atorvastatin on blood-brain barrier permeability during L-NAME hypertension followed by angiotensin-II in rats. | Brain research 20050503 |
| Controversies in antiplatelet therapy for patients with cardiovascular disease. | Circulation 20050503 |
| The role of lipid management in diabetes. | Cardiology clinics 20050501 |
| Effects of cholesteryl ester transfer protein inhibition on high-density lipoprotein subspecies, apolipoprotein A-I metabolism, and fecal sterol excretion. | Arteriosclerosis, thrombosis, and vascular biology 20050501 |
| High-density lipoprotein, but not low-density lipoprotein cholesterol levels influence short-term prognosis after acute coronary syndrome: results from the MIRACL trial. | European heart journal 20050501 |
| Bayesian modelling of multivariate quantitative traits using seemingly unrelated regressions. | Genetic epidemiology 20050501 |
| Effects of ezetimibe on plasma lipoproteins in severely hypercholesterolemic patients treated with regular LDL-apheresis and statins. | Atherosclerosis 20050501 |
| Impact of a pharmaceutical care program in a community pharmacy on patients with dyslipidemia. | The Annals of pharmacotherapy 20050501 |
| Rosuvastatin-associated hepatitis with autoimmune features. | European journal of gastroenterology & hepatology 20050501 |
| Effects of atorvastatin and vitamin E on lipoproteins and oxidative stress in dialysis patients: a randomised-controlled trial. | Journal of internal medicine 20050501 |
| Effects of atorvastatin versus other statins on fasting and postprandial C-reactive protein and lipoprotein-associated phospholipase A2 in patients with coronary heart disease versus control subjects. | The American journal of cardiology 20050501 |
| Atorvastatin induces T cell anergy via phosphorylation of ERK1. | Journal of immunology (Baltimore, Md. : 1950) 20050501 |
| Efficacy of colestimide coadministered with atorvastatin in japanese patients with heterozygous familial hypercholesterolemia (FH). | Circulation journal : official journal of the Japanese Circulation Society 20050501 |
| Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA). | Diabetes care 20050501 |
| Statins have additive effects to vertebral bone mineral density in combination with risedronate in hypercholesterolemic postmenopausal women. | European journal of obstetrics, gynecology, and reproductive biology 20050501 |
| Value for money in disease management of acute coronary syndrome--the price of aspirin to reduce the costs of ACS. | Journal of managed care pharmacy : JMCP 20050501 |
| The beneficial effects of lipid-lowering drugs beyond lipid-lowering effects: a comparative study with pravastatin, atorvastatin, and fenofibrate in patients with type IIa and type IIb hyperlipidemia. | Metabolism: clinical and experimental 20050501 |
| Atorvastatin for the treatment of mild to moderate Alzheimer disease: preliminary results. | Archives of neurology 20050501 |
| Single-pill therapy in the treatment of concomitant hypertension and dyslipidemia (the amlodipine/atorvastatin gemini study). | Journal of clinical hypertension (Greenwich, Conn.) 20050501 |
| A community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial. | Mayo Clinic proceedings 20050501 |
| [The TNT debate gives a lift to the debate about high-dose statins. Lower LDL cholesterol levels further reduce the cardiovascular risk]. | Lakartidningen 20050501 |
| Atorvastatin reduces the plasma lipids and oxidative stress but did not reverse the inhibition of prostacyclin generation by aortas in streptozotocin diabetic rats. | Prostaglandins & other lipid mediators 20050501 |
| Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patients. | Current medical research and opinion 20050501 |
| Ready, aim, treat to hit new cholesterol targets. | Heart advisor 20050501 |
| Statins and autonomic function in chronic heart failure. | Cardiovascular drugs and therapy 20050501 |
| Short-term adjuvant atorvastatin improves frequency domain indices of heart rate variability in stable systolic heart failure. | Cardiovascular drugs and therapy 20050501 |
| Cardiovascular disease risk of type 2 diabetes mellitus and metabolic syndrome: focus on aggressive management of dyslipidemia. | Current diabetes reviews 20050501 |
| Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20050426 |
| Effects of switching statins on lipid and apolipoprotein ratios in the MERCURY I study. | International journal of cardiology 20050420 |
| Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten? | Journal of the American College of Cardiology 20050419 |
| Statins potentiate the IFN-gamma-induced upregulation of group IIA phospholipase A2 in human aortic smooth muscle cells and HepG2 hepatoma cells. | Biochimica et biophysica acta 20050415 |
| Effect of intensive lipid lowering, with or without antioxidant vitamins, compared with moderate lipid lowering on myocardial ischemia in patients with stable coronary artery disease: the Vascular Basis for the Treatment of Myocardial Ischemia Study. | Circulation 20050412 |
| Low-density lipoprotein cholesterol in patients with stable coronary heart disease--is it time to shift our goals? | The New England journal of medicine 20050407 |
| Intensive lipid lowering with atorvastatin in patients with stable coronary disease. | The New England journal of medicine 20050407 |
| Red wine polyphenolics suppress the secretion of ApoB48 from human intestinal CaCo-2 cells. | Journal of agricultural and food chemistry 20050406 |
| [The PROVE IT-TIMI-22 study or the biter being bit]. | Revue medicale suisse 20050406 |
| Differential interaction of 3-hydroxy-3-methylglutaryl-coa reductase inhibitors with ABCB1, ABCC2, and OATP1B1. | Drug metabolism and disposition: the biological fate of chemicals 20050401 |
| Effect of atorvastatin on markers of bone turnover. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20050401 |
| The imidazoline-like drug S23515 affects lipid metabolism in hepatocyte by inhibiting the oxidosqualene: lanosterol cyclase activity. | Biochemical pharmacology 20050401 |
| Effect of monthly atorvastatin and fenofibrate treatment on monocyte chemoattractant protein-1 release in patients with primary mixed dyslipidemia. | Journal of cardiovascular pharmacology 20050401 |
| Statin treatment of patients with diabetes. | Current diabetes reports 20050401 |
| Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension. | American journal of hypertension 20050401 |
| Atorvastatin affects leukocyte gene expression in dyslipidemia patients: in vivo regulation of hemostasis, inflammation and apoptosis. | Journal of thrombosis and haemostasis : JTH 20050401 |
| The acute effect of atorvastatin on proteinuria in patients with chronic glomerulonephritis. | Clinical nephrology 20050401 |
| Influence of microsomal triglyceride transfer protein promoter polymorphism -493 GT on fasting plasma triglyceride values and interaction with treatment response to atorvastatin in subjects with heterozygous familial hypercholesterolaemia. | Pharmacogenetics and genomics 20050401 |
| Genetic and environmental factors affecting the response to statin therapy in patients with molecularly defined familial hypercholesterolaemia. | Pharmacogenetics and genomics 20050401 |
| [Effects of atorvastatin, fluvastatin, pravastatin, and simvastatin on endothelial function, lipid peroxidation, and aortic atherosclerosis in hypercholesterolemic rabbits]. | Arquivos brasileiros de cardiologia 20050401 |
| ['Treating to New Targets': plea for a LDL cholesterol target of or below 75 mg/dl in any patient with coronary heart disease]. | Revue medicale de Liege 20050401 |
| [The comparison of simvastatin and atorvastatin effects on hemostatic parameters in patients with hyperlipidemia type II]. | Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego 20050401 |
| [Coronary disease patient has already LDL of 100 mg/dl. Why lipid lowering is still worthwhile]. | MMW Fortschritte der Medizin 20050324 |
| Thrombin-induced rapid geranylgeranylation of RhoA as an essential process for RhoA activation in endothelial cells. | The Journal of biological chemistry 20050318 |
| Reduction of cerebral infarction in stroke-prone spontaneously hypertensive rats by statins associated with amelioration of oxidative stress. | Stroke 20050301 |
| [The CARDS Study: cardiovascular primary prevention in diabetes patients using Atorvastin]. | Der Internist 20050301 |
| Atorvastatin does not affect the pharmacokinetics of cyclosporine in renal transplant recipients. | European journal of clinical pharmacology 20050301 |
| Statin therapy improves brachial artery vasodilator function in patients with Type 1 diabetes and microalbuminuria. | Diabetic medicine : a journal of the British Diabetic Association 20050301 |
| Sterol-regulatory-element binding protein inhibits upstream stimulatory factor-stimulated hepatic lipase gene expression. | Atherosclerosis 20050301 |
| Endothelium-ameliorating effects of statin therapy and coenzyme Q10 reductions in chronic heart failure. | Atherosclerosis 20050301 |
| Effects of statin therapy on circulating conjugated dienes, a measure of LDL oxidation. | Atherosclerosis 20050301 |
| The effects of atorvastatin in experimental autoimmune uveitis. | The British journal of ophthalmology 20050301 |
| Atorvastatin and myocardial reperfusion injury: new pleiotropic effect implicating multiple prosurvival signaling. | Journal of cardiovascular pharmacology 20050301 |
| Intensive versus moderate lipid lowering with statins in acute coronary syndromes. | Current atherosclerosis reports 20050301 |
| Reversal of atherosclerosis with aggressive lipid lowering. | Current atherosclerosis reports 20050301 |
| Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging. | Journal of the American College of Cardiology 20050301 |
| Adipocytokines as a novel target for the anti-inflammatory effect of atorvastatin in patients with type 2 diabetes. | Diabetes care 20050301 |
| Cyclical Cushing's disease causing recurrent oedema and knee effusions. | Internal medicine journal 20050301 |
| CD40-ligand-dependent induction of COX-2 gene expression in endothelial cells by activated platelets: inhibitory effects of atorvastatin. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20050301 |
| Neuroprotective effects of atorvastatin against glutamate-induced excitotoxicity in primary cortical neurones. | Journal of neurochemistry 20050301 |
| CARDS on the table: should everybody with type 2 diabetes take a statin? | Current medical research and opinion 20050301 |
| Effects of atorvastatin on low-density lipoprotein cholesterol phenotype and C-reactive protein levels in patients undergoing long-term dialysis. | Pharmacotherapy 20050301 |
| Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients. | American heart journal 20050301 |
| Statins in acute coronary syndromes: the sooner, the better? | American heart journal 20050301 |
| Plaque regression--a new target for antiatherosclerotic therapy. | American heart journal 20050301 |
| Atorvastatin has an important acute anti-inflammatory effect in patients with acute coronary syndrome: results of a randomized, double-blind, placebo-controlled study. | American heart journal 20050301 |
| Randomized trial of atorvastatin in improving endothelial function in diabetics without prior coronary disease and having average cholesterol level. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20050301 |
| Comparison of endothelial function in patients with metabolic syndrome on bezafibrate or atorvastatin therapy. | Cardiovascular drugs and therapy 20050301 |
| How common is rhabdomyolysis in patients receiving lipid-lowering therapy? | Nature clinical practice. Cardiovascular medicine 20050301 |
| Influence of withdrawal of statin treatment on proinflammatory response and fibrinolytic activity in humans: an effect independent on cholesterol elevation. | International journal of cardiology 20050227 |
| Relaxant effects of pravastatin, atorvastatin and cerivastatin on isolated rat aortic rings. | Life sciences 20050225 |
| Atorvastatin improves peroxisome proliferator-activated receptor signaling in cardiac hypertrophy by preventing nuclear factor-kappa B activation. | Biochimica et biophysica acta 20050221 |
| Inhibitory effect of fluvastatin on ileal ulcer formation in rats induced by nonsteroidal antiinflammatory drug. | World journal of gastroenterology 20050221 |
| Suppression of autoimmune retinal disease by lovastatin does not require Th2 cytokine induction. | Journal of immunology (Baltimore, Md. : 1950) 20050215 |
| Atorvastatin decreases cellular proliferation and bone matrix expression in the hypercholesterolemic mitral valve. | Journal of the American College of Cardiology 20050215 |
| Statins and nasal polyps. | Annals of internal medicine 20050215 |
| Assessing adherence to statin therapy using patient report, pill count, and an electronic monitoring device. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20050215 |
| Atorvastatin and simvastatin decrease the uptake of acetylated low-density lipoprotein by human monocytes. | Pharmacology 20050201 |
| Attenuation of acute inflammatory response by atorvastatin after spinal cord injury in rats. | Journal of neuroscience research 20050201 |
| Rhabdomyolysis in a patient receiving atorvastatin and fluconazole. | European journal of clinical pharmacology 20050201 |
| Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury. | Cardiovascular research 20050201 |
| Hypolipidemic drugs affect monocyte IL-1beta gene expression and release in patients with IIa and IIb dyslipidemia. | Journal of cardiovascular pharmacology 20050201 |
| A literature search on pharmacokinetic drug interactions of statins and analysis of how such interactions are reflected in package inserts in Japan. | Journal of clinical pharmacy and therapeutics 20050201 |
| Effects of rosuvastatin, atorvastatin, simvastatin, and pravastatin on atherogenic dyslipidemia in patients with characteristics of the metabolic syndrome. | The American journal of cardiology 20050201 |
| Atorvastatin induction of VEGF and BDNF promotes brain plasticity after stroke in mice. | Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 20050201 |
| Existence of a clinically relevant interaction between clopidogrel and HMG-CoA reductase inhibitors? Re-evaluating the evidence. | Basic & clinical pharmacology & toxicology 20050201 |
| Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients. | Circulation 20050201 |
| Effect of pitavastatin on transactivation of human serum paraoxonase 1 gene. | Metabolism: clinical and experimental 20050201 |
| Gender-specific effects of estrogen receptor alpha gene haplotype on high-density lipoprotein cholesterol response to atorvastatin: interaction with apolipoprotein AI gene polymorphism. | Atherosclerosis 20050201 |
| Effects of atorvastatin on reactive hyperemia and inflammatory process in patients with congestive heart failure. | Atherosclerosis 20050201 |
| Rosuvastatin is cost-effective in treating patients to low-density lipoprotein-cholesterol goals compared with atorvastatin, pravastatin and simvastatin: analysis of the STELLAR trial. | European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 20050201 |
| Cost-effectiveness of atorvastatin for the prevention of coronary and stroke events: an economic analysis of the Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA). | European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 20050201 |
| Changes in flow-mediated dilatation, cytokines and carotid arterial stenosis during aggressive atorvastatin treatment in normocholesterolemic patients. | Journal of the Chinese Medical Association : JCMA 20050201 |
| Atorvastatin improves peritoneal sclerosis induced by hypertonic PD solution in rats. | The International journal of artificial organs 20050201 |
| By the way, doctor. I recently started taking Lipitor for high cholesterol. The label says: 'Do not eat grapefruit or drink grapefruit juice at any time while taking this medication.' My doctor didn't warn me about grapefruit. Several medically trained friends have never heard of such a thing. I love grapefruit. Is there really anything to worry about? | Harvard health letter 20050201 |
| [Treatment of cerebral infarction patients with IGT]. | Nihon rinsho. Japanese journal of clinical medicine 20050201 |
| Beneficial effects of raloxifene and atorvastatin on serum lipids. | Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20050201 |
| Effect of statins on LDL particle size in patients with familial combined hyperlipidemia: a comparison between atorvastatin and pravastatin. | Nutrition, metabolism, and cardiovascular diseases : NMCD 20050201 |
| Reaching recommended lipid and blood pressure targets with amlodipine/atorvastatin combination in patients with coronary heart disease. | The American journal of cardiology 20050115 |
| Long-term safety and efficacy of high-dose atorvastatin treatment in patients with familial hypercholesterolemia. | The American journal of cardiology 20050115 |
| C-reactive protein levels and outcomes after statin therapy. | The New England journal of medicine 20050106 |
| Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease. | The New England journal of medicine 20050106 |
| High-dose statins in acute coronary syndromes. | JAMA 20050105 |
| Effect of low dose atorvastatin versus diet-induced cholesterol lowering on atherosclerotic lesion progression and inflammation in apolipoprotein E*3-Leiden transgenic mice. | Arteriosclerosis, thrombosis, and vascular biology 20050101 |
| Effect of atorvastatin on non-cholesterol sterols in patients with type 2 diabetes mellitus and cardiovascular disease. | Pharmacological research 20050101 |
| Comparison of the impact of atorvastatin and simvastatin on apoA-I kinetics in men. | Atherosclerosis 20050101 |
| Antischistosomal action of atorvastatin alone and concurrently with medroxyprogesterone acetate on Schistosoma haematobium harboured in hamster: surface ultrastructure and parasitological study. | Acta tropica 20050101 |
| Effects of atorvastatin on reactive hyperaemia and the thrombosis-fibrinolysis system in patients with heart failure. | Heart (British Cardiac Society) 20050101 |
| Effects of atorvastatin on serum lipids, lipoproteins, and hemostasis. | American journal of hematology 20050101 |
| Atorvastatin: a review of its use in the primary prevention of cardiovascular events in patients with type 2 diabetes mellitus. | Drugs 20050101 |
| Atorvastatin and male infertility: is there a link? | Journal of andrology 20050101 |
| Statin therapy has no significant effect on skin tissue cholesterol: results from a prospective randomized trial. | Clinical chemistry 20050101 |
| Exertion-induced rhabdomyolysis in a patient on statin therapy. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20050101 |
| Atorvastatin reduces platelet-oxidized-LDL receptor expression in hypercholesterolaemic patients. | European journal of clinical investigation 20050101 |
| Modulation of statin-activated shedding of Alzheimer APP ectodomain by ROCK. | PLoS medicine 20050101 |
| Comparison of the efficacy and safety of atorvastatin initiated at different starting doses in patients with dyslipidemia. | American heart journal 20050101 |
| Effect of atorvastatin upon platelet activation in hypercholesterolemia, evaluated by flow cytometry. | Thrombosis research 20050101 |
| Heat shock protein antibody titers are reduced by statin therapy in dyslipidemic subjects: a pilot study. | Angiology 20050101 |
| Are Canadian guidelines for cholesterol lowering in high-risk patients optimal? | The Canadian journal of cardiology 20050101 |
| The collaborative atorvastatin diabetes study: preliminary results. | International journal of clinical practice 20050101 |
| PROVE IT then believe it. | International journal of clinical practice 20050101 |
| Relationship between insulin resistance and effect of atorvastatin in non-diabetic subjects. | Journal of atherosclerosis and thrombosis 20050101 |
| Prevalence of potentially severe drug-drug interactions in ambulatory patients with dyslipidaemia receiving HMG-CoA reductase inhibitor therapy. | Drug safety 20050101 |
| Atorvastatin reduces thrombin generation after percutaneous coronary intervention independent of soluble tissue factor. | Thrombosis research 20050101 |
| Sentence ordered in drug counterfeiting case. | FDA consumer 20050101 |
| Atorvastatin reduces lipopolysaccharide-induced expression of cyclooxygenase-2 in human pulmonary epithelial cells. | Respiratory research 20050101 |
| Adverse events with concomitant amiodarone and statin therapy. | Preventive cardiology 20050101 |
| Acute pancreatitis associated with combined lisinopril and atorvastatin therapy. | Digestive diseases (Basel, Switzerland) 20050101 |
| Effects of atorvastatin on glucose metabolism and insulin resistance in KK/Ay mice. | Journal of atherosclerosis and thrombosis 20050101 |
| Reduction of serum ubiquinol-10 and ubiquinone-10 levels by atorvastatin in hypercholesterolemic patients. | Journal of atherosclerosis and thrombosis 20050101 |
| Statin therapy helps to control blood pressure levels in hypertensive dyslipidemic patients. | Renal failure 20050101 |
| Efficacy and safety of chunghyul-dan (qingwie-dan) in patients with hypercholesterolemia. | The American journal of Chinese medicine 20050101 |
| Targets for low-density lipoprotein cholesterol levels in patients with stable coronary heart disease: where are we now after the 'treating to new targets' (TNT) trial? | Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese 20050101 |
| Cholesterol levels and the benefit of statins in heart failure. | Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese 20050101 |
| Similar medication compliance and control of dyslipidemia with simvastatin or atorvastatin in a staff-model HMO medical clinic. | Journal of managed care pharmacy : JMCP 20050101 |
| Analysis of the global RNA expression profiles of skeletal muscle cells treated with statins. | Journal of atherosclerosis and thrombosis 20050101 |
| Pitavastatin enhanced lipoprotein lipase expression in 3T3-L1 preadipocytes. | Journal of atherosclerosis and thrombosis 20050101 |
| The effect of short-term treatment with atorvastatin on E-selectin levels in severely burned patients. | International journal of clinical pharmacology research 20050101 |
| An association study of 43 SNPs in 16 candidate genes with atorvastatin response. | The pharmacogenomics journal 20050101 |
| Effect of atorvastatin on regional arterial stiffness in patients with type 2 diabetes mellitus. | Journal of atherosclerosis and thrombosis 20050101 |
| A simple and rapid HPLC method for the determination of atorvastatin in human plasma with UV detection and its application to pharmacokinetic studies. | Arzneimittel-Forschung 20050101 |
| Endothelial function in the forearm circulation of patients with the metabolic syndrome--effect of different lipid-lowering regimens. | Cardiology 20050101 |
| JTT-130, a microsomal triglyceride transfer protein (MTP) inhibitor lowers plasma triglycerides and LDL cholesterol concentrations without increasing hepatic triglycerides in guinea pigs. | BMC cardiovascular disorders 20050101 |
| The new fear factor: hazardous drugs revealed. | Geriatric nursing (New York, N.Y.) 20050101 |
| Decreasing LDL cholesterol and medication cost with every-other-day statin therapy. | Preventive cardiology 20050101 |
| Time as a variable with niacin extended-release/lovastatin vs. atorvastatin and simvastatin. | Preventive cardiology 20050101 |
| Considerations in the treatment of dyslipidemia associated with chronic kidney failure and renal transplantation. | Preventive cardiology 20050101 |
| [Estimation of antioxidative effect of atorvastatin and fluvastatin used in primary prevention of coronary heart disease--effect on antioxidative enzymatic activity]. | Wiadomosci lekarskie (Warsaw, Poland : 1960) 20050101 |
| Effect of statin therapy on serum trace element status in dyslipidaemic subjects. | Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) 20050101 |
| Counterfeit drug warning. | FDA consumer 20050101 |
| Avascular necrosis prevention with lipitor in lupus erythematosus. | Lupus 20050101 |
| Safety and efficacy of atorvastatin in patients with severe renal dysfunction. | Scandinavian journal of urology and nephrology 20050101 |
| APOA1 polymorphisms are associated with variations in serum triglyceride concentrations in hypercholesterolemic individuals. | Clinical chemistry and laboratory medicine 20050101 |
| Atorvastatin suppresses homocysteine formation in stimulated human peripheral blood mononuclear cells. | Clinical chemistry and laboratory medicine 20050101 |
| [Changes of elastic properties of magistral arteries in patients with ischemic heart disease during treatment with atorvastatin and simvastatin]. | Kardiologiia 20050101 |
| LDL-C goal attainment with ezetimibe plus simvastatin coadministration vs atorvastatin or simvastatin monotherapy in patients at high risk of CHD. | MedGenMed : Medscape general medicine 20050101 |
| Effect on serum uric acid levels of drugs prescribed for indications other than treating hyperuricaemia. | Current pharmaceutical design 20050101 |
| Atorvastatin affects several angiogenic mediators in human endothelial cells. | Endothelium : journal of endothelial cell research 20050101 |
| [Estimation of antioxidative effect of atorvastatin and fluvastatin used in primary prevention of coronary heart disease--effect on lipid peroxidation]. | Wiadomosci lekarskie (Warsaw, Poland : 1960) 20050101 |
| Prevention of atherosclerosis progression using atorvastatin in normolipidemic coronary artery disease patients--a controlled randomized trial. | Indian heart journal 20050101 |
| Journal Watch: evidence that Atorvastatin reduces the risk of stroke and myocardial infarction in patients with type 2 diabetes, but with no evidence of dyslipidaemia. | The Central African journal of medicine 20050101 |
| Low-dose atorvastatin in severe chronic kidney disease patients: a randomized, controlled endpoint study. | Scandinavian journal of urology and nephrology 20050101 |
| [Coronary heart disease patient reaches LDL level of 100 mg/dl with atorvastatin: how do you continue treatment next year?]. | MMW Fortschritte der Medizin 20041216 |
| [Lean years for patients]. | MMW Fortschritte der Medizin 20041216 |
| Atorvastatin inhibits autoreactive B cell activation and delays lupus development in New Zealand black/white F1 mice. | Journal of immunology (Baltimore, Md. : 1950) 20041215 |
| Statin-associated exacerbation of myasthenia gravis. | Neurology 20041214 |
| Atorvastatin effect on high-density lipoprotein-associated paraoxonase activity and oxidative DNA damage. | European journal of clinical pharmacology 20041201 |
| Intensive statin therapy in acute coronary syndromes: clinical benefits and vascular biology. | Current opinion in lipidology 20041201 |
| Atorvastatin ameliorates renal tissue damage in unilateral ureteral obstruction. | The Journal of urology 20041201 |
| Race, ethnicity, and sociocultural characteristics predict noncompliance with lipid-lowering medications. | Preventive medicine 20041201 |
| Atorvastatin reduces arterial stiffness in patients with rheumatoid arthritis. | Annals of the rheumatic diseases 20041201 |
| Effects of atorvastatin on the clearance of triglyceride-rich lipoproteins in familial combined hyperlipidemia. | The Journal of clinical endocrinology and metabolism 20041201 |
| Assessment of the efficacy of different statins in murine collagen-induced arthritis. | Arthritis and rheumatism 20041201 |
| Resistant arterial hypertension and hyperlipidemia: atorvastatin, not vitamin C, for blood pressure control. | The Israel Medical Association journal : IMAJ 20041201 |
| The grapefruit challenge: the juice inhibits a crucial enzyme, with possibly fatal consequences. | The American journal of nursing 20041201 |
| Inhibitory effect of statins on the proliferation of human breast cancer cells. | International journal of clinical pharmacology and therapeutics 20041201 |
| Effect of aggressive versus moderate lipid-lowering therapy on myocardial ischemia: the rationale, design, and baseline characteristics of the Study Assessing Goals in the Elderly (SAGE). | American heart journal 20041201 |
| [A relationship between insulin resistance and reduction in oxidative stress in vivo by atorvastatin]. | Journal of cardiology 20041201 |
| What did PROVE-IT prove? | Diabetes technology & therapeutics 20041201 |
| Delayed thrombosis after traumatic brain injury in rats. | Journal of neurotrauma 20041201 |
| Multiple antiplatelet effects of clopidogrel are not modulated by statin type in patients undergoing percutaneous coronary intervention. | Platelets 20041201 |
| Statins and osteoporosis: myth or reality? | Minerva medica 20041201 |
| Statins inhibit in vitro calcification of human vascular smooth muscle cells induced by inflammatory mediators. | Journal of cellular biochemistry 20041115 |
| Effect of atorvastatin on left ventricular diastolic function and ability of coenzyme Q10 to reverse that dysfunction. | The American journal of cardiology 20041115 |
| Treatment of severe hypercholesterolemia with atorvastatin in congenital analbuminemia. | The American journal of medicine 20041115 |
| The effect of high glucose on NO and O2- through endothelial GTPCH1 and NADPH oxidase. | Life sciences 20041112 |
| Recurrent acute pancreatitis possibly induced by atorvastatin and rosuvastatin. Is statin induced pancreatitis a class effect? | JOP : Journal of the pancreas 20041110 |
| [Low HDL-cholesterol, high triglycerides--well known but often ignored]. | Praxis 20041110 |
| Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells. | Circulation 20041109 |
| Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: the alliance study. | Journal of the American College of Cardiology 20041102 |
| HMG-CoA reductase inhibitors up-regulate anti-aging klotho mRNA via RhoA inactivation in IMCD3 cells. | Cardiovascular research 20041101 |
| Progesterone abolishes estrogen and/or atorvastatin endothelium dependent vasodilatory effects. | Atherosclerosis 20041101 |
| Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients. | Atherosclerosis 20041101 |
| Is it time for medical therapy for aortic valve disease? | Expert review of cardiovascular therapy 20041101 |
| Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors. | The American journal of cardiology 20041101 |
| Antiplatelet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to coronary artery stenting. | European heart journal 20041101 |
| Atorvastatin reduction of intravascular thrombosis, increase in cerebral microvascular patency and integrity, and enhancement of spatial learning in rats subjected to traumatic brain injury. | Journal of neurosurgery 20041101 |
| Atorvastatin reduction of intracranial hematoma volume in rats subjected to controlled cortical impact. | Journal of neurosurgery 20041101 |
| Statins and rheumatoid arthritis. | Lancet (London, England) 20041101 |
| Statins and rheumatoid arthritis. | Lancet (London, England) 20041101 |
| Statins and rheumatoid arthritis. | Lancet (London, England) 20041101 |
| Predictors of change in low-density lipoprotein size during lipid-lowering treatment in type 2 diabetes. | Metabolism: clinical and experimental 20041101 |
| Statins for patients with type 2 diabetes. | Lancet (London, England) 20041101 |
| Statins for patients with type 2 diabetes. | Lancet (London, England) 20041101 |
| Effect of monthly atorvastatin treatment on hemostasis. | International journal of clinical pharmacology and therapeutics 20041101 |
| Tracking regression and progression of atherosclerosis in human carotid arteries using high-resolution magnetic resonance imaging. | Magnetic resonance imaging 20041101 |
| Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study. | Clinical therapeutics 20041101 |
| The effects of atorvastatin treatment on the fibrinolytic system in dyslipidemic patients. | Japanese heart journal 20041101 |
| [Target values are more often attainable. Almost doubly so many patients with values under 100mg/dl]. | MMW Fortschritte der Medizin 20041028 |
| [CARDS confirms usefulness of LDL lowering in type 2 diabetics]. | Praxis 20041027 |
| [Atorvastatin lowers C-reactive protein in dislipemic patients with type 2 diabetes mellitus]. | Medicina clinica 20041023 |
| Beta4 integrin is involved in statin-induced endothelial cell death. | Biochemical and biophysical research communications 20041022 |
| There is no evidence for an increase in acute coronary syndromes after short-term abrupt discontinuation of statins in stable cardiac patients. | Circulation 20041019 |
| Microcosm evaluation of the effects of an eight pharmaceutical mixture to the aquatic macrophytes Lemna gibba and Myriophyllum sibiricum. | Aquatic toxicology (Amsterdam, Netherlands) 20041018 |
| Absence of interaction between atorvastatin or other statins and clopidogrel: results from the interaction study. | Archives of internal medicine 20041011 |
| Statin-induced improvement of endothelial progenitor cell mobilization, myocardial neovascularization, left ventricular function, and survival after experimental myocardial infarction requires endothelial nitric oxide synthase. | Circulation 20041005 |
| A comparative study of atorvastatin and simvastatin as monotherapy for mixed hyperlipidaemia in Type 2 diabetic patients. | Diabetes research and clinical practice 20041001 |
| The effects of high glucose and atorvastatin on endothelial cell matrix production. | Diabetic medicine : a journal of the British Diabetic Association 20041001 |
| Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. | Diabetes care 20041001 |
| [The role of intestinal absorption blockade in hypercholesterolemia treatment]. | Revista clinica espanola 20041001 |
| Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia. | American heart journal 20041001 |
| [Endothelial dysfunction, inflammation and statins: new evidences]. | Revista espanola de cardiologia 20041001 |
| [Noninvasive assessment of the effect of atorvastatin on coronary microvasculature and endothelial function in patients with dyslipidemia]. | Revista espanola de cardiologia 20041001 |
| Substantially elevated levels of atorvastatin and metabolites in cyclosporine-treated renal transplant recipients. | Clinical pharmacology and therapeutics 20041001 |
| Effects of atorvastatin on fasting plasma and marginated apolipoproteins B48 and B100 in large, triglyceride-rich lipoproteins in familial combined hyperlipidemia. | The Journal of clinical endocrinology and metabolism 20041001 |
| Intravascular ultrasound assessment of coronary atherosclerosis and percutaneous interventions. | Minerva cardioangiologica 20041001 |
| Lipid and apoprotein changes during atorvastatin up-titration in hemodialysis patients with hypercholesterolemia: a placebo-controlled study. | Clinical nephrology 20041001 |
| Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals. 2003. | Atherosclerosis. Supplements 20041001 |
| How low should your cholesterol go? Even lower may be better. For those at highest risk, very low cholesterol levels may help prevent a second heart attack or stroke. | Health news (Waltham, Mass.) 20041001 |
| A pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes in Spain. | The European journal of health economics : HEPAC : health economics in prevention and care 20041001 |
| Skin lipid synthesis inhibition: a possible means for enhancing percutaneous delivery of levodopa. | Current drug delivery 20041001 |
| [Cost-effectiveness of atorvastatin in the early treatment of acute coronary syndromes in Germany based on the MIRACL study]. | Medizinische Klinik (Munich, Germany : 1983) 20040915 |
| Design and baseline characteristics of the Incremental Decrease in End Points through Aggressive Lipid Lowering study. | The American journal of cardiology 20040915 |
| High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial. | Circulation 20040914 |
| Atorvastatin enhances sildenafil-induced vasodilation through nitric oxide-mediated mechanisms. | European journal of pharmacology 20040913 |
| Atorvastatin induces tissue transglutaminase in human endothelial cells. | Biochemical and biophysical research communications 20040910 |
| [Cost effectiveness of atorvastatin for prevention of coronary disease--an analysis of the ASCOT study. Re: the article from DMW 25/26 2004]. | Deutsche medizinische Wochenschrift (1946) 20040910 |
| [Statins and hypertension]. | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20040909 |
| [Lowering of cholesterol. What role is played by the choice of statins?]. | MMW Fortschritte der Medizin 20040902 |
| Effect of the statin atorvastatin on intracellular signalling by the prostacyclin receptor in vitro and in vivo. | British journal of pharmacology 20040901 |
| Statin precipitated lactic acidosis? | Journal of clinical pathology 20040901 |
| Effects of atorvastatin on triglyceride-rich lipoproteins, low-density lipoprotein subclass, and C-reactive protein in hemodialysis patients. | Metabolism: clinical and experimental 20040901 |
| The effect of atorvastatin on markers of bone turnover in patients with type 2 diabetes. | Bone 20040901 |
| Amlodipine/atorvastatin: the first cross risk factor polypill for the prevention and treatment of cardiovascular disease. | Expert review of cardiovascular therapy 20040901 |
| ADP induced platelet degranulation in healthy individuals is reduced by clopidogrel after pretreatment with atorvastatin. | Thrombosis and haemostasis 20040901 |
| Effect of amlodipine-atorvastatin combination on fibrinolysis in hypertensive hypercholesterolemic patients with insulin resistance. | American journal of hypertension 20040901 |
| Effects of low-dose atorvastatin on vascular responses in patients undergoing percutaneous coronary intervention with stenting. | Journal of cardiovascular pharmacology and therapeutics 20040901 |
| Relationship between LDL-C and non-HDL-C levels and clinical outcome in the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study. | Current medical research and opinion 20040901 |
| Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin. | American heart journal 20040901 |
| Recent changes to FDA-approved labeling. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20040901 |
| Bioequivalence study of atorvastatin tablets. | Arzneimittel-Forschung 20040901 |
| Interactions of human P-glycoprotein with simvastatin, simvastatin acid, and atorvastatin. | Pharmaceutical research 20040901 |
| Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial. | Clinical therapeutics 20040901 |
| High-dose statin and COX-2 inhibitor therapy rapidly decreases C-reactive protein level in patients with unstable angina. | Kardiologia polska 20040901 |
| I've taken Lipitor since my first heart attack two years ago, and my LDL has dropped steadily to 140. Given the new LDL guidelines, though, just how am I supposed to go about slashing it to a level of 70? | Health news (Waltham, Mass.) 20040901 |
| Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study. | Circulation 20040831 |
| Antioxidant effects of statins via S-nitrosylation and activation of thioredoxin in endothelial cells: a novel vasculoprotective function of statins. | Circulation 20040817 |
| Lipid-altering changes and pleiotropic effects of atorvastatin in patients with hypercholesterolemia. | The American journal of cardiology 20040815 |
| Intensive versus moderate lipid lowering with statins after acute coronary syndromes. | The New England journal of medicine 20040812 |
| Intensive versus moderate lipid lowering with statins after acute coronary syndromes. | The New England journal of medicine 20040812 |
| Intensive versus moderate lipid lowering with statins after acute coronary syndromes. | The New England journal of medicine 20040812 |
| Intensive versus moderate lipid lowering with statins after acute coronary syndromes. | The New England journal of medicine 20040812 |
| Intensive versus moderate lipid lowering with statins after acute coronary syndromes. | The New England journal of medicine 20040812 |
| Randomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (Atorvastatin for Reduction of MYocardial Damage during Angioplasty) study. | Circulation 20040810 |
| Clinical significance of the atorvastatin-clopidogrel drug-drug interaction. | Circulation 20040810 |
| Potential statin-clopidogrel interaction requires more study. | Circulation 20040810 |
| Statins upregulate PCSK9, the gene encoding the proprotein convertase neural apoptosis-regulated convertase-1 implicated in familial hypercholesterolemia. | Arteriosclerosis, thrombosis, and vascular biology 20040801 |
| Atorvastatin prevents end-organ injury in salt-sensitive hypertension: role of eNOS and oxidant stress. | Hypertension (Dallas, Tex. : 1979) 20040801 |
| The effects of lipid-lowering therapy on paraoxonase activities and their relationships with the oxidant-antioxidant system in patients with dyslipidemia. | Coronary artery disease 20040801 |
| Rhabdomyolysis triggered by cytomegalovirus infection in a heart transplant patient on concomitant cyclosporine and atorvastatin therapy. | Journal of gastroenterology and hepatology 20040801 |
| Colestimide co-administered with atorvastatin attenuates the progression of vascular calcification in haemodialysis patients. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20040801 |
| Interactions between common genetic polymorphisms in ABCG5/G8 and CYP7A1 on LDL cholesterol-lowering response to atorvastatin. | Atherosclerosis 20040801 |
| Atorvastatin improves diabetic dyslipidemia and increases lipoprotein lipase activity in vivo. | Atherosclerosis 20040801 |
| Impact of Vitamin E supplementation on lipoprotein peroxidation and composition in Type 1 diabetic patients treated with Atorvastatin. | Atherosclerosis 20040801 |
| Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes. | Diabetic medicine : a journal of the British Diabetic Association 20040801 |
| Effect of atorvastatin on the expression of CD40 ligand and P-selectin on platelets in patients with hypercholesterolemia. | The American journal of cardiology 20040801 |
| Lipid-lowering response to statins is affected by CYP3A5 polymorphism. | Pharmacogenetics 20040801 |
| No pharmacokinetic or pharmacodynamic interaction between atorvastatin and the oral direct thrombin inhibitor ximelagatran. | Journal of clinical pharmacology 20040801 |
| Atorvastatin-induced activation of Alzheimer's alpha secretase is resistant to standard inhibitors of protein phosphorylation-regulated ectodomain shedding. | Journal of neurochemistry 20040801 |
| Effect of short term treatment with simvastatin and atorvastatin on lipids and paraoxonase activity in patients with hyperlipoproteinaemia. | Current medical research and opinion 20040801 |
| Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. | Lancet (London, England) 20040801 |
| Atorvastatin reduces fibrinogen levels in patients with severe hypercholesterolemia: additional evidence to support the anti-inflammatory effects of statins. | The Israel Medical Association journal : IMAJ 20040801 |
| Beyond cholesterol lowering: effect of statins on markers of cardiovascular disease. | The Israel Medical Association journal : IMAJ 20040801 |
| The use of atorvastatin treatment in usual care environments: pooled analysis of six prospective, observational studies in 90,535 patients. | International journal of clinical pharmacology and therapeutics 20040801 |
| Rheumatoid arthritis treatment progressing. | Health news (Waltham, Mass.) 20040801 |
| Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study. | Circulation 20040727 |
| Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein. | Circulation research 20040723 |
| Effects of atorvastatin (10 mg) on hemostatic and inflammatory parameters in hyperlipidemic patients with angiographically proven coronary artery disease. | The American journal of cardiology 20040715 |
| [Decreasing LDL level moderately or drastically. Is differential therapy with statins available? (interview by Dirk Einecke)]. | MMW Fortschritte der Medizin 20040708 |
| Atorvastatin-induced polyneuropathy. | Annals of internal medicine 20040706 |
| Amlodipine/atorvastatin (Caduet). | The Medical letter on drugs and therapeutics 20040705 |
| HMG-CoA reductase inhibitor, atorvastatin, promotes sensorimotor recovery, suppressing acute inflammatory reaction after experimental intracerebral hemorrhage. | Stroke 20040701 |
| Reduction of intracellular cholesterol accumulation in THP-1 macrophages by a combination of rosiglitazone and atorvastatin. | Biochemical pharmacology 20040701 |
| Statin-induced immunomodulatory effects on human T cells in vivo. | Atherosclerosis 20040701 |
| Improvement in erectile function in men with organic erectile dysfunction by correction of elevated cholesterol levels: a clinical observation. | The Journal of urology 20040701 |
| A pharmacoeconomic evaluation of aggressive cholesterol lowering in Sweden. | International journal of cardiology 20040701 |
| Therapy-refractory systemic juvenile idiopathic arthritis successfully treated with statins. | Rheumatology (Oxford, England) 20040701 |
| Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial. | American heart journal 20040701 |
| Comparison of levels of matrix metalloproteinases, tissue inhibitor of metalloproteinases, interleukins, and tissue necrosis factor in carotid endarterectomy specimens from patients on versus not on statins preoperatively. | The American journal of cardiology 20040701 |
| The effect of statins versus untreated dyslipidaemia on renal function in patients with coronary heart disease. A subgroup analysis of the Greek atorvastatin and coronary heart disease evaluation (GREACE) study. | Journal of clinical pathology 20040701 |
| New LDL goals: even lower? | The Johns Hopkins medical letter health after 50 20040701 |
| Post-stroke atorvastatin treatment reduces neurological deficits and mortality rate in the stroke-prone spontaneously hypertensive rat. | The Journal of pharmacy and pharmacology 20040701 |
| Oxidized low-density lipoprotein induces endothelial progenitor cell senescence, leading to cellular dysfunction. | Clinical and experimental pharmacology & physiology 20040701 |
| Improvement in neurological outcome after administration of atorvastatin following experimental intracerebral hemorrhage in rats. | Journal of neurosurgery 20040701 |
| Long-term safety and tolerability profile of ezetimibe and atorvastatin coadministration therapy in patients with primary hypercholesterolaemia. | International journal of clinical practice 20040701 |
| Atorvastatin enhances bone density in ovariectomized rats given 17beta-estradiol or human parathyroid hormone(1-34). | Endocrine 20040701 |
| [Sequelae of the CARDS Study. LDL of 110 mg/dl still too high?]. | MMW Fortschritte der Medizin 20040624 |
| Statins in rheumatoid arthritis--two birds with one stone? | Lancet (London, England) 20040619 |
| Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial. | Lancet (London, England) 20040619 |
| [Cost-effectiveness of atorvastatin for the prevention of coronary disease. An analysis of the ASCOT study]. | Deutsche medizinische Wochenschrift (1946) 20040618 |
| Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitors. | Biochemical pharmacology 20040615 |
| Efficacy and safety of ezetimibe co-administered with simvastatin compared with atorvastatin in adults with hypercholesterolemia. | The American journal of cardiology 20040615 |
| Atorvastatin completely inhibits VEGF-induced ACE upregulation in human endothelial cells. | American journal of physiology. Heart and circulatory physiology 20040601 |
| Evidence for anti-inflammatory activity of statins and PPARalpha activators in human C-reactive protein transgenic mice in vivo and in cultured human hepatocytes in vitro. | Blood 20040601 |
| Normal pregnancy outcome following inadvertent exposure to rosiglitazone, gliclazide, and atorvastatin in a diabetic and hypertensive woman. | Reproductive toxicology (Elmsford, N.Y.) 20040601 |
| Cell-based screen of HMG-CoA reductase inhibitors and expression regulators using LC-MS. | Analytical biochemistry 20040601 |
| Treating to hypertension targets. | Heart (British Cardiac Society) 20040601 |
| Atorvastatin decreases apolipoprotein C-III in apolipoprotein B-containing lipoprotein and HDL in type 2 diabetes: a potential mechanism to lower plasma triglycerides. | Diabetes care 20040601 |
| Adverse events with concomitant use of simvastatin or atorvastatin and thiazolidinediones. | The American journal of cardiology 20040601 |
| Statins as immunomodulatory agents. | Circulation 20040601 |
| Intensive lipid-lowering therapy in coronary artery disease: implications of the REVERSAL and PROVE-IT trials. | Expert opinion on investigational drugs 20040601 |
| Comparison of two methods of presenting risk information to patients about the side effects of medicines. | Quality & safety in health care 20040601 |
| Update on statins. | Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing 20040601 |
| Effect of atorvastatin on different fibrinolyis mechanisms in hypercholesterolemic subjects. | International journal of cardiology 20040601 |
| Beneficial effects of raloxifene and atorvastatin on serum lipids and HDL phospholipids levels of postmenopausal women. | Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology 20040601 |
| Age-dependent effects of atorvastatin on biochemical bone turnover markers: a randomized controlled trial in postmenopausal women. | Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 20040601 |
| Atorvastatin decreases the coenzyme Q10 level in the blood of patients at risk for cardiovascular disease and stroke. | Archives of neurology 20040601 |
| Managing hyperlipidaemia: a real headache. | Hospital medicine (London, England : 1998) 20040601 |
| Short-term effect of atorvastatin on ischaemic threshold in hypercholesterolaemic patients with stable ischaemic heart disease. | Acta cardiologica 20040601 |
| The effect of atorvastatin on platelet function in patients with coronary artery disease. | Acta cardiologica 20040601 |
| [Effects of atorvastatin on the function of dendritic cells in patients with unstable angina pectoris]. | Zhonghua nei ke za zhi 20040601 |
| [Optimizing the managment of patients with diabetes mellitus: selected clinical trials from the 2004 Congress of the American Diabetes Association]. | Revue medicale de Liege 20040601 |
| Comparison of raloxifene and atorvastatin effects on serum lipids composition of healthy post-menopausal women. | Molecular and cellular biochemistry 20040601 |
| Clopidogrel-atorvastatin interaction. | Circulation 20040525 |
| Atorvastatin reduces CD68, FABP4, and HBP expression in oxLDL-treated human macrophages. | Biochemical and biophysical research communications 20040521 |
| Early intervention with atorvastatin modulates TH1/TH2 imbalance in patients with acute coronary syndrome: from bedside to bench. | Circulation 20040511 |
| Successful reintroduction of statin therapy after myositis: was there another cause? | The Medical journal of Australia 20040503 |
| Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. | Journal of vascular surgery 20040501 |
| Vascular basis for the treatment of myocardial ischemia study: trial design and baseline characteristics. | American heart journal 20040501 |
| Lipitor bests Pravachol at certain doses. | Health news (Waltham, Mass.) 20040501 |
| The effect of high dose atorvastatin therapy on lipids and lipoprotein subfractions in overweight patients with type 2 diabetes. | Atherosclerosis 20040501 |
| Qualitative effect of fenofibrate and quantitative effect of atorvastatin on LDL profile in combined hyperlipidemia with dense LDL. | Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20040501 |
| Cholesterol: low is good. Lower is better. PROVE IT has doctors rethinking how to treat high cholesterol and what's a good target. | Harvard heart letter : from Harvard Medical School 20040501 |
| Cholesterol limbo: How low should the bar go. Ratcheting down LDL to extra-low levels with high-dose statins seems to work wonders. | Harvard health letter 20040501 |
| Class-specific pro-apoptotic effect of statins on human vascular endothelial cells. | Zeitschrift fur Kardiologie 20040501 |
| A statin for a patient with hyperlipidemia and hepatitis C? | Postgraduate medicine 20040501 |
| Effect of atorvastatin on high density lipoprotein cholesterol and its relationship with coronary events: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study. | Current medical research and opinion 20040501 |
| 'Major surprise' in a new study means likely changes in treatment. | Heart advisor 20040501 |
| [LDL adsorption for therapy of hyperlipidemia]. | Nihon rinsho. Japanese journal of clinical medicine 20040501 |
| Atorvastatin treatment decreases inflammatory and proteolytic activity in patients with hypercholesterolemia. | Kardiologia polska 20040501 |
| Circulating monocytes and plasma inflammatory biomarkers in active Crohn's disease: elevated oxidized low-density lipoprotein and the anti-inflammatory effect of atorvastatin. | Inflammatory bowel diseases 20040501 |
| Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors. | Circulation 20040427 |
| Polymorphisms in the multidrug resistance-1 (MDR1) gene influence the response to atorvastatin treatment in a gender-specific manner. | The American journal of cardiology 20040415 |
| Statins downregulate ATP-binding-cassette transporter A1 gene expression in macrophages. | Biochemical and biophysical research communications 20040409 |
| Intensive versus moderate lipid lowering with statins after acute coronary syndromes. | The New England journal of medicine 20040408 |
| Intensive statin therapy--a sea change in cardiovascular prevention. | The New England journal of medicine 20040408 |
| Increasing HDL Cholesterol Levels. | The New England journal of medicine 20040408 |
| Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol. | The New England journal of medicine 20040408 |
| Decreased circulating Fas ligand in patients with familial combined hyperlipidemia or carotid atherosclerosis: normalization by atorvastatin. | Journal of the American College of Cardiology 20040407 |
| Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells. | Circulation research 20040402 |
| ATP binding cassette transporter G5 and G8 genotypes and plasma lipoprotein levels before and after treatment with atorvastatin. | Journal of lipid research 20040401 |
| The HMG-CoA reductase inhibitor atorvastatin prevents atrial fibrillation by inhibiting inflammation in a canine sterile pericarditis model. | Cardiovascular research 20040401 |
| Effects of grapefruit juice on pharmacokinetics of atorvastatin and pravastatin in Japanese. | British journal of clinical pharmacology 20040401 |
| HMG-CoA reductase inhibition causes neurite loss by interfering with geranylgeranylpyrophosphate synthesis. | Journal of neurochemistry 20040401 |
| Atorvastatin as a trigger of autoimmune hepatitis. | Journal of hepatology 20040401 |
| Atorvastatin improves the course of ischemic acute renal failure in aging rats. | Journal of the American Society of Nephrology : JASN 20040401 |
| Effect of statins versus untreated dyslipidemia on serum uric acid levels in patients with coronary heart disease: a subgroup analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20040401 |
| Atorvastatin lowers plasma matrix metalloproteinase-9 in patients with acute coronary syndrome. | Clinical chemistry 20040401 |
| Lipid-lowering drug atorvastatin as an adjunct in the management of diabetic macular edema. | American journal of ophthalmology 20040401 |
| The relationship between cholesteryl ester transfer protein levels and risk factor profile in patients with familial hypercholesterolemia. | Atherosclerosis 20040401 |
| Effect of atorvastatin on impaired vascular function in healthy old men. | Journal of clinical pharmacy and therapeutics 20040401 |
| Effects of switching statins on achievement of lipid goals: Measuring Effective Reductions in Cholesterol Using Rosuvastatin Therapy (MERCURY I) study. | American heart journal 20040401 |
| Serum profiles of matrix metalloproteinases and their tissue inhibitor in patients with acute coronary syndromes. The effects of short-term atorvastatin administration. | International journal of cardiology 20040401 |
| Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammation. | Clinical cardiology 20040401 |
| Believe-it then PROVE-IT. | International journal of clinical practice 20040401 |
| Effects of atorvastatin and simvastatin on low-density lipoprotein subfraction profile, low-density lipoprotein oxidizability, and antibodies to oxidized low-density lipoprotein in relation to carotid intima media thickness in familial hypercholesterolemia. | Journal of investigative medicine : the official publication of the American Federation for Clinical Research 20040401 |
| [Effects of atorvastatin on LPS-induced PGE2 and IL-6 secretions in human pulmonary epithelial cells]. | Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20040401 |
| [Lower, lower, lower. The LDL goal value of 200 mg/dl is still much too high]. | MMW Fortschritte der Medizin 20040325 |
| [Results of randomized study: intensive lipid lowering treatment stops coronary atherosclerosis]. | MMW Fortschritte der Medizin 20040325 |
| [Regarding LDL cholesterol: the lower, the better (interview by Dr. Dirk Einecke)]. | MMW Fortschritte der Medizin 20040325 |
| Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes. | Circulation 20040323 |
| Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. | JAMA 20040303 |
| High-intensity statin treatment for coronary heart disease. | JAMA 20040303 |
| Statins to prevent cardiovascular events in hypertensive patients. The ASCOT-LLA study. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20040301 |
| Does atorvastatin influence serum C-reactive protein levels in patients on long-term hemodialysis? | American journal of kidney diseases : the official journal of the National Kidney Foundation 20040301 |
| Time course differences for statin-induced pleiotropic effects in hypercholesterolemic patients. | International journal of cardiology 20040301 |
| Lack of adverse clopidogrel-atorvastatin clinical interaction. | The American journal of cardiology 20040301 |
| [Atorvastatin for primary prevention of cardiovascular events. ASCOT-LLA Study]. | Der Internist 20040301 |
| Plasma levels of beta-amyloid(1-40), beta-amyloid(1-42), and total beta-amyloid remain unaffected in adult patients with hypercholesterolemia after treatment with statins. | Archives of neurology 20040301 |
| Hypothesis: atorvastatin has pleiotropic effects that translate into early clinical benefits on cardiovascular disease. | Journal of cardiovascular pharmacology and therapeutics 20040301 |
| [Clinical study of the month. REVERAL and PROVE-IT: confirmation of the concept ' the lower, the better' for cholesterol therapy in patients with coronary heart disease]. | Revue medicale de Liege 20040301 |
| Lipid-lowering effects of ethyl 2-phenacyl-3-aryl-1H-pyrrole- 4-carboxylates in rodents. | Molecules (Basel, Switzerland) 20040227 |
| [Interactions of statins with antithrombotic drugs]. | Medizinische Klinik (Munich, Germany : 1983) 20040215 |
| Growth hormone induces low-density lipoprotein clearance but not bile acid synthesis in humans. | Arteriosclerosis, thrombosis, and vascular biology 20040201 |
| Effect of atorvastatin on cyclosporine pharmacokinetics in liver transplant recipients. | The Annals of pharmacotherapy 20040201 |
| More Western hypercholesterolemic patients achieve Japan Atherosclerosis Society LDL-C goals with rosuvastatin therapy than with atorvastatin, pravastatin, or simvastatin therapy. | Circulation journal : official journal of the Japanese Circulation Society 20040201 |
| Plasma antioxidative activity during atorvastatin and fluvastatin therapy used in coronary heart disease primary prevention. | Fundamental & clinical pharmacology 20040201 |
| Rationale, design and methods of the CASHMERE study. | Fundamental & clinical pharmacology 20040201 |
| Hormonal changes with cholesterol reduction: a double-blind pilot study. | Journal of clinical pharmacy and therapeutics 20040201 |
| Emerging therapies for cerebrovascular disorders. | Stroke 20040201 |
| The effects of atorvastatin on endothelial function in diabetic patients and subjects at risk for type 2 diabetes. | The Journal of clinical endocrinology and metabolism 20040201 |
| Germ cell migration in zebrafish is dependent on HMGCoA reductase activity and prenylation. | Developmental cell 20040201 |
| [Role of lipid lowering therapy in patients with peripheral arterial occlusive disease]. | Herz 20040201 |
| Clash of the statins? A trial pitting two popular statins against each other helps answer a far more important question: how low should cholesterol go? | Harvard heart letter : from Harvard Medical School 20040201 |
| Amlodipine and atorvastatin in atherosclerosis: a review of the potential of combination therapy. | Expert opinion on pharmacotherapy 20040201 |
| Oral anticoagulant drug interactions with statins: case report of fluvastatin and review of the literature. | Pharmacotherapy 20040201 |
| Effects of lipid-lowering therapy on coronary artery remodeling. | Coronary artery disease 20040201 |
| [Effect of atorvastatin on the nuclear factor-kappaB and soluble inter-cellular adhesion molecules-1 in patients with acute coronary syndrome]. | Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 20040201 |
| Atorvastatin: gold standard for prophylaxis of myocardial ischemia and stroke - comparison of the clinical benefit of statins on the basis of randomized controlled endpoint studies. | European journal of medical research 20040126 |
| [Statin therapy for hypertensive patients]. | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20040122 |
| Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit? | The American journal of cardiology 20040115 |
| Angiotensin-converting enzyme inhibitors and 3-hydroxy-3-methylglutaryl coenzyme A reductase in cardiac Syndrome X: role of superoxide dismutase activity. | Circulation 20040106 |
| An efficient synthesis of N3,4-diphenyl-5-(4-fluorophenyl)-2-isopropyl-1H-3-pyrrolecarboxamide, a key intermediate for atorvastatin synthesis. | Bioorganic & medicinal chemistry letters 20040105 |
| Effects of atorvastatin versus fenofibrate on apoB-100 and apoA-I kinetics in mixed hyperlipidemia. | Journal of lipid research 20040101 |
| Decreased macrophage paraoxonase 2 expression in patients with hypercholesterolemia is the result of their increased cellular cholesterol content: effect of atorvastatin therapy. | Arteriosclerosis, thrombosis, and vascular biology 20040101 |
| Short-term effects of atorvastatin on haemorheologic parameters, platelet aggregation and endothelium dysfunction in patients with hypercholesterolaemia. | European heart journal 20040101 |
| Statin therapy in patients with coronary artery disease improves the impaired endothelial progenitor cell differentiation into cardiomyogenic cells. | Basic research in cardiology 20040101 |
| Atorvastatin enhances cellular uptake of oxidized LDL in adipocytes from hypercholesterolemic rabbits. | Clinica chimica acta; international journal of clinical chemistry 20040101 |
| Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects. | The American journal of cardiology 20040101 |
| Effect of atorvastatin 80 mg on endothelial cell function (forearm blood flow) in patients with pretreatment serum low-density lipoprotein cholesterol levels <130 mg/dl. | The American journal of cardiology 20040101 |
| CYP3A4 genotypes and plasma lipoprotein levels before and after treatment with atorvastatin in primary hypercholesterolemia. | The American journal of cardiology 20040101 |
| HMG-CoA reductase inhibitors suppress maturation of human dendritic cells: new implications for atherosclerosis. | Atherosclerosis 20040101 |
| The effect of long-term aggressive lipid lowering on ischemic and atherosclerotic burden in patients with chronic kidney disease. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20040101 |
| Liver function test abnormalities and pruritus in a patient treated with atorvastatin: case report and review of the literature. | Pharmacotherapy 20040101 |
| Marked low-density lipoprotein cholesterol reduction below current national cholesterol education program targets provides the greatest reduction in carotid atherosclerosis. | Clinical cardiology 20040101 |
| Aggressive lipid-lowering regimen halts CHD progression. | Geriatrics 20040101 |
| Short-term effect of low-dose atorvastatin on haemorrheological parameters, platelet aggregation and endothelial function in patients with cerebrovascular disease and hyperlipidaemia. | CNS drugs 20040101 |
| Is there a 'best' statin drug? | The Johns Hopkins medical letter health after 50 20040101 |
| Atorvastatin reduces neurological deficit and increases synaptogenesis, angiogenesis, and neuronal survival in rats subjected to traumatic brain injury. | Journal of neurotrauma 20040101 |
| Is Lipitor better than Pravachol? | Health news (Waltham, Mass.) 20040101 |
| C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases. | Medical hypotheses 20040101 |
| Rosuvastatin-induced arrest in progression of renal disease. | Cardiology 20040101 |
| 11th annual retrovirus conference. Drug update: the old, the new, the still to come. | Positively aware : the monthly journal of the Test Positive Aware Network 20040101 |
| What to do about cholesterol now. Here's the take-home message from startling new research findings. | Heart advisor 20040101 |
| Atorvastatin reduced coronary and stroke events in patients with hypertension and without dyslipidemia. | ACP journal club 20040101 |
| High-dose atorvastatin therapy is required for significant improvement of endothelial function in heterozygous familial hypercholesterolaemic patients. | Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners 20040101 |
| Anti-apoptotic effect of atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, on cardiac myocytes through protein kinase C activation. | Clinical and experimental pharmacology & physiology 20040101 |
| Comparative evaluation of the efficacy, safety, and tolerability of rosuvastatin 10 mg with atorvastatin 10 mg in adult patients with hypercholesterolaemia: the first Indian study. | Journal of the Indian Medical Association 20040101 |
| Statin drugs do not affect serum complement activation in vitro. | Scandinavian journal of immunology 20040101 |
| A single-centre retrospective observational study to evaluate the change in total cholesterol and LDL cholesterol in hyperlipidaemic patients switched from atorvastatin to simvastatin. | Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners 20040101 |
| Aggressive lowering of low-density lipoprotein cholesterol: do the studies apply to the elderly? | The American journal of geriatric cardiology 20040101 |
| Battle of the statins, or how the news media can change patient care. | JAAPA : official journal of the American Academy of Physician Assistants 20040101 |
| The lipid-regulating effects of atorvastatin on type 2 elder diabetes patients with hyperlipidemia. | Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20040101 |
| Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristics. | Kidney & blood pressure research 20040101 |
| LDL cholesterol goals rapidly achieved at various starting doses of Pfizer's atorvastatin. | Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners 20040101 |
| Treatment of hyperlipidemia in nonalcoholic fatty liver disease: fat for thought. | Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20040101 |
| Efficacy of omega-3 fatty acids, atorvastatin and orlistat in non-alcoholic fatty liver disease with dyslipidemia. | Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 20040101 |
| Effect of withdrawal of statin on C-reactive protein. | Cardiology 20040101 |
| [Atorvastatin: lipid lowering activity, pleiotropic properties and efficacy in prevention of atherosclerosis and coronary heart disease]. | Kardiologiia 20040101 |
| [Relationship Between Lipid Lowering and Changes of Hemostasis and Inflammation During Use of Statins in Non-ST Elevation Acute Coronary Syndrome]. | Kardiologiia 20040101 |
| [Transient carbamazepine overdose after combination with atorvastatin and roxithromycin]. | Therapie 20040101 |
| Significant reduction in heart attacks in patients taking Pfizer's Lipitor. | Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners 20040101 |
| Formulary conversion programs: the need for patient-specific risk assessment. | MedGenMed : Medscape general medicine 20040101 |
| Atorvastatin reduces remnant lipoproteins and small, dense low-density lipoproteins regardless of the baseline lipid pattern. | Preventive cardiology 20040101 |
| Synthes Award for Resident Research in Spinal Cord & Spinal Column Injury: Statins for the treatment of neurological injury: a role beyond cholesterol lowering. | Clinical neurosurgery 20040101 |
| Statins: much more than just a lipid-lowering therapy. | Indian heart journal 20040101 |
| Lipid metabolism in zebrafish. | Methods in cell biology 20040101 |
| Red wine polyphenolics suppress the secretion and the synthesis of Apo B48 from human intestinal CaCo-2 cells. | BioFactors (Oxford, England) 20040101 |
| 'Rule of 80' for coronary disease? | The National medical journal of India 20040101 |
| Atorvastatin and pravastatin elevated pre-heparin lipoprotein lipase mass of type 2 diabetes with hypercholesterolemia. | Journal of atherosclerosis and thrombosis 20040101 |
| Combined hyperlipidemia in a single subject with tetraplegia: ineffective risk reduction after atorvastatin monotherapy. | The journal of spinal cord medicine 20040101 |
| Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. | Drugs 20040101 |
| Effect of 12-month statin therapy on antioxidant potential of LDL and serum antioxidant vitamin concentrations. | Annals of medicine 20040101 |
| Histological and ultrastructural changes in cross-striation muscle cells, under the influence of atorvastatin-reductase HMG-CoA inhibitor. | Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 20040101 |
| Histological picture of intestinal mucosa of rats after simultaneous administration of atorvastatin and ethyl alcohol. | Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 20040101 |
| High doses of atorvastatin (Sortis) modify the secretory process in the exocrine portion of the pancreas. | Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 20040101 |
| [First comparison of 2 statins shows: only radical LDL lowering stops coronary atherosclerosis]. | MMW Fortschritte der Medizin 20031218 |
| Effect of statins on the progression of bioprosthetic aortic valve degeneration. | The American journal of cardiology 20031215 |
| Sirolimus-atorvastatin drug interaction in the pancreatic islet transplant recipient. | Transplantation 20031215 |
| [LDL cholesterol in normal range. The lower the better? Implications of the GREACE study]. | MMW Fortschritte der Medizin 20031211 |
| An HPLC method for the determination of atorvastatin and its impurities in bulk drug and tablets. | Journal of pharmaceutical and biomedical analysis 20031204 |
| Synergistic effect of angiotensin-converting enzyme (ACE) and 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibition on inflammatory markers in atherosclerotic rabbits. | Clinical science (London, England : 1979) 20031201 |
| Perspectives from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial--Lipid Lowering Trial and the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm. | Current opinion in lipidology 20031201 |
| Comparison of rosuvastatin versus atorvastatin in patients with heterozygous familial hypercholesterolemia. | The American journal of cardiology 20031201 |
| Atorvastatin reduces plasma MCP-1 in patients with acute coronary syndrome. | Clinica chimica acta; international journal of clinical chemistry 20031201 |
| Fatal liver failure with atorvastatin. | Journal of hepatology 20031201 |
| Avasimibe, an ACAT inhibitor, enhances the lipid lowering effect of atorvastatin in subjects with homozygous familial hypercholesterolemia. | Atherosclerosis 20031201 |
| Chylomicron remnants of various sizes are lowered more effectively by fenofibrate than by atorvastatin in patients with combined hyperlipidemia. | Atherosclerosis 20031201 |
| Effects of atorvastatin and pravastatin on glucose tolerance in diabetic rats mildly induced by streptozotocin. | Biological & pharmaceutical bulletin 20031201 |
| Increased levels of pregnancy-associated plasma protein-A in patients with hypercholesterolemia: the effect of atorvastatin treatment. | American heart journal 20031201 |
| Atorvastatin stent coating does not reduce neointimal proliferation after coronary stenting. | Zeitschrift fur Kardiologie 20031201 |
| Asymmetrical dimethylarginine (ADMA) and risk of acute coronary events. Does statin treatment influence plasma ADMA levels? | Atherosclerosis. Supplements 20031201 |
| The significance of femoral intima-media thickness and plaque scoring in the Atorvastatin versus Simvastatin on Atherosclerosis Progression (ASAP) study. | European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 20031201 |
| Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis. | Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20031201 |
| Cognitive impairment associated with atorvastatin and simvastatin. | Pharmacotherapy 20031201 |
| Italian drug policy: ethical aims of essential assistance levels. | Health care analysis : HCA : journal of health philosophy and policy 20031201 |
| The next step in cardiovascular protection. | Atherosclerosis. Supplements 20031201 |
| [Ezetimibe: from pharmacology to clinical trials]. | Annales d'endocrinologie 20031201 |
| Statin face-off. Surprises from the first head-to-head comparison. | Time 20031124 |
| Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina: review of the evidence and methodological considerations. | Circulation 20031118 |
| Effect of atorvastatin on exercise-induced myocardial ischemia in patients with stable angina pectoris. | The American journal of cardiology 20031115 |
| Usefulness of lowering low-density lipoprotein cholesterol to <70 mg/dl and usefulness of C-reactive protein in patient selection. | The American journal of cardiology 20031115 |
| ['Gout tophi' and heart disease in the family]. | Praxis 20031105 |
| Atorvastatin-induced polyneuropathy. | Annals of internal medicine 20031104 |
| Effects of atorvastatin on fasting and postprandial complement component 3 response in familial combined hyperlipidemia. | Journal of lipid research 20031101 |
| Magnitude of HDL cholesterol variation after high-dose atorvastatin is genetically determined at the LDL receptor locus in patients with homozygous familial hypercholesterolemia. | Arteriosclerosis, thrombosis, and vascular biology 20031101 |
| Anaesthetic management of coronary artery bypass grafting in a patient with central core disease and susceptibility to malignant hyperthermia on statin therapy. | British journal of anaesthesia 20031101 |
| Pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. | The American journal of cardiology 20031101 |
| Effect of pretreatment vitamin D levels on in vivo effects of atorvastatin on bone metabolism in patients with heterozygous familial hypercholesterolemia. | The American journal of cardiology 20031101 |
| Spontaneous reports cannot serve as a basis for comparison of two drugs. | The American journal of cardiology 20031101 |
| Effect on high-density lipoprotein cholesterol of maximum dose simvastatin and atorvastatin in patients with hypercholesterolemia: results of the Comparative HDL Efficacy and Safety Study (CHESS). | American heart journal 20031101 |
| Statin use is associated with enhanced collateralization of severely diseased coronary arteries. | American heart journal 20031101 |
| Synthesis and absorption markers of cholesterol in serum and lipoproteins during a large dose of statin treatment. | European journal of clinical investigation 20031101 |
| Differential effects of simvastatin and atorvastatin on high-density lipoprotein cholesterol and apolipoprotein A-I are consistent across hypercholesterolemic patient subgroups. | Clinical cardiology 20031101 |
| Atorvastatin, 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, reduces bone resorption in the elderly. | Journal of the American Geriatrics Society 20031101 |
| Effects of low and high doses of atorvastatin on arterial compliance. | Japanese heart journal 20031101 |
| Atorvastatin reduces interleukin-6 plasma concentration and adipocyte secretion of hypercholesterolemic rabbits. | Clinica chimica acta; international journal of clinical chemistry 20031001 |
| Effect of atorvastatin on apolipoprotein B48 metabolism and low-density lipoprotein receptor activity in normolipidemic patients with coronary artery disease. | Metabolism: clinical and experimental 20031001 |
| Atorvastatin prevents RhoC isoprenylation, invasion, and metastasis in human melanoma cells. | Molecular cancer therapeutics 20031001 |
| Effects of atorvastatin and pravastatin on malondialdehyde-modified LDL in hypercholesterolemic patients. | Circulation journal : official journal of the Japanese Circulation Society 20031001 |
| Effects of atorvastatin therapy on the low-density lipoprotein subfraction, remnant-like particles cholesterol, and oxidized low-density lipoprotein within 2 weeks in hypercholesterolemic patients. | Circulation journal : official journal of the Japanese Circulation Society 20031001 |
| Statins differentially regulate vascular endothelial growth factor synthesis in endothelial and vascular smooth muscle cells. | Atherosclerosis 20031001 |
| Effects of simvastatin and atorvastatin in hypercholesterolemic patients. | Clinical therapeutics 20031001 |
| High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study. | Circulation 20030930 |
| No absolutes. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20030930 |
| Atorvastatin and clopidogrel. | Circulation 20030930 |
| Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease. | Circulation 20030923 |
| 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors decrease Fas ligand expression and cytotoxicity in activated human T lymphocytes. | Circulation 20030923 |
| Safety of atorvastatin derived from analysis of 44 completed trials in 9,416 patients. | The American journal of cardiology 20030915 |
| Lipid-lowering drugs and the risk of depression and suicidal behavior. | Archives of internal medicine 20030908 |
| Inhibition of ileal bile acid transport and reduced atherosclerosis in apoE-/- mice by SC-435. | Journal of lipid research 20030901 |
| The effects of concurrent atorvastatin therapy on the pharmacokinetics of intravenous midazolam. | Anaesthesia 20030901 |
| Effects of atorvastatin on glucose homeostasis, postprandial triglyceride response and C-reactive protein in subjects with impaired fasting glucose. | Diabetic medicine : a journal of the British Diabetic Association 20030901 |
| Effect of atorvastatin on myocardial contractile reserve assessed by tissue Doppler imaging in moderately hypercholesterolemic patients without heart disease. | The American journal of cardiology 20030901 |
| Treatment with amlodipine and atorvastatin have additive effect in improvement of arterial compliance in hypertensive hyperlipidemic patients. | American journal of hypertension 20030901 |
| Effects of atorvastatin on in-stent stenosis in normo- and hypercholesterolemic rabbits. | International journal of cardiology 20030901 |
| Statins increase thrombomodulin expression and function in human endothelial cells by a nitric oxide-dependent mechanism and counteract tumor necrosis factor alpha-induced thrombomodulin downregulation. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20030901 |
| Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells. | Cardiovascular research 20030901 |
| [Clinical study of the month. Premature interruption of ASCOT and CARDS clinical trials of cardiovascular prevention with atorvastatin in patients with arterial hypertension or diabetes mellitus: compromise between ethics and statistics in evidence-based medicine ]. | Revue medicale de Liege 20030901 |
| Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial. | Circulation 20030826 |
| Changes in coronary plaque color and morphology by lipid-lowering therapy with atorvastatin: serial evaluation by coronary angioscopy. | Journal of the American College of Cardiology 20030820 |
| Atorvastatin limits the pro-inflammatory response of rat aortic smooth muscle cells to thrombin. | European journal of pharmacology 20030808 |
| Long term statin treatment reduces lipoprotein(a) concentrations in heterozygous familial hypercholesterolaemia. | Heart (British Cardiac Society) 20030801 |
| Autoimmune hepatitis revealed by atorvastatin. | European journal of gastroenterology & hepatology 20030801 |
| Effect of atorvastatin on ApoE and ApoC-I synthesis and secretion by THP-1 macrophages. | Journal of cardiovascular pharmacology 20030801 |
| Effect of atorvastatin on the concentration, relative distribution, and chemical composition of lipoprotein subfractions in patients with dyslipidemias of type IIA and IIB. | Journal of cardiovascular pharmacology 20030801 |
| Comparison of clinical benefits of clopidogrel therapy in patients with acute coronary syndromes taking atorvastatin versus other statin therapies. | The American journal of cardiology 20030801 |
| Anti-inflammatory effect of atorvastatin (80 mg) in unstable angina pectoris and non-Q-wave acute myocardial infarction. | The American journal of cardiology 20030801 |
| Effect of atorvastatin and fenofibrate on autonomic tone in subjects with combined hyperlipidemia. | The American journal of cardiology 20030801 |
| [Atorvastatin and clopidogrel. A possible drug interaction with clinical consequences still unknown]. | La Revue de medecine interne 20030801 |
| Decrease of hemostatic cardiovascular risk factors by aggressive vs. conventional atorvastatin treatment in patients with Type 2 diabetes mellitus. | Journal of thrombosis and haemostasis : JTH 20030801 |
| Soluble intercellular adhesion molecule-1 and interleukin-6 levels reflect endothelial dysfunction in patients with primary hypercholesterolaemia treated with atorvastatin. | Atherosclerosis 20030801 |
| Elimination of alfentanil delivered by infusion is not altered by the chronic administration of atorvastatin. | European journal of anaesthesiology 20030801 |
| Reduction in serum levels of adhesion molecules, interleukin-6 and C-reactive protein following short-term low-dose atorvastatin treatment in patients with non-familial hypercholesterolemia. | Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 20030801 |
| Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia. | Journal of clinical pharmacology 20030801 |
| [Effects of atorvastatin in multiple sclerosis]. | Nihon rinsho. Japanese journal of clinical medicine 20030801 |
| Statins promote potent systemic antioxidant effects through specific inflammatory pathways. | Circulation 20030729 |
| [Statin soon to become standard addition to antihypertensive therapy? Better prevention of coronary heart disease for hypertensive patients]. | MMW Fortschritte der Medizin 20030724 |
| Hydroxymethylglutaryl coenzyme A reductase inhibition reduces Chlamydia pneumoniae-induced cell interaction and activation. | Circulation 20030722 |
| Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial). | The American journal of cardiology 20030715 |
| Increased endothelin-induced Ca2+ signaling, tyrosine phosphorylation, and coronary artery disease in diabetic dyslipidemic Swine are prevented by atorvastatin. | The Journal of pharmacology and experimental therapeutics 20030701 |
| Effect of atorvastatin on apolipoprotein B100 containing lipoprotein metabolism in type-2 diabetes. | The Journal of pharmacology and experimental therapeutics 20030701 |
| Effects of atorvastatin, simvastatin, and fenofibrate therapy on monocyte chemoattractant protein-1 secretion in patients with hyperlipidemia. | European journal of clinical pharmacology 20030701 |
| Effect of a statin on hepatic apolipoprotein B-100 secretion and plasma campesterol levels in the metabolic syndrome. | International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 20030701 |
| Differential effects of amlodipine and atorvastatin treatment and their combination on atherosclerosis in ApoE*3-Leiden transgenic mice. | Journal of cardiovascular pharmacology 20030701 |
| Effect of atorvastatin on postcardiac transplant increase in low-density lipoprotein cholesterol reduces development of intimal hyperplasia and progression of endothelial dysfunction. | The American journal of cardiology 20030701 |
| Efficacy of atorvastatin and gemfibrozil, alone and in low dose combination, in the treatment of diabetic dyslipidemia. | The Journal of clinical endocrinology and metabolism 20030701 |
| Influence of 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitors on endothelial nitric oxide synthase and the formation of oxidants in the vasculature. | Atherosclerosis 20030701 |
| Atorvastatin reduces microalbuminuria in patients with familial hypercholesterolemia and normal glucose tolerance. | Medical science monitor : international medical journal of experimental and clinical research 20030701 |
| Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial. | The Journal of pediatrics 20030701 |
| Atorvastatin-clopidogrel interaction. | Circulation 20030624 |
| Do hypertensive patients with average cholesterol levels benefit from atorvastatin therapy? | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20030624 |
| [Update cardiology 2001/2002-part II. From unstable coronary syndrome to terminal heart failure]. | Medizinische Klinik (Munich, Germany : 1983) 20030615 |
| Atorvastatin and the ability of clopidogrel to inhibit platelet aggregation. | Circulation 20030610 |
| ASCOT-LLA: questions about the benefits of atorvastatin. | Lancet (London, England) 20030607 |
| ASCOT-LLA: questions about the benefits of atorvastatin. | Lancet (London, England) 20030607 |
| ASCOT-LLA: questions about the benefits of atorvastatin. | Lancet (London, England) 20030607 |
| ASCOT-LLA: questions about the benefits of atorvastatin. | Lancet (London, England) 20030607 |
| ASCOT-LLA: questions about the benefits of atorvastatin. | Lancet (London, England) 20030607 |
| Effect of atorvastatin on postprandial lipoprotein metabolism in hypertriglyceridemic patients. | Journal of lipid research 20030601 |
| Cost effectiveness of statin therapy for the primary prevention of major coronary events in individuals with type 2 diabetes. | Diabetes care 20030601 |
| Time course of serum CK immediately before and after a single muscle cramp. | Muscle & nerve 20030601 |
| Effect of atorvastatin (80 mg) on recurrent ischemia in unstable angina pectoris or non-ST-elevation acute myocardial infarction. | The American journal of cardiology 20030601 |
| Rhabdomyolysis causing AV blockade due to possible atorvastatin, esomeprazole, and clarithromycin interaction. | The Annals of pharmacotherapy 20030601 |
| Statins induce angiogenesis, neurogenesis, and synaptogenesis after stroke. | Annals of neurology 20030601 |
| Comparison of the dose-response relationships of 2 lipid-lowering agents: a Bayesian meta-analysis. | American heart journal 20030601 |
| Atorvastatin markedly improves type III hyperlipoproteinemia in association with reduction of both exogenous and endogenous apolipoprotein B-containing lipoproteins. | Atherosclerosis 20030601 |
| Efficacy of alternate-day dosing versus daily dosing of atorvastatin. | Journal of cardiovascular pharmacology and therapeutics 20030601 |
| Statins benefit people with high blood pressure. | Harvard health letter 20030601 |
| Serum lipid comparison in patients treated by statins or fibrates: existence of bad HDL-C responders to statins. | Acta cardiologica 20030601 |
| Comparative effects of simvastatin and atorvastatin in hypercholesterolemic patients with characteristics of metabolic syndrome. | Clinical therapeutics 20030601 |
| [Coronary disease prevention: only the inhibition of inflammation is important. Why lower lipids, too?]. | MMW Fortschritte der Medizin 20030522 |
| Assessment of egg nutrient compositional changes and residue in eggs, tissues, and excreta following oral administration of atorvastatin to laying hens. | Journal of agricultural and food chemistry 20030521 |
| Effect of ezetimibe coadministered with atorvastatin in 628 patients with primary hypercholesterolemia: a prospective, randomized, double-blind trial. | Circulation 20030520 |
| New lipid-lowering combo proves successful. | Circulation 20030520 |
| HMG-CoA reductase inhibitors reduce senescence and increase proliferation of endothelial progenitor cells via regulation of cell cycle regulatory genes. | Circulation research 20030516 |
| Hydroxymethylglutaryl coenzyme a reductase inhibitors down-regulate chemokines and chemokine receptors in patients with coronary artery disease. | Journal of the American College of Cardiology 20030507 |
| Inhibition of both the apical sodium-dependent bile acid transporter and HMG-CoA reductase markedly enhances the clearance of LDL apoB. | Journal of lipid research 20030501 |
| Pharmacokinetics of atorvastatin and its metabolites after single and multiple dosing in hypercholesterolaemic haemodialysis patients. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20030501 |
| Usefulness of quinapril and irbesartan to improve the anti-inflammatory response of atorvastatin and aspirin in patients with coronary heart disease. | The American journal of cardiology 20030501 |
| Experimental model of postprandial hypertriglyceridemia in sucrose-fed rats and the effectiveness of atorvastatin in the model. | Metabolism: clinical and experimental 20030501 |
| Pretreatment with statins enhances myocardial protection during coronary revascularization. | The Journal of thoracic and cardiovascular surgery 20030501 |
| Drug-induced rhabdomyolysis after concomitant use of clarithromycin, atorvastatin, and lopinavir/ritonavir in a patient with HIV. | AIDS patient care and STDs 20030501 |
| Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs. | CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 20030429 |
| [Following the ASCOT Study. A statin for every hypertensive patient?]. | MMW Fortschritte der Medizin 20030417 |
| Comparison of the frequency of adverse events in patients treated with atorvastatin or simvastatin. | The American journal of cardiology 20030415 |
| Rhabdomyolysis and myalgia associated with anticholesterolemic treatment as potential signs of malignant hyperthermia susceptibility. | Arthritis and rheumatism 20030415 |
| A randomized trial of aggressive lipid reduction for improvement of myocardial ischemia, symptom status, and vascular function in patients with coronary artery disease not amenable to intervention. | The American journal of medicine 20030415 |
| Lipid-lowering effects of TAK-475, a squalene synthase inhibitor, in animal models of familial hypercholesterolemia. | European journal of pharmacology 20030411 |
| What are the odds at ASCOT today? | Lancet (London, England) 20030405 |
| Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. | Lancet (London, England) 20030405 |
| Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy. | JAMA 20030402 |
| Hemostatic effects of atorvastatin versus simvastatin. | The Annals of pharmacotherapy 20030401 |
| Common cholesteryl ester transfer protein gene polymorphisms and the effect of atorvastatin therapy in type 2 diabetes. | Diabetes care 20030401 |
| Effect of atorvastatin on endothelium-dependent vasodilation in patients with coronary artery disease. | The American journal of cardiology 20030401 |
| Are antiplatelet effects of clopidogrel inhibited by atorvastatin? A research question formulated but not yet adequately tested. | Circulation 20030401 |
| By the way, doctor. I'm 84, 5-foot-9, and weigh 160. I do an hour's exercise every day. I take a diuretic, potassium, and calcium-channel blocker. Should I also take Lipitor to avoid a heart attack? | Harvard health letter 20030401 |
| The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease. | Atherosclerosis 20030401 |
| Atorvastatin and omega-3 fatty acids protect against activation of the coagulation system in patients with combined hyperlipemia. | Journal of thrombosis and haemostasis : JTH 20030401 |
| Effect of atorvastatin on lipid parameters, LDL subtype distribution, hemorrheological parameters and adhesion molecule concentrations in patients with hypertriglyceridemia. | Nutrition, metabolism, and cardiovascular diseases : NMCD 20030401 |
| Atorvastatin in dyslipidaemia of the nephrotic syndrome. | Nephrology (Carlton, Vic.) 20030401 |
| Differential effects of lipid-lowering therapies on stroke prevention: a meta-analysis of randomized trials. | Archives of internal medicine 20030324 |
| Comparison of once-daily, niacin extended-release/lovastatin with standard doses of atorvastatin and simvastatin (the ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation [ADVOCATE]). | The American journal of cardiology 20030315 |
| Introduction: rosuvastatin--an efficacy assessment based on pooled trial data. | The American journal of cardiology 20030306 |
| Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups. | The American journal of cardiology 20030306 |
| Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals. | The American journal of cardiology 20030306 |
| Lipid and apolipoprotein ratios: association with coronary artery disease and effects of rosuvastatin compared with atorvastatin, pravastatin, and simvastatin. | The American journal of cardiology 20030306 |
| Benefits of atorvastatin in cholesterol lowering. | Current atherosclerosis reports 20030301 |
| Effect of atorvastatin and clopidogrel on cellular immune function. | Prostaglandins, leukotrienes, and essential fatty acids 20030301 |
| Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndrome. | Diabetes 20030301 |
| Non-high-density lipoprotein cholesterol: a target of lipid-lowering in dialysis patients. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20030301 |
| A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease. | American journal of kidney diseases : the official journal of the National Kidney Foundation 20030301 |
| Effect of atorvastatin (80 mg) and simvastatin (40 mg) on plasma fibrinogen levels and on carotid intima media thickness in patients with familial hypercholesterolemia. | The American journal of cardiology 20030301 |
| Effects of atorvastatin on electrophoretic characteristics of LDL particles among subjects with heterozygous familial hypercholesterolemia. | Atherosclerosis 20030301 |
| Treating dyslipidemia with statins: the risk-benefit profile. | American heart journal 20030301 |
| Prevention of nitrate tolerance by long-term treatment with statins. | Cardiovascular drugs and therapy 20030301 |
| Atorvastatin inhibits expression of minichromosome maintenance proteins in vascular smooth muscle cells. | European journal of pharmacology 20030221 |
| Pathobiology, not angiography, should guide management in acute coronary syndrome/non-ST-segment elevation myocardial infarction: the non-interventionist's perspective. | Journal of the American College of Cardiology 20030219 |
| Effects of combined low-density lipoprotein apheresis and aggressive statin therapy on coronary calcified plaque as measured by computed tomography. | The American journal of cardiology 20030215 |
| The importance of indirect costs in primary cardiovascular disease prevention: can we save lives and money with statins? | Archives of internal medicine 20030210 |
| Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway. | Journal of the American College of Cardiology 20030205 |
| Pharmacological interference with intestinal bile acid transport reduces plasma cholesterol in LDL receptor/apoE deficiency. | FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20030201 |
| Atorvastatin enhances the plasma clearance of chylomicron-like emulsions in subjects with atherogenic dyslipidemia: relevance to the in vivo metabolism of triglyceride-rich lipoproteins. | Atherosclerosis 20030201 |
| Levels of adhesion molecules do not decrease after 3 months of statin therapy in moderate hypercholesterolaemia. | Clinical science (London, England : 1979) 20030201 |
| Atorvastatin dose-dependently decreases hepatic lipase activity in type 2 diabetes: effect of sex and the LIPC promoter variant. | Diabetes care 20030201 |
| Effect of atorvastatin on adhesive phenotype of human endothelial cells activated by tumor necrosis factor alpha. | Journal of cardiovascular pharmacology 20030201 |
| Atorvastatin suppresses interferon-gamma -induced neopterin formation and tryptophan degradation in human peripheral blood mononuclear cells and in monocytic cell lines. | Clinical and experimental immunology 20030201 |
| Atorvastatin causes depressor and sympatho-inhibitory effects with upregulation of nitric oxide synthases in stroke-prone spontaneously hypertensive rats. | Journal of hypertension 20030201 |
| Withdrawal of statin treatment abrogates stroke protection in mice. | Stroke 20030201 |
| Serum noncholesterol sterols during inhibition of cholesterol synthesis by statins. | The Journal of laboratory and clinical medicine 20030201 |
| Low-dose atorvastatin therapy does not augment endothelial function in active hypercholesterolaemic males. | British journal of clinical pharmacology 20030201 |
| Indications and outcome of treatment of hyperlipidemia in pediatric allograft recipients. | Pediatric transplantation 20030201 |
| Atorvastatin treatment for hyperlipidemia in pediatric renal transplant recipients. | Pediatric transplantation 20030201 |
| The effect of lipoproteins on endothelial nitric oxide synthase is modulated by lipoperoxides. | European journal of clinical investigation 20030201 |
| Effect of atorvastatin and pravastatin on serum C-reactive protein. | American heart journal 20030201 |
| [Secondary prevention after ischemic stroke]. | Praxis 20030129 |
| [Effects of atorvastatin on the proliferation and collagen synthesis of rat cardiac fibroblasts]. | Zhonghua yi xue za zhi 20030125 |
| The $10 billion pill. | Fortune 20030120 |
| Raised serum levels of soluble CD40 ligand in patients with familial hypercholesterolemia: downregulatory effect of statin therapy. | Journal of the American College of Cardiology 20030115 |
| Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction. | Circulation 20030107 |
| Sepsis syndrome stimulates proximal tubule cholesterol synthesis and suppresses the SR-B1 cholesterol transporter. | Kidney international 20030101 |
| Strong decrease of high sensitivity C-reactive protein with high-dose atorvastatin in patients with type 2 diabetes mellitus. | Atherosclerosis 20030101 |
| Atorvastatin and the dyslipidemia of early renal failure. | Atherosclerosis 20030101 |
| PAPP-A, a novel marker of unstable plaque, is not influenced by hypolipidemic treatment in contrast to CRP. | Atherosclerosis 20030101 |
| Atorvastatin reduces expression of leukocyte adhesion molecules in patients with hypercholesterolemia. | Atherosclerosis 20030101 |
| Statins and homocysteine. | Atherosclerosis 20030101 |
| The metabolism of clopidogrel is catalyzed by human cytochrome P450 3A and is inhibited by atorvastatin. | Drug metabolism and disposition: the biological fate of chemicals 20030101 |
| Treatment with atorvastatin alters the ratio of interleukin-12/interleukin-10 gene expression [corrected]. | European journal of clinical investigation 20030101 |
| Statins regulate alpha2beta1-integrin expression and collagen I-dependent functions in human vascular smooth muscle cells. | Journal of cardiovascular pharmacology 20030101 |
| Comparative effects of rosuvastatin and atorvastatin across their dose ranges in patients with hypercholesterolemia and without active arterial disease. | The American journal of cardiology 20030101 |
| Comparison of the effects of atorvastatin versus simvastatin on subclinical atherosclerosis in primary preventionas determined by electronbeam tomography. | The American journal of cardiology 20030101 |
| Squalene synthase inhibitors suppress triglyceride biosynthesis through the farnesol pathway in rat hepatocytes. | Journal of lipid research 20030101 |
| HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells. | Arteriosclerosis, thrombosis, and vascular biology 20030101 |
| Cerivastatin and atorvastatin inhibit IL-3-dependent differentiation and IgE-mediated histamine release in human basophils and downmodulate expression of the basophil-activation antigen CD203c/E-NPP3. | Journal of leukocyte biology 20030101 |
| Determination of pharmaceuticals in aqueous samples using positive and negative voltage switching microbore liquid chromatography/electrospray ionization tandem mass spectrometry. | Journal of mass spectrometry : JMS 20030101 |
| Comparison of the efficacy and tolerability of policosanol with atorvastatin in elderly patients with type II hypercholesterolaemia. | Drugs & aging 20030101 |
| hsCRP and HDL effects of statins trial (CHEST): rapid effect of statin therapy on C-reactive protein and high-density lipoprotein levels A clinical investigation. | Heart disease (Hagerstown, Md.) 20030101 |
| Acute pancreatitis possibly associated with combined salicylate and atorvastatin therapy. | JOP : Journal of the pancreas 20030101 |
| Re: Gómez-Gerique, et al. Effect of atorvastatin and bezafibrate on plasma levels of C-reactive protein in combined (mixed) hyperlipidemia. Atherosclerosis 2002;162:245-51. | Atherosclerosis 20030101 |
| Drug interactions: gasoline and matches. | The Canadian journal of cardiology 20030101 |
| [Effect of high doses of atorvastatin on the endothelial function of the coronary arteries]. | Medicina (Kaunas, Lithuania) 20030101 |
| Atorvastatin improves metabolic control and endothelial function in type 2 diabetic patients: a placebo-controlled study. | Journal of endocrinological investigation 20030101 |
| Related factors of meeting National Cholesterol Education Program-recommended goals with atorvastatin. | Journal of atherosclerosis and thrombosis 20030101 |
| Effects of amlodipine, atorvastatin and combination of both on advanced atherosclerotic plaque in APOE*3-Leiden transgenic mice. | Journal of molecular and cellular cardiology 20030101 |
| A 52-week, multicenter, randomized, parallel-group, double-blind, double-dummy study to assess the efficacy of atorvastatin and simvastatin in reaching low-density lipoprotein cholesterol and triglyceride targets: the treat-to-target (3T) study. | Clinical therapeutics 20030101 |
| A model to assess the cost effectiveness of statins in achieving the UK National Service Framework target cholesterol levels. | PharmacoEconomics 20030101 |
| An economic analysis of the Atorvastatin Comparative Cholesterol Efficacy and Safety Study (ACCESS). | PharmacoEconomics 20030101 |
| A pharmacoeconomic evaluation of the Myocardial Ischaemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study in the United Kingdom. | PharmacoEconomics 20030101 |
| Long-term treatment effect of atorvastatin on aortic stiffness in hypercholesterolaemic patients. | Current medical research and opinion 20030101 |
| Interaction between several medicines and statins. | Arzneimittel-Forschung 20030101 |
| Triglyceride-lowering effect of pitavastatin in a guinea pig model of postprandial lipemia. | Arzneimittel-Forschung 20030101 |
| LIFE and ARBITER. | Preventive cardiology 20030101 |
| Variable influence of statins on isoprostanes in hyperlipidemia. | Advances in experimental medicine and biology 20030101 |
| Drug-induced lupus-like syndrome associated with severe autoimmune hepatitis. | Lupus 20030101 |
| Atorvastatin and simvastatin in patients on hemodialysis: effects on lipoproteins, C-reactive protein and in vivo oxidized LDL. | Journal of nephrology 20030101 |
| Atorvastatin affects C-reactive protein levels in patients with coronary artery disease. | Current medical research and opinion 20030101 |
| Reduction of infarct size by short-term pretreatment with atorvastatin. | Cardiovascular drugs and therapy 20030101 |
| Effect of atorvastatin on total lipid profiles assessed by analytical capillary isotachophoresis. | Cardiology 20030101 |
| Effect of pitavastatin on sterol and bile acid excretion in guinea pigs. | Arzneimittel-Forschung 20030101 |
| HIV protease inhibitors and dyslipidemia. | AIDS reviews 20030101 |
| In light of ALLHAT and ASCOT: are there benefits of statins as add-on treatment in hypertensives? | Blood pressure 20030101 |
| [Effects of statins on coronary artery disease. Review of the recent publications]. | Przeglad lekarski 20030101 |
| [Effect of combined antihypertensive and lipid lowering therapy on the level of coronary risk and tissue insulin resistance in patients with metabolic syndrome]. | Kardiologiia 20030101 |
| [Markers of inflammation and platelet aggregation in patients with non ST elevation acute coronary syndrome treated with atorvastatin or pravastatin]. | Kardiologiia 20030101 |
| [Non ST elevation acute coronary syndrome: early use of pravastatin or atorvastatin is associated with divergent changes of parameters of hemostasis]. | Kardiologiia 20030101 |
| Microvascular reactivity in patients with hypercholesterolemia: effect of lipid lowering treatment. | Physiological research 20030101 |
| [Comparative study of lipid lowering effect and influence on platelet aggregation of atorvastatin and simvastatin in patients ischemic heart disease with type II diabetes and combined hyperlipidemia]. | Kardiologiia 20030101 |
| Therapy with statins in patients with refractory rheumatic diseases: a preliminary study. | Lupus 20030101 |
| Behavioral implications of lowering cholesterol levels: a double-blind pilot study. | Psychosomatics 20030101 |
| Effects of atorvastatin on vascular remodeling in spontaneously hypertensive rats. | Journal of Zhejiang University. Science 20030101 |
| [Efficacy of atorvastatin in long-term treatment of patients with ischemic heart disease]. | Kardiologiia 20030101 |
| Recall of counterfeit Lipitor. | FDA consumer 20030101 |
| Clinical pharmacokinetics of atorvastatin. | Clinical pharmacokinetics 20030101 |
| Atorvastatin treatment does not affect gonadal and adrenal hormones in type 2 diabetes patients with mild to moderate hypercholesterolemia. | Journal of atherosclerosis and thrombosis 20030101 |
| Contribution of apo CIII reduction to the greater effect of 12-week micronized fenofibrate than atorvastatin therapy on triglyceride levels and LDL size in dyslipidemic patients. | Annals of medicine 20030101 |
| Design and baseline characteristics of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) study. | Cerebrovascular diseases (Basel, Switzerland) 20030101 |
| [Atorvastatin in the treatment of patients with hereditary hypercholesterolemia]. | Kardiologiia 20030101 |
| Once-daily niacin extended release/lovastatin combination tablet has more favorable effects on lipoprotein particle size and subclass distribution than atorvastatin and simvastatin. | Preventive cardiology 20030101 |
| Long-term hemostatic effects of cholesterol-lowering therapy with atorvastatin. | Pathophysiology of haemostasis and thrombosis 20030101 |
| Atorvastatin is an effective and well-tolerated treatment alternative for patients not achieving target lipid goals with simvastatin. | Journal of the American Pharmacists Association : JAPhA 20030101 |
| Effects of Atorvastatin on LDL sub-fractions and peroxidation in type 1 diabetic patients: a randomised double-blind placebo-controlled study. | Diabetes/metabolism research and reviews 20030101 |
| Early benefit from structured care with atorvastatin in patients with coronary heart disease and diabetes mellitus. | Angiology 20030101 |
| Interaction between fibrates and statins--metabolic interactions with gemfibrozil. | Drug metabolism and drug interactions 20030101 |
| Comparison of the efficacy of rosuvastatin versus atorvastatin, simvastatin, and pravastatin in achieving lipid goals: results from the STELLAR trial. | Current medical research and opinion 20030101 |
| Effects of atorvastatin on lipid profile and non-traditional cardiovascular risk factors in diabetic patients on hemodialysis. | Nephron. Clinical practice 20030101 |
| Statins lower plasma and lymphocyte ubiquinol/ubiquinone without affecting other antioxidants and PUFA. | BioFactors (Oxford, England) 20030101 |
| Statin cardiomyopathy? A potential role for Co-Enzyme Q10 therapy for statin-induced changes in diastolic LV performance: description of a clinical protocol. | BioFactors (Oxford, England) 20030101 |
| The benefit of STent placement and blood pressure and lipid-lowering for the prevention of progression of renal dysfunction caused by Atherosclerotic ostial stenosis of the Renal artery. The STAR-study: rationale and study design. | Journal of nephrology 20030101 |
| Statins in hypercholesterolaemia: a dose-specific meta-analysis of lipid changes in randomised, double blind trials. | BMC family practice 20030101 |
| Histological and morphometrical examinations of suprarenal glands in rats after experimental administration of atorvastatin and ethanol. | Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 20030101 |
| Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells. | Circulation 20021203 |
| Effect of atorvastatin on high-density lipoprotein apolipoprotein A-I production and clearance in the New Zealand white rabbit. | Circulation 20021203 |
| Differential hs-CRP reduction in patients with familial hypercholesterolemia treated with aggressive or conventional statin therapy. | Atherosclerosis 20021201 |
| Coronary artery spasm associated with a moderately severe atherosclerotic stenosis in the proximal LAD. | The Journal of invasive cardiology 20021201 |
| Effects of rosuvastatin and atorvastatin compared over 52 weeks of treatment in patients with hypercholesterolemia. | American heart journal 20021201 |
| Causal structures for evaluating statin class effects. | The Annals of pharmacotherapy 20021201 |
| Statins do not meet expectations for lowering low-density lipoprotein cholesterol levels when used in clinical practice. | The American journal of medicine 20021201 |
| Lipid lowering in hypertension and heart protection: observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) and the Heart Protection Study. | Journal of human hypertension 20021201 |
| Time-dependent effect of statins on platelet function in hypercholesterolaemia. | European journal of clinical investigation 20021201 |
| Plasma fibronectin level and its relationships with lipids, lipoproteins and C-reactive protein in patients with dyslipidaemia during lipid-lowering therapy. | Acta cardiologica 20021201 |
| Toward a role for statins in immunomodulation. | Molecular interventions 20021201 |
| Statin-induced myositis migrans. | Wiener klinische Wochenschrift 20021130 |
| Atorvastatin increases hepatic fatty acid beta-oxidation in sucrose-fed rats: comparison with an MTP inhibitor. | European journal of pharmacology 20021129 |
| [Ezetimib plus statin combination. A strong duo]. | MMW Fortschritte der Medizin 20021128 |
| Tackling multiple sclerosis. | Nature 20021107 |
| The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. | Nature 20021107 |
| Effects of fibrates on metabolism of statins in human hepatocytes. | Drug metabolism and disposition: the biological fate of chemicals 20021101 |
| Effects of rosiglitazone alone and in combination with atorvastatin on the metabolic abnormalities in type 2 diabetes mellitus. | The American journal of cardiology 20021101 |
| Atorvastatin reduces postprandial accumulation and cholesteryl ester transfer protein-mediated remodeling of triglyceride-rich lipoprotein subspecies in type IIb hyperlipidemia. | The Journal of clinical endocrinology and metabolism 20021101 |
| 3-hydroxy-3-methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells. | Arteriosclerosis, thrombosis, and vascular biology 20021101 |
| Efficacy and safety of atorvastatin after pediatric heart transplantation. | The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20021101 |
| Zeroing in on how low cholesterol should go. | Heart advisor 20021101 |
| Isoprenylation is necessary for the full invasive potential of RhoA overexpression in human melanoma cells. | The Journal of investigative dermatology 20021101 |
| The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia. | European journal of clinical pharmacology 20021101 |
| Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury. | Circulation research 20021018 |
| Effects of atorvastatin 80 mg daily early after onset of unstable angina pectoris or non-Q-wave myocardial infarction. | The American journal of cardiology 20021015 |
| Low-density lipoprotein lowering and atherosclerosis progression: does more mean less? | Circulation 20021015 |
| ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness. | Circulation 20021015 |
| The lower the LDL, the better. | Circulation 20021015 |
| Atorvastatin lowers lipoprotein(a) but not apolipoprotein(a) fragment levels in hypercholesterolemic subjects at high cardiovascular risk. | Atherosclerosis 20021001 |
| Comparing the effects of five different statins on the HDL subpopulation profiles of coronary heart disease patients. | Atherosclerosis 20021001 |
| Intensive statin treatment improves baroreflex sensitivity: another cardioprotective mechanism for statins? | Heart (British Cardiac Society) 20021001 |
| Rhabdomyolysis with concurrent atorvastatin and diltiazem. | The Annals of pharmacotherapy 20021001 |
| Effects of atorvastatin on renal function in patients with chronic renal failure. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20021001 |
| Statin-associated myopathy with normal creatine kinase levels. | Annals of internal medicine 20021001 |
| Summaries for patients. Muscle abnormalities in four patients taking statins to treat unfavorable cholesterol levels. | Annals of internal medicine 20021001 |
| Are early clinical effects of cholesterol lowering mediated through effects on inflammation? | Acta physiologica Scandinavica 20021001 |
| Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects. | The American journal of cardiology 20021001 |
| Effect of atorvastatin on endothelium-dependent vasodilation in postmenopausal women with average serum cholesterol levels. | The American journal of cardiology 20021001 |
| Effect of atorvastatin (80 mg) initiated at the time of coronary artery stent implantation on C-reactive protein and six-month clinical events. | The American journal of cardiology 20021001 |
| Is alternate daily dose of atorvastatin effective in treating patients with hyperlipidemia? The Alternate Day Versus Daily Dosing of Atorvastatin Study (ADDAS). | American heart journal 20021001 |
| Comparison of the effects of atorvastatin or fenofibrate on nonlipid biochemical risk factors and the LDL particle size in subjects with combined hyperlipidemia. | American heart journal 20021001 |
| Increased atherosclerosis in diabetic dyslipidemic swine: protection by atorvastatin involves decreased VLDL triglycerides but minimal effects on the lipoprotein profile. | Journal of lipid research 20021001 |
| Effects of atorvastatin on the HDL subpopulation profile of coronary heart disease patients. | Journal of lipid research 20021001 |
| Statins and omega-3 fatty acids in the treatment of dyslipidemia and coronary heart disease. | Minerva medica 20021001 |
| Effects of atorvastatin on aortic pulse wave velocity in patients with hypertension and hypercholesterolaemia: a preliminary study. | Journal of human hypertension 20021001 |
| Anti-thrombotic effects of atorvastatin--an effect unrelated to lipid lowering. | Journal of cardiovascular pharmacology and therapeutics 20021001 |
| [Stable angina pectoris. PTCA improves symptoms, but not prognosis]. | MMW Fortschritte der Medizin 20020926 |
| Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy. | Circulation 20020924 |
| Avasimibe and atorvastatin synergistically reduce cholesteryl ester content in THP-1 macrophages. | European journal of pharmacology 20020906 |
| Raman spectroscopic investigation of atorvastatin, amlodipine, and both on atherosclerotic plaque development in APOE*3 Leiden transgenic mice. | Atherosclerosis 20020901 |
| Atorvastatin therapy in hypercholesterolemic patients suppresses cellular uptake of oxidized-LDL by differentiating monocytes. | Atherosclerosis 20020901 |
| Induction of lipoprotein lipase gene expression in 3T3-L1 preadipocytes by atorvastatin, a cholesterol- and triglyceride-lowering drug. | Pharmacology 20020901 |
| Long term efficacy and safety of atorvastatin in the treatment of severe type III and combined dyslipidaemia. | Heart (British Cardiac Society) 20020901 |
| Effect of atorvastatin on plasma apoE metabolism in patients with combined hyperlipidemia. | Journal of lipid research 20020901 |
| Multiorgan failure induced by atorvastatin. | The American journal of medicine 20020901 |
| Statins, fibrates, and ocular myasthenia. | Lancet (London, England) 20020831 |
| [Maintaining the full benefit of statins. Therapy start 10 years earlier?]. | MMW Fortschritte der Medizin 20020822 |
| Efficacy and safety of atorvastatin in the treatment of hypercholesterolemia associated with antiretroviral therapy. | Journal of acquired immune deficiency syndromes (1999) 20020815 |
| Atorvastatin attenuates remnant lipoprotein-induced monocyte adhesion to vascular endothelium under flow conditions. | Circulation research 20020809 |
| Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux. | Atherosclerosis 20020801 |
| Effects of short-term atorvastatin treatment on global fibrinolytic capacity, and sL-selectin and sFas levels in hyperlipidemic patients with coronary artery disease. | International journal of cardiology 20020801 |
| Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: role of LOX-1. | The Journal of pharmacology and experimental therapeutics 20020801 |
| Alopecia associated with atorvastatin. | The American journal of medicine 20020801 |
| Regulatory effects of HMG CoA reductase inhibitor and fish oils on apolipoprotein B-100 kinetics in insulin-resistant obese male subjects with dyslipidemia. | Diabetes 20020801 |
| Glucose increases endothelial-dependent superoxide formation in coronary arteries by NAD(P)H oxidase activation: attenuation by the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor atorvastatin. | Diabetes 20020801 |
| Atorvastatin in low-density lipoprotein apheresis-treated patients with homozygous and heterozygous familial hypercholesterolemia. | Metabolism: clinical and experimental 20020801 |
| Reduction of bFGF-induced smooth muscle cell proliferation and endothelin receptor mRNA expression by mevastatin and atorvastatin. | Biochemical pharmacology 20020801 |
| The HMG Co-A reductase inhibitors ('statins') and myotoxic effects. | South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20020801 |
| Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice. | Circulation research 20020726 |
| 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase the binding activity and nuclear level of Oct-1 in mononuclear cells. | European journal of pharmacology 20020719 |
| Short-term effect of atorvastatin (80 mg) on plasma lipids of patients with unstable angina pectoris or non-Q-wave acute myocardial infarction. | The American journal of cardiology 20020715 |
| Long-term treatment with atorvastatin in adolescent males with heterozygous familial hypercholesterolemia. | Atherosclerosis 20020701 |
| Atorvastatin treatment induced peroxisome proliferator-activated receptor alpha expression and decreased plasma nonesterified fatty acids and liver triglyceride in fructose-fed rats. | The Journal of pharmacology and experimental therapeutics 20020701 |
| Acute cholestatic hepatitis after reinitiating treatment with atorvastatin. | Journal of hepatology 20020701 |
| Atorvastatin and micronized fenofibrate alone and in combination in type 2 diabetes with combined hyperlipidemia. | Diabetes care 20020701 |
| Aggressive lipid lowering does not improve endothelial function in type 2 diabetes: the Diabetes Atorvastatin Lipid Intervention (DALI) Study: a randomized, double-blind, placebo-controlled trial. | Diabetes care 20020701 |
| Atorvastatin, diabetic dyslipidemia, and cognitive functioning. | Diabetes care 20020701 |
| Dose-response effects of atorvastatin and simvastatin on high-density lipoprotein cholesterol in hypercholesterolaemic patients: a review of five comparative studies. | International journal of cardiology 20020701 |
| Atorvastatin and thrombogenicity of the carotid atherosclerotic plaque: the ATROCAP study. | Thrombosis and haemostasis 20020701 |
| Use of atorvastatin in hyperlipidemic hypertensive renal transplant recipients. | Pediatric nephrology (Berlin, Germany) 20020701 |
| Comparing the efficacy and safety of atorvastatin and simvastatin in Asians with elevated low-density lipoprotein-cholesterol--a multinational, multicenter, double-blind study. | Journal of the Formosan Medical Association = Taiwan yi zhi 20020701 |
| Effects of atorvastatin treatment on sICAM-1 and plasma nitric oxide levels in hypercholesterolemic subjects. | Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20020701 |
| [Absolutely essential in cardiovascular high risk patients. Statins--more than only anticholesteremic drugs]. | MMW Fortschritte der Medizin 20020627 |
| Atorvastatin decreases vascular endothelial growth factor in patients with coronary artery disease. | Journal of the American College of Cardiology 20020619 |
| Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. | Circulation 20020604 |
| Effect of atorvastatin and bezafibrate on plasma levels of C-reactive protein in combined (mixed) hyperlipidemia. | Atherosclerosis 20020601 |
| Effects of micronized fenofibrate versus atorvastatin in the treatment of dyslipidaemic patients with low plasma HDL-cholesterol levels: a 12-week randomized trial. | Journal of internal medicine 20020601 |
| Effect of atorvastatin and fish oil on plasma high-sensitivity C-reactive protein concentrations in individuals with visceral obesity. | Clinical chemistry 20020601 |
| Comparison of extended-release niacin and atorvastatin monotherapies and combination treatment of the atherogenic lipid profile in diabetes mellitus. | The American journal of cardiology 20020601 |
| Risk of adverse events with concomitant use of atorvastatin or simvastatin and glucose-lowering drugs (thiazolidinediones, metformin, sulfonylurea, insulin, and acarbose). | The American journal of cardiology 20020601 |
| High doses of atorvastatin do not affect activity of prothrombinase in patients with acute coronary syndromes. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20020601 |
| Potential neurological value of statins increases. | Nature medicine 20020601 |
| Allelic polymorphism -491A/T in apo E gene modulates the lipid-lowering response in combined hyperlipidemia treatment. | European journal of clinical investigation 20020601 |
| Factorial study of the effects of atorvastatin and fish oil on dyslipidaemia in visceral obesity. | European journal of clinical investigation 20020601 |
| Efficacy of atorvastatin in treating high risk patients to reach low density lipoprotein-cholesterol goals: the Treat to Target (TTT-Israel) Study. | The Israel Medical Association journal : IMAJ 20020601 |
| Routine statin treatment after acute coronary syndromes? | American heart journal 20020601 |
| Efficacy and safety of ezetimibe coadministered with atorvastatin or simvastatin in patients with homozygous familial hypercholesterolemia. | Circulation 20020528 |
| Comparison of effect of intensive lipid lowering with atorvastatin to less intensive lowering with lovastatin on C-reactive protein in patients with stable angina pectoris and inducible myocardial ischemia. | The American journal of cardiology 20020515 |
| Effects of atorvastatin on postprandial plasma lipoproteins in postinfarction patients with combined hyperlipidaemia. | Atherosclerosis 20020501 |
| Reduced expression of endothelial cell markers after 1 year treatment with simvastatin and atorvastatin in patients with coronary heart disease. | Atherosclerosis 20020501 |
| Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonization. | Drug metabolism and disposition: the biological fate of chemicals 20020501 |
| Effect of atorvastatin on chylomicron remnant metabolism in visceral obesity: a study employing a new stable isotope breath test. | Journal of lipid research 20020501 |
| Atorvastatin inhibition of cytokine-inducible nitric oxide synthase expression in native endothelial cells in situ. | British journal of pharmacology 20020501 |
| Mechanism of action of a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor on apolipoprotein B-100 kinetics in visceral obesity. | The Journal of clinical endocrinology and metabolism 20020501 |
| Intensive lipid lowering by statin therapy does not improve vasoreactivity in patients with type 2 diabetes. | Arteriosclerosis, thrombosis, and vascular biology 20020501 |
| Is C-reactive protein an additional, surrogate end-point for statin treatment? | European heart journal 20020501 |
| Short-term effects of atorvastatin on C-reactive protein. | European heart journal 20020501 |
| Increased superoxide anion production by platelets in hypercholesterolemic patients. | Thrombosis and haemostasis 20020501 |
| Pharmacological interactions of statins. | Atherosclerosis. Supplements 20020501 |
| Issues concerning the monitoring of statin therapy in hypercholesterolemic subjects with high plasma lipoprotein(a) levels. | Lipids 20020501 |
| High doses of atorvastatin and simvastatin induce key enzymes involved in VLDL production. | Lipids 20020501 |
| Rhabdomyolysis with acute renal failure probably related to the interaction of atorvastatin and delavirdine. | The American journal of medicine 20020415 |
| Interaction between ritonavir and statins. | The American journal of medicine 20020415 |
| Double-edged role of statins in angiogenesis signaling. | Circulation research 20020405 |
| Chronic urticaria to atorvastatin. | Allergy 20020401 |
| Design of the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT)-TIMI 22 trial. | The American journal of cardiology 20020401 |
| Treatment with atorvastatin ameliorates hepatic very-low-density lipoprotein overproduction in an animal model of insulin resistance, the fructose-fed Syrian golden hamster: evidence that reduced hypertriglyceridemia is accompanied by improved hepatic insulin sensitivity. | Metabolism: clinical and experimental 20020401 |
| A placebo-controlled trial examining atorvastatin in dyslipidemic patients undergoing CAPD. | Kidney international 20020401 |
| A study of the interaction potential of azithromycin and clarithromycin with atorvastatin in healthy volunteers. | Journal of clinical pharmacology 20020401 |
| Effects of simvastatin and atorvastatin on inflammation markers in plasma. | Journal of internal medicine 20020401 |
| Weekly versus daily dosing of atorvastatin. | The Journal of family practice 20020401 |
| Comparison of different treatment regimens in a case of homozygous familial hypercholesterolemia. | Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis 20020401 |
| The early effect of lipid-lowering treatment on carotid and femoral intima media thickness (IMT). | European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 20020401 |
| A preliminary evaluation of neural network analysis for pharmacodynamic modeling of the dosing of the hydroxymethylglutaryl coenzyme A-reductase inhibitors simvastatin and atorvastatin. | Clinical therapeutics 20020401 |
| Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension. | Journal of the American College of Cardiology 20020320 |
| Comparison of efficacy and safety of atorvastatin and simvastatin in patients with dyslipidemia with and without coronary heart disease. | The American journal of cardiology 20020315 |
| Compliance among pharmacies in California with a prescription-drug discount program for Medicare beneficiaries. | The New England journal of medicine 20020314 |
| Pharmacokinetic interactions between protease inhibitors and statins in HIV seronegative volunteers: ACTG Study A5047. | AIDS (London, England) 20020308 |
| Managing dyslipidemia in the high-risk patient. | The American journal of cardiology 20020307 |
| 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation. | Atherosclerosis 20020301 |
| Cholesterol esters regulate apoB48 secretion in CaCo2 cells. | Atherosclerosis 20020301 |
| Atorvastatin treatment beneficially alters the lipoprotein profile and increases low-density lipoprotein particle diameter in patients with combined dyslipidemia and impaired fasting glucose/type 2 diabetes. | Metabolism: clinical and experimental 20020301 |
| Atorvastatin-induced reversible positive antinuclear antibodies. | The American journal of medicine 20020301 |
| Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetes. | Diabetic medicine : a journal of the British Diabetic Association 20020301 |
| Impact of HMG CoA reductase inhibition on small GTPases in the heart. | Cardiovascular research 20020301 |
| Efficacy and safety of atorvastatin 10 mg every other day in hypercholesterolemia. | Journal of the Medical Association of Thailand = Chotmaihet thangphaet 20020301 |
| Reduction in hepatic non-esterified fatty acid concentration after long-term treatment with atorvastatin lowers hepatic triglyceride synthesis and its secretion in sucrose-fed rats. | Biochimica et biophysica acta 20020227 |
| Effects of atorvastatin on oxidized low-density lipoprotein, low-density lipoprotein subfraction distribution, and remnant lipoprotein in patients with mixed hyperlipoproteinemia. | The American journal of cardiology 20020215 |
| Improved fibrinolysis after 1-year treatment with HMG CoA reductase inhibitors in patients with coronary heart disease. | Thrombosis research 20020215 |
| Statins have biphasic effects on angiogenesis. | Circulation 20020212 |
| Comparison of effects on low-density lipoprotein cholesterol and high-density lipoprotein cholesterol with rosuvastatin versus atorvastatin in patients with type IIa or IIb hypercholesterolemia. | The American journal of cardiology 20020201 |
| Pharmacokinetic and pharmacodynamic assessments of HMG-CoA reductase inhibitors when coadministered with everolimus. | Journal of clinical pharmacology 20020201 |
| Safety and efficacy of atorvastatin in heart transplant recipients. | The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 20020201 |
| Cellular antioxidant effects of atorvastatin in vitro and in vivo. | Arteriosclerosis, thrombosis, and vascular biology 20020201 |
| Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type IIA and type IIB. | Arteriosclerosis, thrombosis, and vascular biology 20020201 |
| Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus. | The Journal of clinical endocrinology and metabolism 20020201 |
| Effect of tablet splitting on serum cholesterol concentrations. | The Annals of pharmacotherapy 20020201 |
| Effectiveness of low doses of simvastatin versus atorvastatin: resolving conflicting evidence. | Clinical therapeutics 20020201 |
| The effects of lipid-lowering therapy on low-density lipoprotein auto-antibodies: relationship with low-density lipoprotein oxidation and plasma total antioxidant status. | Coronary artery disease 20020201 |
| Atorvastatin activates PPAR-gamma and attenuates the inflammatory response in human monocytes. | Inflammation research : official journal of the European Histamine Research Society ... [et al.] 20020201 |
| Lipid-lowering effect of atorvastatin in heart transplantation. | Transplantation proceedings 20020201 |
| Atorvastatin versus four statin-fibrate combinations in patients with familial combined hyperlipidaemia. | Journal of cardiovascular risk 20020201 |
| Atorvastatin increases HDL cholesterol in hypercholesterolemic patients. Evidence of a relationship with baseline HDL cholesterol. | Nutrition, metabolism, and cardiovascular diseases : NMCD 20020201 |
| Long-term (18-month) efficacy of atorvastatin therapy in type 2 diabetics at cardiovascular risk. | Nutrition, metabolism, and cardiovascular diseases : NMCD 20020201 |
| Usefulness of Orlistat in the treatment of severe hypertriglyceridemia. | The American journal of cardiology 20020115 |
| Atorvastatin reduces the expression of cyclooxygenase-2 in a rabbit model of atherosclerosis and in cultured vascular smooth muscle cells. | Atherosclerosis 20020101 |
| The case for early statin therapy in acute coronary syndromes. | Cardiology in review 20020101 |
| The effects of three different LDL-apheresis methods on the plasma concentrations of E-selectin, VCAM-1, and ICAM-1. | Journal of clinical apheresis 20020101 |
| [Significance of the follow-up of patients with ischemic cardiopathy in the treatment with atorvastatin as secondary prevention. Pilot study]. | Anales de medicina interna (Madrid, Spain : 1984) 20020101 |
| Combined treatment with fibrates and small doses of atorvastatin in patients with mixed hyperlipidemia. | Current medical research and opinion 20020101 |
| Atorvastatin treatment prevents alterations in coronary smooth muscle nuclear Ca2+ signaling in diabetic dyslipidemia. | Journal of vascular research 20020101 |
| The effect of atorvastatin on hemorheological parameters in rabbits fed on a normal diet. | Clinical hemorheology and microcirculation 20020101 |
| [Myopathy due to statins, a dose-dependent effect, and of what kind?]. | Atencion primaria 20020101 |
| The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. | Current medical research and opinion 20020101 |
| Treatment with atorvastatin to the National Cholesterol Educational Program goal versus 'usual' care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. | Current medical research and opinion 20020101 |
| Statin therapy for Alzheimer's disease: will it work? | Journal of molecular neuroscience : MN 20020101 |
| The effect of statins on mRNA levels of genes related to inflammation, coagulation, and vascular constriction in HUVEC. Human umbilical vein endothelial cells. | Journal of atherosclerosis and thrombosis 20020101 |
| Atorvastatin reduces plasma levels of factor VII activity and factor VII antigen in patients with hyperlipidemia. | Journal of atherosclerosis and thrombosis 20020101 |
| Statins and renal function. | Angiology 20020101 |
| Benefits and menaces related to the use of statins in patients after renal transplantation. | Annals of transplantation 20020101 |
| [Effects of atorvastatin on ischemic acute renal failure in aging rats]. | Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia 20020101 |
| The top 50 prescription medications dispensed in pharmacies in 2001. | General dentistry 20020101 |
| [Some new data concerning effectiveness of amlodipine, atorvastatine and quinaprile for heart diseases]. | Kardiologiia 20020101 |
| [Effect of atorvastatin on endothelial function in patients with familial hypercholesterolemia]. | Kardiologiia 20020101 |
| The discovery and development of atorvastatin, a potent novel hypolipidemic agent. | Progress in medicinal chemistry 20020101 |
| ASCOT--trial hypertensives with normal to elevated cholesterol levels. | Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners 20020101 |
| Attaining United Kingdom-European Atherosclerosis Society low-density lipoprotein cholesterol guideline target values in the Greek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study. | Current medical research and opinion 20020101 |
| The eye lens evaluation of the atorvastatin-treated white rat. | Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 20020101 |
| The influence of Atorvastatin on ultrastructure of rat pancreatic exocrine cells in the course of experimental intoxication with ethanol. | Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 20020101 |
| Effects of Atorvastatin on some inflammatory parameters in severe primary hypercholesterolemia. | Romanian journal of internal medicine = Revue roumaine de medecine interne 20020101 |
| HMG-CoA reductase inhibitors reduce adhesion of human monocytes to endothelial cells. | Biochemical and biophysical research communications 20011214 |
| Inhibition of LOX-1 by statins may relate to upregulation of eNOS. | Biochemical and biophysical research communications 20011214 |
| Effect of atorvastatin treatment on lipoprotein lipase mass in the pre-heparin plasma in Japanese hyperlipidemic subjects. | Clinica chimica acta; international journal of clinical chemistry 20011201 |
| Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men. | The American journal of cardiology 20011201 |
| Effect of atorvastatin, simvastatin, and lovastatin on the metabolism of cholesterol and triacylglycerides in HepG2 cells. | Biochemical pharmacology 20011201 |
| Atorvastatin improves blood rheology in patients with familial hypercholesterolemia (FH) on long-term LDL apheresis treatment. | Atherosclerosis 20011201 |
| Renal cortical cholesterol accumulation is an integral component of the systemic stress response. | Kidney international 20011201 |
| Effect of statin therapy on remnant lipoprotein cholesterol levels in patients with combined hyperlipidemia. | Arteriosclerosis, thrombosis, and vascular biology 20011201 |
| Effect of diet and treatment with statins on platelet-dependent thrombin generation in hypercholesterolemic subjects. | Nutrition, metabolism, and cardiovascular diseases : NMCD 20011201 |
| Low-density-lipoprotein cholesterol goals for patients with coronary disease: treating between the lines. | Circulation 20011127 |
| Squalene synthase inhibitors reduce plasma triglyceride through a low-density lipoprotein receptor-independent mechanism. | European journal of pharmacology 20011123 |
| Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins. | Circulation research 20011109 |
| Is aggressive lipid-lowering therapy preferable to angioplasty in stable coronary artery disease? | The Medical journal of Australia 20011105 |
| Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial--FAT). | Cardiovascular research 20011101 |
| HMG-CoA reductase inhibitors reduce vascular monocyte chemotactic protein-1 expression in early lesions from hypercholesterolemic swine independently of their effect on plasma cholesterol levels. | Atherosclerosis 20011101 |
| Effect of atorvastatin on intracellular calcium uptake in coronary smooth muscle cells from diabetic pigs fed an atherogenic diet. | Atherosclerosis 20011101 |
| Acute statin treatment in reducing risk after acute coronary syndrome: the MIRACL (Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering) Trial. | Current opinion in cardiology 20011101 |
| 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors upregulate inducible NO synthase expression and activity in vascular smooth muscle cells. | Hypertension (Dallas, Tex. : 1979) 20011101 |
| Treatment with atorvastatin improves small artery compliance in patients with severe hypercholesterolemia. | American journal of hypertension 20011101 |
| [60% of patients with coronary disease receive antilipemic drugs. Nevertheless cholesterol often is too high]. | MMW Fortschritte der Medizin 20011101 |
| The use over time of statins in coronary patients in an Italian tertiary referral center. | Italian heart journal : official journal of the Italian Federation of Cardiology 20011101 |
| A randomized, double-blind, placebo-controlled, 8-week study to evaluate the efficacy and safety of once daily atorvastatin (10 mg) in patients with elevated LDL-cholesterol. | Japanese heart journal 20011101 |
| Bilateral pharmacokinetic interaction between cyclosporine A and atorvastatin in renal transplant recipients. | American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20011101 |
| Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis. | Circulation 20011030 |
| Development of tachyphylaxis on statin treatment. | The American journal of cardiology 20011015 |
| What have we learned about the biology of atherosclerosis? The role of inflammation. | The American journal of cardiology 20011011 |
| What is the role of intensive cholesterol lowering in the treatment of acute coronary syndromes? | The American journal of cardiology 20011011 |
| Global risk assessment in the presymptomatic patient. | The American journal of cardiology 20011011 |
| United States Cholesterol Guidelines 2001: expanded scope of intensive low-density lipoprotein-lowering therapy. | The American journal of cardiology 20011011 |
| The use of electron-beam computed tomography as a tool for primary prevention. | The American journal of cardiology 20011011 |
| Cerebrovascular disease and statins: a potential addition to the therapeutic armamentarium for stroke prevention. | The American journal of cardiology 20011011 |
| Insulin resistance syndrome and type 2 diabetes mellitus. | The American journal of cardiology 20011011 |
| Systemic atherosclerosis risk and the mandate for intervention in atherosclerotic peripheral arterial disease. | The American journal of cardiology 20011011 |
| Women and cardiovascular risk. | The American journal of cardiology 20011011 |
| Rationale and design of the St. Francis Heart Study: a randomized clinical trial of atorvastatin plus antioxidants in asymptomatic persons with elevated coronary calcification. | Controlled clinical trials 20011001 |
| A double-blind trial on the effects of atorvastatin on glycemic control in Japanese diabetic patients with hypercholesterolemia. | Clinica chimica acta; international journal of clinical chemistry 20011001 |
| Coadministration of colesevelam hydrochloride with atorvastatin lowers LDL cholesterol additively. | Atherosclerosis 20011001 |
| Raman spectroscopic evaluation of the effects of diet and lipid-lowering therapy on atherosclerotic plaque development in mice. | Arteriosclerosis, thrombosis, and vascular biology 20011001 |
| Effect of statins on bone mineral density and bone histomorphometry in rodents. | Arteriosclerosis, thrombosis, and vascular biology 20011001 |
| Atorvastatin-induced diaphragmatic muscle impairment. | The Annals of pharmacotherapy 20011001 |
| Simvastatin and atorvastatin enhance hypotensive effect of diltiazem in rats. | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20011001 |
| Managed care trends in statin usage. | Managed care (Langhorne, Pa.) 20011001 |
| Effect of atorvastatin on LDL oxidation and antioxidants in normocholesterolemic type 2 diabetic patients. | Clinica chimica acta; international journal of clinical chemistry 20010925 |
| Comparison of the efficacy of atorvastatin versus cerivastatin in primary hypercholesterolemia. | The American journal of cardiology 20010915 |
| Apolipoprotein E genotype affects plasma lipid response to atorvastatin in a gender specific manner. | Atherosclerosis 20010901 |
| Atorvastatin improves endothelial function in renal-transplant recipients. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20010901 |
| Effect of rosuvastatin on low-density lipoprotein cholesterol in patients with hypercholesterolemia. | The American journal of cardiology 20010901 |
| Effect of atorvastatin on serum uric acid levels. | Atherosclerosis 20010901 |
| Short term effect of atorvastatin and vitamin E on serum levels of C3, a sensitive marker of the risk of myocardial infarction in men. | Cardiovascular drugs and therapy 20010901 |
| Achieving and maintaining National Cholesterol Education Program low-density lipoprotein cholesterol goals with five statins. | The American journal of medicine 20010815 |
| Human breath isoprene and its relation to blood cholesterol levels: new measurements and modeling. | Journal of applied physiology (Bethesda, Md. : 1985) 20010801 |
| Effect of niacin and atorvastatin on lipoprotein subclasses in patients with atherogenic dyslipidemia. | The American journal of cardiology 20010801 |
| Heart rate variability after long-term treatment with atorvastatin in hypercholesterolaemic patients with or without coronary artery disease. | Atherosclerosis 20010801 |
| The effect of aggressive versus standard lipid lowering by atorvastatin on diabetic dyslipidemia: the DALI study: a double-blind, randomized, placebo-controlled trial in patients with type 2 diabetes and diabetic dyslipidemia. | Diabetes care 20010801 |
| Effect of atorvastatin on low-density lipoprotein subtypes in patients with different forms of hyperlipoproteinemia and control subjects. | Metabolism: clinical and experimental 20010801 |
| Atorvastatin for acute coronary syndromes. | JAMA 20010801 |
| Atorvastatin for acute coronary syndromes. | JAMA 20010801 |
| The effect of pravastatin and atorvastatin on coenzyme Q10. | American heart journal 20010801 |
| By the way, doctor... My brother takes Mevacor and has been told to take the drug at bedtime. But when I started on Lipitor, my doctor said to take the medication at any time of the day. Why the difference? | Harvard health letter 20010801 |
| Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A-reductase inhibitors (statins). | European journal of clinical pharmacology 20010801 |
| Effects of atorvastatin (and blood pressure lowering comparing amlodipide-based therapy with beta-blocker-based therapy) on serum variables of cholesterol synthesis and absorption, thrombogenicity and on low-density lipoprotein oxidation in vivo. | Journal of human hypertension 20010801 |
| Apheresis technology for prevention and regression of atherosclerosis. | Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis 20010801 |
| Measurement of atherosclerosis progression. | Lancet (London, England) 20010728 |
| Measurement of atherosclerosis progression. | Lancet (London, England) 20010728 |
| Use of intravascular ultrasound to compare effects of different strategies of lipid-lowering therapy on plaque volume and composition in patients with coronary artery disease. | Circulation 20010724 |
| Atorvastatin versus micronized fenofibrate in the treatment of patients with mixed hyperlipoproteinemia. | The American journal of cardiology 20010715 |
| Prolonged inhibition of cholesterol synthesis by atorvastatin inhibits apo B-100 and triglyceride secretion from HepG2 cells. | Atherosclerosis 20010701 |
| Cerivastatin triggers tumor-specific apoptosis with higher efficacy than lovastatin. | Clinical cancer research : an official journal of the American Association for Cancer Research 20010701 |
| The effects of converting from simvastatin to atorvastatin on plasminogen activator inhibitor type-1. | Journal of clinical pharmacology 20010701 |
| Can early treatment with atorvastatin (Lipitor) improve the outcome of patients with acute coronary syndromes? | The Journal of family practice 20010701 |
| Statin therapy and stroke prevention. | Current opinion in cardiology 20010701 |
| Rationale and design for the SARIS trial; effect of statin on atherosclerosis and vascular remodeling assessed with intravascular sonography. Effect of Statin on Atherosclerosis and vascular Remodeling assessed with Intravascular Sonography. | Cardiovascular drugs and therapy 20010701 |
| Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. | Circulation 20010619 |
| Limitation of heart growth in neonatal piglets by simvastatin and atorvastatin: comparison with pravastatin. | American journal of physiology. Heart and circulatory physiology 20010601 |
| Efficacy of atorvastatin in achieving National Cholesterol Education Program low-density lipoprotein targets in women with severe dyslipidemia and cardiovascular disease or risk factors for cardiovascular disease: The Women's Atorvastatin Trial on Cholesterol (WATCH). | American heart journal 20010601 |
| Growth hormone reduces plasma cholesterol in LDL receptor-deficient mice. | FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20010601 |
| Atorvastatin-induced dermatomyositis. | The American journal of medicine 20010601 |
| Effect of atorvastatin on plasminogen activator inhibitor type-1 synthesis in human monocytes/macrophages. | Journal of cardiovascular pharmacology 20010601 |
| HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species. | Hypertension (Dallas, Tex. : 1979) 20010601 |
| Is a mechanical or a metabolic approach superior in the treatment of coronary disease? Results of the atorvastatin versus revascularization (AVERT) trial. | European heart journal 20010601 |
| Effects of low doses of simvastatin and atorvastatin on high-density lipoprotein cholesterol levels in patients with hypercholesterolemia. | Clinical therapeutics 20010601 |
| The effect of atorvastatin on postprandial lipaemia in overweight or obese women homozygous for apo E3. | Acta cardiologica 20010601 |
| HMG-CoA reductase inhibitors (statins) characterized as direct inhibitors of P-glycoprotein. | Pharmaceutical research 20010601 |
| Genetic analysis of digestive physiology using fluorescent phospholipid reporters. | Science (New York, N.Y.) 20010518 |
| Repeated analysis of semen parameters in beagle dogs during a 2-year study with the HMG-CoA reductase inhibitor, atorvastatin. | Toxicological sciences : an official journal of the Society of Toxicology 20010501 |
| Aggressive versus moderate lipid-lowering therapy in postmenopausal women with hypercholesterolemia: Rationale and design of the Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES) trial. | American heart journal 20010501 |
| Atorvastatin. | Expert opinion on pharmacotherapy 20010501 |
| Determinants of variable response to statin treatment in patients with refractory familial hypercholesterolemia. | Arteriosclerosis, thrombosis, and vascular biology 20010501 |
| Statin induced myopathy does not show up in MIBI scintigraphy. | Nuclear medicine communications 20010501 |
| A cost-effectiveness model of alternative statins to achieve target LDL-cholesterol levels. | International journal of clinical practice 20010501 |
| Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels. | Circulation 20010417 |
| Tachyphylaxis in 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. | The American journal of cardiology 20010415 |
| [Prevention in coronary heart disease. Can a CSE inhibitor arrest calcium deposits?]. | MMW Fortschritte der Medizin 20010405 |
| Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. | JAMA 20010404 |
| Lipid-lowering therapy in acute coronary syndromes. | JAMA 20010404 |
| Comparative study of HMG-CoA reductase inhibitors on fibrinogen. | Atherosclerosis 20010401 |
| Linear IgA bullous dermatosis induced by atorvastatin. | Journal of the American Academy of Dermatology 20010401 |
| Chitotriosidase genotype and serum activity in subjects with combined hyperlipidemia: effect of the lipid-lowering agents, atorvastatin and bezafibrate. | Metabolism: clinical and experimental 20010401 |
| Possible short-term amelioration of basilar plaque by high-dose atorvastatin: use of reductase inhibitors for intracranial plaque stabilization. | Journal of neuroimaging : official journal of the American Society of Neuroimaging 20010401 |
| Therapeutic change of HMG-CoA reductase inhibitors in patients with coronary artery disease. | Pharmacotherapy 20010401 |
| The efficacy of atorvastatin in treating patients with hypercholesterolaemia to target LDL-cholesterol goals: the LIPI-GOAL trial. | Acta cardiologica 20010401 |
| Effects of statins on biomarkers of bone metabolism: a randomised trial. | Nutrition, metabolism, and cardiovascular diseases : NMCD 20010401 |
| [Decreasing blood lipids for prevention of coronary heart disease--discussion of the 'permissive LDL level'. Diagnostic imaging facilitates therapeutic decision]. | MMW Fortschritte der Medizin 20010329 |
| Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase. | Molecular pharmacology 20010301 |
| F 12511, a novel ACAT inhibitor, and atorvastatin regulate endogenous hypercholesterolemia in a synergistic manner in New Zealand rabbits fed a casein-enriched diet. | Atherosclerosis 20010301 |
| Comparison of efficacy and safety of atorvastatin (10mg) with simvastatin (10mg) at six weeks. ASSET Investigators. | The American journal of cardiology 20010301 |
| Design and rationale of the ARBITER trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol)--a randomized trial comparing the effects of atorvastatin and pravastatin on carotid artery intima-media thickness. | American heart journal 20010301 |
| Tachyphylaxis and statin drugs. | The American journal of cardiology 20010301 |
| HMG-CoA reductase inhibitors and P-glycoprotein modulation. | British journal of pharmacology 20010301 |
| Statin therapy--what now? | Drug and therapeutics bulletin 20010301 |
| [AVERT [The Atorvastatin versus Revascularization Treatment]]. | Nihon rinsho. Japanese journal of clinical medicine 20010301 |
| [Atorvastatin]. | Nihon rinsho. Japanese journal of clinical medicine 20010301 |
| A clinical focus on statins. | Current opinion in investigational drugs (London, England : 2000) 20010301 |
| Rigorous detection and vigorous treatment of familial hypercholesterolaemia. | Lancet (London, England) 20010224 |
| Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial. | Lancet (London, England) 20010224 |
| Fibrinogen response with simvastatin versus atorvastatin in familial hypercholesterolemia. | The American journal of cardiology 20010201 |
| Effect of atorvastatin 15 mg/week on serum lipids in patients with hypercholesterolemia. | The American journal of cardiology 20010201 |
| Homocysteine and lipid lowering agents. A comparison between atorvastatin and fenofibrate in patients with mixed hyperlipidemia. | Atherosclerosis 20010201 |
| [Statins and unstable angina: MIRACL]. | Annales d'endocrinologie 20010201 |
| Cost-minimization analysis of simvastatin versus atorvastatin for maintenance therapy in patients with coronary or peripheral vascular disease. | Clinical therapeutics 20010201 |
| Treatment of heterozygous familial hypercholesterolemia: atorvastatin vs simvastatin. | Nutrition, metabolism, and cardiovascular diseases : NMCD 20010201 |
| Effects of atorvastatin and omega-3 fatty acids on LDL subfractions and postprandial hyperlipemia in patients with combined hyperlipemia. | Nutrition, metabolism, and cardiovascular diseases : NMCD 20010201 |
| [The role of HDL in the prevention of cardiovascular events]. | Orvosi hetilap 20010121 |
| [Disturbances in cholesterol metabolism]. | Deutsche medizinische Wochenschrift (1946) 20010119 |
| Effective use of statins to prevent coronary heart disease. | American family physician 20010115 |
| Hydroxy-methylglutaryl-coenzyme A reductase inhibition promotes endothelial nitric oxide synthase activation through a decrease in caveolin abundance. | Circulation 20010102 |
| Statin trials in progress: unanswered questions. | Current atherosclerosis reports 20010101 |
| New statins and new doses of older statins. | Current atherosclerosis reports 20010101 |
| Statins in children: what do we know and what do we need to do? | Current atherosclerosis reports 20010101 |
| Effects of atorvastatin versus fenofibrate on lipoprotein profiles, low-density lipoprotein subfraction distribution, and hemorheologic parameters in type 2 diabetes mellitus with mixed hyperlipoproteinemia. | The American journal of cardiology 20010101 |
| Similar effects of atorvastatin, simvastatin and pravastatin on thrombogenic and inflammatory parameters in patients with hypercholesterolemia. | Thrombosis and haemostasis 20010101 |
| Efficacy and drug interactions of the new HMG-CoA reductase inhibitors cerivastatin and atorvastatin in CsA-treated renal transplant recipients. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20010101 |
| [Cost-effectiveness of atorvastatin against simvastatin as hypolipemic treatment in hypercholesterolemic patients in primary care]. | Atencion primaria 20010101 |
| [Lymphocyte infiltration in superficial dermis]. | Annales de dermatologie et de venereologie 20010101 |
| [Atorvastatin (Lipitor): a review of its pharmacological and clinical profile]. | Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20010101 |
| The effect of atorvastatin on serum lipids, lipoprotein(a) and plasma fibrinogen levels in primary dyslipidaemia--a pilot study involving serial sampling. | Current medical research and opinion 20010101 |
| Cost effectiveness of HMG-CoA reductase inhibition in Canada. | The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique 20010101 |
| Cholesterol-lowering effect of NK-104, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, in guinea pig model of hyperlipidemia. | Arzneimittel-Forschung 20010101 |
| Dermographism: an adverse effect of atorvastatin. | The Journal of the American Board of Family Practice 20010101 |
| Atorvastatin prevents glomerulosclerosis and renal endothelial dysfunction in hypercholesterolaemic rabbits. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20010101 |
| Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study. | Indian heart journal 20010101 |
| Statin-stimulated nitric oxide release from endothelium. | Medical science monitor : international medical journal of experimental and clinical research 20010101 |
| A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial. | Current medical research and opinion 20010101 |
| Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin. | Current medical research and opinion 20010101 |
| Synthetic statins: more data on newer lipid-lowering agents. | Current medical research and opinion 20010101 |
| Aggressive LDL-cholesterol lowering with atorvastatin results in regression of atherosclerosis. | Cardiovascular journal of South Africa : official journal for Southern Africa Cardiac Society [and] South African Society of Cardiac Practitioners 20010101 |
| Lipid-lowering medications: what the new guidelines and data mean to women. | The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia 20010101 |
| [Substantiation of increasing doses of statins in clinical practice]. | Terapevticheskii arkhiv 20010101 |
| Atorvastatin: an updated review of its pharmacological properties and use in dyslipidaemia. | Drugs 20010101 |
| Safety of HMG-CoA reductase inhibitors: focus on atorvastatin. | Cardiovascular drugs and therapy 20010101 |
| Using test dose challenges to restore essential therapy in patients with idiopathic anaphylaxis and pharmacophobia: report of a patient with idiopathic anaphylaxis and statin phobia. | Allergy and asthma proceedings 20010101 |
| Can statins reduce the inflammatory response to cardiopulmonary bypass? A clinical study. | Journal of cardiac surgery 20010101 |
| Effect of atorvastatin on serum creatinine levels. | Current medical research and opinion 20010101 |
| Atorvastatin plus pravastatin for the treatment of heterozygous familial hypercholesterolaemia--a pilot study. | Current medical research and opinion 20010101 |
| If LDL-C is the answer...what was the question? What do the data really show? | Heart disease (Hagerstown, Md.) 20010101 |
| Down-regulation of uncoupling protein-3 and -2 by thiazolidinediones in C2C12 myotubes. | FEBS letters 20001027 |
| Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter. | Pharmaceutical research 20000201 |
| Atorvastatin and simvastatin have distinct effects on hydroxy methylglutaryl-CoA reductase activity and mRNA abundance in the guinea pig. | Lipids 19991201 |
| Atorvastatin-induced cholestatic hepatitis in a young woman with systemic lupus erythematosus. Grupo Lupus Virgen de las Nieves. | Archives of internal medicine 19990801 |
| Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin. | Journal of lipid research 19990601 |
| Atorvastatin-induced acute hepatitis with absence of cross-toxicity with simvastatin. | Lancet (London, England) 19990522 |
| Peripheral neuropathy and lipid-lowering therapy. | Southern medical journal 19980701 |
| Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. | The Journal of clinical investigation 19980615 |
| Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation. | Atherosclerosis 19980601 |
| Effect of hypolipidemic drugs on key enzyme activities related to lipid metabolism in normolipidemic rabbits. | European journal of pharmacology 19980424 |
| Hepatic responses to inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase: a comparison of atorvastatin and simvastatin. | Biochimica et biophysica acta 19980123 |